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Staphylococci are opportunistic pathogens responsible for a range of infections. Many 
staphylococcal species are frequently found to be resistant to antibiotics. The 
environment is considered a potential reservoir of genes conferring antibiotic resistance, 
which known as the ‘resistomes’. Monitoring the dissemination of antibiotic resistant 
staphylococci is instrumental to mitigating this global health risk. The overall aim of 
this study was to generate informative data regarding dissemination of antibiotic 
resistance in environmental and public settings. This included looking into the 
distribution, epidemiology characteristic and transfer of oxacillin resistant 
determinant mecA; gaining an insight into genomic features that contribute to 
multiple antibiotic resistance and pathogenicity of one S. epidermidis isolate; and 
understanding the stress responses in mediating oxacillin resistance in S. aureus. 
The use of MALDI-TOF MS allowed identification of staphylococci to species level. 
MALDI-TOF MS data were used for taxonomic analysis of staphylococci, and 
taxonomic data were then combined with isolation sites and antimicrobial susceptibility 
profiles to aid the understanding of dissemination of environmental resistant 
staphylococci.  
The widespread dissemination of antibiotic resistant staphylococci in the environment 
was demonstrated. 12% of staphylococci harboured mecA gene. Community associated 
SCCmec types IV and V were more prevalent than nosocomial associated SCCmec 
types I, II, and III in the environment. 52% of SCCmec were non-typable. In addition, 
14 new environmental S. epidermidis MLST types were reported. 9 antibiotic resistant 
determinants that were responsible for the resistant to 7 antimicrobial classes have been 
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identified in environmental S. epidermidis 118 (G6_2). Proteomic analysis revealed that 
stress responses, including SOS response, stringent response and heat shock response, 
mediate oxacillin resistance in S. aureus. These results demonstrate widespread multiple 
drug resistance in different staphylococcal species isolated from non-healthcare 
environments. This uncontrolled dissemination of multidrug resistant bacteria poses a 
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Chapter 1 Introduction 
1.1 Microbiology of staphylococci 
1.1.1 Morphology 
Staphylococcus spp. are Gram positive cocci, which appear as non-motile, round 
clusters arranged in grape-like formations with diameters ranging from 0.5-1.5 µm 
(Mahon et al., 2014). The Staphylococcus genus is a member of the family 
Staphylococcaceae, which belongs to the order of Bacillales of the class Bacilli, which 
is a part of phylum Firmicutes (Vos et al., 2011). To date, forty-seven species and 23 
sub-species of Staphylococcus spp. have been identified (Becker et al., 2014).   
1.1.2 Biochemical properties 
Based on their ability to produce coagulase, staphylococci species are generally divided 
into two groups:  
1). Coagulase positive, which is almost exclusively represented by S. aureus that can be 
distinguished from other species by its ability to produce coagulase, an enzyme that 
clots the blood plasma. Six species (S. aureus, S. simiae, S. intermedius, S. delphini, S. 
lutrae and S. pseudintermedius) are currently defined as coagulase positive 
staphylococci.  S. aureus is the only human–associated coagulase positive staphylococci 
(Becker et al., 2014). 
2). Coagulase negative, which is represented by a large number of staphylococcal 
species that do not produce the enzyme coagulase. Forty-one species are regarded as 
coagulase negative staphylococci, and 3 species of this group are in fact coagulase 
variable (Taponen et al., 2012, Becker et al., 2014) (Table 1.1).  
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1.1.3 Taxonomy of Staphylococcus spp. 
Recently, Lamers et al., (2012) proposed a refined classification for the Staphylococcus 
genus based on molecular data such as the noncoding 16S rRNA gene and three protein-
encoding genes (dnaJ, rpoB, and tuf). In this four loci based classification species were 
classified into 15 cluster groups, which in turn were categorized into six species groups 
(Auricularis, Hyicus-Intermedius, Epidermidis-Aureus, Saprophyticus, Simulans, and 
Sciuri species groups) based on their phenotypic properties, such as oxidase, novobiocin 







Table 1. 1 Phenotypic and phylogenetic classification of staphylococci species (Becker et al., 2014) 





S. muscae  
S. microti  






























































S. warneri  
S. pasteuri  
Haemolyticus 
S. haemolyticus  
S. devriesei  
S. hominis ssp. hominis 
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 ssp. novobioseticus 




Lugdunensis S. lugdunensis  
Auricularis Auricularis S. auricularis  
Simulans Simulans-Carnosus 




S. condimenti  




S. pettenkoferi  


















S. nepalensis  
Arlettae-Kloosii 
S. arlettae  
S. kloosii  





Oxidase Novobiocin Coagulase Species group Cluster group Species Sub-species 
Positive Resistant Negative Sciuri Sciuri 
 ssp. rodentium 
S. fleirettii  
S. lentus  
S. stepanovicii  
S. vitulinus  
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1.1.4 Lab identification 
Staphylococci are Gram-positive cocci, and they occur singly, in pairs or tetrads (Baron, 
1996). S. aureus is round, with a diameter of 0.8-1.0 μm and forms golden yellow 
colonies (Kearns, 2006, Mahon et al., 2014).  Most coagulase negative staphylococci 
(CoNS) are 1.2-1.4 μm in diameter and mostly appear to be non-pigmented and smooth, 
forming unbroken, shiny, opaque colonies (Becker et al., 2014). Identification of 
Staphylococcal species is very important in recognition of an outbreak and in tracking 
resistance trends (Samb-Ba et al., 2014). Phenotypic, genotypic and proteomic 
approaches may all be applied to aid identification of the bacteria to species (Cherkaoui 
et al., 2010).  
In the clinic, S. aureus is an often encountered pathogen in skin and soft-tissue 
infections (Stryjewski & Chambers, 2008) and adhering to medical devices and 
polymeric surfaces (Zmantar et al., 2010). Therefore, there is a need for rapid assays for 
the detection of S. aureus to aid disease diagnosis and clinical hygiene. In parallel with 
morphological and biochemical identification, molecular identification can be used as a 
relatively rapid, reliable and cost-effective assay. However, identification based on 
DNA and RNA detection and quantification is still time consuming and requires 
numerous consecutive steps (Cherkaoui et al., 2010). Alternatively,  matrix-assisted 
laser desorption/ionization-time-of-flight mass spectrometry (MALDI-TOF MS) can be 
used as a sensitive molecular identification tool, which relies on bacterial proteome 
analysis to determine the species of isolates (Mellmann et al., 2008).  
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1.1.4.1 Conventional identification 
For conventional identification, bacterial species can be determined by phenotypic 
profiles, including Gram-stain results, colony morphologies, growth requirement and 
metabolic activities (Samb-Ba et al., 2014). 
Most of the staphylococci are non-fastidious organisms, and non-selective medium, 
such as nutrient agar, trypticase soy agar, will support their growth (Association et al., 
1912). The culture of most staphylococcal species takes 18 to 24 hours at 35℃ to 37℃ 
to grow (Mahon et al., 2014). In contrast, the growth of small colony variant (SCV) 
takes between 48 and 72 hours at 35℃ to 37℃ (Becker et al., 2014). Growth of 
staphylococci appears as smooth, glistening, entire, opaque and yellow round colonies, 
with a diameter of colonies is 3-6 mm (Mahon et al., 2014). For SCV, the size of the 
colony is 10% of wild-type colonies, and normal growth can be restored under 
favourable conditions (Becker et al., 2014). 
The morphology of staphylococci can be observed by direct microscopic examination, 
and preliminary identification may be achieved by culturing on selective medium. 
Mannitol salt agar (MSA) is a selective medium for staphylococcal species. It contains a 
high concentration of salt (7.5-10% NaCl, w/v), which supports the growth of Gram-
positive bacteria and inhibit the growth of Gram-negative bacteria. The inclusion of 
mannitol and phenol red (pH indicator) in MSA is used to differentiate S. aureus from 
CoNS. Acidification caused by fermentation of mannitol by S. aureus produces yellow 
colonies with yellow zones. In comparison, other staphylococcal species cannot ferment 
mannitol giving small pink colonies with no colour change to the medium (Mahon et al., 
2014). In addition to MSA, Brilliance™ UTI Agar (UTI) is a differential medium for 
the preliminary differentiation of all the main micro-organisms that cause urinary tract 
infections. UTI contains two chromogens, X-Gluc and Red-Gal. X-Gluc is used for 
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identification of enterococci with the presence of β-glucosidase, forming blue 
colonies. Red-Gal is cleaved by the enzyme β-galactosidase produced by E. coli to 
produce pink colonies, and both chromogens can be cleaved by coliform bacteria 
(Enterobacter, Klebsiella) to produce dark blue or purple colonies. In addition, the UTI 
also contains tryptophan, which detects deaminase activity of Proteus, 
Morganella, and Providencia spp., giving brown colonies. In contrast, Staphylococcus 
appears with normal pigmentation on UTI, and water-soluble pigments (pyocyanin and 
pyoverdin) produced by Pseudomonas aeruginosa give blue-green colour on solid agar 
(Mahon et al., 2014, Carricajo et al., 1999). 
In addition to morphology and selective agar identification, the coagulase assay is a 
rapid method for identifying S. aureus. Cell-bound coagulase causes visible 
agglutination of antigen coated latex beads (Mahon et al., 2014). The API
®
 STAPH test 
is a simplified commercial phenotypic identification approach combining a series of 
biochemical tests. After comparing the reads with reference chart, the unknown 
staphylococcal species can be identified (Mahon et al., 2014). Phenotypic tests are a 
significant component of a detailed identification profile; however limitations should be 
recognized. The phenotypic characterizations can be altered based on the culture 
conditions, environmental stresses or gene transfer. Non-accurate identification or 
failure can be caused by common species displaying atypical phenotypes, rare species 
presenting a non-characterized phenotype, and lags in updating the phenotypic database 
(Petti et al., 2005).  
1.1.4.2 16S rRNA gene sequencing 
The 16S rRNA gene is a component of the 30S small subunit of prokaryotic ribosomes 
(Woese & Fox, 1977). The 16S rRNA gene sequencing has been used to study bacterial 
taxonomy since 1970s (Janda & Abbott, 2007), and is a prevalent method in bacterial 
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identification (Clarridge, 2004). The 16S rRNA gene sequencing is used for 
identification as it is: evolutionarily stable; exists in all bacteria; and is informative 
(Janda & Abbott, 2007). The 16S rRNA gene sequencing procedure includes following 
steps: DNA extraction, mixture of PCR components (template DNA, primers, buffer, 
deoxynucleotides), PCR (denaturation, annealing and extension), and subsequent 
sequencing (Mahon et al., 2014). 16S rRNA gene sequencing provides reliable 
identification results, although the preceding steps are time consuming and costly 
(Cherkaoui et al., 2010).  
1.1.4.3 MALDI-TOF MS 
In 1996, a paper detailing the rapid identification of intact microorganisms using 
matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-
TOF MS)  was published in the Nature Biotechnology (Claydon et al., 1996). This 
revolutionary new technique allows automatic, reliable and fast identification without 
prior knowledge of the type of microorganism (Maier et al., 2006). The principle of 
MALDI-TOF MS identification is as followings: the whole cell protein biomarkers are 
analysed by using mass spectrometry (Maier et al., 2006, Ryzhov & Fenselau, 2001), 
and the procedure provides a unique mass spectral fingerprint of microorganism. Then 
the detected mass spectrum pattern is compared with reference patterns in the database 
for identification (Maier et al., 2006). 96 samples can be analysed within one run (Risch 
et al., 2010). 
Sample preparation of MALDI-TOF MS is simple and spectra can be obtained within 
minutes (Maier et al., 2006), and different growth medium compositions have little 
effect in the peak pattern distribution (Maier et al., 2006). Low cost, rapid turnaround 
time and accuracy make MALDI-TOF MS more appealing than conventional and 16S 
rRNA gene sequencing identification (Cherkaoui et al., 2010).  
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1.1.4.3.1 Procedure of MALDI-TOF MS 
MALDI-TOF MS identification is a six-step process. ①  The cellular protein is 
extracted with formic acid and acetonitrile; ② The protein is mixed with a matrix (α-
cyano-4-hydroxycinnamic acid; HCCA);  ③ The matrix together with a sample are 
irradiated by UV light, and subsequently vaporized and ionized; ④ The velocity of 
ionized particles differ according to their mass-to-charge ratio (m/z) values, and lighter 
ions moves faster through the drift space until they reach the detector; ⑤ The detector 
detects the mass of the particles present in the peak; ⑥  Pattern matching of the 
unknown microorganism is accomplished through comparison of the peaks with the 
database. The database is generated with specific peak information by measurement of 
reference bacterial species (Maier et al., 2006, Karas & Krüger, 2003). Bruker biotyper 
3.1 software (Bruker Daltonic, Coventry, UK) is used for analysing mass spectral (Lee 
et al., 2013). The score value generated by biotyper 3.1 (Bruker Daltonic, Coventry, UK) 
is determined by three components: ① the matches of the unknown spectrum with the 
reference spectrum, ② the matches of the reference spectrum against the unknown 
spectrum, ③ the intensities of the matched peaks. Score 0 (no match) to 1.000 (perfect 
match) is firstly generated, and then convert into a log score (0 to 3). The reliability of  
the identification is based on log score also known as score value: high confidence (log 
score ≥ 1.7), and incorrect (log score < 1.7) (Cherkaoui et al., 2010). 
1.1.4.3.2 Reproducibility of MALDI-TOF MS 
Reproducibility refers to the similarity of the replicate spectra of the same strain, and it 
is used to assess reliability and efficacy of the sample preparation process (Majcherczyk 
et al., 2006). Minor differences in MALDI-TOF MS profiles may result in 
misidentification of closely related strains; hence, it is of great important to assess 
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reproducibility of MALDI-TOF MS in identifying bacteria to strain level (Majcherczyk 
et al., 2006).  
Automated data acquisition of MALDI-TOF MS present higher reproducibility than 
manual data acquisition as the automated method is more objective than a human 
operator (Schumaker et al., 2012). Even though few studies applied on the 
reproducibility of MALDI-TOF MS, it is necessary to measure and quantify the 
reproducibility to enable reproducibility located on a proper threshold to make sure the 
reliability of identification at species level (Schumaker et al., 2012).  
1.1.4.4 Taxonomic classification  
16S rRNA gene sequencing can be used for taxonomic classification and phylogenetic 
tree analysis (Takahashi et al., 1999, Grundmann et al., 2002, Zhang et al., 2006, 
Jørgensen et al., 2005). MALDI-TOF MS, as a new powerful tool for rapid and accurate 
identification of wide range microorganisms, has also been demonstrated to be a 
promising tool to taxonomically classify microbial species (Maier et al., 2006).  
1.1.4.4.1 Phylogenetic relationship based on 16S rRNA gene 
Comparison of 16S rRNA gene sequence variation is a classical method in determining 
phylogenetic relationship of bacteria, and it has been widely accepted and used in 
research and reference labs (Weisburg et al., 1991). Phylogenetic trees are important 
because they can be used  to assess evolutionary distance and relationships between 
bacteria (Ludwig & Schleifer, 1994). Maximum likelihood methods and Pearson 
correlation methods are used to build phylogenetic tree (Ludwig & Schleifer, 1994). 
1.1.4.4.2 Taxonomic relationship based upon MALDI-TOF MS profiles  
A family tree, which is similar to 16S rRNA gene sequencing based phylogenetic tree, 
can be built based on MALDI-TOF MS profile. The family tree can be used to elucidate 
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the taxonomic relationships between staphylococcal species (Maier et al., 2006).  Since 
the ribosomal protein has been proven to be stable and abundant in bacteria, the pattern 
of ribosomal protein observed by MALDI-TOF MS can reflect ribosomal DNA 
sequencing (Maier et al., 2006, Hotta et al., 2010). 
1.1.4.4.3 Bionumeric 
BioNumerics 7.5 (Applied Maths, Belgium) was released in 1996, is a platform for the 
management, storage and statistical analysis of all types of biological data, including 
sequences, Pulsed-field gel electrophoresis (PFGE) patterns, and spectra. In addition, 
BioNumerics 7.5 (Applied Maths, Belgium) can build dendrograms for any selected 
experiments， such as sequences and MALDI-TOF MS profile. With a majority of 
similarity and distance coefficients and clustering methods provided by BioNumerics 
7.5 (Applied Maths, Belgium), the most appropriate clustering for all data types and 
clustering purposes can be achieved. BioNumerics 7.5 (Applied Maths, Belgium) can 
handle up to 20000 entries, and provide powerful and efficient interpreting tools, 
including two-way zoom-sliders, swapping and abridging of branches, rerooting of trees, 
displaying data in various modes, and assigning colours or symbols to groups. In 
addition, it can add entries or delete entries from large clustering without affecting other 
entries (http://www.applied-maths.com/).  
1.1.5 Molecular characterization  
Diverse genotypes of S. aureus have been characterized, however, coagulase negative 
staphylococci have not been studied to the same extent (Becker et al., 2014). Different 
molecular and genomic methods, including staphylococcal cassette chromosome mec 
(SCCmec), multi-locus sequence typing (MLST), pulsed-field gel electrophoresis 
(PFGE) and whole genome sequencing (WGS) can be used for accurate identification of 
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clonal diversity of staphylococcal species (Leonard & Markey, 2008). However, single 
locus DNA-sequencing of the repeat region of the staphylococcal protein A gene (spa) 
analysis can be limited only to S. aureus (Leonard & Markey, 2008).  
1.1.5.1 SCCmec 
Staphylococcal cassette chromosome mec (SCCmec) is an important feature to define 
the clonal diversity in methicillin resistant staphylococci (Becker et al., 2014). The mec 
complex and the ccr complex are two essential components of SCCmec (Ito et al., 2003). 
The mec complex contains the mecA gene that encodes methicillin resistant penicillin 
binding protein 2a, and regulatory gene mecI, mecR1 and IS431 (Ito et al., 2003). The 
second essential region is the ccr complex, composed of two sites specific recombinase 
genes ccrA and ccrB, which are responsible for the mobility of SCCmec (Ito et al., 
2003).  SCCmec types are determined by varied combination of the ccr and the mec 
complex (Ito et al., 2003). 
Until now, the mec complex has been assigned into 6 classes according to their 
structures (Table 1.2) (IWG-SCC, 2009), and 8 ccr types have been assigned (IWG-
SCC, 2009) (Table 1.3). The rest component of SCCmec is a junkyard region, of which 
genes may involve in the non-β-lactam antibiotic resistance and heavy metal resistance 
(Ito et al., 2003). 
 
Table 1. 2 Structure of mec complex (IWG-SCC, 2009) 
mec complex Structure 
Class A  IS431–mecA–mecR1–mecI 
Class B IS431–mecA–mecR1–IS1272 
Class C1 IS431–mecA–mecR1–IS431 (two IS431s were in the same direction) 
Class C2 IS431–mecA–mecR1–IS431(two IS431s were in the opposite direction) 
Class D IS431–mecA–mecR1 




Table 1. 3 Structure of ccr complex (IWG-SCC, 2009) 
ccr complex ccr gene 
Type 1 A1B1 
Type 2 A2B2 
Type 3 A3B3 
Type4 A4B4 
Type 5 C1 
Type 6 A5B3 
Type 7 A1B6 
Type 8 A1B3 
 
SCCmec has been classified into 11 allotypes based on the combination of mec complex 
and ccr complex, and can be further classified into subtypes according to the differences 
in junkyard region (IWG-SCC, 2009) (Table 1.4). In addition, the diversity of SCCmec 
types are also contributed by lack of mec complex, ccr complex or both ccr and mec 
complex (Katayama et al., 2003, Harrison et al., 2013, Shore & Coleman, 2013).  
Table 1. 4 Currently identified SCCmec types in S.aureus strains 
SCCmec types ccr complex mec complex 
I 1(A1B1) B 
II 2(A2B2) A 
III 3(A3B3) A 
IV 2(A2B2) B 
V 5(C1) C2 
VI 4(A4B4) B 
VII 5(C1) C1 
VIII 4(A4B4) A 
IX 1(A1B1) C2 
X 7(A1B6) C1 
XI 8(A1B3) E 
 
Two SCCmec typing methods have been used: the first is introduced by Zhang et al., 
(2005), and the second one is reported by Kondo et al., (2007). According to Kondo et 
al., (2007), SCCmec types are determined by the combination of the type of ccr 
complex and class of mec complex. With this method, SCCmec type I, II, III, IV, V, VI, 
VIII and IX can be determined.  For Zhang’s method, SCCmec type I, II, III, V and IVa, 
IVb, IVc and IVd can be identified directly from PCR products (Zhang et al., 2005).  
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It is reported that SCCmec type I, II and III are healthcare associated types, and 
SCCmec type II and III are responsible for multiple non-β-lactam antibiotic resistance 
of S. aureus (Rybak & LaPlante, 2005). Meanwhile, SCCmec type IV and V is more 
associated with community isolated S. aureus (Rybak & LaPlante, 2005, Monecke et al., 
2014). 
1.1.5.2 MLST 
Multi-locus sequence typing (MLST) is a highly discriminatory method for genotypic 
typing of staphylococcal species, and is excellent for exploring long-term 
epidemiologically unrelated isolates (Enright et al., 2000). Currently, MLST can be 
used for S. aureus and S. epidermidis typing.  Seven housekeeping genes, chosen for 
MLST, are assigned as distinct alleles, and each allele is a partially conserved ribosomal 
gene.  Seven allele sequences are transferred into allele numbers via the MLST database 
(Enright et al., 2000, Widerström et al., 2012) (http://www.mlst.net/).  Afterwards, a 
sequence type (ST) can be assigned by combination of seven alleles. Identical ST is 
regarded as belonging to same lineage, and non-matching ST is considered to be of 
unknown type. For unknown ST type, a new ST type will be assigned (Strommenger et 
al., 2008). 
1.1.5.3 PFGE 
Pulse-field gel electrophoresis (PFGE) is a powerful epidemiological typing method, 
and is well known to differentiate genetic variation of related isolates (Strommenger et 
al., 2008). PFGE has been applied in clinical microbiology to determine the relatedness 
of bacteria from epidemic incidence (King, 2006). In United States, PFGE has been 
proven to be a discriminating way to monitoring the spread of ORSA (McDougal et al., 
2003). PFGE can provide the fingerprint of the genome, and the fingerprint reflects the 
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differences in composition of genetic background (Sanches et al., 1995). Therefore 
PFGE can differentiate phenotypically closely related bacteria (On & Harrington, 2001).  
PFGE is an umbrella term for the alternating of an electric field in more than one 
direction through a solid matrix to achieve the separation of fragments (Woodford & 
Johnson, 1998). PFGE involves embedding organisms in low gelling temperature 
agarose, lysing the cell in situ, digesting the DNA molecule with a restriction enzyme; 
transferring the prepared low gelling temperature agarose gel into the wells of agarose 
gel (Woodford & Johnson, 1998). Restriction enzyme digested fragments are then 
separated by CHEF Mapper® which changes the direction of current into predetermined 
pattern (Tenover et al., 1995). The restriction enzyme for digestion of S. aureus and 
coagulase negative staphylococci is SmaI, and the numbers of restriction fragments are 
approximately 15-20 pieces. However, the size of fragments is quite different, for S. 
aureus is 10-700 kb, and for coagulase negative staphylococci is 5-400 kb (Tenover et 
al., 1995). Because of varied fragments, S. aureus and coagulase negative staphylococci 
can be differentiated by PFGE patterns. PFGE has been proved to be an accurate tool in 
staphylococcal epidemiological studies; however, for comparison of epidemiologically 
unrelated staphylococci, MLST is more useful (Jørgensen et al., 2005). Therefore, it is 
recommended to combine MLST and PFGE when characterizing bacteria population 
(Jørgensen et al., 2005). 
1.1.5.4 WGS 
More precise epidemiology typing can be achieved by using the whole genome 
sequencing. This analysis for monitoring the outbreak of methicillin-resistant 
Staphylococcus aureus (MRSA) in clinical settings has been widely used (Harris et al., 
2013). Comparative analysis of whole genome sequences can provide an insight into 
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evolution of virulence and antibiotic resistance, transmission and pathogenic diversity 
(Gill et al., 2005, Harris et al., 2013, Zhang et al., 2003).  
1.2 Epidemiology of staphylococci 
1.2.1 Ecological niches of staphylococci  
Diverse microbial populations constitute the human microbiome. Among these, 
staphylococci are known to be associated with the skin and mucous membranes (Baron, 
1996).   
1.2.1.1 S. aureus 
S. aureus is predominantly found in the nasal passage and axillae (Kloos & Bannerman, 
1994). 20% of humans are persistent carriers of S. aureus, whereas 60% are 
intermediate carriers, and the remaining are non-carriers (Kluytmans et al., 1997). S. 
aureus is capable of long term survival outside of the host body, which is an important 
contributing factor to its dissemination in the environment (Spendlove & Fannin, 1983). 
Depending on the texture of the non-host surfaces and colony size, S. aureus can 
survive from days to months (Neely & Maley, 2000).  
1.2.1.2 S. epidermidis 
S. epidermidis is a normal resident of human skin making almost 90% of the total 
human skin microflora (Baron, 1996, Kloos & Bannerman, 1994, Pfaller & Herwaldt, 
1988). In addition to human skin, S. epidermidis is known to be colonized on medical 
devices, and form biofilms. Moreover, S. epidermidis has been found in food and 
animals such as cats, cattle, dogs, goats, gorillas, horses, pigs, and sheep (Becker et al., 
2014) (Table 1.5).  
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1.2.1.3 Other staphylococci 
The main habitat of S. auricularis is external ear of human (Kloos & Schleifer, 1983) 
(Table 1.5). S. capitis is found on the forehead and scalp region of humans, and also 
found in animals such as cats, dogs, horses (Kloos & Schleifer, 1975) (Table 1.5). S. 
caprae is found on skin, anterior nares of human and animals such as goats 
(Vandenesch et al., 1995) (Table 1.5). 
S. hominis and S. haemolyticus are widely distributed in the human body, including 
head, axillae, arms, legs, pubic, and inguinal regions.  In addition, they can also be 
found in milk, fermented food and domestic animals such as cats, dogs, goats, and pigs 
(Palazzo et al., 2008) (Table 1.5).  
S. pettenkoferi and S. lugdunensis mainly colonize the human skin. S. lugdunensis can 
also be found in animals such as cats, and dogs, whereas, the distribution of S. 
pettenkoferi in the environment has not been clarified  (Becker et al., 2014; Trülzsch et 
al., 2007) (Table 1.5). 
S. saprophyticus colonize rectum and genitourinary tract, and it is the second only to E. 
coli in its association with urinary tract infections (UTI) (Becker et al., 2014, Pfaller & 
Herwaldt, 1988). In addition, S. saprophyticus can be isolated from ferment food and 
animals such as cattle, cats, and sheep (Becker et al., 2014) (Table 1.5).  
S. simulans is found on the human skin such as legs, arms heads and in the urethra of 
healthy woman (Otto, 2009). Moreover, it can also be found in animals such as cattle, 
horses and sheep (Becker et al., 2014) (Table 1.5). 
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S. warneri, S. sciuri, and S. cohnii are found on human skin and animals (Pfaller & 
Herwaldt, 1988, Grice & Segre, 2011); meanwhile, S. warneri is also known to colonize 
on fermented foods (Pfaller & Herwaldt, 1988)  (Table 1.5). 
S. equorum, S. pasteuri and S. xylosus are associated with animal and fermented food, 
such as milk, cheese, and sausage (Becker et al., 2014). S. equorum is frequently 
isolated from cattle, goats, horses, and sheep, while S. pasteuri is more associated with 
pigs, and S. xylosus is isolated from cats, clams, goats, horses, insectivores, lower 
primates, rodents, and sheep (Becker et al., 2014) (Table 1.5). 
S. simiae has been isolated from South American squirrel monkeys over a decade ago 
(Pantucek, 2005), and S. arlettae is isolated from animals, such as cattle, goats, pigs, 













Table 1. 5 Colonization site of each staphylococcal species 
Species Colonization sites 
S. arlettae Textile, tannery industrial effluents; Cattle, goats, pigs, poultry, 
sheep 
S. aureus Human nasal passage,  axillae, anterior nares 
S. auricularis Human external ear 
S. capitis Human forehead, scalp; Cats, dogs, horses 
S. caprae Human skin, anterior nares; Goat 
S. cohnii Human skin; Dogs, goats, poultry 
S. epidermidis Human skin, mucous membranes of the nasopharynx; Fermented 
sausages; Cats, cattle, dogs, goats, gorillas, horses, pigs, sheep 
S. equorum  Fermented food; Cattle, goats, horses, sheep 
S. haemolyticus Human skin; Milk, fermented food; Cats, cattle, dogs, horses, goats, 
pigs, sheep 
S. hominis Human skin; Goat milk, fermented food; Cats, dogs, goats, pigs, 
sheep  
S. lugdunensis Human skin; Cats, chinchillas, dogs, goats, guinea pigs 
S. pasteuri Fermented sausage; Pigs 
S. pettenkoferi Human skin 
S. saprophyticus Human skin; Fermented food; Horses, goats, sheep, cats, 
S. sciuri Human skin; Cattle, dolphins 
S. simiae Squirrel monkeys 
S. simulans Human skin; Cattle, horses, sheep 
S. warneri Human skin; Fermented food; Dogs, cats, goats, horses, insectivores, 
monkeys, pigs, prosimians, rodents, sheep 
S. xylosus Human skin; Fermented food; Cats, clams, goats, horses, 
insectivores, lower  primates, rodents, sheep 
 
1.2.2 Hospital associated staphylococci  
S. aureus was defined as a pathogen in 1880, and its virulence was demonstrated in 
1941 (Archer, 1998). The first clinical methicillin-resistant S. aureus (MRSA) infection 
was reported in United Kingdom in 1961. By 1968, MRSA infection cases have been 
described all over the world (Huang et al., 2006). Now, S. aureus is a virulent pathogen 
which is the most common causes of nosocomial infection (Archer, 1998).  
S. aureus is an opportunistic pathogen, which can cause a range of pathologies from 
minor infection such as skin infections to life threatening diseases such as toxic shock 
syndrome (Parsonnet et al., 2005, Stevens et al., 2010). The toxic syndrome is caused by 
superantigenic toxic shock syndrome toxin-1 (TSST-1) and enterotoxin (Foster, 2005b). 
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In addition to this, S. aureus can cause bacteraemia, endocarditis, metastatic infections, 
and sepsis. It has been shown that bacteraemia and endocarditis are associated with use 
of catheters  (Lowy, 1998), while in contrast; metastatic infection and sepsis develop 
more in minor infections (Lowy, 1998). S. aureus also produces enterotoxins (SEs), 
which can cause food poisoning (Le Loir et al., 2003) (Table 1.6).  
Little is known about S. simiae, however, S. simiae and S. aureus may have evolved 
from a common ancestor, and they are then split by increased pathogenicity of S. aureus 
through horizontal gene transfer (Suzuki et al., 2012)  No S. simiae associated infection 
has been reported (Table 1.6). 
In microbiology labs, nosocomial CoNS have been recognized as culture contaminants 
for a long time, and their pathogenic role has only recently been recognized (Becker et 
al., 2014).   
S. epidermidis is the most common causes of neonate infection, which often includes 
bacteraemia, foreign body-related sepsis (catheter infection, prothetic vascular grafts 
infection, cardiac devices infection), shunt-associated infection (cerebrospinal fluid 
infection), endocarditis, urinary infections,  endophthalmitis and surgical site infection 
(Becker et al., 2014; Huebner & Goldmann, 1999). Most of infections occur in 
populations with either exposure to multiple risk factors (drug abuser, hospitalization) 
or with hypo immunity (Lowy, 1998; Vuong & Otto, 2002) (Table 1.6). 
Other CoNS that can cause clinical infections are the followings: S. auricularis, S. 
capitis, S. caprae, S. cohnii, S. equorum, S. haemolyticus, S. hominis, S. lugdunensis, S. 
pasteuri, S. pettenkoferi, S. saprophyticus, S. sciuri, S. simulans, S. warneri, and S. 
xylosus (Becker et al., 2014).  The infections caused by each CoNS species are shown 
below (Table 1.6). 
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S. hominis and S. haemolyticus are less frequently the causes of clinical infections than 
S. aureus and S. epidermdis, but relatively higher than other CoNS species (Becker et al., 
2014). S. hominis is mainly associated with sepsis (Palazzo et al., 2008; Sorlozano et al., 
2009), while S. haemolyticus is known to be a common cause of sepsis in hospital 
(Pereira et al., 2014) (Table 1.6).  
Infections caused by S. capitis have been reported, but are rarer than those caused by S. 
hominis and S. haemolyticus (Becker et al., 2014). S. capitis is the main cause of 
infections in neonate intensive care unit (Gras-Le Guen et al., 2007) (Table 1.6). 
S. saprophyticus is the common causes of urinary tract infection (Kuroda et al., 2005; 
Widerström et al., 2012). Additionally, it can also cause bacteraemia, endocarditis, 
sepsis and neonate infections (Table 1.6). 
S. lugdunensis is associated with variety of human infections, such as endocarditis 
(Vandenesch et al., 1993), osteomyelitis (Murdoch et al., 1996), soft skin, corneal 
infection (Böcher et al., 2009), bacteraemia, and sepsis (Tee et al., 2003) (Table 1.6). 
S. sciuri and S. auricularis are considered to be nosocomial staphylococcal species. S. 
sciuri is the common cause of endocarditis, wound and tissue infection (Stepanović et 
al., 2001). Whereas, S. auricularis has been reported to be implicated in skin, soft tissue 
and neonate infections (Kloos & Schleifer, 1983) (Table 1.6). 
S. pettenkoferi has been firstly recovered from human clinical specimens as a pathogen 
in 2007 (Trülzsch et al., 2007), and more infections that are caused by S. pettenkoferi 
have been reported recently, such as sepsis, osteomyelitis, and bacteraemia (Hashi et al., 
2015; Loiez et al., 2007; Mihaila et al., 2012; Song et al., 2009) (Table 1.6). 
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S. simulans, as an opportunistic pathogens, may cause bone, joint infection, sepsis and 
osteomyelitis (Kloos & Schleifer, 1975; Males et al., 1985; Widerström et al., 2012) and  
sometimes can be recovered from wounds, lesions and abscesses (Otto, 2009) (Table 
1.6). 
S. warneri is known to cause bacteremia, endocarditis and vertebral osteomyelitis, 
(Center et al., 2003), and S. equorum has been reported to be associated with sepsis and 
corneal infection (Pinna et al., 1999) Moreover, S. caprae may cause endocarditis, bone 
infection, urinary infection and sepsis (Ross et al., 2005; Vandenesch et al., 1995) 
(Table 1.6).  
Few S. cohnii, S. xylosus and S. pasteuri associated infections are reported. S. cohnii has 
been first reported to cause bacteremia in a colon cancer patient in 2003 (Basaglia et al., 
2003),  and a more recent report of S. cohnii associated multiple brain abscesses is in 
2005 (Yamashita et al., 2005). S. xylosus associated sepsis is reported in 2012 
(Giordano et al., 2012) (Table 1.6). The pathogenic role of S. pasteuri has not been 
clarified; however, it is reported that S. pasteuri is responsible for causing sepsis in a 
patient (Savini et al., 2009) (Table 1.6).  
S. arlettae is mainly associated with animals, and there is no clinical case reported for 





 Table 1. 6 Infections caused by staphylococcal species 
Species Infections  
Sepsis Endocarditis Bacteremia Neonate  Soft tissue  Urinary Bone  Skin  Osteomyelitis Endovasculitis  Joint  Corneal Respiratory  Endophthalmitis 
S. aureus √ √ √  √  √ √  √ √  √  
S. epidermidis  √ √ √ √  √        √ 
S. lugdunensis √ √ √  √    √   √   
S. saprothyticus √ √ √ √  √         
S. caprae √ √    √ √        
S. simulans √      √  √  √    
S. auricularis    √ √   √       
S. pettenkoferi √  √      √      
S. sciuri  √   √   √       
S. warneri √   √  √         
S. capitis  √  √           
S. cohnii √  √            
S. equorum √           √   
S. haemolyticus √              
S. hominis √              
S. pasteuri √              
S. xylosus          √     
S. arlettae               





1.2.3 Community associated staphylococci 
The research of community associated staphylococci is focused on methicillin resistant 
S. aureus. Traditionally, MRSA has been considered to be a nosocomial acquired 
pathogen; however, it has emerged as community acquired pathogen. The first 
community-associated MRSA (CA-MRSA) infection in the United States was reported 
in 1980 (Becker et al., 2014). Prevalence of CA-MRSA infection in the United States 
began in the 1990s; followed by reports that patient with CA-MRSA associated 
infections lack risk factors such as hospitalization, nursing home, and immune-
compromised conditions (Huang et al., 2006).   
1.2.4 Environmental staphylococci 
The environmental distribution of microorganisms is mainly in soil and water (natural 
water, drinking water, sewage, wastewater), and most of environmental microorganisms 
are non-pathogenic (Wright, 2010). Antibiotic resistant environmental microorganisms 
are widely distributed due to exposure of antibiotic-producing bacteria in soil, and 
therefore act as the biggest reservoir of antibiotic resistance genes (Cantas et al., 2013; 
Wright, 2010). In addition, human use of antibiotics has also reached the biosphere, and 
thus contributed to the antibiotic resistance of microorganisms (Cantas et al., 2013; 
Wright, 2010). Environmental antibiotic resistant staphylococci have been rarely 
reported, however, animal and food associated staphylococci have been studied, 
including species such as S. arlettae, S. aureus, S. capitis, S. caprae, S. cohnii, S. 
epidermdis, S. equorum, S. haemolyticus, S. hominis, S. lugdunensis, S. pasteuri, S. 
saprophyticus, S. sciuri, S. simiae, S. simulans, S. warneri, and S. xylosus (Becker et al., 
2014) (Table 1.5).  
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1.2.5 Transmission of staphylococci 
The transmission of antibiotic resistant pathogenic staphylococci is the main global 
cause of epidemic outbreaks in both health care facilities and the community 
(Widerström et al., 2012). In a clinical setting, person to person transmission of 
staphylococcal species occurs by exposure to the hands of staphylococci colonized 
health care workers and medical devices such as catheter, implanted ports (Becker et al., 
2014; Lowy, 1998). In the community, the transmission of methicillin-resistant S. 
aureus (MRSA) occurs in crowded places, through personal items such as towels, 
cosmetics, lotion, bedding, nail clipper, toothpaste, headphones, and close human 
contact (Hudson et al., 2013; Johansson et al., 2007; Mollema et al., 2010). The 
transmission of MRSA is observed through household items, pets and public transport 
(Manian, 2003; Rankin et al., 2005; Scott et al., 2008; Simões et al., 2011; Turabelidze 
et al., 2006; Van Duijkeren et al., 2004).  
Pets and livestock can be another reservoir of antibiotic resistance (Ho et al., 2011). 
Several studies demonstrated that MRSA in people is equal to or greater than its 
prevalence in pets (Gandolfi-Decristophoris et al., 2012). The transmission of MRSA 
from human to animals or from animals to human is not well studied; however, MRSA 
are more likely to be isolated from people who have direct contact with animals 
(Gandolfi-Decristophoris et al., 2012). Veterinary staff, pets owners, and farmers are 
high risk group for MRSA carriage although they do not have a  direct contact with 
hospitals (Gandolfi-Decristophoris et al., 2012). The occupation risk for veterinary staff 
is relatively high because of close proximity to MRSA infected pets or livestock (Zhang 
et al., 2011). Without effective cleanliness and isolation practice, they may be under risk 
of MRSA colonization and transmission (Vincze et al., 2014). MRSA colonisation of 
animals and contaminated food products is a potential source of persistent infection of 
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those who handle animals and food, such as pet owners, famers, catering staff  (Furuya 
& Lowy, 2006; Gandolfi-Decristophoris et al., 2012). 
Public transportation associated transmission is quite different from household 
transmission. International travel has greatly accelerated the dissemination of antibiotic 
resistant isolates, including MRSA (Zhou et al., 2014). Individuals who travel from the 
developing world with poorer hygiene standards to economically developed countries 
are more likely to transfer antibiotic resistant isolates (Ostholm-Balkhed et al., 2013). 
Ostholm-Balkhed et al., (2013) reported that individuals in Scandinavian countries who 
have travelled to Asia at least once have 12.5-fold increase in propensity for 
colonization of antibiotic resistant isolates than individuals who have never visited Asia. 
Although well-designed studies are required to systematically evaluate the transmission 
risk in travellers, empirical studies and observations have confirmed that globalisation is 
playing an important role in the spread of antibiotic resistance (Zhou et al., 2014).  
There are several factors that can affect the transmission in hospitals, public places and 
households. Community settings are characterized by transient contact of a diverse 
population, but households involve high-intensity contact between the same individuals, 
so the dynamic of transfer is different (Furuya & Lowy, 2006). Crowding in poor 
hygiene areas  such as slums is one of the factors that increase the risk of transmission, 
and also duration of human colonization may increase the transmission (Hanssen et al., 
2004). Hygiene measures and decolonization of a carrier can efficiently reduce the 
incidence of soft tissue infection caused by the antibiotic resistance bacteria (Furuya & 
Lowy, 2006).  
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1.3 Pathogenicity of staphylococci 
The ability of an organism to cause diseases is defined as pathogenicity (COLOSS, 
2016). The pathogenicity of staphylococci is reflected by human colonization and 
infection  (Lowy, 1998).  
The pathogenicity of S. aureus has been well characterized. The immune system 
protects humans from S. aureus infections in various ways, including physical barriers, 
innate response and acquired responses (Foster, 2005b).  However, S. aureus can 
overwhelm immune defences by colonizing on catheters or medical devices, entering 
the host along with catheter, adhering to host, and obstructing the immune response 
(Foster, 2005b). Several proteins are involved in the abiotic surface attachment of S. 
aureus, including non-covalently linked surface-associated protein (Atl, ClpP) and 
covalently linked surface protein (bap). Proteins involved in the attachment to host also 
include non-covalently linked surface-associated protein (efb, embp) and covalently 
linked surface protein (bap, sdrC, sdrD, sdrE). After adherence to the host surface, S. 
aureus impede the immune response by secreting virulence factors (pvl, hlg), which 
inhibit or kill immune cells. Panton-Valentine leucocidin (pvl) and γ-haemolysin (hlg) 
are leukotoxin, which are toxic to leukocytes (Becker et al., 2014). In addition, S. 
aureus can be internalized by the host cells, and stay as small colony variant in these 
cells. Finally, S. aureus can cause infections by secretion of extracellular enzymes, such 
as proteinase, lipase, and nuclease. These extracellular enzymes will cause cytolytic 
effects of host cells, facilitate the destruction of host tissue and contribute to septic 
shock (Foster, 2005b).  
In comparison with S. aureus, the pathogenicity of S. epidermidis is firstly contributed 
by their ability in colonize on medical devices such as catheters, implanted ports, and 
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form biofilms (Becker et al., 2014; Foster, 2005b).  The genetic control of biofilm 
synthesis is intercellular adhesion gene (ica), which form biofilms by synthesising 
intercellular adhesion factor (Arciola et al., 2001) (Table 1.7). Biofilm formation is 
known to protect S. epidermidis against external adverse factors, and increase the 
pathogenicity (Cramton et al., 1999). Four steps are involved in the formation of 
biofilms, including attachment, formation of multi-layer cell aggregates, maturation and 
dissociation (Cramton et al., 1999). Like S. aureus, S. epidermidis can also penetrate the 
immune system of the host. The proteins that are involved in abiotic and biotic surface 
attachment of S. epidermidis includes: non-covalently linked surface-associated proteins 
(AtlE, ClpP) and covalently linked surface proteins (bap, SdrF, SdrG, SdrH). Moreover, 
covalently linked surface protein encoding gene bap in S. epidermidis is believed to be 
acquired from S. aureus via transfer of a pathogenic island (SaPIbov2) (Otto, 2013). 
Extracellular enzymes of S. epidermidis, such as geh, lipA, favour the bacteria to invade 
host tissue and defence system (Becker et al., 2014). Additionally, S. epidermidis 
produces a less toxic molecule - phenol soluble modulins that serve as immune evasion 
molecule (Foster, 2005b). The function of phenol soluble modulins involves in 
pathogenesis and initiate the host inflammatory response (Liles et al., 2001).  
Many virulence factors facilitate the diseases and increasing pathogenicity of 
staphylococci, including extracellular toxins and surface proteins.  The virulence factors 
in S. aureus have been well characterized; however, less is known about virulence 
factors in CoNS (Becker et al., 2014).  Comparative genomic analysis showed 




1.3.1 Extracellular toxins 
Many studies have been used to explore the extracellular toxins of staphylococci, and 
Table 1.7  shows a summary of extracellular toxins found in S. aureus (Gill et al., 2005). 
In addition to the pvl and hlg mentioned above, various virulence factors are identified 
in S. aureus. Enterotoxin and exotoxin are pyrogenic toxin superantigens, which are 
recognized by T-cell receptors, and cause non-specific activation of T cells. High level 
expression of cytokine by T-cells then leads to toxic shock syndrome (Dinges et al., 
2000; Foster, 2005b). Serine proteinase (htrA), esterase (lipA), beta hemolysin (hlb), 
cell wall hydro-lase (lytN), and lytic transglycosylases (isaA) are involved in host tissue 
invasion (Frankel et al., 2011; O’Callaghan et al., 1997; Rigoulay et al., 2004; Stapleton 
et al., 2007; Su et al., 2004) (Table 1.7). Proteinase (ssp) and lipase (lip) are known to 
cause host tissue damage (Stehr et al., 2003; Zarfel et al., 2013) (Table 1.7), while 
Leukotoxin D (lukD) is an immunity cell damage factor (Malachowa et al., 2012) 
(Table 1.7). Thermonuclease (nuc) and staphylococcal protein A (spa) are responsible 
for immunity evasion (Berends et al., 2010) (Table 1.7). Clp protease (Clp) is 
recognized as a stress response protein, which can degrade misfolded protein and 









Table 1. 7 Extracellular toxins in S. aureus (Gill et al., 2005) 
Extracellular 
toxins 
Examples Functions Reference 
Enterotoxin sea 
Pyrogenic toxin superantigen 
(Massive cytokine release triggered 
toxic shock syndrome) 
Foster, 2005b 
Exotoxin setC 
Pyrogenic toxin superantigen 
(Massive cytokine release triggered 
toxic shock syndrome) 
Dinges et al., 
2000 
Serine protease htrA Host tissue invasion  
Rigoulay et al., 
2004 
Protease ssp 
Host tissue damage (Cleave 
fibrinogen-binding protein) 
Zarfel et al., 
2013 
Lipase lip 
Immunity cell damage (Damage 
surface structures of the immune 
cells) 
Stehr et al., 
2003 
Leukotoxin D lukD 





Host tissue invasion (Extracellular 
lipase,  degrade phospholipids from 
lung surfactants)  
Su et al., 2004 
Beta hemolysin hlb 





Immunity evasion (Encodes for a 
thermostable nuclease, promote 
neutrophil extracellular traps 
evasion ) 





Host tissue invasion (Non-covalent 
surface assocation protein)   
Frankel et al., 
2011 
Clp protease clp 
Stress adaptation (Degrade mis-fold 
protein) Biofilm formation  





Host tissue invasion (Required for 







Immunity evasion (Exhibits broad 
binding specificity with other 
proteins, which favours evasion of 
the innate and adaptive immune 
systems) 





Biofilm synthesis (Synthesis 
polysaccharide intercellular 
adhesin) 
Arciola et al., 
2001 
 
In addition to the virulence genes mentioned above, there are several genes that 
contribute to the increased pathogenicity of staphylococci. Quaternary ammonium 
compounds (QAC) are used in the food industry for low toxic detergent, however, the 
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QAC-resistant genes (qac) were emerged in staphylococci (Heir et al., 1998). copZ_2, 
copA_2 and csoR_1 variants are associated with copper transport,  whose function is 
known to manage cellular copper and adapt to copper stress (Harrison et al., 2000; 
Schelder et al., 2011). Zhu et al., (2013) reported that heavy metal may act as selection 
pressure of antibiotic resistance genes in bacteria. In addition, metal resistance is also 
associated with interspecies gene transfer (Méric et al., 2015).  
The virulence gene, gehD, which mediate the binding of bacteria to human collagen, is 
known to be expressed exclusively by S. epidermidis. In addition, the homology gehC is 
involved in the colonization of S. epidermidis on skin (Vuong & Otto, 2002).  
1.3.2 Surface proteins 
The success of staphylococci as a pathogen is partially due to their various surface 
proteins, which facilitate host cell invasion and residency. As well as host cell invasion, 
surface proteins are involved in several other functions, including adhesion, evasion of 
immune system, and formation of biofilm (Becker et al., 2014).  In addition, surface 
proteins are varied from strain to strain due to the acquisition and loss of certain 
virulence determinants, which further complicates medical treatment (Otto, 2010). 
The surface protein genes found in S. aureus and S. epdiermidis are listed in the Table 









Table 1. 8 Surface protein genes found in S. aureus and S. epidermidis 
Gene Functions Sources Reference 
clf a S. aureus Schaffer et al., 2006 
fnb a S. aureus Gill et al., 2005 
sdrC a S. aureus  Gill et al., 2005 
sdrD a S. aureus McCrea et al., 2000 
sdrE a S. aureus Foster et al., 2014 
sdrF a S. epidermidis Foster et al., 2014 
sdrG a S. epidermidis Foster et al., 2014 
sdrH a S. epidermidis Foster et al., 2014 
map a S.aureus Gill et al., 2005 
















Gill et al., 2005, Otto, 2013 
efb a S. aureus Gill et al., 2005 
pls c S. aureus Josefsson et al., 2005  
Note: a: Adherence to host tissue (extracellular matrix, fibrinogen, fibronectin, collagen, 








Autolysin (atl) is expressed in S. aureus, and for other CoNS, the homology of atl 
which mediates initial adhesion functions are found in S. epidermidis (atlE), S. caprae 
(atlC), S. saprophyticus (aas), S. lugdunensis (atlL), S. warneri (atlWM) (Becker et al., 
2014). In addition, the homologous of covalently linked surface protein (bap) is also 
found in S. simulans, S. heamolyticus and S. cohnii (Becker et al., 2014). Additionally, 
several surface proteins that are found both in S. aureus and S. epidermidis, including 
cell wall associated fibronectin binding protein (ebh), elastin binding protein (ebp), cell 
wall surface anchor protein (sas) and bifunctional autolysin (atl) (Gill et al., 2005) 
(Table 1.8). Moreover, cell wall surface anchor protein encoding gene sas is known to 
transfer from S. epidermidis to S. aureus via prophage (Otto, 2013).  The serine-
aspartate repeat (sdr) are characterized to be surface proteins (Foster et al., 2014).  sdrC, 
sdrD, sdrE are found uniquely in S. aureus, while sdrF, sdrG, sdrH are exclusively 
expressed by S. epidermidis (Foster et al., 2014; McCrea et al., 2000). pls is believed to 
be the methicillin resistant surface protein (Gill et al., 2005). 
1.3.3 Pathogenicity determination approaches 
The pathogenesis of staphylococci is associated with cell surface proteins, adhesion 
factors and secreted toxins (Ythier et al., 2012). Different approaches have been used to 
study the pathogenicity of staphylococci, including genomics, transcriptomics, and 
proteomics (Ythier et al., 2012).  
1.3.3.1 Whole genome sequencing 
Whole genome sequencing (WGS) reveals genetic relatedness down to the level of the 
single nucleotide, and it offers a feasible method for local, national and international 
monitoring and infection control (Price et al., 2013). For important pathogens, whole 
genome sequencing can provide an insight into the genomic composition that facilitates 
to its increasing pathogenicity (Gill et al., 2005).   
48 
 
1.3.3.1.1 Whole genome sequencing technique 
DNA fragments are sequenced by a WGS platform, and then resembled into contigs for 
further analysis (Price et al., 2013). Three generations of sequencing platforms have 
been launched since 1977, and each generation has become more rapid and cost 
effective. The third generation of sequencing allows real time observation of 
construction of  DNA strands, whereas the others are looking at reconstructing DNA 
fragments (Price et al., 2013).   
1.3.3.1.2 Genomic feature of staphylococci 
The circular genome of staphylococci is composed of 2.5 to 2.8 million base pairs, 
including genetic background and genomic islands (Gill et al., 2005; Kuroda et al., 2005; 
Price et al., 2013; Takeuchi et al., 2005). The function of two parts DNA are as 
followings: (1) genetic background are inherited from ancestral bacteria, which contains 
housekeeping genes involved in basic synthetic functions that is essential for the 
survival of bacteria; (2) genetic islands (GI) are acquired by horizontal transfer and 
which encodes virulence or antibiotic resistance genes (Ito et al., 2003). The 
staphylococcal cassette chromosome mec (SCCmec) is one of the GI types which carry 
antibiotic resistance genes (Ito et al., 2003).  
1.3.3.1.3 Whole genome variation 
Genetic variation analysis can be determined by comparison of each genome within a 
population with their reference genome sequence of the species (Arber, 2000). Six types 
of genetic variation are found: (1) loss of one or more bases; (2) gain one or more bases; 
(3) base substitution; (4) rearrangement of multiple segments; (5) copy number 
variation; and (6) DNA segment inversion (Arber, 2000). Loss or gain of bases may 
cause two results. In the first case, deletion /insertion of one or two bases into a protein 
coding region can have profound influence, which can lead to complete malfunction of 
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the protein (frameshift) (Trun & Trempy, 2009). Deletion or insertion of three or 
multiples of three bases will lead to loss or gain one or several amino acids in the 
middle of encoding region (Trun & Trempy, 2009). In this case, the protein function 
may or may not be altered depending on the position and codon type (Trun & Trempy, 
2009). Genomic variation may have huge impact on the organisms and result in 
different phenotypes, such as immune evasion ability changes (Richards et al., 2015), 
antimicrobial susceptibility changes (Chen et al., 2014; Dengler et al., 2013), and 
virulence changes (Sapp et al., 2014). In comparison, the plasmids are much smaller 
than the chromosomes, and encodes proteins that are not essential for survival of 
bacteria; however, many plasmids harbour genes confer adaptive advantages, such as 
antibiotic resistance genes, and virulence genes (Chen et al., 2014; Dengler et al., 2013; 
Sapp et al., 2014). The numbers of varied plasmids that confers different phenotype and 
pathogenicity of staphylococci can also be determined by whole genome sequencing 
(Gill et al., 2005).  
1.3.3.2 Whole proteomic approach 
Another approach towards understanding the pathogenicity of staphylococci uses 
proteomic analysis (Enany et al., 2014).  The advantage of proteomic analysis is that it 
can determine the expression of virulence genes (Enany et al., 2014). Liquid 
chromatography coupled with tandem mass spectrometry (LC-MS/MS) is one of the 
techniques that are applied for staphylococci proteomic analysis (Bernardo et al., 2004).  
1.3.3.2.1 LC-MS/MS 
LC-MS/MS can be used for identification of bacterial proteins, and thus provide an 
insight into protein expression of bacteria (Murray, 1997).  This approach has been 
widely applied for staphylococcal research by exploring the protein expression 
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differences of an isolate cultured under different conditions or between genetically 
closely related species (Murray, 1997).    
LC-MS/MS can show protein expression differences of each individual with similar 
genome composition. Encoding of orthologous proteins, or similar proteins in different 
quantities can lead to different phenotypic characteristics and performance (Murray, 
1997). 
LC-MS/MS is a technique that combines liquid chromatography and mass spectrometry. 
Liquid chromatography (LC) is used to remove impurities from the sample, separate 
component mixtures and ionize samples (Niessen, 2006). One benefit of liquid 
chromatography is the separation of isomers. Isomers are known to have exactly the 
same mass and cannot be differentiated by mass spectra. Additionally, liquid 
chromatography removes the risk of ion suppression, where one compound affects the 
ionization of another compound (Jemal, 2000). The second part, MS/MS is the 
combination of two mass spectrum analysers in single instrument, and the advantages of 
MS/MS are to increase sensitivity. The precursor ions which are transferred by liquid 
chromatography are fragmented by the first MS filters, selected ions are then monitored 
by the second mass analyser (Jemal, 2000). The information produced by the mass 
spectrometer: in the form of a list of peak intensities and mass to charge (m/z) values, 
can be manipulated and compared with genome and protein databases to identify the 
proteins (Murray, 1997). Therefore, with the combination of liquid chromatography and 
MS/MS, all the compounds present in a peak can be identified and the purity of sample 
can be checked (Jemal, 2000).  
1.3.3.2.2 Scaffold software 
The reliability of protein identification is affected by the accuracy and reproducibility of 
LC-MS/MS studies. Searle, (2010) demonstrates that the confidence in protein 
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identification can be increased by using Scaffold, a software tool in bioinformatics, 
which converts the peptide scores produced by various database search engines, into 
probabilities of peptide identification. These results are corroborated and combined with 
the so-called greedy algorithms, a group calculation method developed by Scaffold to 
reduce falsely reported protein identification (Searle, 2010).  
The staphylococcal genomic plasticity contributes to the development of virulence and 
multiple antibiotic resistance in staphylococci (Takeuchi et al., 2005),  which in turn 
increase their pathogenicity and make antibiotic therapy less effective (Otto, 2010; 
Takeuchi et al., 2005).  Complete genome sequencing and proteomic analysis can 
provide an insight into the genomic features and their expression which contribute to the 
increasing pathogenicity in staphylococci (Enany et al., 2014; Gill et al., 2005).  
1.4 Antibiotic resistance  
1.4.1 History of antibiotic resistance   
When Fleming first discovered penicillin, he warned that the abuse of antibiotics may 
lead to the development of antibiotic resistance of microorganisms and contribute to 
their dissemination (Bartlett et al., 2013).  Unfortunately, the public did not heed 
Fleming’s warning and the continuing growth of antibiotic resistance in microorganisms 
has been driven by the massive overuse of antimicrobial agents (Bartlett et al., 2013). 
Penicillin was first introduced in World War II, and soon after introduction, 
penicillinase producing S. aureus has been widely found in hospital environments 
(Chambers, 2001). Currently, the development of new antibiotics has been hampered by 
economic and regulatory barriers, and few new antibiotics have been discovered in last 
decade (Bartlett et al., 2013);  however, antibiotic resistance has been reported all over 
the world, including Africa, America, Asia, Eastern Mediterranean, European, and 
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Pacific region (WHO, 2014). In USA, the prevalence of MRSA increased from 5-10% 
to 50% in hospital isolates in the past two decades (Chambers, 2001). Meanwhile, it is 
shown that up to 40% MRSA infections were acquired in health individuals from the 
community (Chambers, 2001). Unfortunately, the phenomenon is of multiple, not single, 
antibiotic resistance. The first multiple antibiotics resistant microorganism were 
reported in the late 1950s (Levy & Marshall, 2004). In 2007, the number of multidrug-
resistant bacteria infections was 400,000; 25,000 of these were lethal in Europe (Bush et 
al., 2011). 
Bacterial antibiotic resistance has serious health and economic consequences. The 
infection caused by antibiotic resistant staphylococci makes treatment harder, and then 
result in worse clinical outcome, even death (Cosgrove, 2006; Palumbi, 2001). First, the 
side effects of second line (cefixime and colistin) and third line (rifabutin and 
levofloxacin) antibiotics are far more frequent and severe than first line antibiotics 
(penicillin), including dizziness, fever, diarrhoea, renal dysfunction and leukopenia 
(Cosgrove & Carmeli, 2003; Cunha, 2001; Iravani et al., 1988; Levin et al., 1999). 
Second, treatment may be delayed by less effective antimicrobials, and lead to surgical 
procedure to eradicate illness (Harris et al., 1999; Levine et al., 1991). Meanwhile,  the 
cost of antibiotic resistance associated infection is significantly higher than non-
antibiotic resistant related infection, as antibiotic resistance associated infection often 
leads to longer hospitalization, surgical treatment and use of other antibiotics. Thus the 
economic burden on patients, health care facilities and even the whole society is 
increased (Lautenbach et al., 2001; Silver, 2011).  
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1.4.2 Limitation in tackling with antibiotic resistance 
Over 20 new classes of antibiotic agents have been marketed between 1929 and 1970s. 
This was the so-called ‘golden age of antibiotic discovery’ (Laxminarayan et al., 2013). 
Since 1987 just two new classes have been discovered and commercialised 
(Laxminarayan et al., 2013; Silver, 2011). Although 20 new antimicrobial agents have 
been launched since 2010, all of them are analogues of existing classes of antibiotics 
(Butler & Cooper, 2011). In 2015, a promising antibiotic, designated as teixobactin, was 
discovered, and has activity against Gram-positive bacteria only with no detectable 
resistance. However, the development of teixobactin is still in its early stages, its 
clinical efficacy remains to hope for (Ling et al., 2015). Despite the noble endeavours of 
academia and industry, the focus on low-risk synthetic approaches to develop analogues 
of existing classes instead of traditional screening of natural products, and over-reliance 
of genomic approaches has reduced our global antibiotic discovery infrastructure 
(Coates et al., 2011). 
The development and administration of preventive vaccines against infectious diseases 
has reduced the use of antibiotics, however, this is only true in some cases, such as 
Haemophilus influenza, Neisseria meningitides and Streptococcus pneumoniae (Peltola, 
2000; Frasch & Bash, 2003; Kyaw et al., 2006). Vaccine clinical development is a long, 
expensive and high-risk process involving extensive human evaluation of efficacy and 
safety before commercialisation (Curtiss, 2002).  
Trends in the falling efficacy of several antibiotics and the consequential health and 
economic burdens require effective monitoring (Bartlett et al., 2013) The collection of 
antibiotic resistance data is crucial for informing public health authorities, governments, 
policy makers and industry stakeholders to make better  decisions to mitigate this threat 
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and discourage the overuse of antibiotics  (Bartlett et al., 2013). Natural microflora in 
humans will evolutionarily develop resistance to antibiotics after extended exposure to 
antimicrobial selection pressures, giving rise to the emergence of opportunistic bacterial 
‘superbugs’ (Jernberg et al., 2010). These opportunistic bacteria are considered to be a 
major cause of pandemic infections worldwide, and threaten the lives of the most 
vulnerable individuals of society such as children, elderly and immune-compromised 
individuals (Bartlett et al., 2013). All the resistance genes that are present in humans, 
animals and the environment are defined as bacterial resistomes. Moreover, the 
transmissible characteristic of these resistant genetic elements contribute to the 
emergence of antimicrobial resistance in patient, clinical settings and the wider 
environment (Wright, 2007).  
1.4.3 Antibiotic resistance mechanisms 
Staphylococcal infection is a significant cause of morbidity all over the world (Diekema 
et al., 2001), and the presence of antibiotic resistance made staphylococcal infection 
even worse (Diekema et al., 2001).  Antibiotics, also named as antimicrobial agents, are 
used for treatment of staphylococcal infections; however, staphylococci have evolved 
several mechanisms to reduce their susceptibility to antibiotics, such as mutations, and 
acquisition of resistance genes (Livermore, 2003).  
1.4.3.1 Resistance to beta-lactam 
After Fleming’s serendipitous discovery of penicillin, during the ‘penicillin era’ 
between 1940 and 1960, penicillin was widely considered to be a “magic bullet” which 
can kill all Gram-positive bacteria without harming human hosts (Ehrlich & 
Himmelweit, 1956; Gensini et al., 2007). However penicillin resistance was observed in 
a hospital setting, as early as 1942, just two years after the introduction of penicillin for 
55 
 
clinical use.  Within two decades, about 80% of both hospital- and community-acquired 
S. aureus isolates were observed to have developed resistance to penicillin  (Appelbaum, 
2007a). Resistant strains expressed penicillinase, a specific type of β-lactamase, shows 
specific activity against penicillin through hydrolysis of the β-lactam ring. Penicillin is 
inactivated and loses its ability to inhibit the synthesis of cell wall (Abraham & Chain, 
1940). Four classes of β-lactamase have now been identified, and they are differentiated 
by nucleotide sequences and crystal structures. However, all of them share several 
highly conserved amino acid sequences, which is responsible for targeting β-lactam 
antibiotics (Appelbaum, 2007a).  
1.4.3.2 Resistance to beta-lactam by expression additional penicillin binding protein 
1960-1978 is the era of natural and synthetic penicillin development, which include 
methicillin, oxacillin, ampicillin and other semisynthetic penicillin, and they can inhibit 
the growth of Gram-negative and Gram-positive bacteria (Medeiros, 1997). The 
bactericidal mechanism of beta-lactam antibiotics are known to bind to penicillin 
binding protein (PBP) to disrupt the synthesis of the peptidoglycan which is essential 
for formation of  the bacterial cell wall (Tomasz et al., 1989).   
Methicillin resistant was reported in S. aureus in the United Kingdom in 1961, just a 
year after it was firstly introduced to clinical use in 1960.   In 1968, MRSA was 
reported all over the world (Huang et al., 2006), Today, MRSA strains are found 
worldwide, and most are multidrug resistant (Appelbaum, 2006). There is a new 
mechanism in methicillin resistant staphylococci, which is markedly different from the 
penicillin resistance mechanism. Methicillin resistant in S. aureus involves an altered 
target site due to an acquired penicillin-binding protein 2a (PBP2a) with low affinity to 
β-lactam antibiotics. Even with the presence of methicillin, penicillin-binding protein 2a 
can still promote synthesis of the bacterial cell wall (Appelbaum, 2007b).  
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Cell wall is essential for survival of bacteria, as it protects microorganisms from 
intracellular and extracellular pressures, enabling normal cellular function and division 
(Typas et al., 2012). Penicillin-binding proteins (PBPs) catalyse the glycan strand 
polymerization and the cross-linking of glycan chains, which is necessary for synthesis 
of cell wall (Tulinski et al., 2012). There are 3 subdivisions of PBPs identified in 
staphylococci: Class A, Class B and Class C.  PBP2 belongs to the class A division 
which is encoded by the pbp2 gene, and PBP2a belongs to class B division encoded by 
the pbp2a gene (Tulinski et al., 2012). pbp2 is located in all staphylococcal species, and 
TPase and TGase domain of PBP2 are known to catalyse the transpeptidation and 
transglycosylation in crosslinking of peptidoglycan (Pinho et al., 2001). In the presence 
of methicillin, the TPase domain of PBP2 will be blocked, and thus inhibits the 
transpeptidation. Methicillin resistant S. aureus additionally acquired a mecA gene, 
which encodes for penicillin binding protein 2a (PBP2a) with a low affinity to β-lactam 
antibiotics (Tulinski et al., 2012). TPase domain of PBP2a involves in transpeptidation, 
and TGase domain of PBP2 is collaborative for transglycosylation in presence of 
methicillin. Therefore, PBP2a and PBP2 maintain normal functions and thus resistant to 
β-lactam antibiotics (Pinho et al., 2001) (Fig 1.1). In addition to mecA, four categories 
of mecA gene homologs (mecA1, mecA2, mecB, mecC) have been reported based on 
their similarity to original mecA gene (Ito et al., 2012). The mecC gene shares less than 
70% similarity with the original mecA gene, and is present in SCCmec type XI 
recovered from human, veterinary and wild sources (Becker et al., 2014). Although the 
mechanism by which the mecC gene mediated oxacillin resistance has not been 
elucidated, it is confirmed that the mecC gene encodes a different type of penicillin 
binding protein 2a (PBP2amecC). This PBP2amecC mediate the high level oxacillin 
resistance of S. aureus (Paterson et al., 2014). The mecA and mecC gene are subject to 
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PCR and used to explore the methicillin resistant determinants (García-Álvarez et al., 
2011; Murakami et al., 1991).  
Methicillin-resistant S. aureus (MRSA) has been represented by mecA gene positive and 
methicillin (oxacillin) resistant; however, the presence of oxacillin susceptible MRSA 
(OS-MRSA) exhibit a new type of MRSA (Hososaka et al., 2007). Although the OS-
MRSA is phenotypically susceptible to oxacillin, it is believed that most OS-MRSA is 
oxacillin hetero-resistance. Therefore the treatment with beta-lactam antibiotics may be 
ineffective (Ikonomidis et al., 2008). 
 
Figure 1. 1 The activity of PBP2 and PBP2a in the crosslinking of the peptidoglycan of 
methicillin-resistant S. aureus. The TPase domain of PBP2a is involved in 
transpeptidation, and the TGase domain of PBP2 is involved in transglycosylation in the 
presence of methicillin (Pinho et al., 2001).  
1.4.3.3 Resistance to aminoglycoside 
The anti-microbial activity of aminoglycoside antibiotics such as kanamycin, 
gentamicin, streptomycin, is based on their ability as protein synthesis inhibitors. 
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Aminoglycoside antibiotics are known to bind to the 30S ribosomal subunit and thus 
inhibit protein synthesis; however, the staphylococcal strains have evolved several 
mechanisms to inhibit aminoglycoside activity (Mingeot-Leclercq et al., 1999; Schmitz, 
1999). Currently, two aminoglycoside resistance mechanisms have been widely 
accepted. The first mechanism involves reduced drug uptake, which is due to membrane 
impermeabilisation (Mingeot-Leclercq et al., 1999). The second is due to 
aminoglycoside-modifying enzymes produced by staphylococci that, inactivate the 
aminoglycosides by covalently attaching key functional groups of antibiotics, thus 
decreasing aminoglycosides ribosomal binding affinity, and resulting in high-level 
resistance (Mingeot-Leclercq et al., 1999; Schmitz, 1999). The aminoglycoside-
modifying enzymes are encoded by acetyltransferase (AAC), adenylyltransferase (ANT) 
or phosphotransferase (APH), and resistant to gentamicin is mediated by a bifunctional 
enzyme displaying AAC and APH activity (Schmitz, 1999). Moreover, AAC-APH gene 
is located on a conjugative plasmid Tn4001, which is widely distributed in S. aureus 
and CoNS; whereas kanamycin and streptomycin resistance are determined by ANT and 
APH (Schmitz, 1999).   
1.4.3.4 Resistance to macrolides 
The antibacterial activity of macrolides is achieved by inhibiting protein synthesis 
(Vester & Douthwaite, 2001). Macrolides are characterized to be the polyketide group 
of compounds, which includes carbomycin and erythromycin (Vester & Douthwaite, 
2001; Weisblum, 1995). Four macrolides resistance mechanisms have been identified. 
Firstly, the presence of macrolide efflux pumps (msr) in staphylococci has contributed 
to the macrolides resistances (Schmitz et al., 2000). In S. aureus, macrolide resistance is 
associated with msrA gene that encodes an ABC-transporter-mediated efflux (Matsuoka 
et al., 2003). Secondly, a mph gene located at downstream of msrA gene has been 
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known to inactivates macrolide antibiotics by encoding a phosphotransferase, and the 
expression of mph gene is associated with presence of msrA gene (Matsuoka et al., 
2003). Thirdly, enzymes (ere) is known to inactivate macrolide by hydrolysing the 
lactone ring nucleus of macrolide (Schmitz et al., 2000). Finally, macrolide resistance in 
staphylococci can be achieved by alteration of macrolide target site – 23S rRNA 
(Weisblum, 1995). A gene named erythromycin ribosome methylation (erm) encodes 
23S rRNA methylase, which is responsible for conformation change of 23S rRNA 
(Schmitz et al., 2000). erm mediated methylation of adenine residue of 23S rRNA 
domain V lead to the reduced affinity to macrolide, and thus confer to macrolide 
resistance (Vester & Douthwaite, 2001; Weisblum, 1995). The erm gene has been 
collected from diverse range of resources, and 30 different kinds of erm have now been 
identified (Weisblum, 1995). 
1.4.3.5 Resistance to phenicols 
Chloramphenicol is categorized to phenicols class, and is a bacteriostatic drug that stops 
bacterial growth by inhibiting protein synthesis. Chloramphenicol prevents protein 
chain elongation by inhibiting the peptidyl transferase activity of the bacterial ribosome 
(Jardetzky, 1963). Chloramphenicol resistance in staphylococci is due to an inducible 
enzyme: chloramphenicol acetyltransferase, which acetylates chloramphenicol, and 
thereby inactivates the chloramphenicol (Shaw et al., 1970).  
1.4.3.6 Resistance to steroid and fosfomycin 
Fusidic acid is a steroid antibiotic derived from the fungus Fusidium coccineum 
(Godtfredsen et al., 1962), which fight against severe Gram-positive infections by 
interfering with the function of the elongation factor G (EFG). EFG is known to transfer 
peptidyl-tRNA from the ribosomal A site to the P site, and then the messenger RNA is 
able to move one codon forward. Meanwhile, GTP is hydrolysed into GDP to provide 
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energy for this process, and EFG dissociates from the ribosome in a complex with GDP. 
EFG is encoded by fusA gene (Martemyanov et al., 2001). Fusidic acid prevents the 
dissociation of EFG from ribosome by binding to EFG on the ribosome, and thus blocks 
the next stage of protein synthesis (Martemyanov et al., 2001). Fusidic acid resistance in 
S. aureus is due to fusA gene mutation associated EFG structure alteration, and the 
altered EFG has low affinity to fusidic acid. Even in the presence of fusidic acid, EFG 
can be dissociated from the ribosome and is able to continue with next step in protein 
synthesis (Martemyanov et al., 2001). Brown & Thomas, (2002) has reported striking 
increase in fusidic acid resistance of clinical S. aureus, and warned about the decreased 
efficacy of fusidic acid in treatment of serious MSSA infections. Fosfomycin is an 
antibiotic that is known to inhibit cell wall synthesis, and fosfomycin resistance is 
mediated by fosA gene. The fosA gene encodes a glutathione S-transferase, which forms 
a covalent bond with fosfomycin, and then inactivates fosfomycin (Bernat et al., 1997). 
1.4.3.7 Resistance to monoxycarbolic acid 
Monoxycarbolic acid is a class of antibiotics, and mupirocin is one of the representative 
antibiotics (Cookson, 1998). Mupirocin was introduced into clinical practice in the UK 
in 1985, and it has been proved to be an extremely effective and successful topical 
antibiotic for treatment of nasal and skin MRSA infections (Cookson, 1998). Mupirocin 
is an analog of isoleucine which competitively binds to isoleucyl tRNA synthetase, and 
thus inhibit protein synthesis (Hodgson et al., 1994); however, resistant strains were 
reported shortly after introduction of the Mupirocin (Cookson, 1998). Different 
mechanisms are involved in low-level resistance and high-level resistance. Ile has been 
known to encode isoleucyl tRNA synthase, which specifically recognize isoleucine and 
transport to ribosome for protein synthesis (Lodish, 2008).  Low-level resistance is due 
to the mutation in a chromosomally encoded Ile, and high-level resistance has been 
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shown to be due to the acquisition of an additional novel gene IleS. Mutation in Ile and 
acquisition of IleS are both lead to reduced affinity of isoleucyle tRNA synthase to 
mupirocin (Cookson, 1998; Hodgson et al., 1994). 
1.4.3.8 Resistance to tetracycline 
Tetracycline is a broad-spectrum polyketide antibiotic produced by the Streptomycetes, 
it is used for the treatment of bacterial infections as it inhibits protein synthesis (Ng et 
al., 2001). There are three mechanisms involved in tetracycline resistance, including: 
using energy-dependent efflux (encoded by tet(K) gene) of tetracycline (Gibbons & Udo, 
2000); alteration of the ribosome to prevent the effective binding of tetracycline; 
enzymatic inactivation of tetracycline (Ng et al., 2001).  
1.4.3.9 Resistance to glycopeptide 
Glycopeptide antibiotics include vancomycin, teicoplanin, ramoplanin and decaplanin. 
Glycopeptides are known to inhibit the growth of bacteria by obstructing cell wall 
synthesis (Hiramatsu, 2001).  For staphylococci, glycopeptide antitiobitcs can bind to 
acyl-D-alanyl-D-alanine in peptidoglycans, and therefore prevent the cross linking 
process of cell wall synthesis (Hiramatsu, 2001). Vancomycin resistance/intermediate S. 
aureus increase cell-wall thickness by producing more peptidoglycan, and thus 
vancomycin are trapped in peptidoglycan layers and cannot access to peptidoglycan 
synthesis sites. However, vancomycin resistance at the genetic level has not been 
clarified yet (Appelbaum, 2007a).  
1.4.4 In vitro susceptibility testing overview 
Antimicrobial susceptibility test is a standard clinical lab procedure, and rational 
selection of antibiotics for treatment is determined by assessing possible antibiotic 
resistance in bacteria (Jorgensen & Ferraro, 2009). In addition, susceptibility test can 
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provide information on decreased susceptibility of bacteria to antibiotics (Mahon et al., 
2014). Nowadays, human, veterinary and agricultural use of antibiotics means that large 
quantities of antibiotics have been continuously released into the environment (Batt et 
al., 2006; Dı́az-Cruz et al., 2003; Kummerer, 2003); however, little is known about the 
dissemination of antibiotic resistant staphylococci in environment.  
1.4.4.1 Overview of commonly used susceptibility testing methods  
Antibiotic susceptibility test is a routine procedure during phenotyping in clinical 
microbiology and microbiology research labs (Jorgensen & Ferraro, 2009). The most 
widely used testing methods in modern clinical lab are the antimicrobial gradient 
method and the disc diffusion method (Jorgensen & Ferraro, 2009).  
The antimicrobial gradient method involves placing a commercial plastic antibiotic 
gradient strip on standardized bacterial suspension covered plates, and MIC is 
determined by inhibited growth point along the strip (Jorgensen & Ferraro, 2009). The 
gradient diffusion method is a simple and time efficient way to determine MIC of tested 
isolates.  Moreover, the gradient diffusion method is consistent with the traditional 
broth dilution method (Jorgensen & Ferraro, 2009).  
The disk diffusion method depends on the formation of a radial gradient around the 
antimicrobial agent. The antimicrobial agent is released from the disc and radially 
diffuses into the agar, giving a concentration gradient. At a specific distance from the 
centre, the concentration of antibiotic is too low to inhibit the growth of the test 
organism, and the inhibition zone is formed. After comparing the diameter of the 
inhibition zone with standard criteria, the susceptibility results are interpreted as 
`susceptible`,` intermediate` or `resistance`(Mahon et al., 2014).   
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1.4.4.2 Overview the standards for interpreting antimicrobial susceptibility results 
With the global increase in microbial resistant to antibiotics, there is a need for 
universally recognized standards to interpret the susceptibility of microorganisms 
(Jorgensen & Ferraro, 2009). There are three globally recognized standards for the 
interpretation of antimicrobial susceptibility test results: British Society of 
Antimicrobial Chemotherapy (BSAC), the Clinical and Laboratory Standards Institute 
method (CLSI) and the European Committee on Antimicrobial Susceptibility Testing 
(EUCAST). The different standards of MIC and zone diameter breakpoints for 
staphylococci are showed in Table 1.9 (Creagh & Lucey, 2007; Howe & Andrews, 2012; 
Testing, 2014; Wikler, 2007). 
Criteria for gentamicin, vancomycin, oxacillin and cefoxitin are different for 
interpreting S. aureus and CoNS, whereas, interpretive critertia for streptomycin and 
cefepime is specific for S. aureus (Creagh & Lucey, 2007; Howe & Andrews, 2012; 
Testing, 2014; Wikler, 2007; Wayne, 2014). Interpretive criteria for penicillin, 
amoxicillin, erythromycin, tetracycline, chloramphenicol, fusidic acid and mupirocin 
are generally for Staphylococcus spp. (Creagh & Lucey, 2007; Howe & Andrews, 2012; 




Table 1. 9 Zone Diameter and Minimum Inhibitory Concentration (MIC) Interpretive Standards for Staphylococcus spp.  (Howe & Andrews, 
2012; Testing, 2014; Wayne, 2014; Wikler, 2007) 
 BSAC  CLSI   EUCAST   


























(Disc content ) 
R> I S≤ R≤ I S≥  R> I S≤ R≤ I S≥  R> I S≤ R≤ I S≥  
Aminoglycosides                      
Gentamicin   
(10 µg) 
1 - 1 19 - 20  8 - 4 12 13-
14 
15  1 - 1 18 - 18 S.aureus 
Gentamicin   
(10 µg) 
- - - - - -  - - -  - -  1 - 1 22 - 22 CoNS 
Streptomycin 
(10 µg) 
- - - - - -  - - - 14 - 22 S. aureus - - - - - -  
β-lactams                      
Oxacillin 
(1 µg) 
2 - 1 14 - 15  4 - 2 10 - 13 S. aureus 2 - 0.25 - - -  
Oxacillin 
(1 µg) 
       0.5 - 0.25 17 - 18 CoNS - - - - - -  
Penicillin G 
(1U) 
0.12 - 0.12 24 - 25  0.12 - 0.12 28 - 29 10 U - - - - - -  
Amoxicillin 
(10 µg) 
- - - - - -  4 - 2 19 - 20  - - - - - -  
Note: The criteria in bold is used to interpret the antibiotic susceptibility test results in this study. 
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(Disc content ) 
R> I S≤ R≤ I S≥  R> I S≤ R≤ I S≥  R> I S≤ R≤ I S≥  
Cefepime  
(30 µg) 
- - - - - -  32  8 14 15-
17 
18 S.aureus  - - - - - -  
Cefoxitin 
(10 µg) 
4   21 - 22 S. aureus 8  4 21  22 S. aureus 
30  µg 
   22  22 S. aureus 
30  µg 
Cefoxitin 
(10 µg) 
4   21 22-
26 
27 CoNS    24  25 CoNS  
30  µg 
   25  25 CoNS 
30  µg 
Glycopeptides                      
Vancomycin 
(5 µg) 








S. aureus - - 2 - - - S. aureus 2  2 -  - S. aureus 
Vancomycin 
(5 µg) 
4 - 4 - CoNS   4    CoNS 4  4 -  - CoNS 
Macrolides                      
Erythromycin 
(5 µg) 
2 2 1 16 17-
19 
20  8 - 0.5 13 14-
22 
23 15  µg 2  1 18  21 15  µg 
Tetracyclines                      
Tetracycline 
(10 µg) 
2 2 1 19 - 20  16 - 4 14 15-
18 
19 30  µg 2  1 19  22 30  µg 
Phenicols                      
Chloramphenicol 
(30 µg) 
8 - 8 14 - 15 10  µg 32 - 8 12 13-
17 
18  8  8 18  18  
Note: The criteria in bold is used to interpret the antibiotic susceptibility test results in this study.  
a: Andrews & Testing, 2001; b: Creagh & Lucey, 2007 
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Note: The criteria in bold is used to interpret the antibiotic susceptibility test results in this study.  
a: Andrews & Testing, 2001; b: Creagh & Lucey, 2007  
 
 
 BSAC  CLSI  EUCAST 


























(Disc content ) 
R> I S≤ R≤ I S≥  R> I S≤ R≤ I S≥  R> I S≤ R≤ I S≥  
Steroid                      
Fusidic acid 
(10 µg) 
1 - 1 29 - 30  - - - 24 - 32  1  1 24  24  
Monoxycarbolic 
acid 








27  - - 4 - - 19
b
 5  µg 256 - 1 13 - 13 200  µg 
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1.4.4.3 Quality control of susceptibility testing 
S. aureus NCTC6571 is a β-lactamase negative isolate, and susceptible to all the routine 
antibiotics (Table 1.10). The MIC of S. aureus NCTC 6571 to oxacillin is 0.125 mg l
-1 
(Seaman et al., 2004). S. aureus NCTC 6571 is used as a control strain in all lab based 
susceptibility tests, including clinical diagnosis microbiology labs in the UK (Kearns, 
2006). S. aureus NCTC 6571 has been included as a control in all the susceptibility tests 

















Table 1. 10 Antibiotic susceptibility profile of S. aureus NCTC6571 
 
 Antibiotics 
 PEN OX VAN MUP CHL TET ERY GEN FD AMP CEC CRO RIF TEC 
S.aureus 
NCTC6571 
S S S S S S S S S S S S S S 
Note: R, resistant; S, susceptible; PEN, penicillin G; OX, oxacillin; VAN, vancomycin; MUP, mupirocin; CHL, chloramphenicol; TET, 





Much attention has been focused on clinical antibiotic resistant pathogens as they are 
the direct cause of illness; however, the antibiotic resistant microorganisms in the 
environment are also a cause for concern (Blair et al., 2014).  Therefore, attentions 
should be focused not only on pathogenic, but also on non-pathogenic bacteria and 
potential antibiotic resistance genes (Wright, 2007). The development of antibiotic 
resistance in microorganism is a natural evolutionary phenomenon and exposure to 
antibiotic producing microorganisms may contribute to the selection of antibiotic 
resistance genes in environmental microorganisms (Blair et al., 2014).  However, recent 
studies have shown that the mutation rates of microorganism increased when exposed to 
antibiotics, emphasising the role of antibiotics in driving the antibiotic resistance 
evolutionary process (Wright, 2007). In this case, antimicrobial agents from 
antimicrobial producing bacteria in soil habitats, humans, and animal therapeutics, 
sewage, agricultural and veterinary industries made environment a potential reservoir of 
antibiotic resistance genes (Cantas et al., 2013). Therefore, antibiotic resistance genes 
from environmental microorganism comprise a huge proportion of the resistome 
(Wright, 2007). It is necessary to include non-pathogenic microorganisms in antibiotic 
resistance research in order to impede the resistance before it appears in pathogens 
(Cantas et al., 2013). 
1.6 Genomics related to antibiotic resistance  
The presence of antibiotic resistance is determined by two factors: antibiotics and 
antibiotic resistant determinants (Levy & Marshall, 2004). The continuous flow of 
antibiotics from human treatment, veterinary and agricultural industries to the 
environment contribute to the selection of antibiotic resistant bacteria (Levy & Marshall, 
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2004); however, mechanistic details of the evolutionary development of antibiotic 
resistance still need to be clarified (Kemper, 2008; Zhang et al., 2009, Otto, 2013).  
Acquisition of antibiotic-resistance significantly complicates the treatment of bacterial 
infections (Levy & Marshall, 2004), and it is belived that bacteria acquire antibiotic 
resistance via transfer of antibiotic resistant elements or genetic mutations  (Otto, 2013). 
Horizontal transfer of antibiotic resistant determinants is considered to be reason for 
dissemination of resistance in bacteria (Bloemendaal et al., 2010). In addition, 
resistance traits caused by chromosome mutation can be transmitted vertically to 
offspring (Hastings et al., 2004).  
1.6.1 Lateral transfer of antibiotic resistance 
Recently, using different genome sequence approaches, Méric et al., (2015) has shown 
that S. aureus and S. epidermidis share half of the genome with 40% of the core genes 
in S. epidermidis and 24% of the core genes in S. aureus and considerable interspecies 
mobile genetic elements has been shared by both species, such as SCCmec, pathogenic 
islands, plasmids, and transposons. Staphylococcal species that share the same 
environmental niches are in close proximity for genetic exchange, such as conjugation, 
phage transduction, and uptake of naked DNA (Otto, 2013).  
Methicillin resistant in staphylococcal species is due to the mecA gene, which is located 
on a mobile genetic island SCCmec. mecA encodes penicillin binding protein 2a, which 
has low affinity to beta-lactam antibiotics (Mkrtchyan et al., 2013). Methicillin 
susceptible isolates are considered to have acquired mecA genes via horizontal transfer 
of SCCmec elements, and then result in the dissemination of mecA gene between 
staphylococcal species (Bloemendaal et al., 2010). Clinical research showed that 
methicillin resistant S. aureus was formed in vivo by acquiring SCCmec from 
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methicillin resistant S. epidermidis (Bloemendaal et al., 2010). However, replication of 
mecA gene transfer via conjugation between the same two clinical staphylococci in vitro 
is not successful (Bloemendaal et al., 2010). To date, the transfer of SCCmec via 
conjugation and transformation has been seldom reported (Otto, 2013). Although the 
phage mediated SCCmec transfer was observed within S. aureus, the phage mediated 
transfer of SCCmec between different staphylococcal species has not been reported 
(Otto, 2013). For now, the mechanism of SCCmec transfer between staphylococcal 
species is yet to be clarified (Otto, 2013).  To my knowledge, the replication of mecA 
gene transfers with environmental staphylococci in vitro has not yet been investigated. 
1.6.2 Vertical transfer of antibiotic resistance  
In addition to horizontal transfer of antibiotic resistance genes, bacteria inherit 
resistance vertically from their ancestors (Hastings et al., 2004). The resistance traits, 
which can be vertically transferred to their offspring, includes structural changes of the 
antibiotic target which reduces the antibiotic affinity; increasing efflux efficiency to 
remove the antibiotics from the bacteria, and increasing activity of the degradative 
system (Hastings et al., 2004). Efflux pump is one of the significant contributing factors 
for antibiotic resistance (Gupta et al., 2010). Efflux pump are membrane proteins that 
mediate energy dependent transportation of antimicrobial agents out of cell, including 
EmrB/QacA family drug resistance transporters and ATP binding cassette (ABC) 
transportor (Gupta et al., 2010; Solheim et al., 2007).   
Genetic variation can be triggered by stress conditions, and confers adaptive mutations 
traits (Foster, 2005a). Stress environment, such as antibiotics, UV-light, pH, oxidative 
stress, temperature and heavy metals, increase the genetic variation and thus contribute 
selective advantages (Foster, 2005a). Bacterial stress responses can be categorized into 
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the SOS response, the general stress response, heat-shock response and stringent 
response (Foster, 2005a).   
1.6.2.1 SOS response 
The SOS response is triggered when the bacteria are subjected to DNA damage.  LexA 
and RecA genes are involved in regulation of the SOS stress response in E.coli. LexA is 
a repressor of the SOS response, and RecA is promoter of SOS response (Miller et al., 
2004). SOS response is known to be a defence mechanism for bacteria to resist β-lactam 
antibiotics (Miller et al., 2004). The SOS response is known to help bacterial 
propagation by inhibiting cell division during repair of DNA damage (Miller et al., 
2004). In addition, The SOS system regulates a global response which upregulates 
genes involved in DNA repair and cell survival (Maiques et al., 2006).   
1.6.2.2 General stress response 
The RpoS and MutS genes are involved in the general stress response of E. coli, and 
RpoS is known to direct RNA polymerases to their promoters for transcribing proteins 
necessary for cell survival (Guisbert et al., 2008). Mismatch repair is crucial for 
maintaining the integrity of the chromosome, and MutS is the gene that is in charge of 
mismatch repair in eukaryotes. Mismatch repair has been known to have the following 
functions: (1) repair the errors of DNA replication process; (2) intermediate 
recombination process (Kolodner, 1996).   
The upregulation of thioredoxin is a stress response of oxygen damage, and the 
upregulation of thioredoxin is essential to protect cells from oxygen damage (Bore et al., 
2007), whereas, oxygen response has been reported in acid-shock response as indirect 
stress response (Bore et al., 2007).  
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1.6.2.3 Heat shock response 
Heat shock response is triggered by subjecting a cell to a temperature increase, and 
involves upregulation of the transcription of heat shock proteins (HSPs) (Guisbert et al., 
2008; Muthaiyan et al., 2012). HSPs are involved in part of the cell's internal repair 
mechanism and protein folding and stabilization (Guisbert et al., 2008; Muthaiyan et al., 
2012).  For example, GroE (Hsp 60) gene is crucial for maintaining the structure and 
formation of proteins at any temperature (Guisbert et al., 2008), and GroE can also 
protect RNA polymerase holoenzyme from heat inactivation (Ziemienowicz et al., 
1993). DnaJ is Hsp40 chaperone, which has been known to control protein homeostasis 
in the cell (Cuéllar et al., 2013). Moreover, GrpE is another chaperone protein, which 
has been reported to assistant reactivation of heat-inactivated RNA polymerase 
(Ziemienowicz et al., 1993). The heat shock response can also be induced by DNA 
damage (Guisbert et al., 2008; Muthaiyan et al., 2012). 
1.6.2.4 Stringent response 
The stringent response is triggered by nutrient limitation.  In E. coli, the main gene 
involved in stringent response is ppGpp gene. ppGpp gene regulates the expression of 
RNA (Guisbert et al., 2008). Stringent response generally reduces the capability of 
protein synthesis, however, it increases the synthesis of amino acid for protein that is 







1.7 Research Aims 
Staphylococci are opportunistic pathogens responsible for the range of infections, and 
the presence of antibiotic resistance in staphylococci is a potential threat to public health. 
As a result of natural evolutionary process, the environment may act as a reservoir of 
antibiotic resistance genes. The uses of antibiotics are a major pressure for the 
mobilization of antibiotic resistance genes from environment to human pathogens. 
However, little is known about the antibiotic resistance in environmental staphylococci.  
This study aims to: 
1. Determine the dissemination of staphylococci in human related environment, 
and look to the taxonomic correlation of staphylococci isolated from different 
sites;  
2. Assess antibiotic resistance of staphylococci in the environment, and investigate 
the antibiotic susceptibility profile variation of taxonomically closely related 
staphylococci; 
3. Investigate molecular characterization of mecA gene positive staphylococci;  
4. Investigate the genome features that contribute to the antibiotic resistance and 
virulence of one S. epidermidis isolate with high-level oxacillin resistance;  
5. Assess mecA gene transfer with environmental staphylococci in vitro, and 
compare the protein expression differences of S. aureus cultured with and 
without oxacillin supplemented agar.   
The study is composed of 11 chapters, including the chapter 1: the introduction, which 
discusses the research context of this project; chapter 2: outlines the material and 
methods used in experimental procedures; chapter 3, 4, 5, 6, 7, 8 are focused on results; 
chapter 9 includes discussion of the findings; Chapter 10 draws upon the entire thesis 
and gives a brief summary; and chapter 11 indicates the future work. 
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Chapter 2   Materials and Methods   
The presence of antibiotic resistance genes is a natural evolutionary process, and it has 
been suggested that the environment may act as a reservoir of such antibiotic resistance 
genes (Wright, 2007). The development of new antibiotics does not seem assuring to 
solve the increasing threat of antibiotic resistance, as bacteria; in particular, 
staphylococci continue to adapt new strategies for their survival.  Hence, it is necessary 
to generate data on the dissemination of antibiotic-resistant bacteria that would help the 
public health authorities to develop new strategies for infection control (Bartlett et al., 
2013). In this study, different microbiological, molecular, genomic and proteomic 
techniques were used to determine the diversity, dissemination, resistance and virulence 
features of environmental staphylococci.    
2.1 Sample collection 
Bacterial cultures were recovered from multiple sources at various time points during 
2012 to 2014. Sterile swabs were used to sample the surfaces of different general public 
settings and human hands. Human hands sampling was conducted with the general 
public without restriction of age, gender or race and not included healthcare residents. A 
high volume air sampler (Cherwell SAS Super 100) was used to collect air samples 
from one hotel. After collection, the samples were shipped to the lab within 1-3 hours.  
All the samples (except air samples) in this study were collected using COPAN dry 
swabs (Copan Diagnostics Inc., USA), and all collection sites were in London, United 
Kingdom. The period and the sites of sample collection were as follows: ① Oct 2012 
and Apr 2013 - different sites of hotels (DSH); ② Apr 2013 - hotel air samples (HAS); 
③ Apr 2013, July 2013 and July 2014 - human hands (HH); ④ July 2013 - baby care 
facilities (BCF); ⑤  July 2013 - handbags (HB); ⑥  Sep 2013 - different sites of 
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supermarkets (DSS); ⑦ July 2014 - different sites of restaurants (DSR); ⑧ Aug 2014 
and Sep 2014 - different sites of  transportation facilities (DST); ⑨ Nov 2014 - different 
sites of a library (DSL).  HAS were collected using a high volume air sampler 
(Cherwell SAS Super 100). These were collected using filter-based electret capture 
technology. Sterilized air sampler was filled with “contact plate”, and the airflow of 
sample collection was between 200 and 1000 litres per min.  
2.2 Isolation of staphylococci 
In the laboratory, all swabs were suspended in 1 ml sterile 0.9 % saline, and then were 
inoculated onto Nutrient Agar (NA, Oxoid Basingstoke, UK), Mannitol Salt Agar plates 
(MSA, Oxoid Basingstoke, UK) and Brilliance UTI® agar (UTI, Oxoid Basingstoke, 
UK). These were incubated aerobically at 37℃ for 24-72 h. For air samples, the contact 
plates were transferred and incubated at 37℃ for 24-72 h. 
The numbers of colonies on NA were recorded by counting colonies on the whole plate 
as such counting colonies as seen on the half of the plate and then multiplying it by 2 or 
counting the colonies on the quarter of plate and then multiplying by 4 to estimate the 
total number of colonies on each plate. MSA in this study was used for the preliminary 
discrimination of S. aureus (mannitol fermenting) and CoNS (mannitol non-fermenting), 
and also selectively isolate staphylococcal species. The acidic byproduct was produced 
by fermentation of mannitol will cause the phenol red in the MSA to turn yellow; 
otherwise, there is no colour change to the medium.  UTI contains chromogenic 
substrates, which can provide preliminary colorimetric identification of the main 
microorganisms that cause urinary tract infection (Fig 2.1). The determination of 
species is in accordance to manufacturer’s instructions. E.coli: pink/red colony; 
Enterococcus spp.: turquoise/blue-green colony; coliforms: dark blue/purple colony; 
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Proteus, Morganella, Providencia: brown halo colony; Pseudomonas spp.: brown/green 
colony; staphylococci, streptococci: non-pigmented white colony (http://www.oxoid. 
com/pdf/24021_oxoid_clarity_UTI.pdf) (Fig 2.1). 
 
 
Figure 2. 1 Colour of bacteria on the dehydrate Brilliance
TM
 UTI agar.  Image was 
adapted from:http://www.oxoid.com/UK/blue/prod_detail/prod_detail.asp? pr=CM0949. 
 
Multiple morphological colonies were picked from NA, MSA accordingly, and 
resulting pure single colony transferred to a fresh NA plate, incubated 18-24 h. The 
culture was stored in the beads at – 80℃ (Microbank, Fisher Scientific, UK). 




2.3.1 MALDI-TOF MS identification 
Traditionally, identification of staphylococcal species has been assessed by testing 
phenotypic characteristics, or 16S rRNA gene sequencing methods (Janda & Abbott et 
al, 2007). A simple, rapid and reliable identification method – matrix-assisted laser 
desorption/ionization-time-of-flight mass spectrometry (MALDI-TOF MS) has been 
employed for identification (Maier et al, 2006). This method has been widely available 
for identification of many microorganism species (Seng et al., 2009).  
The preparation of matrix solution and sample preparation was carried out according the 
manufacturer’s instructions (Bruker Daltonics, Coventry, UK).  
Basic organic solvent (OS) was prepared with 50% (v/v) acetonitrile (Sigma-Aldrich, 
UK), and 2.5% (v/v) tri-fluor-acetic-acid (TFA) (Sigma-Aldrich, UK). To make the 
matrix solution, 250 µl OS was added to 2.5 mg α-Cyano-4-hydroxycinnamic acid 
(HCCA) matrix (Bruker Daltonics, Coventry, UK) and vortexed until all the crystals 
were completely dissolved.  
3-5 colonies of overnight culture were added into 300 µl distilled water, and mixed with 
900 µl absolute ethanol. The suspension was centrifuged for 2 min at 13000 g, and the 
supernatant was then completely withdrawn by carefully pipetting. Dried pellets were 
mixed with 25 µl 70% (v/v) formic acid and then with 25 µl pure Acetonitrile (AN). 
The mixture was centrifuged for 2 min at 13000 g. 1 µl supernatant from the previous 
step was spotted on target plate (Bruker Daltonics, Coventry, UK) (Fig 2.2), and 
overlaid with 1 µl of α-Cyano-4-hydroxycinnamic acid (HCCA) matrix (Bruker 




 Figure 2. 2 2a: Bruker 96 polished target plate; 2b: Biotyper 3.1 identification sectional 
drawing;   Measured classified green (score value ≥ 2.0): highly probable species 
identification;     Measured, classified yellow (2 ≥ score value ≥ 1.7): probable genus 
identification;    Measured classified red (score value ≤ 1.7): not reliable identification; 
aa  Zeroline spectrum, not classified: no spectrum was detected  (Pictures were taken by 
me).  
 
The spectra were detected by MALDI-TOF MS (Bruker Daltonics, Coventry, UK), and 
the resulting spectra for each isolate was analysed by Biotyper 3.1 software (Bruker 
Daltonic, Coventry, UK). Escherichia coli DH5α was used as a standard for calibration 
and quality control.  
2.3.2 Reproducibility of MALDI-TOF MS 
The definition of reproducibility is the capability of a technology to yield the same 
results when the same sample is tested repeatedly (Trindade et al., 2003).  Isolates 
selected to assess the reproducibility of MALDI-TOF MS were prepared according to 
manufacturer’s instructions (Bruker Daltonics, Coventry, UK) mentioned in 2.3.1, and 
two target plates were used at the same time in this study.  The supernatant of each 
isolate was spotted twice on each target plate to make duplicates, and then covered with 
α-Cyano-4-hydroxycinnamic acid (HCCA) matrix (Bruker Daltonics, Coventry, UK). 
For reproducibility, one target plate was analysed by MALDI-TOF MS (Microflex LT), 
in the meantime, the other target plate was analysed by MALDI-TOF MS (Autoflex). 
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Spectra generated by both MALDI-TOF MS were analysed by Biotyper 3.1 for 
microbial identification.  
2.3.3 16S rRNA gene sequencing identification 
16S rRNA gene PCR and sequencing were also used to identify a small proportion of 
the environmental staphylococcal isolates to confirm the reliability of MALDI-TOF MS 
identification method.  
2.3.3.1 Primers 
The following primers were used for the amplification of the partial 16S rRNA gene 
sequence (Benagli et al., 2011):     
UNI16S RNA-L (nucleotide sequence 5’ -ATTCTTAGAGTTTGATCATGGCTCA- 3’) 
and UNI16SRNA-R (nucleotide sequence 5’ -ATGGTACCGTGTGACGGGCGGTGT 
GTA- 3’), which allows the amplification of a 1400 bp DNA fragment. 
2.3.3.2 PCR reaction system 
All PCR in this study was performed by T100
T
 Thermal cycler (BIO-RAD, UK). 
Template DNA for PCR was prepared by resuspending one loop (10 µl, Thermo 
Scientific
TM
, UK) of bacteria in 100 µl 1×TE buffer (10 mM Tris, 1 mM EDTA). The 
mixture was boiled for 10 min and then centrifuged at 3000 g for 5 min. The 
supernatant was used as DNA template (Hanssen et al., 2004). Alternatively, QIAamp 
DNA extraction kit (Qiagen, Crawley, UK) was used for DNA extraction. 
PCR was prepared according to the protocol used by Benagli et al., (2011). The mixture 




 High-Fidelity DNA Polymerase (NEB, UK), 
0.2 mM of each deoxynucleotide triphosphates, 1×Phusion® High-Fidelity Buffer, 
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approximately 10 ng template DNA, 1.5 mM MgCl2 and 0.8 µM of each primer in a 
final volume of 25 µl. 
PCR thermal cycling conditions were 5 min at 95°C for 1 cycle, followed by 35 cycles 
of 30 sec at 94°C, 30 sec at 52°C, 1 min at 72°C, and finalized by extension at 72°C for 
10 min (Benagli et al., 2011).  
2.3.3.3 Gel electrophoresis 
Agarose gel electrophoresis was used to detect all PCR products in the size range of 100 
bp to 10 kbp. Molecular grade agarose (Melford, UK) was dissolved in 1x TAE buffer 
(40 mM Tris base, 40 mM acetic acid, 1 mM EDTA) (Sigma-Aldrich, UK) to make 1.0% 
(w/v) agarose, and then mixed with ethidium bromide to a final concentration of 0.1 mg 
l
-1
 (Fisher Scientific). The solidified gel was then placed in gel electrophoresis buffer (1
×TAE buffer), samples and 2-Log DNA ladder (0.1-10 kbp) (NEB, UK) were loaded 
into the wells, and 120 V was applied across the gel for 1 to 2 hours. Bromophenol 
blue/xylene cyanol dye front was monitored to see the migration of samples. The gel 
was visualized by a UV transilluminator (Syngene, Cambridge, UK) and saved as a jpg 
or TIFF files (Syngene, Cambridge, UK). The same gel electrophoresis system was used 
for mecA gene, mecC gene, SCCmec typing, and MLST detection.  
2.3.3.4 Sequencing 
The PCR products were purified by cycle pure kit (Qiagen, Crawley, UK) or gel 
extraction kit (Qiagen, Crawley, UK), and sequencing was performed commercially by 
Eurofins MWG operon (Eurofins Genomics, i54 Business Park, Valiant Way, 
Wolverhampton, UK). PCR purified products were sent out at concentrations of 50-100 
ng µl
-1
 along with the 10 pmol µl
-1
 corresponding oligonucleotides. Results were 
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usually archived in the Eurofin account within 3 working days. The same sequencing 
system was used in MLST sequencing.   
2.4 Antibiotic susceptibility test 
In this study, the antibiotic susceptibility of staphylococci was measured by disc 
diffusion and antimicrobial gradient methods.  
2.4.1 Disc diffusion test 
Antibiotic susceptibility to 12 antibiotics were tested using standard disk diffusion 
methods as previously described (Mahon et al., 2014). Antibiotic susceptibilities to 
oxacillin (1 µg), vancomycin (5 µg), gentamicin (10 µg),  mupirocin (20 µg), 
amoxicillin (10 µg), erythromycin (5 µg),  tetracycline (10 µg),  streptomycin (10 µg),  
cefepime (30 µg) ,  fusidic acid (10 µg) ,  penicillin G (1 unit)  and chloramphenicol (30 
µg) were tested  (Mast Group, Merseyside, UK). The panel of 12 antibiotics used 
belonged to 8 different classes of antibiotics. These antibiotics were selected as these 
are the most common antibiotics used for profiling of antibiotic susceptibility in 
staphylococci. The amount of antibiotic on the discs is recommended by BSAC and 
CLSI standards (Howe & Andrew, 2012; Creagh & Lucey, 2007).  
Antibiotic susceptibility tests of 120 staphylococcal isolates were carried out by the 
final year project students studying Biomedical Science program in 2014. 
2.4.2 MIC test 
The minimum inhibitory concentration (MIC) to oxacillin was additionally evaluated 
using ‘‘M.I.C. evaluators’’ (Oxoid Ltd., Basingstoke, UK). The antimicrobial gradient 
method towards oxacillin was applied to all mecA gene positive staphylococci. Test 
methods and interpretation were according to manufacturer’s instruction. The MIC strip 
(Oxoid Ltd, Basingstoke, UK) is a plastic strip with an antibiotic gradient from the 
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lowest concentration (0.015 mg l
-1
) at the bottom to the highest concentration (256 mg l
-
1
) at the top. The MIC strips were placed on the surface of pre-inoculated iso-sensitest 
agar plates, and the scale was facing up. After 18-24 h incubation, the lids of petri 
dishes were removed, and the MICs were determined where the growth ellipse 
intersects the MIC strip (Fig 2.3) (Jorgensen & Ferraro, 2009).  
 
Figure 2. 3 Photograph of isosensitest agar plate with a MIC strip (oxacillin) (Picture 
was taken by me) 
2.4.3 Interpretation 
BSAC standards were used to interpret gentamicin, vancomycin, penicillin, 
erythromycin, tetracycline, fusidic acid and mupirocin (Howe & Andrews, 2012). The 
antibiotics (oxacillin, cefepime, streptomycin, chloramphenicol, amoxicillin) that cannot 
be interpreted by BSAC, were interpreted by CLSI standards (Creagh & Lucey, 2007; 
Wayne, 2014). In addition, MIC of oxacillin was interpreted with CLSI standards. 
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2.5 Molecular characterization of staphylococci   
2.5.1 mecA gene detection 
2.5.1.1 mecA gene determined by polymerase chain reaction 
2.5.1.1.1 Primers 
Two pairs of primers were used for mecA gene exploration, including met1, met2 
(Hanssen et al., 2004) and mA1, mA2 (Kondo et al., 2007) (Table 2.1). 
Table 2. 1 Two sets of primers for mecA gene PCR 
mecA Primers Primer sequence Amplicon size 
(bp) 
Reference 
met1 GGGATCATAGCGTCATTATTC 527 Hanssen et al, 2004 
met2 AACGATTGTGACACGATAGCC   
mA1 TGCTATCCACCCTCAAACAGG 286 Kondo et al, 2007 
mA2 AACGTTGTAACCACCCCAAGA   
 
2.5.1.1.2 PCR reaction system 
For met1 and met2 primers, the PCR was prepared according to Hanssen et al., (2004) 
with minor modification. The PCR were carried out with the standard PCR mixture with 
Phusion
®





 High-Fidelity DNA Polymerase, 0.2 mM each dNTP, 1× 
Phusion
®
 High-Fidelity Buffer, approximately 10 ng template DNA and 1.5 mM MgCl2. 
0.8 µM of each primer in a final volume of 25 µl (Hanssen et al., 2004). For mA1 and 
mA2 primers, the PCR preparation was referred to Kondo et al., (2007).  The reaction 
mixtures contained approximately 10 ng templates DNA, 0.1 µM oligo-nucleotide 
primers. 0.2 mM of each deoxynucleotide triphosphates, 3.2 mM MgCl2, Ex Taq buffer, 
and 2.5 U Ex Taq polymerase (Takara Bio Inc., Tokyo. Japan) in a final volume of 25 
µl (Kondo et al., 2007).  
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2.5.1.1.3 PCR cycle  
The PCR program for met1 and met2 primers started with an initial denaturation step at 
94℃ for 5 min followed by 35 cycles of denaturation at 94℃ for 30 s, annealing at 52℃ 
for 30 s, and extension at 72℃ for 1 min, ending with a final extension step at 72℃ for 
10 min and followed by a hold at 4℃ (Hanssen et al., 2004).  For mA primers, the PCR 
program began with an initial denaturation step at 94℃ for 2 min followed by 30 cycles 
of denaturation at 94℃ for 2 min, annealing at 57℃ for 1 min, and extension at 72℃ for 
2 min; and a final elongation step at 72℃ for 2 min (Kondo et al., 2007).  
2.5.1.2 mecA gene determination by Southern blotting 
Southern blotting was performed for several isolates recovered from study to confirm 
the presence of mecA gene. 
2.5.1.2.1 Genomic DNA extraction 
Fresh culture was prepared on nutrient agar (Oxoid Basingstoke, UK) for 24 hours. 
DNA extraction was undertaken using the DNA extraction kit (Qiagen, Crawley, UK) 
according to manufacturer’s instruction. The colonies of 2 to 4 plates were collected for 
one extraction column to obtain a high concentration of DNA. 
2.5.1.2.2 DNA Probe  
mecA gene primers (mA1 and mA2) were used to amplify the DNA probe for Southern 
blotting. The probe was amplified by PCR DIG probe synthesis kit with some minor 
modification (Roche, F. Hoffmann-La Roche Ltd). 50 µl PCR mixture tube contains: 
0.25 µl of each primer, 5 µl 10×PCR buffer with MgCl2, 5 µl 10×PCR DIG probe 
synthesis mix, 0.75 µl enzyme mix, approximately 10 ng template DNA , 3.4 µl MgCl2 
solution. The PCR program was as followings:  denaturation at 94℃ for 5 min, 30 
86 
 
cycles of denaturation at 94℃ for 1 min, annealing at 50℃ for 1 min, extension at 72℃ 
for 2 min, and final extension was 72℃ for 10 min. 
2.5.1.2.3 DNA digestion 
The digestion of genomic DNA was carried out with restriction enzyme Cla I (5000U 
ml
-1
) (Biolabs, New England) according to manufacturer’s instruction with minor 
modification. The digestion system contained 2 µg genomic DNA, 5 µl buffer 4, 2 µl 
Cla I (5000 U ml
-1
), BSA 0.5 µl and dH2O 12.5 µl. The digestion was performed at 37℃ 
for 1 hour. 
2.5.1.2.4 Gel electrophoresis 
After running the gel at 100 V for 10 min, the voltage has been reduced to 36 V and left 
for 7 hours. An image of the gel was taken, and band size comparison was visualised by 
placing a ruler parallel to the length of the gel. Clear bands are indicative of complete 
digestion.  
2.5.1.2.5 DNA Transfer 
Firstly, the gel was bathed in depurination solution for 15 min, and then washed by 
dH2O. Secondly, the gel was bathed in the denaturation buffer for 30 min, and washed 
by dH2O. Finally, the gel was bathed in neutralisation buffer for 1 hour, and washed in 
dH2O. 
One layer of Whatman 3 mm paper was placed on the large plastic gel tray, with two 
sides in 20×SSC solution. The paper was soaked by 20×SSC, and a stripette was used to 
roll out any air bubbles. The paper was then topped by one layer of smaller Whatman 3 
mm paper, and again the smaller Whatman 3mm paper was soaked in 20×SSC.  Air 
bubbles in the smaller Whatman 3mm paper were rolled out. The agarose gel containing 
the genomic DNA digests was placed on top, soaked by 20×SSC, and then lined edges 
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by cling film. A waterproof seal was formed around it, so that all the 20×SSC was 
drawn up through only the gel and membrane. An Amersham Hybond-N Nylon 
membrane (GE Healthcare, UK) was lined up with the gel, and the right corner of the 
nylon membrane was cut for labelling. The nylon membrane was placed on the gel, 
soaked by 20×SSC and air bubbles were rolled out from nylon membrane. The nylon 
membrane was then topped with one gel sized Whatman 3 mm paper, again soaked by 
20×SSC and air bubbles was rolled out from Whatman 3 mm paper. A packet of 
handtowels was piled up on the gel sized Whatman 3 mm paper, and topped by a plastic 
lid and weight. Two hours later, 20×SSC soaking through the gel and membrane into 
the tissue was checked and left overnight.  
2.5.1.2.6 DNA hybridization 
Pre-hybridization solution was warmed up to 68℃ and sonicated fish sperm DNA was 
thawed. The membrane was disassembled, and transferred into the UV crosslinker. 
Membrane DNA-side up was fixed by UV crosslinker, and the membrane was then 
soaked in 25 ml pre-hybridization solution mixed with 0.2 mg ml
-1
 sonicated fish sperm 
DNA, and incubated in a sealed box at 68℃ for 6 hours. The mecA gene probe was 
denatured at 80℃ for 15 min, and 30 µl of the probe was then added into the pre-
hybridization solution to make hybridization solution. The membrane was soaked in 
hybridization solution, and incubated overnight in a sealed the box. The membrane was 
washed in 2×SSC, 0.2% (w/v) SDS solutions at room temperature for 15 min, and then 
washed in 0.2×SSC, 0.2% (w/v) SDS solutions at room temperature for 15 min. 
After hybridization and stringency washes, the membrane was incubated in 100 ml 
blocking solution for 30 min at room temperature, and incubated in 20 ml antibody 
solution (2 µl Anti-Digoxigenin-AP, 20 ml Blocking solution) at room temperature for 
30 min. The membrane was washed twice with 100 ml washing buffer, and then 
88 
 
equilibrated in 20 ml detection buffer at room temperature for 2-5 min. Membrane 
DNA-side up was placed on an opened-up plastic bag and 2 ml diluted CSPD 
(Appendix I.3) solution was applied on the top.  The other side of the plastic bag was 
folded over the top of the membrane to make the CSPD solution distributed evenly over 
the membrane surface, and the edges around the membrane were sealed by the plastic 
sealer. The sealed membrane was kept in the cassette to avoid light damage, and 
incubated at 37℃ for 15 min. The membrane was exposed to X-ray film for 10 min, and 
the film was developed. First, the film was bathed in developer solution until the image 
appears, and then rinsed with water. Then, the film was bathed in fixer solution for 30 s, 
and rinsed with water again. Finally, the film was hung up to dry. 
2.5.2 mecC gene detection 
The presence of mecC gene was detected in oxacillin resistant staphylococcal isolates, 
and one pair of primers was used in this study. 
2.5.2.1 Primers 
mecC_Uni_F: GGATCTGGTACAGCATTACAACC, mecC_Uni_R: TGCTTTAAATC 
RATMTTGCCG was used to determine the mecC gene, which gives a 332 bp product 
(García-Álvarez et al., 2011).  
2.5.2.2 PCR reaction system 
The PCR was carried out by method used by García-Álvarez et al., (2011). A 25 μl PCR 
reaction was conducted containing 12.5 µl Phusion
®
 High-Fidelity PCR Master Mix 




 High-Fidelity DNA Polymerase, 0.2 mM each 
dNTP, 1× Phusion® High-Fidelity Buffer) (NEB, UK), 4 mM MgCl2, 0.15 mM KCl, 15 
mM Tris, 4 μM of each primer, and approximately 10 ng of DNA template.  
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2.5.2.3 Cycling scheme for PCR 
The cycling programme starts with a denaturation step at 94℃ for 4 min, and 32 cycles 
of denaturation for 45 s at 94℃, annealing for 45 s at 60℃, and extension for 45 s at 
72℃, with a final extension step 72℃ for 5 min (García-Álvarez et al., 2011).  
2.5.3 SCCmec typing 
SCCmec is a mobile genetic island with two essential components, mec complex and 
ccr complex (IWG-SCC, 2009). Eleven SCCmec types have been identified to date. 
Typing was based on the combination of mec complex and ccr complex (IWG-SCC, 
2009). SCCmec types I to IX (except VII) were tested in this study. 
2.5.3.1 Primers 
The SCCmec M-PCR typing assay contains 8 pairs of primers including the unique and 
specific primers for SCCmec types and subtypes I, II, III, IVa, IVb, IVc, IVd and V 
(Zhang et al., 2005). Primers for SCCmec types and subtypes were as followings: I 
(Type I-F, Type I-R), II (Type II-F, Type II-R), III (Type III-F, Type III-R), IVa (Type 
IVa-F, Type IVa-R), IVb (Type IVb-F, Type IVb-R), IVc (Type IVc-F, Type IVc-R), 
IVd (Type IVd-F, Type IVd-R) and V (Type V-F, Type V-R) (Table 2.2). 
Another approach used for SCCmec typing was determined by the combination of mec 
complex and ccr complex types. Multiplex PCR was used to determine mec complex: 
class A mec (mI6, mA7), class B mec (IS7, mA7), and class C mec (IS2, mA7). 
Multiplex PCR was also used for ccr complex: type 1 ccr (α1, βc); type 2 ccr (α2, βc); 
and type 3 ccr (α3, βc). Single target PCR was applied to type 4 ccr (α4.2, β4.2) and 
type 5 ccr (γF, γR). These primers and their respective concentrations used in the PCR 
were listed in Table 2.2.  
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The specific concentration of each primer can be explained by the previously described 




Table 2. 2 Primers for SCCmec typing 
primer Oligonucleotide sequence(5’-3’) Concentration 
(µM) 
Amplicon Size  
(bp) 
Specificity Reference 
Type I-F GCTTTAAAGAGTGTCGTTACAGG 0.048 613 SCCmec I Zhang et al., 2005 
Type I-R GTTCTCTCATAGTATGACGTCC 0.048    
Type II-F CGTTGAAGATGATGAAGCG 0.032 398 SCCmec II Zhang et al., 2005 
Type II-R CGAAATCAATGGTTAATGGACC 0.032    
Type III-F CCATATTGTAGTACGATGCG 0.04 280 SCCmec III Zhang et al., 2005 
Type III-R CCTTAGTTGTCGTAACAGATCG 0.04    
Type IVa-F GCCTTATTCGAAGAAACCG 0.104 776 SCCmec IVa Zhang et al., 2005 
Type IVa-R CTACTCTTCTGAAAAGCGTCG 0.104    
Type IVb-F TCTGGAATTACTTCAGCTGC 0.092 493 SCCmec IVb Zhang et al., 2005 
Type IVb-R AAACAATATTGCTCTCCCTC 0.092    
Type IVc-F ACAATATTTGTATTATCGGGAGAGC 0.078 200 SCCmec IVc Zhang et al., 2005 
Type IVc-R TTGGTATGAGGTATTGCTGG 0.078    
Type IVd-F CTCAAAATACGGACCCCAATACA 0.28 881 SCCmec IVd Zhang et al., 2005 
Type IVd-R TGCTCCAGTAATTGCTAAAG 0.28    
Type V-F GAACATTGTTACTTAAATGAGCG 0.06 325 SCCmec V Zhang et al., 2005 
Type V-R TGAAAGTTTGTACCCTTGACACC 0.06    
mI6 CATAACTTCCCATTCTGCAGATG 0.08 1963 Class A mec Kondo et al., 2007 
mA7 ATATACCAAACCCGACAACTACA 0.08    
IS7 ATGCTTAATGATAGCATCCGAATG 0.08 2827 Class B mec Kondo et al., 2007 
mA7 ATATACCAAACCCGACAACTACA 0.08    
IS2 TGAGGTTCAGATATTTCGATGT 0.08 804 Class C mec Kondo et al., 2007 
mA7 ATATACCAAACCCGACAACTACA 0.08    
βc ATTGCCTTGATAATAGCCITCT 0.08 695 Type 1 ccr Kondo et al., 2007 
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primer Oligonucleotide sequence(5’-3’) Concentration 
(µM) 
Amplicon Size  
(bp) 
Specificity Reference 
α1 AACCTATATCATCAATCAGTACGT 0.08    
Βc ATTGCCTTGATAATAGCCITCT 0.08 937 Type 2 ccr Kondo et al., 2007 
α2 TAAAGGCATCAATGCACAAACACT 0.08    
βc ATTGCCTTGATAATAGCCITCT 0.08 1791 Type 3 ccr Kondo et al., 2007 
α3 AGCTCAAAAGCAAGCAATAGAAT 0.08    
α4.2 GTATCAATGCACCAGAACTT 0.08 1287 Type 4 ccr Kondo et al., 2007 
β4.2 TTGCGACTCTCTTGGCGTTT 0.08    
γR CCTTTATAGACTGGATTATTCAAAATAT 0.08 518 Type 5 ccr Kondo et al., 2007 






2.5.3.2 PCR reaction system 
For Zhang et al’s method, PCR mixture contains 50 mM KCl, 20 mM Tris-HCl (pH 
8.4), 2.5 mM MgCl2, 0.2 mM of each deoxynucleoside  triphosphate (dATP, dUTP, 
dGTP, and dCTP) (Fisher Scientific UK LTD), various concentration of the respective 
primers (Table 2.2), approximately 10 ng template DNA, 1× Phusion® High-Fidelity 




 High-Fidelity DNA Polymerase (NEB, UK) (Zhang 
et al., 2005).  
For Kondo et al’s method, the reaction mixture contain 10 ng chromosomal DNA, 0.1 
µM primers, 0.2 mM each dNTP, 3.2 mM MgCl2. 20 unit ml
-1
 of Phusion® High-
Fidelity DNA Polymerase and 1× Phusion® High-Fidelity Buffer (Kondo et al., 2007).  
2.5.3.3 Cycling scheme for PCR 
The amplification for SCCmec types and SCCmec subtypes I, II, III, IVa, IVb, IVc, IVd 
and V was performed in a T100
T
 Thermal cycler (Bio-rad, UK) beginning with an initial 
denaturation step at 94℃ for 5 min followed by 10 cycles of denaturation at 94℃ for 45 
s, annealing at 65℃ for 45 s, and extension at 72℃ for 1.5 min. Another 25 cycles of 
denaturation at 94℃ for 45 s, annealing at 55℃ for 45 s, and extension at 72℃ for 1.5 
min, ending with a final extension step at 72℃ for 10 min and followed by a hold at 4℃ 
(Zhang et al., 2005).  
For mec complex and ccr complex, PCR was run with T100
T
 Thermal cycler (Bio-rad, 
UK) beginning with an initial denaturation step at 94℃ for 2 min followed by 30 cycles 
of denaturation at 94℃ for 2 min, annealing at 57℃ for 1 min, and extension at 72℃ for 
2 min; and a final elongation step at 72℃ for 2 min (Kondo et al., 2007).   
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2.5.4 Multi-locus sequence typing of S. epidermidis 
Multi-locus sequence typing (MLST) determines the relationship of the isolates with 
international reported types using the DNA sequences of housekeeping genes (Thomas 
et al., 2007). In this study, MLST types were assigned to S. epidermidis. 
2.5.4.1 primers 
The primers used for Multi-locus sequence typing (MLST) of S. epidermidis are as 









Carbamate Kinase (arcC) arcC F TGTGATGAGCACGCTACCGTTAG 
arcC R TCCAAGTAAACCCATCGGTCTG 
Shikimate dehydrogenase (aroE) aroE F CATTGGATTACCTCTTTGTTCAGC 
aroE R CAAGCGAAATCTGTTGGGG 
ABC transporter (gtr) gtr F CAGCCAATTCTTTTATGACTTTT 
gtr R GTGATTAAAGGTATTGATTTGAAT 
DNA mismatch repair protein (muts) muts F GATATAAGAATAAGGGTTGTGAA 
muts R GTAATCGTCTCAGTTATCATGTT 
Pyrimidine operon regulatory protein (pyrR) pyr F GTTACTAATACTTTTGCTGTGTTT 
pyr R GTAGAATGTAAAGAGACTAAAATGAA 
Triosephosphate isomerase (tpiA)  tpi F ATCCAATTAGACGCTTTAGTAAC 
tpi R TTAATGATGCGCCACCTACA 
Acetyl coenzyme A acetyltransferase (yqiL) yqiL F CACGCATAGTATTAGCTGAAG 




2.5.4.2 PCR reaction system 
PCR was prepared according to the unified scheme of Thomas et al., (2007), 
Wisplinghoff et al., (2003) and Wang et al., (2003). PCR were carried out with the 
standard PCR mixture with Phusion
®
 High-Fidelity PCR Master Mix with HF Buffer 




 High-Fidelity DNA Polymerase, 0.2 
mM each dNTP, 1× Phusion
®
 High-Fidelity Buffer, 1.5 mM MgCl2. 0.8 µM of each 
primer and approximately 10 ng template DNA in a final volume of 25 µl. 
2.5.4.3 Cycling scheme for PCR 
PCR involved an initial denaturation of 95°C for 3 min; 34 cycles of denaturation at 
95°C for 30 s, annealing at 50°C for 1 min, and extension at 72°C for 1 min; with a final 
extension of 72°C for 10 min (Thomas et al., 2007; Wang et al., 2003; Wisplinghoff et 
al., 2003).  
2.6 Whole genomic sequence 
2.6.1 Identification of S. epidermidis 118 (G6_2) 
The S. epidermidis 118 (G6_2) was recovered from hotel (DSH) in Oct 2012 in London, 
UK.  
Preliminary identification was achieved by using Matrix-assisted laser desorption/ 
ionization time-of-flight mass spectrometry (Microflex LT, MALDI-TOF MS, Bruker 
Daltonics, Coventry, UK) as described previously (Mkrtchyan et al., 2013).  
Genomic DNA of S. epidermidis 118 (G6_2) was prepared using a QIAamp DNA 
extraction kit (Qiagen, Crawley, UK). 16S rRNA gene sequencing was performed as 
described previously (Okazaki et al., 2009), and amplified PCR products were 
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sequenced by Eurofins MWG operon (Eurofins Genomics, i54 Business Park, Valiant 
Way, Wolverhampton, UK). 
2.6.2 General test of S. epidermidis 118 (G6_2) 
Genomic DNA was extracted with the DNA extraction kit (Qiagen, Crawley, UK). 
mecA gene detection was determined by methods described by Hanssen et al., (2004). 
SCCmec type was carried out by mec and ccr complexes PCR accordingly (Kondo et 
al., 2007).   
The antibiotic susceptibility of S. epidermidis 118 (G6_2) was tested against 13 
antibiotics using disk diffusion methods (Mast Group, Merseyside, UK)， including 
oxacillin (1 µg), vancomycin (5 µg), gentamicin (10 µg),  mupirocin (20 µg), 
amoxicillin (10 µg), erythromycin (5 µg),  tetracycline (10 µg),  streptomycin (10 µg),  
cefepime (30 µg) ,  fusidic acid (10 µg),  penicillin G (1 unit), cefoxitin (10 µg),  and 
chloramphenicol (30 µg). In addition, the minimum inhibitory concentration (MIC) of 
the isolate to oxacillin was determined using ‘‘M.I.C. evaluators’’ (Oxoid Ltd, 
Basingstoke, UK).  
2.6.3 Whole genomic sequence assembly and comparative genomics 
A draft genome sequence of S. epidermidis 118 (G6_2) was produced using HiSeq 2000 
technology.  Genomic DNA was extracted using the MasterPure™ Gram Positive DNA 
Purification Kit (Cambio, Dry Drayton, UK) from overnight cultures grown from single 
colonies in 5 ml of tryptic soy broth overnight at 37℃. Illumina library preparation was 
carried out as described previously (Quail et al., 2008), and genome sequencing using 
Hi-Seq 2000 performed following the manufacturer’s standard protocols (Illumina, 
Little Chesterfield, UK). The whole genome sequence was performed by Dr Gavin K 
Paterson (University of Hull). 
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The raw fastq data was retrieved and quality trimmed using Trimmomatic (version 0.35) 
with default settings, specifying a phred cutoff of Q20.  Read quality was assessed using 
FastQC. The Kraken (version 0.10.5-beta) metagenomic pipeline, KronaTools 
Metagenomics App (version 2.5) was used to assess library purity, that is, it was not a 
mixed sample and validate that the species was S. epidermidis.  De novo assemblies 
were performed using SPAdes Genomic Assembler (version 3.5.0), default PE settings, 
from which only contigs greater than 500 bp in length were taken for further analysis.  
Using the program, Andi (version 0.9.4-beta) the de novo assembled 118 (G6_2) 
genome along with 92 assembled staphylococcal genomes were aligned, clustered and 
visualized using PHYLIP and FigTree.  Annotations were performed using the pipeline 
Prokka (version 1.11).  The resultant annotated genome was used for all subsequent 
comparative genomic studies; including BLAST based genome comparisons visualized 
using the Blast Ring Image Generator (version 0.95) and Mauve (version snapshot 
2015-02-13).  The Presence/absence of genes was assessed using the Roary pipeline 
(version 3.4.2).  BlastP was used to identify potential virulence factors, as defined by 
the VFDB (http://www.mgc.ac.cn/VFs/) and PHI-base (http://www.phi-base.org/ 
about.php), whereby a cut off of ≥ 50% sequence identity over ≥ 50% of the total 
alignment percentage ( = (alignment length/query length)*100) to help determine 
sequence homology.  
2.6.4 Reference strains 
Reference strains for comparative genomic analysis include methicillin resistant S. 
aureus N315 (ASM964v1), biofilm forming S. epidermidis RP62a (ASM1192v1), and 
non-biofilm forming S. epidermidis ATCC12228 (ASM764v1). 
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2.6.5 Nucleotide sequence accession numbers  
Reads for S. epidermidis 118 (G6_2) was stored in European Bioinformatics Institute 
(EMBL-EBI). 
2.6.6 Antibiotic resistance gene determination 
The whole genomic sequences were uploaded to the ResFinder 2.1, which is one of the 
services provided by Center for Genomic Epidemiology (https://cge.cbs.dtu.dk 
/services/ResFinder/). The resistance genes were displayed on the website, with 
similarity to reference genes, and location sites in the genome.  
2.7 mecA gene transfer via broth mating experiment 
In order to find out the possibility of mecA gene transfer from environmental CoNS to S. 
aureus in vitro, mating experiment was performed.  
2.7.1 Cell stock 
The microorganisms used in mating experiment were listed in Table 2.4. 
Table 2. 4 Organisms used in mating experiment 
Organism name Source 
S. aureus NCTC 6571 Oxford University 
S. hominis 399 Environmental culture collection  
  
2.7.2 Mating experiment 
Broth mating experiments were performed in triplicate using mecA gene positive S. 
hominis 399 as donor and mecA gene negative S aureus NCTC 6571 as a recipient. For 
conjugation, 1 ml of overnight culture of donor and 2 ml of the recipient were mixed 
and inoculated in 5 ml NB (Oxoid Ltd, Basingstoke, UK) and incubate for 18 h at 37℃ 
with gentle shaking. After incubation, 100 µl of the culture were spread on a MSA 





(Oxoid Ltd, Basingstoke, UK) and incubated at 37℃. The growth of colonies was 
detected after 24-48 h.  
2.7.3 Prolex
TM
 staph XTRA latex tests 
The transconjugants were then identified by Prolex
TM
 Staph XTRA Latex system 
(Prolab Diagnostics, Neston, South Wirral, UK) following the manufacturer’s 
instruction. 
One drop of the Prolex™ Staph XTRA Latex Reagent was dispensed on the test card, 
mixed with several colonies, and the agglutination/non-agglutination can be observed in 
20 sec. A negative control was tested at the same time. 
For positive results, a high level of agglutination can be observed within 20 sec; and no 
visible agglutination is indicative of negative results. 
2.7.4 MIC oxacillin tests 
The minimum inhibitory concentration (MIC) to oxacillin were evaluated using ‘‘M.I.C. 
evaluators’’ (Oxoid Ltd., Basingstoke, UK). Antimicrobial gradient method towards 
oxacillin was applied to transconjugant and recipient. Test methods and interpretation 
were undertaken according to manufacturer’s instruction. Iso-sensitest agar overlaid 
with fresh culture was prepared for testing. MIC strips contain oxacillin was put on the 
surface of agar plates. After overnight incubation, the results were interpreted by the 
ellipse of inhibition area from the upper side of the plate.  
2.7.5 Pulse-field gel electrophoresis  
In addition to 16S rRNA gene sequencing of transconjugant, the pulse-field gel 
electrophoresis (PFGE) was applied to determine the genetic pattern of donor, recipient 
and transconjugant.  
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2.7.5.1 Preparation of genomic DNA digestion samples 
The bacteria were pelleted and washed in PBS, before being re-suspended in 1% Low 
Melting Point Agarose (BioRad, UK) in buffer (10 mM Tris pH 8.0, 1 M NaCl) at a 
density of 10
8
 cells per ml held at 42°C, prior to being dispensed into a mould (BioRad, 
UK) to form suitable DNA blocks. These were allowed to set on ice for 30 minutes 
before being transferred into a digestion buffer consisting of 3% (w/v) sarkosyl, 0.5 M 
EDTA and 100 µg ml
-1
 of proteinase K. Samples were incubated at 56°C for 24 hours 
before being stored at 4°C until use. DNA blocks were loaded onto a 1% (w/v) agarose 
gel and sealed using 1% (w/v) Low melting point agarose before being loaded onto the 
CHEF Mapper II system (BioRad, UK). 
2.7.5.2 PFGE program 
A phage λ ladder (48.5 kb-1,000 kb) was used as a marker. To separate chromosomal 
DNA from 200 kbp to 2.2 Mbp, a 1% (w/v) agarose gel was run in 0.5 × TBE at 12°C, 
at a gradient of 6 V cm
-1
 with the angle of 120 degree in a linear fashion for a total of 30 
hours.  
2.7.5.3 Gel screening 
Following the electrophoresis, the gel was removed and stained a solution 1 mg ml
-1
 
ethidium bromide in 1 × TAE electrophoresis buffer for 30 minutes before visualizing 
on a UV transilluminator (Syngene, Cambridge, UK).  
The PFGE was performed by Dr Bruno Pichon (Public Health England, London, UK). 
2.8 Proteomic analysis  
Recepient and transconjugant were selected to do comparative proteomic analysis with 
LC-MS/MS, and the method follows the research procedure of Applied and Functional 
Genomics department, Public Health England. 
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2.8.1 Protein extraction 
The cell lysate was produced by using the ‘glass beads’ method (Dekio et al., 2013). A 
full loop of fresh culture was collected and then transferred into a 2 ml vial with 150 µl 
lysis buffer (0.5 M sucrose, 20 mM maleic acid, pH 6.5, 20 mM MgCl2, 6 mg ml
-1
 
lysozyme, and 1 mM PMSF). After mixed thoroughly, 1 g glass beads (Sigma-Aldrich, 
UK) were added to the mixture. The highest setting of the vortex mixer was used, and 
the suspension was vortex mixed 3 - 5 times for 1 min. Each time the cells were kept on 
ice for 1 minute between vortex mixes.  
After mixing, the cells were pelleted by centrifugation at 21000 g for 20 min. The 
supernatant were transferred into 1.5 ml eppendorf tubes, and kept at -20℃ until further 
use. 
2.8.2 Protein concentration 
Protein concentration was determined by Bradford assay (Bio-Rad, USA). BSA was 
used as standard, and the protein standard curve was obtained from seven concentration 
of BSA (0.05 mg ml
-1
, 0.1 mg ml
-1
, 0.2 mg ml
-1
, 0.4 mg ml
-1
, 0.6 mg ml
-1
, 0.8 mg ml
-1
 
and 1 mg ml
-1
). Each sample was diluted 10 times, and 20 µl of cell lysate was mixed 
with 180 µl Bradford reagent (Sigma-Aldrich, UK). The absorbance at 595 nm of each 
protein sample was detected as duplicates in a 96 well plates using the FLUOstar 
Omega Microplate Reader (BMG LABTECH, Offenburg, Germany). The concentration 
was calculated using the FLUOstar Omega evaluation software (BMG LABTECH, 
Offenburg, Germany). Pre-set Bradford templates can be used to do the calculations.  
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2.8.3 One-dimensional SDS-PAGE  
10 μg protein of each sample was loaded on a 10% (w/v) Bis–Tris gel (Invitrogen, UK), 
and protein was separated at a voltage of 180 V for 30 min using MES running buffer 
(Invitrogen, UK) in accordance with the manufacturer’s instructions. 
2.8.4 In-gel tryptic digestion of protein for LC-MS/MS 
The gel was stained by colloidal Coomassie (Sigma-Aldrich, UK). Each gel lane was 
cut into 12 pieces and bands were placed in wells in a 96 well plate accordingly. The 
stain was washed by 50% (v/v) methanol (Fisher Scientific, UK) for 2 ×20 min, and 
then left in 50% (v/v) methanol overnight for thorough de-staining. Dehydration was 
achieved by soaking in 100% (v/v) acetonitrile (Fisher Scientific, UK) for 10 min and 
dried for 5 min, 10 mM DTT (GE Healthcare, UK) was used for reduction, and 55 mM 
iodoacetamide was added for alkylation. Dehydrated gels were incubated with10 ng μl
-1
 
porcine trypsin (modified sequencing grade; Promega, USA) for 16 h at 37°C, and 
peptides were extracted by addition of 2% (v/v) acetonitrile (Fisher Scientific, UK) and 
0.1% (v/v) trifluoroacetic acid (TFA) (Sigma-Aldrich, UK) for 1 h. After centrifugation, 
the supernatant were collected and stored at −80°C for further use.  
2.8.5 LC-MS/MS analysis of tryptic peptides 
2.8.5.1 EASY-nLC 
The proteolytic digests of the protein extracts were further separated by a split-free 
EASY-nLC 1000 liquid chromatograph system (Thermo Scientific, UK) and analysed 
by Thermo LTQ Orbitrap Classic mass spectrometers (Thermo Electron, Bremen, 
Germany). Peptide mixtures were initially trapped and desalted on a reversed phase trap 
column (C18, 300 µm i.d. × 3 mm, Thermo Scientific., UK) and further separated on an 
analytical reversed-phase (RP) nano column (C18, 3 µm particle size, 75 µm i.d. × 15 
cm, Thermo Scientific., UK). Separation were achieved using a 38-minute linear 
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gradient of 4 to 45% solvent B (99.9% CH3CN/0.1% formic acid, v/v) versus solvent A 
(99.9% H2O/0.1% formic acid, v/v), then to 90% B and held at 90% B for an additional 
9 mins, at a flow rate of 300 nl min
-1
.  
2.8.5.2 LTQ Orbitrap  
MS/MS experiments were performed on the Thermo Finnigan Orbitrap Classic mass 
spectrometer (Thermo Electron, Bremen, Germany) equipped with a nanospray 
ionization source and a Stainless Steel Emitters (length 105 mm, with sleeve O.D. 360 
µm).  The mass spectrometer was operated in positive mode. Helium was used as 
collision gas but no sheath and auxiliary gas were applied. Full MS scans were acquired 
in the Orbitrap mass analyzer over the m/z 350–2000 range with resolution 60,000 (m/z 
400). The target value was 5.00E+05. The twenty most intense peaks with charge state 
≥ 2 were selected for sequencing and fragmented in the ion trap with normalized 
collision energy of 35%, activation q = 0.25, activation time of 10 ms, and one 
microscan. The target value was 1.00E+04. The ion selection threshold was 500 counts, 
and the maximum allowed ion accumulation times were 500 ms for full scans and 100 
ms for collision-induced dissociation (CID). Tandem MS (MS/MS) data was acquired 
in ‘data-dependent’ mode. The six most abundant peptide precursor ions detected in the 
preceding survey scan were dynamically selected and subjected for CID in the linear ion 
trap to generate MS/MS spectra. Samples were analysed as biological triplicates.  
2.8.5.3 Searching database 
Peptide identification was performed using Proteome Discoverer (version 1.4.1; Thermo 
Scientific) against staphylococcal database downloaded from Uniprot. The workflow 
consisting of the following nodes (and respective parameters): Spectrum Selector for 
spectra pre-processing (precursor mass range: 350–5000 Da; S/N Threshold: 1.5), 
Sequest-HT as search engine (Protein Database: see below; Enzyme: Trypsin; Max. 
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missed cleavage sites: 2; Peptide length range 6–144 amino acids; Max. Delta Cn: 0.05; 
Precursor mass tolerance of 10.0 ppm; Fragment mass tolerance of 0.60 Da; Static 
modification: cysteine carbamidomethylation; Dynamic modification: methionine 
oxidation), and percolator for peptide validation (FDR<1 % based on peptide q-value).  
EASY-nLC, LTQ Orbitrap, and searching database were performed by Dr Min Fang 
(Public Health England, London, UK).  
2.9 Bioinformatic analysis 
 
2.9.1 mecA and mecC gene 
mecA and mecC gene PCR product in the gel were analysed by Syngene software 
(Syngene, Cambridge, UK), and band matching was performed by position to determine 
the size of PCR product.  
2.9.2 SCCmec typing  
PCR products of SCCmec typing were also analysed by band matching tool to confirm 
the size (Syngene, Cambridge, UK).  
According to Zhang’s SCCmec typing method, SCCmec type I to V was determined by 
the size of PCR products directly (Zhang et al., 2005).  
SCCmec typing method introduced by Kondo et al., (2007) was based on the 
combination of ccr complex and mec complex. The types were determined using the 
guidelines proposed by the International Working Group on the Staphylococcal Cassette 
Chromosome elements (IWG-SCC, 2009) (http://www.sccmec.org/Pages/SCC_Classi-
ficationEN.html). 
2.9.3 BioNumerics analysis 
In this study, BioNumerics
 
7.5 (Applied Maths, Belgium) was employed to analyse 
MALDI-TOF MS data of staphylococcal species. In order to improve the quality and 
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reliability of cluster analysis, isolates of each site with high quality spectra were chosen 
to do cluster analysis.   
2.9.3.1 Taxonomic analysis of selected staphylococci 
MALDI-TOF MS raw data were imported into BioNumerics
 
7.5 (Applied Maths, 
Belgium) software. The dendrogram tree was built by clicking ‘Clustering>Calculate> 
Advance cluster analysis’ in the comparison window. Topscore UPGMA was chosen to 
build a standard dendrogram tree, and the radial tree was generated by click 
‘Edit>Remove root’. 
Three-dimensional (3D) scatter plots were built by clicking ‘Clustering>Calculate> 
Cluster analysis (similarity matrix)', and comparison setting was based on ‘pearson 
correlation>UPGMA method'. A standard dendrogram tree was built, and 3D image was 
generated by click ‘Multi-dimensional scaling>Use metric algorithm'. 
2.9.3.2 Taxonomic analysis of staphylococci based on isolation sites 
MALDI-TOF mass spectrometry of isolates recovered from different sites were 
taxonomically analysed by BioNumerics
 
7.5 (Applied Maths, Belgium) software 
package. In order to differentiate each sample collection site, different colours were 
used, each of which indicates a specific site. The dendrogram tree and 3D images were 
built based on UPGMA method according to the BioNumerics 7.5 manual (Applied 
Math, Belgium).   
2.9.3.3 Taxonomic analysis of staphylococci based on Antibiotic susceptibility  
All selected isolates were additionally grouped based on their antibiotic susceptibility 
profiles. In these groups, red colour was selected to demonstrate the presence of 
multiple resistant (resistance to two or more antibiotics) staphylococci and green colour 
was selected for susceptible staphylococci isolates.   
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2.9.4 Multi-locus sequence typing   
Each housekeeping gene locus sequence was uploaded into the MLST database 
(http://www.mlst.net/) to obtain a single locus type. All 7 single locus types were then 
combined to query for the match in the database (http://www.mlst.net/).  New MLST 
types are required be sent to the S. epidermidis curator Dr Maria Miragaia via email 




















Chapter 3 Isolation, purification of environmental Staphylococci 
Staphylococci on human skin, have been responsible for wide range of infections: from 
minor skin infection to life threatening toxic shock syndrome (Monecke et al., 2011). 
Various virulence factors and antibiotic resistance genes contribute to increased 
pathogenicity of staphylococci (Oliveira & Tomasz, 2002). Determination and 
clarification of the virulence factors and antibiotic resistance require collection of 
staphylococcal isolates from clinical environment (Oliveira & Tomasz, 2002). Since 
environmental staphylococci acts as a reservoir of antibiotic resistant determinants for 
clinical pathogens (Blair et al., 2014), it would be necessary to assess dissemination of 
antibiotic resistant environmental staphylococci. A large quantity of staphylococci 
recovered from hands and 8 inanimate sites were included in this study. 
3.1 Sample collection  
Permission was first granted to gain access and sample inanimate sites and hands of 
anonymous volunteers all over the London, United Kingdom.  The findings for each site 
were given to each manager/owner for their permission.  The sample collection detailed 
in Table 3.1, consists of the followings: ① 65 samples were collected from the baby 
care facilities (BCF); ② 188 swabs collected from different sites of four hotels (DSH); 
③ 20 samples were collected from different sites of one public library (DSL); ④ 36 
samples were collected from different sites of three restaurants (DSR); ⑤ a total of 37 
samples were collected from different sites of five supermarkets (DSS); ⑥ 54 swabs 
were collected from different sites of transportation facilities (DST); ⑦ 12 hotel air 
samples (HAS) were collected from 12  hotel rooms; ⑧ 43 samples were isolated from 
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anonymous volunteers’ handbags (HB); ⑨ 124 swabs were sampled from the hands of 
randomly selected anonymous volunteers (HH)  (Table 3.1). 
In addition, sampling sites of eight inanimate sites and human hands were as followings: 
① BCF include dummies, soft play, mother’s change bags, child car seats and nappy 
changing area; ② DSH includes TV remote controls, mattresses, pillows, duvets, tables, 
basin surface, lift buttons, hand dryers, water taps, paper dispensers, toilet rims, toilet 
floor, toilet handles, wardrobe handles, bedside lights, keyboards and room carpet floor; 
③ DSL were sampled from books; ④ DSR include knife handles and fork handles; ⑤ 
DSS include shelves and trolley handles; ⑥ DST include seats, hand rail of buses, 
pelican crossing buttons on Mile End road, between Queen Mary University of London 
and Royal London hospital; ⑦ HAS were sampled from hotel room air; ⑧ HB includes 
anonymous volunteers’ handbags; ⑨  HH include anonymous volunteers’ hands in 
London area (Table 3.1).  All specimens were transferred to the laboratory within 1-3 














Table 3. 1 Samples collected from hands and hands related inanimate sites 





Mother’s change bags 
Child car seats 
Nappy changing area 
DSH 

















Room carpet floor 










Pelican crossing buttons 
54 113 Seats 
Hand rails 
HAS Inside of hotel rooms 12 30 
HB Handbags 43 64 
HH Hands 124 287 
Note: BCF- baby care facilities; DSH- different sites of hotels; DSL- different sites of a 
library; DSR- different sites of restaurants. DSS- different sites of supermarkets; DST-
different sites of transportation facilities; HAS- hotel air samples; HB- handbags; HH- 
human hands. 
 
3.2 Isolation  
After sample collection, a total of 579 samples were plated onto NA (Oxoid Ltd, 
Basingstoke, UK), MSA (Oxoid Ltd, Basingstoke, UK) and UTI (Oxoid Ltd, 
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Basingstoke, UK) plates accordingly. The numbers of isolates recovered from each site 
were as follows: BCF: 77 isolates; DSH: 282 isolates; DSL: 50 isolates; DSR: 152 
isolates; DSS: 176 isolates; DST: 113 isolates; HAS: 30 isolates; HB: 64 isolates; HH: 
287 isolates (Table 3.1). 
The numbers of colonies on NA ranged from none to uncountable. No uncountable 
results were found in following sites: DSL, DSR, DSS, DST, HAS, HB and HH. 
However, 40% of DSH samples had uncountable numbers of colonies, and followed by 
BCF samples (11%). 
Mannitol fermented and not-fermented colonies were recovered from all nine sites: BCF, 
DSH, DSL, DSR, DSS, DST, HAS, HB and HH. The species found at each site 
differentiated by UTI (Oxoid Ltd, Basingstoke, UK) were as follows: BCF: 
Enterococcus spp., E.coli, Proteus, Pseudomonas spp. staphylococci; DSH: 
Enterococcus spp., E.coli, Proteus, Pseudomonas spp., staphylococci; DSL: E.coli, 
staphylococci; DSR: Enterococcus spp., E.coli, Pseudomonas spp., staphylococci; DSS: 
Enterococcus spp., E.coli, Pseudomonas spp., staphylococci; DST: Enterococcus spp., 
E.coli, staphylococci; HAS: E.coli, staphylococci; HB: E.coli, staphylococci; HH: 
Enterococcus spp., E.coli, Pseudomonas spp., staphylococci (Fig 3.1).  
 
 






Following the isolation process, a total of 1231 isolates were purified, including 77 
isolates from BCF, 282 from DSH, 50 from DSL, 152 from DSR, 176 from DSS, 113 
from DST, and 30 from HAS, 64 from HB, 287 from HH (Table 3.1). 79 out of 1231 
isolates were eliminated from further investigation as their morphological 
characteristics were not consistent with staphylococci.   
3.4 Chapter summary 
The isolation of environmental bacteria included: 
1. Nine sampling sites:  BCF, DSH, DSL, DSR, DSS, DST, HAS, HB, HH were 
included in this study; 
2. A total of 1231 isolates recovered from human hands and inanimate sites. 
Determination the dissemination of antibiotic resistance requires the collection of 
staphylococcal isolates. This chapter introduced the collection and isolation of bacteria 
from human hands and 8 human-related inanimate sites using microbiology techniques. 
Baby care facilities and handbags are personal items, while hotels, hotel air, library, 
restaurants, supermarkets and transportation facilities are public settings. The 
importance of the predominant staphylococcal species of each site will be discussed in 
the discussion chapter. Evaluation of the sampling sites as reservoirs for antibiotic-







Chapter 4 Identification of environmental staphylococci 
The importance of rapid and accurate identification of microorganism has been well 
characterized (Valentine et al., 2005; Yao et al., 2002).  MALDI-TOF MS has been 
proven to be a reliable and efficient tool for identification of clinical staphylococci (Van 
Veen et al., 2010).  In our study, it was necessary to identify a large number of 
staphylococci, and MALDI-TOF MS was employed to determine these isolates. The 
reproducibility of MALDI-TOF MS was assessed in this study. In addition, classical 
16S rRNA gene sequencing was employed to evaluate the efficacy of MALDI-TOF MS 
in identifying environmental staphylococci.  
The spread of staphylococci from person to person are mainly via hands, and hands that 
frequently touch inanimate sites can be important bacterial reservoirs for transmission 
(Johansson et al., 2007; Mollema et al., 2010). However, little is known about the 
connection of staphylococci isolated from different sites. Here, I reported taxonomic 
analysis based on MALDI-TOF MS profile. A total of 411 staphylococci recovered 
from BCF, DSL, DSH, DSR, DSS, DST, HAS, HB, HH were selected to analyse the 
possible taxonomic relationship. In addition, the taxonomic relationship of each species 
was described separately.    
4.1 Bacterial identification by MALDI-TOF MS 
To determine the species of purified isolates, a total of 1152 isolates representing each 
of the collection sites were identified by MALDI-TOF MS. The control identification 
index of the MALDI-TOF MS, Biotyper 3.1 score values were 2.314 to 2.422 (with a 
mean of 2.371 ± 0.044 S.D) for Escherichia coli DH5α. Of the 1152 monomicrobial 
bacterial cultures, 991 (86%) produced acceptable identification scores of ≥ 1.7 using 
the MALDI-TOF MS - Biotyper 3.1 identification system. This included 844 (85%) 
114 
 
cultures with high confidence scores of ≥ 2.0 and 147 (15%) cultures with intermediate 
confidence scores of 1.70 to 1.99. Of 991 monomicrobial cultures, 971 (98%) contained 
Gram-positive organisms, 19 (2%) contained Gram-negative organisms, and one fungus. 
Within 991 monomicrobial cultures, 67 species were identified in this study, which, 
except for one fungus, consisted of 9 Gram-negative species, and 57 Gram-positive 
species (Fig 4.1). 
Gram-positive bacteria: the distribution of confidence scores within the 971 Gram-
positive cultures, 14% intermediate (1.7 to 1.99), and 86% high (2.0 to 3.0) (Table 4.1). 
718 out of the 971 Gram-positive cultures were identified to be staphylococci, of which 
618 produced high confidence scores of ≥ 2.0, at meantime, and 100 produced 
intermediate confidence scores (Table 4.1). Despite the diversity of Gram-positive 
species, most of these isolates were identified to be staphylococci. There were 19 
staphylococcal species that were identified in this study:  S. arlettae, S. auricularis, S. 
aureus, S. capitis, S. caprae, S. cohnii, S. epidermidis, S. equorum, S. haemolyticus, S. 
hominis, S. lugdunensis, S. pasteuri, S. pettenkoferi, S. saprophyticus, S. sciuri, S. 
simiae, S. simulans, S. warneri, and S. xylosus, which makes one third of all Gram-
positive species. (Table 4.1) 
Gram-negative bacteria:  11 of 19 (58%) Gram-negative cultures generated high 







Table 4. 1 MALDI-TOF MS identification of environmental isolates 
Organism No of isolates Division 






Staphylococcus epidermidis 198 G+ 28 170 
Staphylococcus hominis 173 G+ 19 154 
Staphylococcus haemolyticus 79    G+ 11 68 
Staphylococcus capitis 79 G+ 9 70 
Staphylococcus warneri 68 G+ 11 57 
Staphylococcus pasteuri 34    G+ 2 32 
Staphylococcus saprophyticus 20     G+ 5 15 
Staphylococcus cohnii 14 G+ 3 11 
Staphylococcus aureus 12     G+ 0 12 
Staphylococcus simiae 10     G+ 5 5 
Staphylococcus sciuri 6       G+ 1 5 
Staphylococcus pettenkoferi 5       G+ 3 2 
Staphylococcus lugdunensis 5 G+ 0 5 
Staphylococcus equorum 3      G+ 1 2 
Staphylococcus caprae 2       G+ 0 2 
Staphylococcus xylosus 2       G+ 1 1 
Staphylococcus auricularis 2       G+ 0 2 
Staphylococcus simulans 1 G+ 0 1 
Staphylococcus arlettae 1 G+ 0 1 
Staphylococcus sp 4 G+ 1 3 
Acinetobacter lwoffii 4 G- 1 3 
Acinetobacter sp 1 G- 1 0 
Aerococcus viridans 5 G+ 2 3 
Alcaligenes faecalis 2 G- 1 1 
Bacillus altitudinis 1 G+ 1 0 
Bacillus cereus 4 G+ 3 1 
Bacillus cohnii 1 G+ 0 1 
Bacillus flexus 1 G+ 0 1 
Bacillus licheniformis 5 G+ 2 3 
Bacillus megaterium 2 G+ 1 1 
Bacillus oshimensis 1 G+ 1 0 
Bacillus pumilus 2 G+ 1 1 
Bacillus subtilis 5 G+ 3 2 
Bacillus thuringiensis 1 G+ 0 1 
Bacillus weihenstephanensis 1 G+ 1 0 
Brevibacterium casei 5 G+ 2 3 
Candida parapsilosis 1 F
a
 0 1 
Corynebacterium afermentans 3 G+ 2 1 
Corynebacterium amycolatum 1 G+ 1 0 
Corynebacterium aurimucosum 7 G+ 0 7 
Corynebacterium falsenii 1 G+ 0 1 
Corynebacterium minutissimum 2 G+ 0 2 
Corynebacterium 
pseudodiphtheriticum 
1 G+ 1 0 
Corynebacterium striatum 1 G+ 0 1 
Dermacoccus nishinomiyaensis 3 G+ 1 2 
Dietzia cinnamea 1 G+ 0 1 
Enterobacter cloacae 1 G- 0 1 
Note: a: F: fungus; b: The match of MALDI-TOF MS identification at the species level with a 
score value ≥2.0 and at a genus level with a score value 1.7-1.99. 
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Organism No of isolates Division 






Kocuria carniphila 7 G+ 1 6 
Kocuria kristinae 13 G+ 1 12 
Kocuria marina 3 G+ 2 1 
Kocuria palustris 13 G+ 2 11 
Kocuria rhizophila 9 G+ 2 7 
Kocuria rosea 2 G+ 0 2 
Kocuria sedentarius 2 G+ 1 1 
Kytococcus schroeteri 3 G+ 0 3 
Kytococcus sedentarius 3 G+ 2 1 
Micrococcus luteus 138 G+ 4 134 
Micrococcus lylae 1 G+ 0 1 
Micrococcus terreus 1 G+ 1 0 
Moraxella_sg_Moraxella osloensis 2 G- 1 1 
Nesterenkonia lacusekhoensis 1 G+ 0 1 
Pantoea agglomerans 2 G- 2 0 
Proteus mirabilis 5 G- 1 4 
Pseudomonas luteola 1 G- 0 1 
Pseudomonas oryzihabitans 1 G- 1 0 
Rothia amarae 1 G+ 0 1 
Rothia dentocariosa 2 G+ 1 1 
Total no. of isolates 991  147 844 
% genus    15 - 
% species    - 85 
Note: a: F: fungus;b: The match of MALDI-TOF MS identification at the species level 






































Figure 4. 1  MALDI-TOF MS identification of environmental isolates 
BCF: baby care facilities; DSH: different sites of hotels; DSL: different sites of a library; 
DSR: different sites of restaurants; DSS: different sites of supermarkets; DST: different 
sites of transportation facilities; HAS: hotel air samples; HB: handbags; HH: human-




4.2 Reproducibility of MALDI-TOF MS 
MALDI-TOF MS reproducibility was assessed for environmental isolates. 
Reproducibility of MALDI-TOF MS identification was determined for 1-3 isolates of 
18 species: S. aureus, S. auricularis, S. capitis, S. caprae, S. cohnii, S. epidermidis, S. 
equorum, S. haemolyticus, S.hominis, S. lugdunensis, S. pasteuri, S. pettenkoferi, S. 
saprophyticus, S. sciuri, S. simiae, S. simulans, S. warneri, and S. xylosus, and the 
results were shown in Table 4.2. Duplicates of thirty-four selected isolates were 
analysed by two different modes of MALDI-TOF MS. 
Table 4. 2  Reproducibility of MALDI-TOF MS identification 
ID Bruker Microflex LT Score value Bruker Autoflex Score 
value 
12 S. aureus 2.37 S. aureus 2.264 
12 S. aureus 2.442 S. aureus 2.28 
13 S. aureus 2.402 S. aureus 2.315 
13 S. aureus 2.429 S. aureus 2.335 
15 S. auricularis 2.014 S. auricularis 1.831 
15 S. auricularis 1.914 S. auricularis 1.857 
52 S. capitis 2.235 S. capitis 2.275 
52 S. capitis 2.011 S. capitis 2.177 
53 S. capitis 1.926 S. capitis 1.994 
53 S. capitis 1.888 S. capitis 1.985 
95 S. caprae 2.015 S. caprae 1.84 
95 S. caprae 2.149 S. caprae 1.983 
96 S. caprae 1.986 S. caprae 1.821 
96 S. caprae 1.898 S. capitis 1.8 
107 S. cohnii 2.161 S. cohnii 2.049 
107 S. cohnii 2.177 S. cohnii 2.165 
122 S. epidermidis 2.215 S. epidermidis 2.216 
122 S. epidermidis 2.15 S. epidermidis 2.154 
134 S. epidermidis 2.299 S. epidermidis 2.135 
134 S. epidermidis 2.166 S. epidermidis 2.098 
135 S. epidermidis 2.11 S. epidermidis 2.246 
135 S. epidermidis 2.125 S. epidermidis 2.235 
310 S. equorum 1.8 S. equorum 1.998 
310 S. equorum 1.76 S. equorum 1.886 
311 S. equorum 2.041 S. equorum 1.86 
311 S. equorum 2.165 S. equorum 1.959 
377 S. haemolyticus 2.242 S. haemolyticus 2.016 
377 S. haemolyticus 2.114 S. haemolyticus 2.04 
384 S. haemolyticus 1.842 S. haemolyticus 1.746 
384 S. haemolyticus 1.744 S. haemolyticus 1.784 
385 S. haemolyticus 2.189 S. haemolyticus 2.102 
Note: Isolate in bold suggests inconsistent identification. 
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ID Bruker Microflex LT Score value Bruker Autoflex Score 
value 
385 S. haemolyticus 2.329 S. haemolyticus 2.043 
400 S. hominis 2.504 S. hominis 2.529 
400 S. hominis 2.137 S. hominis 2.22 
402 S. hominis 2.325 S. hominis 2.12 
402 S. hominis 2.251 S. hominis 2.045 
564 S. lugdunensis 2.29 S. lugdunensis 2.183 
564 S. lugdunensis 2.377 S. lugdunensis 2.332 
567 S. lugdunensis 2.203 S. lugdunensis 2.061 
567 S. lugdunensis 2.284 S. lugdunensis 2.282 
579 S. pasteuri 2.055 S. pasteuri 2.054 
579 S. pasteuri 1.981 S. pasteuri 2.049 
597 S. pasteuri 2.238 S. pasteuri 2.069 
597 S. pasteuri 2.127 S. pasteuri 2.087 
607 S. pettenkoferi 2.01 S. pettenkoferi 1.935 
607 S. pettenkoferi 1.929 S. pettenkoferi 2.009 
608 S. saprophyticus 1.726 S. saprophyticus 1.763 
608 S. saprophyticus 1.735 S. cohnii 1.801 
   S. saprophyticus 1.726 
609 S. saprophyticus 1.769 S. saprophyticus 1.984 
609 S. saprophyticus 2.018 S. saprophyticus 1.94 
632 S. sciuri 2.089 S. sciuri 2.028 
632 S. sciuri 2.092 S. sciuri 2.03 
632 S. sciuri 1.97 S. sciuri 1.957 
632 S. sciuri 1.973 S. sciuri 2.005 
636 S. simiae 1.845 S. simiae 1.825 
636 S. simiae 1.996 S. simiae 1.922 
638 S. simiae 2.021 S. simiae 1.844 
638 S. simiae 1.93 S. simiae 1.942 
644 S. simulans 1.837 S. simulans 1.826 
644 S. simulans 1.949 S. simulans 1.84 
654 S. warneri 2.391 S. warneri 2.209 
654 S. warneri 2.48 S. warneri 2.112 
686 S. warneri 2.249 S. warneri 2.26 
686 S. warneri 2.455 S. warneri 2.134 
704 S. warneri 1.977 S. warneri 2.175 
704 S. warneri 1.996 S. warneri 2.163 
713 S. xylosus 1.808 S. xylosus 1.997 
713 S. xylosus 1.865 S. xylosus 2.1 
Note: Isolate in bold suggests inconsistent identification. 
A total of 68 targets were detected by two different modes of MALDI-TOF MS 
accordingly, and only one target (1.5%) showed an inconsistent result; however, the 
second match was found to be S. saprothyticus. This demonstrates the precision and 
relibility of the MALDI-TOF MS identification method. The scores generated by both 
MALDI-TOF MS were close to each other, although minor fluctuations were observed. 
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The fluctuation was between 0.001 and 0.368: thirty-six (53%) targets with score 
difference below 0.1, twenty three (34%) between 0.1 and 0.2, seven (10%) between 0.2 
and 0.3, and 2 (3%) above 0.3.   
Sixty-seven typing results could be confirmed, thus leading to an inter-laboratory 
reproducibility of 98.5%.  
4.3 16S rRNA gene sequencing 
To assess the reliability of MALDI-TOF MS identification, 60 isolates of 17 
staphylococcal species, including S. auricularis, S. capitis, S. caprae, S. cohnii, S. 
epidermidis, S. equorum, S. haemolyticus, S. hominis, S. lugdunensis, S. pasteuri, S. 
pettenkoferi, S. saprophyticus, S. sciuri, S. simiae, S. simulans, S. warneri, and S. 
xylosus, were evaluated by 16S rRNA gene sequencing to compare with the results 
obtained by MALDI-TOF MS identification.  Selected isolates were identified by 
MALDI-TOF MS, and 55 (92%) isolates were consistent with the results of 16S rRNA 
measurement. Five misidentified isolates were identified to be staphylococci, but 
different species. 
Thirteen isolates were identified with score values ranging from 2.300 to 3.000 by 
MALDI-TOF MS, and 13 (100%) were consistent with 16S rRNA identification 
methods.  Thirty-eight isolates were identified with score values ranging from 2.000 to 
2.299, and 33 (87%) were concordant with 16S rRNA identification results. Nine 
isolates with score values ranging from 1.700 to 1.999 were 100% concordant to species 
with 16S rRNA method. 
5 staphylococci strains, including 327, 331, 338, 409, 614, were determined different 
species by 16S rRNA gene sequencing, all of which produced confidence scores 
ranging from 2.000 to 2.299. Two of them were misidentified; the first (strain 338) was 
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identified as S. aureus using 16S rRNA and as S. haemolyticus using the MALDI-TOF 
MS. The other (strain 409) was identified as S. equorum according to 16S rRNA and as 
S. hominis using the MALDI-TOF MS. For the rest of 3 isolates (strain 327, 331, 614), 
16S rRNA indicated possible identification as same as MALDI-TOF MS did, but not as 
the primary match. (Table 4.3)  In general, 16S rRNA results support the MALDI-TOF 
MS identification. Discordant results were found in 5 isolates at the species level, and 
no discordant result was found at the genus level. In addition, the data obtained from 
MALDI–TOF MS method were consistent with the results of 16S rRNA measurement 
for 92% at the species level and 100% at genus level. Even for 9 isolates identified with 
score value range from 1.700 to 1.999, the 100% consistence was confirmed at the 
species level. With regard to turnaround time, it took only 2.5 min to obtain the results 
with MALDI-TOF MS in this study, which was more efficient than 16S rRNA PCR 
methods to yield the same results (Table 4.3). 
Table 4. 3  Identification results obtained by MALDI–TOF MS in comparison to those 
obtained by partial 16S rRNA gene sequence-based species identification 
ID MALDI-TOF MS  16S rRNA 
Species Score value  Species 
15 S. aurialuaris 2.342 S. auricularis (T); ATCC 33753; D83358 
52 S. capitis 1.821 S. capitis (T); L37599 
 
95 S. caprae 2.318 S. caprae (T); ATCC 35538; AB009935 
 
96 S. caprae 2.223 S. caprae (T); ATCC 35538; AB009935 
 
99 S. cohnii 1.734 S. cohnii (T); ATCC 29974; D83361 
 
106 S. cohnii 2.114 S. cohnii (T); ATCC 29974; D83361 
 
107 S. cohnii 2.292 S. cohnii (T); ATCC 29974; D83361 
 
120 S. epidermidis 2.094 S. epidermidis (T); ATCC 14990; D83363 
 
122 S. epidermidis 2.293 S. epidermidis (T); ATCC 14990; D83363 
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ID MALDI-TOF MS 16S rRNA 
 Species Score value Species 
310 S. equorum 1.846 S. equorum (T); RP29; AF527483 
311 
 
S. equorum 2.005 S. equorum (T); ATCC 43958; AB009939 
317 S. haemolyticus 2.016 S. haemolyticus (T); CCM2737; X66100 
 
318 S. haemolyticus 2.163 S. haemolyticus (T); CCM2737; X66100 
 
321 S. haemolyticus 2.257 S. haemolyticus (T); CCM2737; X66100 
 
322 S. haemolyticus 2.300 S. haemolyticus (T); CCM2737; X66100 
 
323 S. haemolyticus 2.279 S. haemolyticus (T); CCM2737; X66100 
 
325 S. haemolyticus 2.353 S. haemolyticus (T); CCM2737; X66100 
 
327 S. haemolyticus 2.150 
S. saprophyticus (T); ATCC 15305; 
AP008934 
 
S. haemolyticus (T); CCM2737; X66100 
 
328 S. haemolyticus 2.251 S. haemolyticus (T); CCM2737; X66100 
 
329 S. haemolyticus 2.239 S. haemolyticus (T); CCM2737; X66100 
 
330 S. haemolyticus 2.124 
 
S. haemolyticus (T);  CCM2737; X66100 
331 S. haemolyticus 2.179 
S. aureus (T); ATCC 12600; L36472 
 
S. haemolyticus (T); CCM2737; X66100 
 
334 S. haemolyticus 1.905 S. haemolyticus (T); CCM2737; X66100 
 
335 S. haemolyticus 1.895 S. haemolyticus (T); CCM2737; X66100 
 
336 S. haemolyticus 2.251 S. haemolyticus (T); CCM2737; X66100 
 
337 S. haemolyticus 2.377 S. haemolyticus (T); CCM2737; X66100 
 
338 S. haemolyticus 2.078 S. aureus (T); ATCC 12600; L36472 
 
343 S. haemolyticus 1.949 S. haemolyticus (T); CCM2737; X66100 
 
344 S. haemolyticus 2.257 S. haemolyticus (T); CCM2737; X66100 
 
345 S. haemolyticus 2.141 S. haemolyticus (T); CCM2737; X66100 
 
347 S. haemolyticus 2.209 S. haemolyticus (T); CCM2737; X66100 
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ID MALDI-TOF MS  16S rRNA 
 Species Score value Species 
348 S. haemolyticus 2.344 S. haemolyticus (T); CCM2737; X66100 
 




S. haemolyticus 2.320 S. haemolyticus (T); CCM2737; X66100 
379 S. haemolyticus 2.191 S. haemolyticus (T); CCM2737; X66100 
 
380 S. haemolyticus 2.362 S. haemolyticus (T); CCM2737; X66100 
 
400 S. hominis 2.255 S. hominis (T); DSM 20328; X66101 
 
401 S. hominis 2.433 S. hominis (T); DSM 20328; X66101 
 
402 S. hominis 2.431 S. hominis (T); DSM 20328; X66101 
 
403 S. hominis 2.352 S. hominis (T); DSM 20328; X66101 
 
405 S. hominis 2.165 S. hominis (T); DSM 20328; X66101 
 
406 S. hominis 2.333 S. hominis (T); DSM 20328; X66101 
 
409 S. hominis 2.203 S. equorum (T); ATCC 43958; AB009939 
 
567 S. lugdunensis 2.290 S. lugdunensis (T); ATCC 43809; 
AB009941 
569 S. pasteuri 
 
2.192 S. pasteuri (T); ATCC 51129; AB009944 
579 S. pasteuri 2.294 S. pasteuri (T); ATCC 51129; AB009944 
 
592 S. pasteuri 2.399 S. pasteuri (T);ATCC 51129; AB009944 
 
604 S. pettenkoferi 1.772 S. pettenkoferi (T); B3117; AF322002 
 
607 S. pettenkoferi 2.153 S. pettenkoferi (T); B3117; AF322002 
 
609 S. saprophyticus 2.119 S. saprophyticus (T); ATCC 15305; 
AP008934 
614 S. saprophyticus 2.235 
S. capitis (T); ATCC 49326; AB009937 
 
S. saprophyticus (T); ATCC 15305; 
AP008934 
 
630 S. sciuri 2.008 S. sciuri (T); DSM 20345T; AJ421446 
 
632 S. sciuri 2.190 S. sciuri (T); DSM 20345T; AJ421446 
 
636 S. simiae 2.049 S. simiae (T); CCM 7213; AY727530 
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ID MALDI-TOF MS  16S rRNA 
 Species Score value  Species 
639 S. simiae 1.897 S. simiae (T); CCM 7213; AY727530 
 
644 S. simulans 1.879 S. simulans (T); ATCC 27848; D83373 
 
653 S. warneri 2.236 S. warneri (T); L37603 
 
654 S. warneri 2.254 S. warneri (T); L37603 
 
656 S. warneri 2.069 S. warneri (T); L37603 
 
714 S. xylosus 2.162 S. xylosus (T); ATCC 29971; D83374 
 
4.4 MALDI-TOF MS data analysis 
4.4.1 Cluster analysis of selected staphylococci 
To find out the potential taxonomic relationships based on MALDI-TOF MS profiles of 
staphylococci, 411 isolates recovered from the general public and different 
environmental sites were selected for cluster analysis. This included isolates recovered 
from BCF; DSH; DSL; DSR; DSS; DST; HAS; HB; HH, and 13 out of 19 species 
identified were systematically analysed by BioNumerics 7.5 (Applied Math, Belgium). 
Eleven out of 411 isolates identified were S. aureus, and 12 other staphylococcal 
species include S. epidermidis (n=123), S. hominis (n=111), S. warneri (n=35), S. 
capitis (n=50), S. haemolyticus (n=42), S. pasteuri (n=21), S. saprophyticus (n=9), S. 
simiae (n=4); S. cohnii (n=2);  S. caprae (n=1), S. lugdunensis (n=1), and  S. simulans 
(n=1). 
The unrooted dendrogram was built based on MALDI-TOF MS data. It was the 
reflection of the traditionally rooted dendrogram tree, but more compact. Each spot at 
the end of the branch represented a staphylococcal isolate.  9 major clusters, of 
staphylococci species were identified, including S. hominis, S. haemolyticus, S. 
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epidermidis, S. pasteuri, S. warneri, S. aureus, S. saprophyticus, S. capitis, and S. 
simiae (Fig 4.2).  
 
 
Figure 4. 2  Unrooted cluster analysis of staphylococci species using MALDI-TOF MS. 
Staphylococcal species were distributed in different clades and the circles were used to 
show the species forming these clades. The branches within each clade present the 
taxonomic relationship of staphylococci. 
4.4.2 Cluster analysis of Staphylococcus spp. recovered from each site 
4.4.2.1 Dominant species of each site 
The presence of staphylococcal species differed between sites. The most common 
species isolated from DSL were S. haemolyticus and S. epidermidis; whereas S. 
epidermidis and S. capitis were predominant among the isolates recovered from DST 
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and HB. Moreover, S. epidermidis together with S. hominis were predominant among 
the isolates recovered from the HH, DSS and DSR. S. haemolyticus and S. hominis were 
predominant among the isolates recovered from the DSH. In addition, S. haemolyticus 
was predominant among the isolates recovered from HAS. The most common species 
isolated from BCF was S. hominis (Table 4.4). 
Table 4. 4  Predominant and common staphylococcal species recovered from the human 
hands and different environmental sites 
Sites  Predominant species  Commonly isolated species  
BCF S. hominis S. epidermidis 
DSH S. haemolyticus S. hominis 
DSL S. haemolyticus  S. epidermidis 
DSR S. epidermidis S. hominis 
DSS S. epidermidis S. hominis 
DST S. epidermidis S. capitis 
HAS S. haemolyticus - 
HB S. epidermidis S. capitis 
HH S. epidermidis S. hominis 
Note: BCF- baby care facilities; DSH- different sites of hotels; DSL-different sites of a 
library; DSR: different sites of restaurants. DSS-different sites of supermarkets; DST-
different sites of transportation facilities; HAS- hotel air samples; HB-handbags; HH- 
human hands. 
 
4.4.2.2 Cluster analysis of isolates recovered from different sites 
Three-dimensional scaling was performed to demonstrate the overall relationship of 411 
staphylococcal isolates (Fig 4.3). Based on the data, all isolates were distributed into 4 
groups. Groups 1, 2, 3 lacked the extensive diversity which was observed in the fourth 
group (Fig 4.3). 
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The stick is the visualization of the dendrogram, and the two spots that are connected by 
a stick are connected in the dendrogram. The X, Y, and Z axis are arbitrary units. It’s 
the distance between the isolates that represent the similarity, and that distance exists of 
components in all three axis.  
In the three-dimensional scaling, the similarity matrix is used to determine the 3D 
position. Isolates that have 100% similarity will be place on top of each other, with no 
distance between them. In contrast, the lower their similarity with each other, the higher 
their distance in the plot.  
 
 
Figure 4. 3 Three-dimensional (3D) scatter plot of 411 staphylococci recovered from 9 
sites.  BCF ; DSH ; DSL  ; DSR  ; DSS  ; DST  ; HAS ; HB  ; HH  . X: -0.4 
to 0.4; Y: -0.2 to 0.4; Z: -0.2 to 0.4. 
 
4.4.2.3 Correlation of staphylococci isolated from different sites 
Staphylococcal isolates recovered from different sites were taxonomically closely 
related. Staphylococcus spp. recovered from HH were taxonomically closely related to 
those isolated from BCF, DSH, DSL, DSR, DSS, DST, HAS, HB and HH (Fig 4.4a), 
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and staphylococcal isolates recovered from BCF were taxonomically closely related to 
those recovered from BCF, DSH, DSL, DSS, DST, HB and HH (Fig 4.4b). In addition, 
staphylococci isolated from DSS were taxonomically closely related to staphylococci 
isolated from BCF, DSH, DSR, DST, HH and DSS itself. Staphylococci recovered from 
DST were taxonomically closely related to staphylococci recovered from BCF, DSR, 
DSS, HH and DST (Fig 4.5a). Staphylococci recovered from DSH were taxonomically 
closely related to those recovered from BCF, DSS, HAS, HH and DSH (Fig 4.5b). 
Whilst staphylococci isolated from DSR were taxonomically closely related to isolates 
recovered from DST, HH and DSR, the staphylococci recovered from DSL were 
taxonomically closely related to those isolated from HH, BCF and DSL.  In addition, 





Figure 4. 4  Isolates recovered from human hands were taxonomically closely related to 
staphylococci recovered from transportation facilities, restaurants, hotels, supermarkets, 
handbags, baby care facilities, library, hotel air and human hands itself. The blue line 
that was used to connect color spots and showed dissemination of taxonomically closely 




Figure 4. 5   Isolates recovered from baby care facilities were taxonomically closely 
related to staphylococci recovered from transportation facilities, hands, hotels, 
supermarkets, handbags, library and baby care facilities itself. The blue line that was 
used to connect color spots and showed dissemination of taxonomically closely related 
staphylococci recovered from the indicated sites. 
 
Staphylococcal isolates recovered from HAS were taxonomically closely related to 




Figure 4. 6 Isolates recovered from transportation facilities were taxonomically closely 
related to staphylococci recovered from restaurants, hands, supermarkets, baby care 
facilities and transportation facilities itself.  The blue line that was used to connect color 
spots and showed dissemination of taxonomically closely related staphylococci 






Figure 4. 7 Isolates recovered from hotels were taxonomically closely related to 
staphylococci recovered from hands, supermarkets, baby care facilities, hotel air and 
hotels itself. The blue line that was used to connect color spots and showed 
dissemination of taxonomically closely related staphylococci recovered from the 
indicated sites. 
 
4.4.2.4 Cluster analysis of each staphylococcal species recovered from different sites 
In addition, cluster analysis has been applied to each Staphylococcus spp. to determine 
the taxonomic relationships of each species isolated from different sites. 
It was demonstrated that S. hominis isolates recovered from 8 different sites, including 
BCF, DSH, DSL, DSR, DSS, DST, HB and HH, were taxonomically related. The 
distribution of 111 S. hominis isolates in the unrooted cluster resulted in the formation 
of 13 clades. S. hominis isolates which were recovered from the same sites such as DSS, 
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HH, BCF, DSR were found to be taxonomically closely related as they appeared in the 
same cluster. However, it was also observed taxonomic relationship among these S. 
hominis isolates that were recovered from different sites such as DSS and DSR and 
those recovered from DSR and DSH.  Moreover, S. hominis isolates recovered from 
DSS and HH, DSR and HH, DSH and HH, BCF and DSH, HB and BCF, BCF and DSL 
were also located in the same cluster, demonstrating their taxonomic close relationship 
(Fig 4.6a).  
 
Figure 4. 8 8a and 8b 8a Three-dimensional (3D) scatter plot of S. hominis isolates 
recovered from BCF, DSH, DSL, DSR, DSS, DST, HH, HB. BCF ; DSH , DSL  , 
DSR , DSS  , DST , HH  , HB  .X: -0.2 to 0.2;  Y: -0.2 to 0.4; Z: -0.2 to 0.2. 8b. 
Three-dimensional (3D) scatter plot of S. haemolyticus isolates recovered from BCF, 
DSH, DSL, DSR, DSS, HAS, HB, HH. BCF ; DSH ; DSL  ; DSR  ; DSS   ; HAS 
 ; HB  ;HH  .X:-0.2 to 0.4;  Y: -0.2 to 0.4;  Z: -0.6 to 0.0.  
The X, Y, and Z axises are arbitrary units. It represents the distance between the closely 
related isolates and that the distance exists in all three axises. Isolates that have 100% 
similarity are above each other, with no distance between them. As less their similarity 
is, the more the distance is between them in the plot. 
 
S. haemolyticus isolates recovered from 8 different sites, including BCF, DSH, DSL, 
DSR, DSS, HAS, HB, and HH were distributed in 3 large clades. One of these 3 clades 
was mainly formed by isolates recovered from HH. Similar to S. hominis, S. 
haemolyticus isolates recovered from DSH, DSL appeared in the same cluster, 
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indicating their taxonomically closely related. Interestingly, S. haemolyticus isolates 
recovered from different sites were also taxonomically closely related as they appeared 
in the same cluster. This included isolates recovered from HH and HAS, HH and DSR, 
HH and DSH, BCF and DSH. Moreover, S. haemolyticus recovered from DSH were 
located in the same cluster with S. haemolyticus recovered from HAS. Therefore, there 
is a possibility that isolates recovered from different sites in the hotels and air harbour 
the same populations of Staphylococcus spp. In addition, it was found that one of S. 
haemolyticus isolates recovered from DSR formed a distinctive branch (Fig 4.6b).  
In relation to S. epidermidis isolates, it was found that isolates recovered from BCF, 
DSH, DSL, DSR, DSS, DST, HH, and HB were taxonomically related. In addition, 
these isolates were organised into nine large clusters. S. epidermidis recovered from HH, 
DSR, DSS, DSL and DST were in the same cluster with S. epidermidis recovered from 
HH, DSR, DSS, DSL, and DST. In addition, the results showed that S. epidermidis 
isolates recovered from DST were located in the same cluster as those isolated from 
BCF, indicating their taxonomically closely related. Additionally, S. epidermidis 
isolates recovered from HH and DSH, HH and DSR, HH and DST, HH and DSS, HH 
and BCF, HH and HB, DSS and DSL, DSS and BCF, DSS and DSR, DSS and DSH, 





Figure 4. 9  9a and 9b 9a Three-dimensional (3D) scatter plot of S. epidermidis isolated 
from BCF, DSH, DSL, DSR, DSS, DST, HB, HH. BCF ; DSH  ; DSL  ; DSR  ; 
DSS  ; DST  ; HB ; HH  . X: -0.4 to 0.1; Y: -0.2 to 0.3; Z: -0.2 to 0.2. 9b. Three-
dimensional (3D) scatter plot of S. capitis isolated from BCF, DSH, DSL, DSR, DSS, 
DST, HB, HH. BCF ; DSH  ; DSL  ; DSR  ; DSS  ; DST  ; HB  ; HH  . X: -
0.6 to 0.0; Y: -0.2 to 0.4; Z: -0.2 to 0.1.  
The X, Y, and Z axises are arbitrary units. It represents the distance between the closely 
related isolates and that the distance exists in all three axises. Isolates that have 100% 
similarity are above each other, with no distance between them. As less their similarity 
is, the more the distance is between them in the plot. 
 
 
S. capitis isolates recovered from BCF, DSH, DSL, DSR, DSS, DST, HB and HH were 
arranged into three major clades. The majority of isolates in clade 1 included those 
recovered from DSL. The remaining isolates recovered from HH, DST, DSH, DSS, 
DSR, HB and BCF were evenly distributed within all 3 clades. S. capitis isolates 
recovered from DST, DSH, and HH were located in the same cluster as those recovered 
from DST, DSH, and HH. In addition, S. capitis isolates recovered from HH and DSH, 
HH and DSR, HH and DSS, BCF and DSL, BCF and DSH, DST and DSH, DST and 




Thirty-six S. warneri isolates recovered from BCF, DSH, DSL, DSR, DSS, DST and 
HH were used for cluster analyses and resulted in the formation of 3 major clades. The 
first clade was formed by S. warneri recovered from DST and HH, whereas the second 
clade was formed by those recovered from DSL and DSH and the third clade was 
formed by S. warneri recovered from BCF, HH and DSR.  S. warneri recovered from 
DSR, HH, DST, and DSL were related to those isolates recovered from DSR, HH, DST, 
and DSL as they found to be located in the same clade. Moreover, S. warneri recovered 
from HH and DSR, HH and DST, DST and DSS, DST and DSH, DSS and DSH, DSL 
and BCF were originated from the same cluster (Fig 4.8a). 
 
Figure 4. 10  10a and 10b 10a. Three-dimensional (3D) scatter plot of S. warneri 
isolated from BCF, DSH, DSL, DSR, DSS, DST, HH. BCF ; DSH  ; DSL  ; DSR ; 
DSS  ; DST ; HH . X: -0.4 to 0.0; Y: -0.2 to 0.3; Z: -0.2 to 0.1. 10b. Three-
dimensional (3D) scatter plot of S. pasteuri isolated from DSH, DSR, DSS, DST, HB, 
HH. DSH ; DSR ; DSS  ; DST  ; HB  ; HH  . X: -0.2 to 0.4; Y: -0.3 to 0.2; Z: -
0.2 to 0.2.  
The X, Y, and Z axises are arbitrary units. It represents the distance between the closely 
related isolates and that the distance exists in all three axises. Isolates that have 100% 
similarity are above each other, with no distance between them. As less their similarity 




Nineteen S. pasteuri isolates recovered from DSH, DSR, DSS, DST, HB and HH 
formed a distinct clade. It was observed close taxonomic relationship between S. 
pasteuri isolates recovered from DST and DSS, HH and DSR as they were located in 
same cluster (Fig 4.8b).   
Eleven S. aureus isolates have been analysed in this study. It was found that S. aureus 
isolates that were recovered from six different sites (BCF, DSH, DSR, DSS, HB, HH) 
formed 2 major clades. Two S. aureus isolates recovered from DSR were found to be 
located in the same clade. S. aureus isolates recovered from DSR and DSS were 
taxonomically closely related to those recovered from DSR and DSS. Apart from this, 
two S. aureus isolates, (one recovered from DSH and the other from HH) were found to 
be located in same cluster, demonstrating their close taxonomic relationship (Fig 4.9a). 
 
Figure 4. 11 11a and 11b 11a. Three dimensional (3D) scatter plot of S. aureus isolated 
from BCF, DSH, DSR, DSS, HB, HH. BCF ; DSH ; DSR  ; DSS ; HB  ;HH . X: 
-0.2 to 0.1; Y: -0.1 to 0.2; Z: -0.1 to 0.05. 11b. Three-dimensional (3D) scatter plot of S. 
saprothyticus isolated from BCF, DSH, DSL. BCF  ; DSH  ; DSL   .X: -0.3 to 0.0; 
Y: -0.15 to 0.1; Z: -0.04 to 0.04.  
The X, Y, and Z axises are arbitrary units. It represents the distance between the closely 
related isolates and that the distance exists in all three axises. Isolates that have 100% 
similarity are above each other, with no distance between them. As less their similarity 
is, the more the distance is between them in the plot. 
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Eight S. saprophyticus isolates were recovered from BCF, DSH, and DSL. S. 
saprophyticus isolated from DSH were located in same cluster as those isolated from 
BCF (Fig 4.9b).  
Cluster analysis was applied to four S. simiae isolates, and they all were from DST. 
Interestingly, the clade formed by these isolates was located between S. warneri and S. 
caprae (Fig 4.10).   
  
 
Figure 4. 12  Three-dimensional (3D) scatter plot of S. simiae isolates recovered from 
DST. DST . X: -0.04 to 0.02; Y: -0.01 to 0.02; Z: -0.008 to 0.004. 
The X, Y, and Z axises are arbitrary units. It represents the distance between the closely 
related isolates and that the distance exists in all three axises. Isolates that have 100% 
similarity are above each other, with no distance between them. As less their similarity 
is, the more the distance is between them in the plot. 
 
4.5 Chapter summary 
The identification of environmental bacteria showed that: 
1. 991 out of 1152 (86%) were shown reliable identification; 
2. 718 (62%) were identified to be Staphylococcus spp.; 
3. Reproducibility of MALDI-TOF MS identification was confirmed by obtaining 
results from two modes of MALDI-TOF MS in fully automated fashion;  
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4. 16S rRNA gene sequencing results confirmed the reliability of MALDI-TOF MS 
identification; 
5. Cluster analysis of staphylococci isolated from different sites was found to be 
taxonomically closely related. 
It is important to do rapid and accurate identification of microorganisms in 
microbiology study. This chapter introduced the identification of staphylococcal isolates 
with MALDI-TOF MS, and tested the reproducibility and reliability of MALDI-TOF 
MS in identifying environmental staphylococci. Moreover, MALDI-TOF MS data were 
combined with isolation sites to do cluster analysis. Evaluation of the diversity of 
environmental staphylococcal species will be discussed in the discussion chapter. The 
importance of reliability and reproducibility in identifying environmental staphylococci 
will also be discussed later. Finally, the taxonomic relationship of staphylococci isolated 














Chapter 5 Phenotypic analysis of environmental staphylococci 
The emergency of antibiotic resistance in clinical staphylococci has been widely 
reported (Appelbaum, 2006; Brennan et al., 2011). The presence of antibiotic resistance 
put a great challenge in treatment (IWG-SCC, 2009), and the antibiotic susceptibility 
test is of great important for clinicians to select the right antimicrobial agents (Jorgensen 
& Ferraro, 2009). In addition,  antimicrobial susceptibility tests can be applied to 
environmental microorganisms to survey the influence caused by overuse of antibiotics 
(Wang et al., 2008). Environmental staphylococci may act as a reservoir of antibiotic 
resistance genes, so it is necessary to include less frequently diseases associated 
microorganisms in antibiotic resistance research in order to prevent the resistance before 
it appears in pathogens (Blair et al., 2014). Antibiotic susceptibility tests were applied to 
677 environmental recovered staphylococci. In addition, antibiotic susceptibility 
profiles were combined with MALDI-TOF MS identification data for systematic 
taxonomic analysis.  
5.1 Antibiotic susceptibility test  
The antibiotic susceptibility was determined by comparing the diameter of inhibition 
zone with BSAC or CLSI standards (Howe & Andrew., 2012; Creagh & Lucey., 2007). 
Antibiotic resistance patterns were determined for 677 strains of staphylococci from 9 
sites, and 649 (96%) staphylococcal isolates were resistant to more than one antibiotic. 
Resistance to penicillin, and fusidic acid was recorded in more than 60% of all 
staphylococcal species. Resistance to the other compounds tested was as follows: 
erythromycin 33%, streptomycin 31%, amoxicillin 27%, vancomycin 24%, tetracycline 
18%, mupirocin 16%, cefepime 10%, gentamicin 10%, oxacillin 7%, and 
chloramphenicol 5%. For the resistance to non-β-lactam antibiotics, 453 staphylococcal 
isolates (67%) were resistant to fusidic acid, 226 isolates (33%) were resistant to 
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erythromycin, and the varied antibiotic resistance ratio of other non-β-lactam antibiotics 
such as gentamicin, vancomycin and chloramphenicol (Table 5.1). In addition to these 
non-β-lactam antibiotic resistant strains, 448 (66%) of the staphylococcal strains were 
resistant to the traditional β-lactam antibiotic penicillin, and 50 (7%) of staphylococcal 
isolates were resistant to oxacillin which express additional penicillin-binding protein 
(Fig 5.1).  
Apart from high ratio resistant to penicillin and fusidic acid, there were species patterns 
of resistance: S. epidermidis, S. hominis and S. pasteuri were predominantly resistant to 
erythromycin, whereas S. capitis has relatively low resistance ratio (1%) of gentamicin, 
and shows relatively high ratio of streptomycin (45%) resistance.  Additionally, S. 
warneri presents higher resistant (47%) to streptomycin (Table 5.1). The data sets of the 
rest of the species were of less than 30 isolates, however, these staphylococcal species: 
S. arlettae, S. aureus, S. auricularis, S. caprae, S. cohnii, S. equorum, S. lugdunensis, S. 
pettenkoferi, S. saprophyticus, S. sciuri, S. simiae, S. simulans, and S. xylosus, had 
similar antibiograms with species which had more than 30 isolates. For example, there 
were high levels of penicillin and fusidic acid resistance in all of small data sets species 
except for S. simiae (n=10). In addition to penicillin and fusidic acid, S. sciuri has high 
resistance ratio of oxacillin (67%), mupirocin (67%), and streptomycin (67%).  
Multi-resistance was seen in 677 tested staphylococcal species, including one isolate 
resistant to 11 antibiotics, one isolate resistant to 10 antibiotics, five to 9 antibiotics,   
seventeen isolates resistant to 8 antibiotics, thirteen to 7 antibiotics, forty-four to 6 
antibiotics, fifty-eight to 5 antibiotics, one hundred and six to 4 antibiotics, one-hundred 
and thirty-eight to 3 antibiotics, one hundred and sixty-one to 2 antibiotics, and one 
hundred and five to 1 antibiotic. Twenty-eight staphylococcal isolates were susceptible 




Table 5. 1  Antibiotic susceptibility profile of environmental staphylococci 
Test result 
 
No of resistant isolates/No of  tested isolates  (% resistance) 
 









































18/20 (90) 4/20 (20) 5/20 (25) 1/20 (5) 2/20 (10) 20/20 (100) 2/20 (10) 5/20 (25) 7/20 (35) 3/20 (15) 2/20 (10) 
Note: oxacillin (1µg);  penicillin G (1 unit); vancomycin (5 µg); mupirocin (20 µg); cefepime (30 µg); gentamicin (10 µg); fusidic acid (10 µg); streptomycin (10 µg)； amoxicillin (10 µg); 





No of resistant isolates/No of  tested isolates  (% resistance) 
 















































2/2 (100) 0/2 (0) 0/2 (0) 2/2 (100) 2/2 (100) 2/2 (100) 1/2 (50) 1/2 (50) 0/2 (0) 0/2 (0) 0/2 (0) 
Note: oxacillin (1µg);  penicillin G (1 unit); vancomycin (5 µg); mupirocin (20 µg); cefepime (30 µg); gentamicin (10 µg); fusidic acid (10 µg); streptomycin (10 µg)； amoxicillin (10 µg); 








No of resistant isolates/No of  tested isolates  (% resistance) 
 
































































Note: oxacillin (1µg);  penicillin G (1 unit); vancomycin (5 µg); mupirocin (20 µg); cefepime (30 µg); gentamicin (10 µg); fusidic acid (10 µg); streptomycin (10 µg)； amoxicillin (10 µg); 







































Figure 5. 1  Percent of environmental staphylococci resistant to penicillin G, fusidic acid, erythromycin, streptomycin, amoxicillin, vancomycin, 
tetracycline, oxacillin, mupirocin, cefepime, gentamicin and chloramphenicol 
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5.2 MIC (oxacillin) test  
In addition to the antibiotic susceptibility tests, oxacillin MICs was determined for 
mecA gene positive coagulase negative staphylococci and all S. aureus. The oxacillin 
MICs for tested staphylococci were highly variable with MICs ranging from 0.015 mg l
-
1
 to 256 mg l
-1
.  
5.3 Antibiotic susceptibility of taxonomically closely related 
staphylococci 
As well as determinining the potential taxonomic relationships based upon MALDI-
TOF MS profiles of staphylococci, antibiotic susceptibility profiles of these 411 
staphylococcal isolates were combined to assess the antibiotic susceptibility variations 
of taxonomically closely related staphylococci.   
5.3.1 Antibiotic susceptibility of staphylococci 
Three-hundred and twenty-six (80%) out of 411 staphylococci were resistant against 2 
or more antibiotics, including 1 staphylococci isolates resistant to 10 antibiotics, 4 to 9 
antibiotics, 10 isolates were resistant to 8 antibiotics, 7 to 7 antibiotics, 20 to 6 
antibiotics, 29 to 5 antibiotics, 59 to 4 antibiotics, 89 to 3 antibiotics, 107 to 2 
antibiotics, and 63 to 1 antibiotic. Of all isolates tested only 22 were susceptible to all 
antibiotics tested.  
5.3.2 Antibiotic resistance patterns of taxonomically closely related 
staphylococci 
As noted above, MALDI-TOF MS data of 411 staphylococci were combined with 
antibiotic susceptibility profiles to determine the antibiotic resistant patterns of 
taxonomically closely related staphylococci. Staphylococci resistant to more than 2 
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antibiotics were considered as multiple antibiotic resistant, whereas susceptible isolates 
were those that demonstrated resistant to one antibiotic or none. The distribution of 
antibiotic resistance patterns in staphylococcal isolates was analysed with BioNumerics 
7.5 (Applied Math, Belgium). It was demonstrated that susceptible and multiple 
resistant isolates were taxonomically closely related (Fig 5.2), and 30 multidrug 
resistant isolates were taxonomically closely related to 30 susceptible isolates 
respectively, indicating that these might belong to the same genotype of the founding 
strain. 
 
Figure 5. 2 Three-dimensional (3D) scatter plot of multiple antibiotic resistant  and 
susceptible  staphylococci. X: -0.4 to 0.4; Y: -0.2 to 0.4; Z: -0.2 to 0.4.  
The X, Y, and Z axises are arbitrary units. It represents the distance between the closely 
related isolates and that the distance exists in all three axises. Isolates that have 100% 
similarity are above each other, with no distance between them. As less their similarity 




5.3.3 Cluster analysis of each staphylococcal species combined with 
antibiotic susceptibility profile 
Staphylococcal species selected for antibiotic susceptibility profile associated cluster 
analysis were S. aureus, S. capitis, S. epidermidis, S. haemolyticus, S. hominis, S. 
pasteuri, S. saprophyticus, S. simiae, and S. warneri. 
Ninety-four (85%) multiple resistant and 17 (15%) susceptible S. hominis were analysed. 
Eight multiple antibiotic resistant S. hominis were taxonomically closely related to 8 
susceptible S. hominis (Fig 5.3a).  
 
Figure 5. 3 3a and 3b 3a. Three-dimensional (3D) scatter plot of multiple resistant  
and susceptible  isolates of S. hominis. X:-0.2 to 0.2; Y: -0.2 to 0.4; Z: -0.2 to 0.2. 3b. 
Three-dimensional (3D) scatter plot of multiple resistant  and susceptible  isolates of 
S. epidermidis. X: -0.4 to 0.1; Y: -0.2 to 0.3; Z: -0.2 to 0.2.   
The X, Y, and Z axises are arbitrary units. It represents the distance between the closely 
related isolates and that the distance exists in all three axises. Isolates that have 100% 
similarity are above each other, with no distance between them. As less their similarity 




Eighty-five (69%) multiple resistant and 38 (31%) susceptible S. epidermidis were 
analysed. It was found that 14 multiple antibiotic resistant S. epidermidis were 
taxonomically closely related to 14 susceptible S. epidermidis (Fig 5.3b).  
In this study, thirty-nine (93%) multiple resistant and 3 (7%) susceptible S. 
haemolyticus were determined. Of those only one multiple resistant S. haemolyticus was 
found taxonomically closely related to one susceptible S. haemolyticus (Fig 5.4a).  
 
Figure 5. 4 4a and 4b 4a. Three-dimensional (3D) scatter plot of multiple resistant  
and susceptible  isolates of S. haemolyticus. X: -0.2 to 0.4; Y: -0.4 to 0.2; Z: -0.6 to 0.0.  
4b. Three-dimensional (3D) scatter plot of multiple resistant  and susceptible   
isolates of S. capitis. X: -0.6 to 0.0; Y: -0.2 to 0.4; Z:-0.2 to 0.1.  
The X, Y, and Z axises are arbitrary units. It represents the distance between the closely 
related isolates and that the distance exists in all three axises. Isolates that have 100% 
similarity are above each other, with no distance between them. As less their similarity 
is, the more the distance is between them in the plot. 
 
 
38 (76%) multiple resistant and 12 (24%) susceptible S. capitis were determined. It was 
found that 3 multiple resistant S. capitis were taxonomically closely related to 3 
susceptible S. capitis. The distribution of the resistant (Red) S. capitis isolates on the left 
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side, and susceptible isolates on the right side of the cube indicated that these isolates 
were not related to one another (Fig 5.4b). 
Thirty (86%) multiple resistant and 5 (14%) susceptible isolates of S. warneri were 
determined. From these isolates only 1 multiple resistant S. warneri was found to be 
taxonomically closely related to 1 susceptible S. warneri (Fig 5.5a). 
 
Figure 5. 5 5a and 5b 5a Three-dimensional (3D) scatter plot of multiple resistant  and 
susceptible  isolates of S. warneri. X: -0.6 to 0.0; Y: -0.2 to 0.3; Z: -0.2 to 0.1 5b. 
Three-dimensional (3D) scatter plot of multiple resistant  and susceptible  isolates of 
S. pasteuri. X: -0.2 to 0.4; Y: -0.3 to 0.2; Z: -0.2 to 0.2.  
The X, Y, and Z axises are arbitrary units. It represents the distance between the closely 
related isolates and that the distance exists in all three axises. Isolates that have 100% 
similarity are above each other, with no distance between them. As less their similarity 
is, the more the distance is between them in the plot. 
 
 
For S. pasteuri, 18 (86%) multiple resistance and 3 (14%) susceptible isolates were 
determined. It was found that two multiple resistant S. pasteuri were taxonomically 
closely related to two susceptible S. pasteuri (Fig 5.5b). 
In this study, ten multiple resistant and 1 susceptible S. aureus were determined. It was 
showed that multiple resistant S. aureus were not related to this susceptible S. aureus 
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(Fig 5.6a).  In addition, it was found that all S. saprophyticus isolates (n=9) were 
multiple resistant (Fig 5.6b). Moreover, 3 multiple resistant and 1 susceptible S. simiae 
were determined and it was found that one of multiple resistant S. simiae was 
taxonomically closely related to 1 susceptible S. simiae (Fig 5.7).  
 
Figure 5. 6 6a and 6b 6a. Three-dimensional (3D) scatter plot of multiple resistant  
and susceptible  isolates of S. aureus. X: -0.2 to 0.1; Y: -0.1 to 0.2; Z:-0.1 to 0.05. 6b. 
Three-dimensional (3D) scatter plot of multiple resistant  and susceptible  isolates of 
S. saprophyticus. X: -0.3 to 0.0; Y: -0.15 to 0.1; Z:-0.04 to 0.04.  
The X, Y, and Z axises are arbitrary units. It represents the distance between the closely 
related isolates and that the distance exists in all three axises. Isolates that have 100% 
similarity are above each other, with no distance between them. As less their similarity 






Figure 5. 7 Three-dimensional scatter plot of multiple resistant  and susceptible  
isolates of S. simiae. X: -0.04 to 0.02; Y: -0.01 to 0.02; Z: -0.008 to 0.004.  
The X, Y, and Z axises are arbitrary units. It represents the distance between the closely 
related isolates and that the distance exists in all three axises. Isolates that have 100% 
similarity are above each other, with no distance between them. As less their similarity 
is, the more the distance is between them in the plot. 
5.3.4 Variations of antibiotic susceptibility profile of taxonomically closely 
related staphylococci 
In order to identify antibiotic susceptibility variations of taxonomically closely related 
staphylococci, two representative isolates recovered from different sites as well as from 
the same sites were selected from each cluster. Staphylococcal species selected for these 
analyses were S. hominis, S. epidermidis, S. haemolyticus, S. capitis and S. warneri 
(Appendix II.2). 
Thirty-five closely related clusters were determined for S. hominis. Twenty-five of these 
clusters were formed by the isolates recovered from different sites.  In 2 clusters 
(clusters 1-2) were detected only one antibiotic susceptibility variation, in 3 clusters 
(clusters 3-5) two antibiotic susceptibility variations, in 10 clusters (clusters 6-15) 3, in 
5 clusters (clusters 16-20) 4, in 2 clusters (clusters 21-22) 5, in 3 clusters (cluster 23- 25) 
6. In total ten clusters were formed by the isolates recovered from the same site. There 
was no obvious antibiotic susceptibility variation observed in three clusters (cluster 26-
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28). However, 1 antibiotic susceptibility variation was detected in 2 clusters (cluster 29-
30), two in 2 clusters (cluster 31-32), three in 1 cluster (cluster 33), and four in 2 
clusters (cluster 34-35) (Appendix II.2 ).  
For S. epidermidis, thirty-four taxonomically closely related clusters were identified.  
Twenty-two of these clusters were formed by isolates recovered from different sites.  
No antibiotic sensitivity difference was detected in one cluster (cluster 1). One 
antibiotic susceptibility variation was detected in 3 clusters (cluster 2-4), two in 3 
clusters (cluster 5-7), three in 7 clusters (cluster 8-14), four in 5 clusters (cluster 15-19), 
five in 1 cluster (cluster 20), six in 1 cluster (cluster 21), and seven in 1 cluster (cluster 
22). S. epidermidis isolates recovered from the same sites formed twelve clusters. In 
two out of 12 clusters (cluster 23-24) there is no antibiotic susceptibility variation, 
however, one antibiotic susceptibility variation was detected in 4 clusters (cluster 25-
28), two in 2 clusters (cluster 29-30), three in 1 cluster (cluster 31), six in 1 cluster 
(cluster 32), seven in 1 cluster (cluster 33), and eight in 1 cluster (cluster 34) (Appendix 
II.2).  
Moreover, antibiotic susceptibility variations were determined for twelve taxonomically 
closely related clusters of S. haemolyticus. Six out of 12 clusters were formed by the 
isolates recovered from different sites. In 2 clusters (cluster 1-2) were detected 4 
antibiotic variations, six in 1 cluster (cluster 3), seven in 1 cluster (cluster 4), and eight 
in 2 clusters (cluster 5-6). Six clusters were formed by isolates recovered from the same 
site and in 1 cluster (cluster 7) was found 1 antibiotic susceptibility variation, three in 1 
cluster (cluster 8), five in 1 cluster (cluster 9), six in 2 clusters (cluster 10-11), and 
seven in 1 cluster (cluster 12) (Appendix II.2). 
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Fifteen taxonomically closely related clusters of S. capitis were analysed for antibiotic 
susceptibility variations.  Eleven out of 15 clusters were formed by the isolates 
recovered from the different sites. In one such cluster (cluster 1) was found no antibiotic 
susceptibility variation, and further three variations in 3 clusters (cluster 2-4), four in 3 
clusters (cluster 5-7), five in 3 clusters (cluster 8-10), and seven in 1 cluster (cluster 11). 
Among those clusters that were formed by isolates recovered from the same site two 
antibiotic susceptibility variations were detected in 2 clusters (cluster 12-13), three in 1 
cluster (cluster 14), and nine antibiotic susceptibility variations in 1 cluster (cluster 15)  
(Appendix II.2).  
10 taxonomically closely related clusters of S. warneri, were also examined for 
antibiotic susceptibility variations. Five out of 10 clusters were formed by isolates 
recovered from different sites, in one of which (cluster 1) was detected one antibiotic 
susceptibility variation. Three antibiotic variations were detected in 2 clusters (cluster 2-
3), four in 1 cluster (cluster 4), and six in 1 cluster (cluster 5). Moreover, five clusters 
were formed by isolates from the same site. In 4 of five clusters (cluster 6-9) were 
observed 3 antibiotic variations and in 1 cluster (cluster 10) was detected 6 antibiotic 
variations (Appendix II.2).  
5.3.5 Percentage of multiple resistant staphylococci recovered from each site 
In addition to find out variation of antibiotic susceptibility profile of taxonomically 
closely related staphylococci, the number of susceptible and multiple resistant 
staphylococci in each site was summarized.  A total of 325 (80%) of all staphylococci 
isolates were multiple resistant, and 86 were susceptible. Table 5.2 demonstrates the 
distribution of multiple resistant and susceptible staphylococci in each site. All five 
staphylococcal isolates recovered from HAS were multiple antibiotic resistant. Thirty-
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one (94%) of all isolates recovered from BCF were multiple resistant staphylococci, and 
2 (6%) were susceptible. More than 80% staphylococci isolates recovered from DSH 
(n=46), DSS (n=51), HH (n=86) and DSL (n=22) were also multiple resistant. Forty-
eight (72%) of 67 isolates recovered from DSR were multiple resistant.  In addition, 6 
(60%) and 30 (58%) of staphylococci isolates recovered from HB and DST respectively 
were also multiple resistance (Table 5.2).  
 








Hotel air  5 5(100%) 0(0%) 
Baby care facilities 33 31(94%) 2(6%) 
Library 25 22(88%) 3(12%) 
Hotels 53 46(87%) 7(13%) 
Supermarkets 59 51(86%) 8(14%) 
Human hands 107 86(80%) 21(20%) 
Restaurants 67 48(72%) 19(28%) 
Handbags 10 6(60%) 4(40%) 










5.4 Chapter summary 
The antibiotic susceptibility profile of staphylococci showed that: 
1. Six hundred and forty-eight (96%) staphylococci were found to be resistant to at least 
one antibiotic;  
2. Cluster analysis showed that 30 multidrug resistant staphylococci were 
taxonomically closely related to 30 susceptible staphylococci;  
3. No obvious differences of antibiotic susceptibility profiles were observed between 
clusters that were formed by isolates recovered from different sites and clusters that 
were formed by isolates recovered from same site. 
Antimicrobial susceptibility tests can be applied to environmental microorganisms to 
survey the dissemination of antibiotic-resistant environmental staphylococci. This 
chapter introduced the antibiotic susceptibility of staphylococci, and analysed the 
antibiotic susceptibility variation of taxonomically closely related staphylococci. The 
comparison of antibiotic susceptibility profiles and multiple antibiotic resistance ratios 
with clinical studies will be carried out in the discussion chapter. Evaluation of 
environment act as a reservoir of antibiotic-resistant staphylococci will be carried out in 
the discussion chapter. Finally, the antibiotic susceptibility profiles will be combined 
with MALDI-TOF MS data to assess antibiotic susceptibility variation of taxonomically 









Chapter 6 Genotypic analysis of selected staphylococci 
Methicillin resistant S. aureus (MRSA) is a major public health problem, and infections 
caused by MRSA confer severe economic and healthy consequences (Köser et al., 2012). 
Methicillin resistant of MRSA is due to additionally acquired a mecA gene, which 
encodes for penicillin binding protein 2a (PBP2a) with a low affinity to β-lactam 
antibiotics (Tulinski et al., 2012). In this study, the mecA gene PCR was used to explore 
the dissemination of mecA gene positive environmental staphylococci. 
Oxacillin susceptible mecA positive S. aureus (OS-MRSA) have been reported in 
clinical isolates, and precaution in avoiding selection of high oxacillin resistant MRSA 
during treatment processes has been advocated (Hososaka et al., 2007). However, little 
is known about oxacillin susceptible mecA positive coagulase negative staphylococci 
(OS-MRCoNS). In this study, the occurrence of OS-MRCoNS was assessed, and the 
expression of PBP2a of mecA gene positive staphylococci with varied MIC was 
determined.  
The application the of molecular typing system has greatly promoted the pursuit of 
staphylococcal epidemiology studies, which in turn improved the efficiency of health 
care facilities to track the source and transmission of staphylococcal outbreak (Oliveira 
& Tomasz, 2002). In addition, molecular epidemiology has been employed to determine 
the population structure of environmental microbial pathogens (Oliveira & Tomasz, 
2002). Here, SCCmec and MLST approaches were employed for the systematic typing 
of environmental staphylococci.   
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6.1 mecA gene  
6.1.1 Detection of mecA gene for all staphylococci 
The presence of mecA gene was determined for 714 staphylococcal isolates. PCR was 
undertaken with approapriate positive and negative controls. Eighty-nine (12%) mecA 
positive staphylococci were detected; however, among these MRSA was not found. S. 
sciuri had the highest mecA positive ratio (83%) among 19 staphylococcal species, 
followed by S. cohnii (36%), S. haemolyticus (24%), S. pettenkoferi (20%), and S. 
lugdunensis (20%). No mecA gene was found in 8 species, including S. aureus, S. 
simiae, S. equorum, S. caprae, S. xylosus, S. auricularis, S. simulans, and S. arlettae. 
Apart from the species mentioned above, the rest of the species’ mecA positive ratio was 

















Table 6. 1 mecA gene positive isolates recovered from general public settings 
 Species No of isolates Number of mecA positive isolates (%) 
S. epidermidis 198 24(12) 
S. hominis 173 11(6) 
S. haemolyticus 79 19(24) 
S. capitis 79 6(8) 
S. warneri 68 9(13) 
S. pasteuri 34 4(12) 
S. saprophyticus 20 4(20) 
S. cohnii 14 5(36) 
S. aureus 12 0(0) 
S. simiae 10 0(0) 
S. sciuri 6 5(83) 
S. pettenkoferi 5 1(20) 
S. lugdunensis 5 1(20) 
S. equorum 3 0(0) 
S. caprae 2 0(0) 
S. xylosus 2 0(0) 
S. auricularis 2 0(0) 
S. simulans 1 0(0) 
S. arlettae 1 0(0) 
Total 714 89(12) 
 
The antimicrobial resistances patterns of the 89 mecA-positive staphylococci are shown 
in Table 6.2. Eighty-four of mecA gene positive isolates were multidrug-resistant 




Table 6. 2  Molecular characterisation and antibiotic resistance of mecA gene positive staphylococci isolated from environment 





71 HH S. capitis  S S S S S S R S S S S + - - I* 0.5 
75 HH S. capitis  R S S S S R R S S S S + Class A NT NT 0.5 
81 HH S. capitis  R S S R S R R R R S S + NT 5 NT 0.5 
70 HH S. capitis R S S S S S R S S R S + NT 5 NT 0.25 
83 HH S. capitis S S R S S R R S S S S + NT 5 NT 0.12 
24 DSH S. capitis S S S S S R R S S S S + NT 1 NT 0.12 
106 HAS S. cohnii R S R R S R I S S S S + Class C  5 V 2 
108 HH S. cohnii S S S I S R R S R R S + Class A NT NT 1 
107 HAS S. cohnii R R S R S R R S R R R + Class A 5 V 1 
100 DSH S. cohnii R S R S S S S R R S S + Class A 5 5A 1 
97 BCF S. cohnii R S S R S R R S R S S + Class B 1 I 0.25 
118 DSH S. epidermidis R S R R R R I R R R S + Class B 2 IV 256 
279 HH S. epidermidis R R S S S R S S R S S + Class B 2 IV 2 
127 DSH S. epidermidis  R R S I S S S R R R S + Class C 5 V 2 
139 DSR S. epidermidis R R R R S R S R R R S + Class C 5 V 2 
191 DSS S. epidermidis R S S S S R S R S S S + Class B 4 VI 2 
308 HH S. epidermidis R S R S S R S R R S S + Class B NT NT 2 
153 DSH S. epidermidis R S S S S R S S S S S + Class C 5 V 1 
187 DSS S. epidermidis R R S S S S S S R S S + Class C 5 V 1 
134 DSL S. epidermidis R S S S S R R R R R S + Class B 1 I 1 
Note: * determined by Zhang’s method. R: resistant, S sensitive. I: intermediate 
BCF- baby care facility; DSH- different sites of hotels; DSL- different sites of a library; DSR- different sites of restaurants; DSS- different 
sites of supermarkets; DST- different sites of transportation facilities; HAS- hotel air samples; HB- handbags; HH- human hands.  
   A: amoxicillin (10 µg); CEF: cefepime (30 µg); C: chloramphenicol (30 µg); E: erythromycin (5 µg); FC: fusidic acid (10 µg); GM: 
gentamicin (10 µg); MUP: mupirocin (20 µg); OX: oxacillin (1 µg); PG: penicillin G (1 unit); S: streptomycin (10 µg); T: tetracycline (10 
µg); VAN: vancomycin (5 µg). 
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259 HH S. epidermidis  R S S R S R R R R S S + Class C 5 V 1 
234 HB S. epidermidis  S S R S S R R S R R S + Class A NT NT 1 
135 DSL S. epidermidis R S S S S R R R R R S + Class B 2 IV 0.5 
124 DSH S. epidermidis  R R S R S R R R S R S + Class B 2 IV 0.5 
133 DSL S. epidermidis R S S S S R R R R R S + Class B 3 3B 0.5 
126 HH S. epidermidis  R R S I S S R R R S S + - - III* 0.5 
257 HH S. epidermidis  R S S S S S S R I R S + Class A 1 1A 0.12 
249 DSH S. epidermidis  R R S S S R R S S R S + NT 2 NT 0.12 
119 DSH S. epidermidis R S S S S S S R I R S + Class C 5 V 0.12 
111 BCF S. epidermidis R S S S S S S S S S S + Class A 2 II 0.12 
202 DST S. epidermidis S R R S S R I S S S S + Class B 5 5B 0.12 
264 HH S. epidermidis S S R S S R R S S S S + Class B 2 IV 0.06 
125 DSH S. epidermidis  S R S I S S R S S S S + NT 5 NT 0.06 
185 DSS S. epidermidis R R S S S S S S S S S + Class C NT NT 0.06 
129 DSL S. epidermidis R S S S S R R R R R S + Class B 1 I 0.03 
379 HAS S. haemolyticus R S S R S R R S R R S + Class A 5 5A 256 
316 DSH S. haemolyticus R R R R S R I S R S R + Class C 5 V 256 
317 DSH S. haemolyticus R R S R R R R R R R R + Class A 2 II 256 
318 DSH S. haemolyticus R S S R R R R R R S S + Class C 5 V 8 
319 DSH S. haemolyticus R S S R S R I R R S S + Class C 5 V 8 
362 DSL S. haemolyticus R S S I S S R R S S S + Class C 5 V 2 
367 DSL S. haemolyticus R S S R S S R R S S S + Class C 5 V 2 
Note: * determined by Zhang’s method. R: resistant, S sensitive. I: intermediate 
BCF- baby care facility; DSH- different sites of hotels; DSL- different sites of a library; DSR- different sites of restaurants; DSS- different 
sites of supermarkets; DST- different sites of transportation facilities; HAS- hotel air samples; HB- handbags; HH- human hands.  
   A: amoxicillin (10 µg); CEF: cefepime (30 µg); C: chloramphenicol (30 µg); E: erythromycin (5 µg); FC: fusidic acid (10 µg); GM: 
gentamicin (10 µg); MUP: mupirocin (20 µg); OX: oxacillin (1 µg); PG: penicillin G (1 unit); S: streptomycin (10 µg); T: tetracycline (10 
µg); VAN: vancomycin (5 µg). 
162 
 





355 DSH S. haemolyticus  R S S R R R R R S R S + Class C 5 V 2 
384 HH S. haemolyticus R S R S S R R S S S S + Class C 5 V 2 
320 DSH S. haemolyticus R R R R S R I S S R R + Class A 1 1A 1 
380 HAS S. haemolyticus R R R S S R R S R R R + Class C 5 V 0.5 
321 DSH S. haemolyticus R R S S S R I R S S S + Class C 5 V 0.25 
322 DSH S. haemolyticus R S S S S S I R S R S + Class A 1 1A 0.25 
382 HH S. haemolyticus R S S I S R R S R S S + - - II* 0.25 
324 DSH S. haemolyticus R S S S S S I R S R S + Class B 1 I 0.12 
323 DSH S. haemolyticus S S S S R S R R I R S + Class A 2 II 0.12 
381 HH S. haemolyticus S S S I S S R S S S S + Class B 5 5B 0.12 
360 DSH S. haemolyticus  S S S S S R S S S S R + Class B 5 5B 0.06 
369 DSL S. haemolyticus R S S S S R R S R S R + Class B 1 I 0.03 
399 DSH S. hominis R R S S S R S S S S R + Class A 1 1A 8 
413 DSH S. hominis  S S R S S R R S S S S + Class C 5 V 2 
506 DSS S. hominis S R S S S R S S S S S + Class B 1 I 0.5 
498 DSS S. hominis R S S S S R S S R S S + Class A NT NT 0.5 
426 DSH S. hominis  R S S I S R R R R S S + Class A NT NT 0.25 
430 DSH S. hominis  R S R S S R R S S S S + NT 5 NT 0.12 
400 DSH S. hominis R R R S S R S R R R S + Class A 1 1A 0.12 
326 DSH S. hominis S S S S S S S R I S S + Class A 1 1A 0.06 
401 DSH S. hominis R S R R S R I R R S S + Class A 1 1A 0.06 
412 DSH S. hominis R S S S S R S R R S S + NT 1 NT 0.06 
Note: * determined by Zhang’s method. R: resistant, S sensitive. I: intermediate 
BCF- baby care facility; DSH- different sites of hotels; DSL- different sites of a library; DSR- different sites of restaurants; DSS- different 
sites of supermarkets; DST- different sites of transportation facilities; HAS- hotel air samples; HB- handbags; HH- human hands.  
   A: amoxicillin (10 µg); CEF: cefepime (30 µg); C: chloramphenicol (30 µg); E: erythromycin (5 µg); FC: fusidic acid (10 µg); GM: 
gentamicin (10 µg); MUP: mupirocin (20 µg); OX: oxacillin (1 µg); PG: penicillin G (1 unit); S: streptomycin (10 µg); T: tetracycline (10 
µg); VAN: vancomycin (5 µg). 
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391 BCF S. hominis R S S S S R S S S S S + NT 5 NT 0.03 
564 DSH S. lugdunensis R S S S S S I S R S S + Class A 5 5A 0.5 
593 HH S. pasteuri  R S S S R R R R S S S + NT 5 NT 0.5 
597 HH S. pasteuri R S R I S S R S S S S + NT 5 NT 0.5 
589 HB S. pasteuri  R S S S S R R S R S S + Class A 5 5A 0.25 
592 HH S. pasteuri  S S R S S R R S S S S + Class B 5 5B 0.25 
603 DSH S. pettenkoferi R R S R R R R R R R R + Class A 5 5A 8 
616 BCF S. saprophyticus R R R S S R I R R R S + NT 5 NT 256 
612 BCF S. saprophyticus R S R S S R S S R S S + NT NT NT 1 
627 HH S. saprophyticus R S I S S R S S S R S + Class B 5 5B 0.5 
621 DSS S. saprophyticus R S R R S R S R S R S + Class B 2 IV 0.25 
628 DSH S. sciuri R R S R S R I S S S R + Class A 5 5A 16 
630 HH S. sciuri  R R R I S R R S S S S + Class A 4 VIII 2 
632 DSH S. sciuri  R S S I S R R R S S S + Class A 5 5A 1 
633 DSH S. sciuri  R S R I R R R R S S S + Class B 5 5B 1 
629 HH S. sciuri  S S R S S S S S S S S + - - II* 0.25 
659 DSH S. warneri  R R R S S R R R S S S + NT 5 NT 0.5 
704 HH S. warneri  R S S I S R R R R S S + Class C 5 V 0.5 
662 DSH S. warneri  R S S S R R R R S R S + Class C 5 V 0.25 
694 HH S. warneri R S S S S S S S S R S + - - I* 0.25 
653 DSH S. warneri R S S S S S I S R S S + Class A 5 5A 0.25 
654 DSH S. warneri R R S S S R I S S S S + Class C 5 V 0.25 
655 BCF S. warneri S S R S R R R S I S S + Class B 1 I 0.12 
648 BCF S. warneri  R S S S R R S R S S S + NT 5 NT 0.06 
645 BCF S. warneri R S S S S R S S S S S + NT 4 NT 0.015 
Note: * determined by Zhang’s method. R: resistant, S sensitive. I: intermediate 
BCF- baby care facility; DSH- different sites of hotels; DSL- different sites of a library; DSR- different sites of restaurants; DSS- different 
sites of supermarkets; DST- different sites of transportation facilities; HAS- hotel air samples; HB- handbags; HH- human hands.  
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   A: amoxicillin (10 µg); CEF: cefepime (30 µg); C: chloramphenicol (30 µg); E: erythromycin (5 µg); FC: fusidic acid (10 µg); GM: gentamicin 
(10 µg); MUP: mupirocin (20 µg); OX: oxacillin (1 µg); PG: penicillin G (1 unit); S: streptomycin (10 µg); T: tetracycline (10 µg); VAN: 
vancomycin (5 µg).  
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No mecA gene was found in twelve S. aureus isolates, all of which were phenotypically 
susceptible to oxacillin. MICs of 12 mecA-negatives S. aureus isolates ranged from 0.06 
to 0.12 mg l
-1
.   
The presence of the mecA gene was also demonstrated in 702 staphylococcal species, 
including: S. epidermidis, S. haemolyticus, S. sciuri, S. cohnii, S. hominis, S. 
saprophyticus, S. lugdunensis, S. pasteuri, S. capitis, S. warneri, and S. pettenkoferi 
(Table 6.2); however, the carriage of mecA did not always result in strains 
demonstrating significant levels of resistant to oxacillin. Thirty-nine of the 89 (44%) 
mecA positive staphylococci were found to have MICs below 0.5 mg l
-1
 to oxacillin 
(Table 6.2). Of 24 mecA-positive S. epidermidis isolates, 9 (38%) were classified as 
susceptible (oxacillin). Eight strains of 17 S. haemolyticus (47%) that tested positive for 
the mecA gene demonstrated susceptible to oxacillin. This inconsistency is also 
observed in other species, S. hominis (7/11), S. sciuri (1/5), S. cohnii (1/5), S. 
saprophyticus (1/4), S. lugdunensis (0/1), S. pasteuri (2/4), S. capitis (3/6), S. warneri 
(7/9), and S. pettenkoferi (0/1) (Table 6.2). 
6.1.2 mecA gene expression in selected staphylococci 
mecA gene is oxacillin resistance determinant (Tulinski et al., 2012), however, MICs of 
44 % mecA gene positive isolates in this study were found to be below 0.5 mg l
-1
. In 
order to clarify this inconsistence, LC-MS/MS were applied to 4 selected staphylococci 
with MICs ranged from 0.12 to 256 mg l
-1
. 
6.1.2.1 Protein extraction 
To start mecA gene expression analysis, protein was extracted and the concentration was 
determined by Bradford assay (Sigma Aldrich, UK). The concentration of each sample 
is shown in the Table 6.3. 
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Table 6. 3  Protein concentration of 4 staphylococci 
ID Concentration (µg µl
-1
) 
S. hominis 506 2.18081 
S. haemolyticus 318 2.37212 
S. epidermidis 118 (G6_2) 3.48394 
S. epidermidis 111 3.10822 
 
6.1.2.2 PBP 2a expression 
Penicillin binding protein 2a was expressed in S. haemolyticus 318 and S. epidermidis 
118 (G6_2), and the expression of PBP 2a in S. epidermidis 118 (G6_2) was 1.5 times 
more than that in S. haemolyticus 318; however, penicillin binding protein 2a was not 
found in S. hominis 506 and S. epidermidis 111 (Table 6.4). 
Table 6. 4  Quantified expression of penicillin binding protein in 4 staphylococci by 
LC-MS/MS 
ID MIC (mg l
-1
) mecA gene Spectrum number count 
PBP2a PBP2 
S.epidermidis 111 0.12 + 0 1 
S.hominis 506 0.5 + 0 1 
S.haemolyticus 318 8 + 1 7 
S.epidermidis 118 (G6_2) 256 + 2 1 
6.2 SCCmec typing 
After determining the mecA gene positive staphylococcal isolates, the SCCmec types of 
89 mecA-positive isolates were examined. 20 staphylococci (22%) carried SCCmec V, 
followed by SCCmec type I (9 isolates, 10%), type IV (6 isolates, 7%), type II (5 
isolates, 6%), one type III (1%), one type VI (1%), and one type VIII (1%). In addition, 
seven isolates harboured a new SCCmec type 1A, which carried combination of class A 
mec complex and ccr type 1. Of the fifteen isolates that were non-typeable, eight carried 
a combination of class A mec complex and ccrC, six carried a combination of class B 
mec and ccrC, and one carried class B mec and ccr type 3. Additionally, 24 isolates 
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Table 6. 5  Diversity of SCCmec types in coagulase negative staphylococci 
 I II III IV V VI VIII 1A 3B 5A 5B NT Total No 
S. capitis 1           5 6 
S. cohnii 1    2     1  1 5 
S. epidermidis 2 1 1 5 6 1  1 1  1 5 24 
S. haemolyticus 2 3   9   2  1 2  19 
S. hominis 1    1   4    5 11 
S. lugdunensis          1   1 
S. pasteuri          1 1 2 4 
S. pettenkoferi          1   1 
S. sciuri  1     1   2 1  5 
S. saprophyticus    1       1 2 4 
S. warneri 2    2     1  4 9 




6.3 Multi-locus sequence typing  
Following the determination of SCCmec types, MLST was performed to determine the 
housekeeping genes of 19 S. epidermidis. MLST is an accurate typing approach used for 
microorganisms, and MLST type is determined by combination of seven housekeeping 
gene locus (Thomas et al., 2007).  Each housekeeping gene of 19 S. epidermidis were 
compared with the MLST database, and arc C, aro E, gtr of 120 were determined to be 
new locus as there was no match in the database. gtr of 119 was determined to be a new 
locus, as no homology in the database was found. MLST typing revealed that 17 S. 
epidermidis strains represent new MLST types.  MLST type of S. epidermidis 120, 119，
122，121,  279, 133, 134, 135, 126, 259, 124, 127, 234, 187, 308, 153 and 191 were 
assigned as ST515, ST516, ST517, ST518, ST599, ST600, ST600, ST600, ST601, 
ST602, ST602, ST603, ST604, ST605, ST606, ST607 and ST608. S. epidermidis 133, 
134 and 135 were isolated from DSL, and they shared the same MLST type ST600. S. 
epidermidis 259 was isolated from HH, while S. epidermidis 124 was isolated from 
DSH.  Both of them were ST602 (Table 6.6). In addition, S. epidermidis 139 were 






Table 6. 6 MLST types identified in S. epidermidis 
ID Species Sites arcC aroE gtr muts pyr Tpi yqil ST 
118 S. epidermidis  Hotels 2 1 1 1 2 1 1 ST59 
119 S. epidermidis  Hotels 1 2 5 1 1 1 14 ST516 
120 S. epidermidis  Hotels 28 25 5 5 7 5 11 ST515 
121 S. epidermidis  Hotels 1 2 1 1 1 1 14 ST518 
122 S. epidermidis  Hotels 1 2 2 6 2 16 1 ST517 
124 S. epidermidis  Hotels 57 1 2 2 4 1 1 ST602 
127 S. epidermidis  Hotels 57 10 5 5 10 16 21 ST603 
133 S. epidermidis Library 57 1 2 2 4 1 4 ST600 







ID Species Sites arcC aroE gtr muts pyr Tpi yqil ST 
135 S. epidermidis Library 57 1 2 2 4 1 4 ST600 
139 S. epidermidis  Restaurants 3 3 5 5 7 4 4 ST360 
153 S. epidermidis  Restaurants 57 1 22 2 2 16 1 ST607 
187 S. epidermidis  Supermarkets 57 1 1 2 2 1 1 ST605 
191 S. epidermidis  Supermarkets 57 3 5 5 7 14 11 ST608 
234 S. epidermidis  Handbags 57 1 1 1 2 41 1 ST604 
126 S. epidermidis  Hands 57 25 9 5 6 1 8 ST601 
259 S. epidermidis  Hands 57 1 2 2 4 1 1 ST602 
279 S. epidermidis  Hands 57 17 5 5 3 4 31 ST599 
308 S. epidermidis  Hands 57 1 2 2 4 7 1 ST606 
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6.4 Chapter summary 
Genotypic characterisation of staphylococci showed that: 
1. mecA gene was found in eighty-nine (12%) staphylococcal isolates; 
2. Thirty-nine of the 89 (44%) isolates that were mecA positive were found to have 
MICs below 0.5 mg l
-1
 to oxacillin; 
3. Expression of PBP 2a was found in high oxacillin resistant mecA positive 
staphylococci, but not in oxacillin susceptible mecA positive staphylococci; 
4. SCCmec type I, II, III, IV, V, VI, VIII were determined in environmental 
staphylococci; 
5. Fourteen new MLST types were determined in 19 selected staphylococci.  
MRSA is a potential public health threat, which has been recovered from both clinical 
and community associated settings all over the world. However, little is known about 
the dissemination of methicillin-resistant staphylococcal isolates recovered from the 
environment. This chapter introduced the dissemination of mecA gene positive 
staphylococci and molecular characterization of mecA gene positive staphylococci.  The 
correlation of mecA-positive and phenotypic oxacillin susceptibility in environment 
staphylococci will be assessed by comparing with clinical staphylococci in the 
discussion chapter, and then the existence of the oxacillin susceptible mecA-positive 
environmental staphylococcal isolates will be assessed in the discussion chapter. The 
prevalent SCCmec types in the environment will be compared with community-
associated SCCmec types and hospital-associated SCCmec types. Finally, the MLST 
types of environmental staphylococci will be compared with international reported 




Chapter 7 Genomic analysis of S. epidermidis 118 (G6_2) 
Complete genome sequencing of staphylococci can provide insights into important 
genomic features and assess the variation of plasmids that contribute to the 
pathogenicity of staphylococci (Gill et al., 2005). Whole genome sequencing has been 
used to analyse clinical significant staphylococci, transmission of S. aureus in health 
care facilities, and antibiotic resistance in clinical isolates (Harris et al., 2013; Peleg et 
al., 2012; Price et al., 2013); however, complete genomic features of environmental 
isolated staphylococci has been rarely reported. Since environmental staphylococci may 
act as a reservoir for antibiotic resistance genes (Wright, 2007), it would be necessary to 
gain insights into the genomic feature of environmental staphylococci. Whole genome 
sequencing was applied to S. epidermidis 118 (G6_2), which was recovered from a 
hotel room. MIC of S. epidermidis 118 (G6_2) against oxacillin was 256 mg l
-1
, and 
phenotypically resistant to 11 out of 13 tested antibiotics. 
7.1 Bacteria 
S. epidermidis 118 (G6_2) was isolated and purified from a hotel room in London area 
in 2013, and it was resistant to all tested antibiotics, except vancomycin and 
chloramphenicol. Moreover, the MIC of S. epidermidis 118 (G6_2) was determined to 
be 256 mg l
-1
 against oxacillin. In addition, the mecA gene was identified and the 
SCCmec was determined to be type IV for this isolate.   




7.2 Phylogenetic relationship with clinical reference S. epidermidis 
S. epidermidis 118 (G6_2) and publically available assembled 92 S. epidermidis were 
chosen to show the phylogenetic relationship (Fig 7.1). S. epidermidis 118 (G6_2) was 
highlighted in red. The S. epidermidis most similar to S. epidermidis 118 (G6_2) was 
boxed in red; however, the phylogenetic relationship was distinguishable as it formed a 
distinct branch (Fig 7.1).  
The 92 reference isolates were referred to datasets of clinical S. epidermidis (Roach et 
al., 2015; Tewhey et al., 2014). Isolates SRR1656389, SRR1656376 and SE_BCM-
HMP0060 (Roach et al., 2015) were in a distinct clade and shown to be most similar to 
S. epidermidis 118 (G6_2) (Fig 7.1).  Whereby, S. epidermidis 118 (G6_2) is closest to 








7.3 General genomic features and plasmids 
General genomic features of S. epidermidis 118 (G6_2), S. epidermidis PR62a, S. 
epidermidis ATCC12228 and S. aureus N315 were shown in Table 7.1. In general, the S. 
epidermidis 118 (G6_2) genome comprises of one chromosome (2408357 bp in length) 
and six plasmids, annotated as pG6_2_1 to pG6_2_6 (the largest, pG6_2_1, is 10570 
and the smallest, pG6_2_6, is 3426 bp in length), with an average G+C content of 
32.02%. It has a total (chromosome and plasmids) of 2213 predicted protein coding 
sequences, of which 21.5% were annotated as hypothetical and 14.3% were annotated 






Table 7. 1 General features of S. epidermidis 118 (G6_2) and reference staphylococci 
 S. aureus S. epidermidis 
N315 RP62a ATCC 12228 118 (G6_2) 
Chromosome     
Length of sequences 2814816 2616530 2499279 2408357 
G+C content 32.80% 32.1% 32.10% 32.02% 
Protein coding region 2595 2391 2419 2213 
Ribosomal RNAs 16 19 16 4 
16S 5 6 5  
23S 5 6 5  
5S 6 7 6  
Transfer RNAs 62 59 60 60 
Plasmid     
Length of sequences 24653 27310 P1:4439 P1：10570 
   P2:4679 P2：4909 
   P3:8007 P3：4588 
   P4:17261 P4：4576 
   P5:24370 P5：4271 
   P6:6585 P6：3426 
Antibiotic resistance genes     
Beta-lactamase   + + 
tetracycline resistant protein   + + 
Bleomycin resistant protein     
Penicillin binding proteins     
Bifunctional AAC-APH  +  + 
Aminoglycoside phosphotransferase + +   
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 S. aureus S. epidermidis 
N315 RP62a ATCC 12228 118 (G6_2) 
Penicillin binding protein 2a + +  + 
Fosfomycin resistance protein  +  + 
Macrophage scavenger receptors    + 
Inactivating enzymes    + 
Isoleucyl RNA synthetase    + 











7.4 Genotypic prediction of antibiotic resistance 
Antibiotic resistance prediction, using the ResFinder (version 2.1) online tool (Center 
for Genomic Epidemiology), revealed a wide range of potential resistance features 
dispersed across the chromosome and plasmids (Table 7.2).  A total of seven resistance 
phenotypes were predicted and included: aminoglycoside resistance (aac(6’) – aph(2”) 
genes, 100% identity); beta-lactam resistance (borne from the presence of both the 
mecA and blaZ genes, 100% identity); fosfomycin resistance (fosA gene, 100% identity); 
macrolide resistance (mph(C) gene, 100% identity); macrolide, lincosamide and 
streptogramin B resistance (msr(A) gene, 98.98% identity); and tetracycline resistance 
(tet(K) gene, 99.93% identity).  Of these, only mecA and fosA were mapped to the 
chromosome, the remainder were localised to the plasmids, specifically, plasmid 
pG6_2_1 harboured blaZ, pG6_2_2 has the gene tet(K), pG6_2_3 has both mph(C) and 
msr(A), and pG6_2_4 possessed the aac(6’) – aph(2”) genes.  
With the 13 tested antibiotics, S. epidermidis 118 (G6_2) was shown to be 
phenotypically resistant to streptomycin (aminoglycoside antibiotic), gentamicin 
(aminoglycoside antibiotic), penicillin (beta-lactam antibiotic), oxacillin (beta-lactam 
antibiotic), amoxicillin (beta-lactam antibiotic), cefepime (beta-lactam antibiotic), 
cefoxitin (beta-lactam antibiotic), erythromycin (macrolide antibiotic), tetracycline 
(tetracylines antibiotic), fusidic acid (steroid antibiotic), and mupirocin 
(monoxycarbolic acid antibiotic).  
The antibiotic resistance genes determined by WGS correlated with the phenotypic data 
is as follows:  aac(6')-aph(2'') encodes for aminoglycoside-modifying enzymes,  
resulting in aminoglycoside resistance (streptomycin and gentamicin); blaZ encodes β-
lactamase, responsible for beta-lactam resistance (penicillin);  mecA encodes penicillin-
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binding protein 2a, responsible for beta-lactam resistance (oxacillin, cefoxitin, cefepime 
and amoxicillin); fosA encodes fosfomycin resistance protein, responsible for 
fosfomycin resistance; msr(A) encodes macrophage scavenger receptors, responsible for 
macrolide, lincosamide and streptogramin B resistance; mph(C) encodes inactivating 
enzymes, responsible for  macrolide resistance (erythromycin); and tet(K) encodes the 
tetracycline efflux pump, responsible for tetracycline resistance; The resistance 
determinants towards streptomycin, gentamicin, penicillin, oxacillin, cefoxitin, 
amoxicillin, cefepime, erythromycin, tetracycline were successfully predicted by 
ResFinder (version 2.1) online tool (Center for Genomic Epidemiology). These 
however did not predict genes responsible for fusidic acid and mupirocin resistance 
using ResFinder (version 2.1). The determinants responsible for mupirocin resistance 
have been found in Prokka annotated file. Mupirocin resistance in S. aureus can be 
caused by acquisition of an additional isoleucyl RNA synthetase (ileS) gene (Hodgson 
et al., 1994).  In this study, ileS gene responsible for the resistance of mupirocin was 
present in S. epidermidis 118 (G6_2). Although it is expected to be captured by 
ResFinder tool, it does not make part of the database and hence it was overlooked. 
Fusidic acid resistance occurs due to the mutations in the fusA encoding elongation 
factor G (EF-G) or rplF (or fusE) (Howden & Grayson, 2006). These mutations cannot 
be captured by ResFinder as it only identifies acquired resistance genes.  
Comparative analysis with reference strains revealed that S. epidermidis RP62a includes 
five antibiotic resistance genes, including aminoglycoside resistance spc genes (100% 
identity) and aac(6’) – aph(2”) genes (100% identity); beta-lactam resistance mecA 
(100% identity); fosfomycin resistance (fosA gene, 99.07% identity); macrolide 
resistance gene, erm(A) (100% identity). Only two resistance genes, including beta-
lactam resistance blaZ genes (100% identity) and tetracycline resistance genes (tet(K) 
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gene, 99.93% identity) were found in S. epidermidis ATCC12228. Four antibiotic 
resistance genes were found in S. aureus N315: aminoglycoside resistance spc genes 
(100% identity) and aadD genes (99.74% identity); beta-lactam resistance mecA gene 





Table 7. 2  Genotypic prediction of antibiotic resistance of S. epidermidis 118 (G6_2) 
Product Gene name Accession number 
(Identity %) 




























Genome 104692..105120 Fosfomycin 























ileS - - - Fusidic acid 
resistance 
Steroid Fusidic acid 
Elongation 
factor G  





7.5 Functional genes uniquely found in S. epidermidis 118 (G6_2) 
104 genes were uniquely found in the chromosome of S. epidermidis 118 (G6_2), when 
compared to the reference strains in this study. The majority were annotated as 
hypothetical, while the remainder comprised of a variety of functions, including heavy 
metal transport, regulatory, HTH domain, transpose and metabolic proteins.  There were 
eight genes that were exclusively found in one of S. epidermidis 118 (G6_2) plasmids. 
The majority of these were annotated as hypothetical, of the remainder the gene qacC, 
yheS and Tn552 were identified. 
7.6 Comparative virulence genes 
Comparison of S. epidermidis 118 (G6_2) with S. aureus N315 showed that (1) 312 
genes were in common; (2) 32 genes were uniquely found in S. epidermidis 118 (G6_2); 
(3) 522 genes were missing in S. epidermidis 118 (G6_2). Comparison of S. epidermidis 
118 (G6_2) with S. epidermidis RP62a revealed that (1) 303 genes were in common; (2) 
40 genes were uniquely found in S. epidermidis 118 (G6_2); (3) 75 genes were missing 
in S. epidermidis 118 (G6_2). Comparison of S. epidermidis 118 (G6_2) with S. 
epidermidis ATCC12228 showed that (1) 306 genes were common; (2) 38 genes were 
uniquely found in S. epidermidis 118 (G6_2); (3) 44 genes were missing in S. 
epidermidis 118 (G6_2) (Table 7.3). 
 
Table 7. 3  Comparision of virulence genes between S. epidermidis 118 (G6_2) and 
reference staphylococci 
S. epidermidis Virulence genes S. aureus S. epidermidis 
  N315 RP62a ATCC12228 
 Unique  32 40 38 
118 (G6_2) Common  312 303 306 




There were 266 genes present in all four staphylococcal isolates in this study. The 
intracellular adhesion genes icaA, icaB, icaC, icaD and icaR responsible for biofilm 
formation (Cramton et al., 1999) were not present in S. epidermidis 118 (G6_2) and S. 
epidermidis ATCC12228.  In contrast, icaA was present in S. aureus N315 (Zhang et al., 
2003) and S. epidermidis RP62a (Kaplan et al., 2011). In addition, the genes copZ_2, 
copA_2 and csoR_1 variants associated with copper transport were determined in S. 
epidermidis 118 (G6_2) (Harrison et al., 2000; Schelder et al., 2011). A further 34 other 
heavy metal associated genes were shown to be homologous between S. epidermidis 
118 (G6_2) and S. epidermidis RP62a and ATCC12228.  Forty-eight genes were shown 
to be specific to S. aureus N315, primarily associated with iron transport and 
metabolism.   
Virulence determinants in each staphylococcal species were shown in Table 7.4. A total 
of 29 virulence genes belonging to 14 virulence factors families were found in S. 
epidermidis 118 (G6_2), which is less than S. aureus N315 (n=61) but more than S. 
epidermidis RP62a (n=19) and ATCC 12228 (n=18). Thirteen virulence factors were 
found in common between the four staphylococcal strains, including htrA, sspA, sspB, 
lip, lipA, hlb, nuc, clpP, clpB, clpX, clpC clpE and isaA. Twelve virulence genes, setC, 
sspP, lip_1, lip_2, lip2_1, lip2_2, lipR_2, lipM, lipL, lipR, sfpA, and sigD, were 
uniquely found in S. epidermidis 118 (G6_2). isaB, lytN and cptV were found in both S. 
epidermidis 118 (G6_2) and S. aureus N315, but not in S. epidermidis RP62a and 
ATCC 12228. The gene geh was the only common gene found in S. epidermidis 118 






Table 7. 4 Virulence genes in S. epidermidis 118 (G6_2) and reference staphylococci 
Virulence factor S.aureus S.epidermidis 
N315 RP62a ATCC12228 118 (G6_2) 
 Gene Gene Gene Gene 
Enterotoxin sea    
 sec3    
 seg    
 sei    
 sel    
 sem    
 sen    
 seo    
 sep    
 yent1    
 yent2    
Exotoxin set1    
 set2    
 set3    
 set4    
 Set6    
 set7    
 set8    
 set9    
 set10    
 set11    
 set12    
 set13    
 set14    
 set15    
 -   setC 
Exfoliative toxin  eta    
Toxic shock syndrome toxin tsst    
Serine protease splA    
 splB    
 splC    
 splD    
 splF    
 htrA htrA htrA htrA 
     
Serine V8 protease sspA sspA sspA sspA 
Cysteine protease sspB sspB sspB sspB 
 sspC    
    sspP 
Lipase lip lip lip lip 
    lip_1 
    lip_2 
    lip2_1 
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Virulence factor S.aureus S.epidermidis 
N315 RP62a ATCC12228 118 (G6_2) 
 Gene Gene Gene Gene 
    lip2_2 
    lipR_2 
  geh geh geh 
  geh1, gehC geh1,gehC  
  geh2, gehD geh2, gehD  
Lipase/esterase lipA lipA lipA lipA 
    lipL 
    lipM 
    lipR 
Leukotoxin D lukD    
Leukotoxin E lukE    
Leukocidin F lukF    
Leukocidin M lukM    
Alpha hemolysin hly    
Beta hemolysin hlb hlb hlb hlb 
Delta hemolysin hld hld hld  
Gamma hemolysin, 
component A 
hlgA    
Gamma hemolysin, 
component C 
hlgC    
Gamma hemolysin, 
component B 
hlgB     
Hyaluronate lyase hysA    
Thermonuclease 
nuclease 
nuc nuc nuc nuc 
Cell wall hydrolase lytN   lytN 
Clp protease, procolytic 
subunit 
clpP clpP clpP clpP 
Clp protease, ATP 
binding subunit 
clpB clpB clpB clpB 
Clp protease, ATP 
binding subunit 
clpX clpX clpX clpX 
Clp protease, ATP 
binding subunit 
clpC clpC clpC clpC 
Clp protease, ATP  
binding submit 
clpE clpE clpE clpE 
Staphylococcal 
protein A Spa 
Spa    
Phenol-soluble modulin hldc    
Immunodominant 
staphylococcal antigen A 
isaA isaA isaA isaA 
Immunodominant 
staphylococcal antigen B 
isaB   isaB 
cytoplasmic proteins isdl    
Pilin Subunit Gene    sfpA 
Sigma D factor    sigD 
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Virulence factor S.aureus S.epidermidis 
 N315 RP62a ATCC1228 118 (G6_2) 
 Gene Gene Gene Gene 
Intercellular adhesion gene ica ica   
ATPase_copper_transporter ctpV   cptV 
 
Surface protein genes identified in each staphylococcal species were shown in Table 7.5. 
Eight surface protein genes were found in S. epidermidis 118 (G6_2), of which sdrC, 
sdrD, sdrG, ebh, ebp, and atl were involved in adherence to host tissue, pls involved in 
methicillin resistant, and sasK involved in binding to heme-iron (Gill et al., 2005).  
Surface protein genes, sdrC and sdrD were present in both S. epidermidis 118 (G6_2) 
and S. aureus N315, and pls were appeared in S. epidermidis 118 (G6_2) and RP62a. 
sdrG and ebp were present in three S. epidermidis. Furthermore, sasK, ebh and atl were 
found in all staphylococcal species. Moreover, surface protein genes found in S. 
epidermidis 118 (G6_2) (n=8) was less than S. aureus N315 (n=19) and S. epidermidis 







Table 7. 5  Surface proteins of S. epidermidis 118 (G6_2) and reference staphylococci 
Genes Functional name Function 
S.aureus S.epidermidis 
N315 RP62a ATCC12228 G6_2 
clfA Clumping factor A a +    
clfB Clumping factor B a +    
fnbA Fibronectin  binding protein A a +    
fnbB Fibronectin  binding protein B a +    
sdrC SdrC a +   + 
sdrD SdrD a +   + 
sdrE SdrE a +    
sdrF SdrF a  + +  
sdrG SdrG a  + + + 
sdrH SdrH a  + +  
spa ProteinA a,b +    
pls Methicillin resistant surface protein d  +  + 
sasC Cell wall surface anchor protein d +    
sasG Cell wall surface anchor protein d + + +  
sasK Cell wall surface anchor protein c + + + + 
isdC Heme transporter d +    
isdI Heme degrading moxooxygenase a +    
map Extracellular adherence protein a +    
empbp Extracellular matrix and plasma binding protein a +    
ebh Cell wall-associated fibronectin binding protein a + + + + 
efb Fibrinogen binding protein a +    
ebp Elastin binding protein a  + + + 
atl Biofunctional autolysin a + + + + 
Note: a, adherence to host tissue (extracellular matrix, fibrinogen, fibronectin, collagen, elastin, endothelial and epithelial cells); b, evasion of 
host defense; c, binding to heme-iron; d, unknown; 
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7.7 Chapter summary 
Whole genome analysis of S. epidermidis 118 (G6_2) showed that:  
1. Environmental S. epidermidis 118 (G6_2) formed distinctive branch with clinical 
reference S. epidermidis; 
2. Nine antibiotic resistance genes were found in genome of S. epidermidis 118 (G6_2); 
3. Multiple virulence and anti-detergent genes were determined in S. epidermidis 118 
(G6_2). 
Antibiotic resistance is a major global threat to public health and increasingly antibiotic 
resistant bacteria are emerging from different ecological niches, including 
environmental sources. Little is known of the genetic variations associated with strains 
isolated from environmental sources and/or general public settings. 
S. epidermidis is an opportunistic pathogen primarily recovered from infections arising 
from healthcare associated medical devices. Genome sequencing of S. epidermidis 
strains have been reported, however, these have been limited to commensal and 
nosocomial strains.  To understand the genetic background of environmental S. 
epidermidis strains, whole genome sequence analysis of multidrug-resistant S. 
epidermidis 118 (G6_2) was performed.   
The comparative analysis of S. epidermidis 118 (G6_2) and clinical reference strains of 
S. aureus N315 and other S. epidermidis RP62a and ATCC12228 genomes will be 
discussed in the discussion chapter.  Evaluation of the antibiotic resistance and 
virulence in environmental multidrug-resistant S. epidermidis 118 (G6_2) will be 




Chapter 8 mecA gene transfer via mating experiment 
Wielders et al., (2001) reported the evidence of in vivo transfer of mecA gene between 
clinical S. aureus isolates, and Bloemendaal et al., (2010) also showed the evidence of 
in vivo SCCmec transfer from S. epidermidis to S. aureus during antibiotic therapy, 
Bloemendaal et al have attempted to replicate the SCCmec transfer in vitro; however, 
the transfer of mecA/SCCmec in vitro has not been reported (Bloemendaal et al., 2010). 
After reviewing the present findings, mating experiment mediated transferring of 
mecA/SCCmec from environmental staphylococci to S. aureus NCTC6571 in vitro was 
applied. Additionally, comparative proteomic analysis provided functional genomics 
data for S. aureus to resistant to antibiotic. 
8.1 mecA gene amplification in conjugants 
The broth mating method was used to determine the mecA gene transfer, 10 trans-
conjugants were isolated and purified with mannitol salt agar supplemented with 4 mg l
-
1
 oxacillin, and mecA gene PCR were applied to these ten conjugants. S aureus 
NCTC6571 (recipient) showed a negative result, and S. hominis 399 (donor), conjugants 
No 3, 6, 7 and 10, showed positive results. These conjugants were then tested with 
another pair of mecA gene primers (286 bp), and conjugant No7 was showed positive 




Figure 8. 1 Gel image of mecA gene PCR product. A 527 bp mecA primers (Hanssen et 
al., 2004), B 286 bp mecA primers (Kondo et al., 2007); Sa: S. aureus; SH: S.hominis 
399; 3: conjugant No3; 6: conjugant No6; 7: conjugant No7; 10: conjugant No10; M: 
DNA ladder. 
 
8.2 16S rRNA gene sequencing of conjugant 
The species of conjugant was identified by partial 16S rRNA gene sequencing. The 
partial 16S rRNA gene of conjugant No7 was amplified, and the sequence was 
examined to be S. aureus in comparison with the nucleotide database at National Center 




8.3 ProlexTM staph XTRA latex tests and MIC of conjugant 
The conjugant was also tested by Staph latex test, which showed a positive result. The 
MICs of S aureus NCTC 6571 (recipient), S. hominis 399 (donor) and No7 (conjugant) 
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were determined. The recipient was fully susceptible to oxacillin, with MIC value of 
0.125 mg l
-1
, and the MIC of conjugant was 0.25 mg l
-1
, which indicated fully 
susceptible to oxacillin. However, the conjugant could grow on mannitol salt agar 
supplemented with 4 mg l
-1
 oxacillin. The potential reason for this conflict phenomenon 
may be due to the mannitol salt agar, which contains high concentration of salt. In order 
to confirm the transfer of mecA gene between S. hominis and S. aureus, Southern 
blotting and PFGE were applied to donor, recipient and conjugant. 
8.4 Southern blotting 
After determining the MIC of conjugant, donor and recipient, Southern blotting was 
applied to determine the presence of the mecA gene in conjugant. According to Southern 
blotting results, the presence of mecA gene was confirmed in donor, but not in S. aureus 
NCTC6571 (recipient) and conjugant No7. 
8.5 PFGE results 
To avoid contamination of conjugant No7, pulse-field gel electrophoresis was used to 
examine the genetic patterns of donor, recipient and conjugant. PFGE showed that the 
conjugant and S. aureus NCTC 6571 (recipient) had the same pattern, but was different 
from the donor (Fig 8.2). The same PFGE pattern indicated the presence of one strain, 




Figure 8. 2 PFGE patterns of donor, recipient and conjugant. λ = M Wt Ladder; Lane 1 
= Donor (S. hominis, mecA positive); Lane 2 = Recipient (S. aureus, mecA negative); 
Lane 3 = Conjugant No7  
 
8.6 Comparative proteomic analysis  
As noted above, no mecA gene was detected in conjugant No7 based on Southern 
blotting, however, conjugant No7 could survive and propagate on 4 mg l
-1
 oxacillin 
supplemented MSA. The colonies of conjugant No7 on oxacillin supplemented MSA 
were small and sticky. Comparative proteomic analysis was then applied to clarify 
protein expression differences between S. aureus NCTC 6571 and conjugant No7.  
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8.6.1 Protein extraction 
The first stage of comparative proteomic analysis was protein extraction. S. aureus 
NCTC 6571 was cultured on mannitol salt agar, and meanwhile conjugant No7 were 
cultured on mannitol salt agar supplemented with 4 mg l
-1
 oxacillin.  
Protein was extracted and the concentration was determined by Bradford assay (Sigma 
Aldrich, UK). The concentration of each sample was shown in the Table 8.1.  















S.aureus NCTC 6571 
 
3.46308 1.66304 1.36051 
Conjugant No 7 
 
4.04837 7.67402 7.42345 
 
8.6.2 In-gel trypsin digestion 
Second, 10 µg of protein extract was loaded on to a gel and separated by 1D SDS-
PAGE using MES running buffer (Invitrogen, UK) in accordance with the 
manufacturer’s instructions. The 1D SDS-PAGE band patterns of S. aureus and 
conjugant No7 was showed in figure 8.3.  
 
Figure 8. 3 1D SDS-PAGE (triplicates) band patterns of S. aureus and conjugant No7. 
M:  protein ladder, Sa: S. aureus (cultured on MSA); No7: conjugant (cultured on 
oxacillin suppl MSA). 
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8.6.3 Comparative analysis of protein expression 
The comparative analysis of protein expression demonstrated that various proteins were 
upregulated or exclusively expressed in conjugant No7 but not in S. aureus NCTC 6571. 
All of these proteins could be classified into 7 categories by function: including proteins 
involved in efflux, cell wall synthesis, virulence, reparation, stress response, 
degradation, and translation.  
A total of 1353 proteins were detected by LC-MS/MS, and 757 proteins were both 
found in S. aureus (recipient) and conjugant No7. 300 proteins were uniquely expressed 
in S. aureus (recipient), and 296 proteins were uniquely expressed in conjugant No7 
(Fig 8.4).  
                    
Figure 8. 4 Overview of protein expression differences in S. aureus NCTC 6571 and 
conjugant No7 
 
No penicillin binding protein 2a was found in both S. aureus and conjugant. However, 
EmrB/QacA subfamily protein, drug resistance transporter (A6QJJ3, 71 KDa), and 
ATP-binding cassette transporter (A6QIF7, 33 KDa) were increasingly expressed in the 
conjugant. EmrB/QacA subfamily protein, drug resistance transporter and ATP binding 
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cassette transporter can be implicated in antibiotic resistance through facilitating the 
export of various cytotoxic drugs out of the membrane (Dawson & Locher, 2006; 
Lomovskaya & Lewis, 1992) (Table 8.2). In addition, the upregulation of these two 
transporters are also involved in the stringent response of bacteria (Anderson et al., 
2006).   
In addition to the protein involved in efflux, increased expression of proteins involved 
in cell wall synthesis were also observed in the conjugant, such as UDP-N-
acetylmuramate-L-alanine ligase (A6QFM8, 45 kDa), penicillin binding protein 2 
(A6QG81, 83 kDa); glycosyl transferase group 2 family protein (A6QDN2, 66 kDa) , 
and glutamate racemase (MURI, 30 kDa) (Fotheringham et al., 1998; Munshi et al., 
2013; Rebets et al., 2014; Sauvage et al., 2008) (Table 8.2). However, the expression of 
penicillin binding protein 1 (A6QG81, 83 kDa) remains the same in both samples 
(Sauvage et al., 2008). 
Moreover, in conjugant cultured with oxacillin, the virulence factors, including 
clumping factor A (CLFA, 97 kDa); zinc metalloprotease (A6QEG3, 78 kDa); Clp 
protease, procolytic subunit (CLPP, 22 kDa); Clp protease, chaperone protein (A6QFI5, 
98 kDa); Clp protease, ATP- binding subunit  (A6QEH7, 91 kDa), were specifically 
present or expressed at an increased level (Bloemendaal et al., 2010; Gill et al., 2005; 
Josefsson et al., 2001) (Table 8.2). 
DNA ligase (DNLJ, 75 kDa) which is involved in DNA repair was found exclusively in 
conjugant (Cynthia Chen et al., 2002; Hanawalt & Cooper, 1979). Another repair 
protein is DNA mismatch repair protein MutS (MUTS, 100 kDa), whose function is 
known to correct DNA replication mismatch during the adverse influences on the 
genome (O’Neill, 2002). The expression of MutS was found to remain the same. 
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29 stress response proteins were identified, including 4 SOS response proteins, 13 
stringent response proteins, and 12 heat-shock response proteins. The stress response 
proteins of bacteria are important for survival during imposition of environmental 
stresses (Anderson et al., 2006) (Table 8.2). All SOS response proteins were found to be 
upregulated in conjugant in comparison with S. aureus.  10 stringent response proteins 
(except aspartate-semialdehyde dehydrogenase, sulphite reductase and threonine 
synthase) were upregulated in the conjugant. The expression of 7 heat shock response 
proteins was increased, whereas the expression of 5 heat shock response proteins 
remains the same in conjugant.  Notably, no cold shock protein was found in both 
isolates (Table 8.2).  
Thioredoxin, which is essential to protect cells from oxygen damage, was upregulated 
in conjugant (Bore et al., 2007). Additionally, four proteins that belong to heat shock 
protein family were found to be upregulated in conjugant (Table 8.2). Chaperone 
protein DnaJ and DnaK is known to maintain normal function of cell and solubilize the 
protein aggregates (Cuéllar et al., 2013; Mogk et al., 2003), and small heat shock 
protein GrpE (Hsp20) and molecular chaperone Hsp31 are involved in protein folding 
and stabilization (Muthaiyan et al., 2012).  
ATP-dependent protease subunit (HSLV, 20 kDa) and Dead-box RNA helicase 
(A6QIS5, 57 kDa) that are involved in degradation process in cells were found to be 
upregulated in the conjugant. HslU–HslV is a bacterial proteasome, the function of 
which is known to preserve cellular homeostasis by degrading substrate polypeptides 
(Shi & Kay, 2014). In addition, Dead box RNA helicase are involved in bacterial 
mRNA degradation (Py et al., 1996).   
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Expression differences were also found in 30S ribosomal proteins and 50S ribosomal 
protein. Increased expression of 30S ribosomal proteins S6, S9, S10, S11, S12, S13, 
S20, S21 and 50S ribosomal proteins L3, L4, L5, L6, L10, L13, L15, L17, L18, L19, 
L21, L22, L23 were observed in the conjugant. Apart from this, the 50S ribosomal 
proteins L24 and L32 were not expressed in conjugant but in S. aureus (recipient). 
However, 50S ribosomal protein L14 was exclusively expressed in conjugant (Table 
8.2). 
363 out of 475 (76 %) uncharacterized proteins were up-expressed in conjugant cells, 
and 92 uncharacterized proteins were uniquely expressed in the conjugant whereas 102 
uncharacterized proteins were exclusively expressed in S. aureus. Unfortunately, the 
functions of these proteins are not currently known. 
 
Table 8. 2 Comparative analysis of peptides identified in S. aureus NCTC 6571 and 
conjugant No7 
Protein ID Size Category Spectrum count 




Drug resistance transporter, 
EmrB/QacA subfamily 
protein (opp) 
71 KDa Efflux pumps 
 
1 2 
ABC transporter  
 
33 KDa Efflux pumps 
 
1 4 
Penicillin-binding protein 2 
(pbpB) 
83 KDa Cell wall synthesis 
 
3 9 
Penicillin-binding protein 1 
(pbpA) 
83 KDa Cell wall synthesis 
 
1 1 
Glycosyl transferase group 
2 family protein  











45 KDa Cell wall synthesis  2 8 
Zinc metalloprotease  
(ftsH) 
78 KDa Virulence factor 9 15 
Clp protease, procolytic 
subunit  
(clpP) 
22 KDa Virulence factor 12 18 
Clp protease, Chaperone 
protein (ClpB) 
98 KDa Virulence factor 5 7 
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Protein ID Size Category Spectrum count 




Clp protease, ATP binding 
subunit  (clpC) 
91 KDa Virulence factor 15 24 
Clumping factor A 
(clfA) 
97 KDa Virulence factor 0 3 
DNA Ligase 
(ligA) 
75 KDa Reparation  0 1 
DNA mismatch repair 
protein (Muts) 
100 KDa Reparation 1 1 
Thioredoxin homolog 
 
12 KDa Oxygen response 4 11 
Heat shock protein 20 
(GrpE) 
16 KDa Heat shock protein 1 4 
Chaperone protein DnaJ  
(DnaJ) 
66 KDa Heat shock protein 0 3 
Chaperone protein DnaK 
(DnaK) 




32 KDa Heat shock protein 3 12 
Protein recA 
(recA) 
38 KDa SOS response 2.6 4 
Mechanosensitive channel 
protein  (mscL) 
14 KDa SOS response 1 3 
Excinuclease ABC, A 
subunit (uvrA) 
105 KDa SOS response 1 1.3 
Excinuclease ABC, B 
subunit (uvrB) 
77 KDa SOS response 3 4 
Accessory gene regulator 
protein A (agrA) 
28 KDa Stringent response 1 2 
Glycine cleavage system T 
protein (gcvT) 
40 KDa Stringent response 11 16 
Aspartate-semialdehyde 
dehydrogenase (asd) 
36 KDa Stringent response 1 1 
Bifunctional autolysin 
(atl) 
137 KDa Stringent response 105 142 
Fibrinogen-binding protein 
(fbp) 
76 KDa Stringent response 1 2 
Histidinol-phosphate 
aminotransferase (hisC) 
40 KDa Stringent response 2 3 
Oligopeptide ABC 
transporter (oppC) 
40 KDa Stringent response 2.3 2.6 
Oligopeptide ABC 
transporter (oppD) 
40 KDa Stringent response 2 3 
Oligopeptide ABC 
transporter (oppF) 
36 KDa Stringent response 5 7 
Peptide methionine 
sulfoxide reductase  (msrA) 
21 KDa Stringent response 4 7 
Proline dehydrogenase 
(putA) 
38 KDa Stringent response 4 6 
Sulfite reductase 
(cysJ) 
72 KDa Stringent response 2 2 
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Protein ID Size Category Spectrum count 
(Gene)   S. aureus  Conjugant 




38 KDa Stringent response 1 1 
Riboflavin synthase, beta 
subunit  (ribH) 
16 KDa Heat shock response  7 10 
Glycine betaine/ 
carnitine/choline ABC 
transporter  (opuCA) 
46 KDa Heat shock response  3 5 
Orotidine 5-phosphate 
decarboxylase  (pyrF) 
26 KDa Heat shock response  2 4 
Purine nucleoside 
phosphorylase  (deoD) 
26 KDa Heat shock response  13 18 
Transcriptional regulator  
(ctsR) 
18 KDa Heat shock response  1 1 
Urease, gamma subunit 
(ureA) 
11 KDa Heat shock response  10 10 
Urease, beta subunit 
(ureB) 
15 KDa Heat shock response  6 7 
Urease, alpha subunit 
(ureC) 
62 KDa Heat shock response  11 13 
Urease accessory protein 
(ureD) 
32 KDa Heat shock response  1 1 
Urease accessory protein 
(ureE) 
17 KDa Heat shock response  12 14 
Urease accessory protein 
(ureF) 
26 KDa Heat shock response  1 1 
Urease accessory protein 
(ureG) 
22 KDa Heat shock response  1 1 
ATP-dependent protease 
subunit (HslV) 
20 KDa Degradation 1 7 
Dead-box RNA helicase 
(csh) 
57 KDa Degradation 3 16 
30S ribosomal protein S6 
 
12 KDa Translation 7 30 
30S ribosomal protein S9 
 
15 KDa Translation 6 19 
30S ribosomal protein S10 
 
12 KDa Translation 12 20 
30S ribosomal protein S11 
 
14 KDa Translation 6 32 
30S ribosomal protein S12 
 
15 KDa Translation 3 13 
30S ribosomal protein S13 
 
14 KDa Translation 20 36 
30S ribosomal protein S20 
 
9 KDa Translation 5 21 
30S ribosomal protein S21 
 
7 KDa Translation 1 2 
50S ribosomal protein L3 
 
24 KDa Translation 6 11 
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Protein ID Size Category Spectrum count 
(Gene)   S. aureus Conjugant 
   NCTC6571 No7 
50S ribosomal protein L4 
 
22 KDa Translation 8 21 
50S ribosomal protein L5 
 
20 KDa Translation 24 74 
50S ribosomal protein L6 
 
20 KDa Translation 20 51 
50S ribosomal protein L10 
 
18 KDa Translation 11 43 
50S ribosomal protein L13 
 
16 KDa Translation 7 28 
50S ribosomal protein L14 
 
13 KDa Translation 0 4 
50S ribosomal protein L15 
 
16 KDa Translation 8 24 
50S ribosomal protein L17 
 
14 KDa Translation 13 52 
50S ribosomal protein L18 
 
13 KDa Translation 13 42 
50S ribosomal protein L19 
 
13 KDa Translation 5 25 
50S ribosomal protein L21 
 
11 KDa Translation 18 57 
50S ribosomal protein L22 
 
13 KDa Translation 10 51 
50S ribosomal protein L23 
 
11 KDa Translation 10 37 
50S ribosomal protein L24 
 
12 KDa Translation 4 0 
50S ribosomal protein L32 
 
6 KDa Translation 1 0 
 
8.7 Chapter summary 
The study of mecA gene transfer has confirmed that: 
1. mecA gene transfer between staphylococcal species was not observed; 
2. Proteins involved in efflux, virulence, stress response and gene expression regulation 




Methicillin-resistant determinants mecA gene is known to be located on staphylococcal 
cassette chromosome mec. Although it has been defined as a mobile genetic element, 
the transfer mechanism of SCCmec has not been clarified. This chapter introduced the 
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mecA gene transfer via conjugation from environmental S. hominis to S. aureus. 
Although the transfer of mecA gene was not observed, the proteins involved in efflux, 
virulence, stress response, and cell wall synthesis were observed to be upregulated in 
conjugant. In the discussion chapter, the failure of mecA gene transfer and the proteins 





















Chapter 9 Discussion  
The introduction of antibiotics to clinical infection treatment has revolutionised 
medicine (Gensini et al., 2007), and thousands of lives have been saved since their first 
discovery (Fishman et al., 1998; Leibovici et al., 1998; Sykes, 2001; Wielders et al., 
2001). However, the growing danger of antibiotic resistant is recognized internationally 
(Alanis, 2005).  Currently, there is an alerting global threat of antibiotic resistance, and 
concerns have been raised all over the world (WHO, 2014).  WHO Antimicrobial 
Resistance Global Report showed the β-lactam resistant proportion of S. aureus in 2014, 
including African Region (12-80%), Americas (21-90%), Eastern Mediterranean Region 
(10-53%), European Reigion (0.3-60%), South-East Asia (10-26%), Westen Pacific 
Region (4-84%). Lowest β-lactam resistance ratio was found in Aisa; however, only 3 
countries were included. Together with publications of other Asia countries, the ratio 
was 2-81% (WHO, 2014).  
Microorganisms are continuously evolving various antibiotic resistance mechanisms for 
their adaptation in environment, and thus the development of new antibiotics will not 
help to solve the problem of antibiotic resistance in the long term (Alanis, 2005).  
However, the collection of antibiotic resistance data is useful, since these data can 
inform decisions of public health organization to publicize the need for reduced 
antibiotic abuse and emphasis the optimal use of antibiotics (Bartlett et al., 2013).  In 
this case, it is of great important to apply basic resistance-related research for antibiotic 
resistance screening (Bartlett et al., 2013).  
The threat of antibiotic resistance in hospital and community associated staphylococci is 
a big concern for public health (Bradford, 2001; Hampton, 2013). The environment has 
been considered to be a potential reservoir of antibiotic resistance genes, which 
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immensely contribute to the resistome (Wright, 2007). Many studies addressed the issue 
of MRSA and MRCoNS in hospital settings but little is known about the situation in the 
environment and public settings (Brennan et al., 2011; Kinnevey et al., 2012; Zong et al., 
2011).  
This study has provided a systematic analysis of antibiotic resistance environmental 
staphylococci ， includes identification of staphylococci with MALDI-TOF MS, 
statistical analysis of antibiotic resistance, the carriage of mecA gene, molecular 
characterision of mecA positive staphylococci, complete genomic analysis of one S. 
epidermidis isolate, assessment of the transfer of antibiotic resistance genes between 
staphylococcal species, and look into the stress response associated oxacillin resistance 
of MSSA. 
Staphylococcus spp. 
Staphylococci are classified into six species groups by Lamers et al., (2012) and Becker 
et al., (2014) according to their genotypic relationships and phenotypic properties. In 
this study, 19 staphylococcal species have been identified belonging to 5 species groups, 
except for Hyicus-Intermedius (Becker et al., 2014). S. aureus can cause numerous 
different kinds of infections, such as skin, soft-tissue, bone, joint, respiratory infections, 
endovasculitis, sepsis and endocarditis, followed by S. epidermidis (n=6), S. 
lugdunensis (n=6), S. saprophyticus (n=5), while infections caused by S. simiae and S. 
arlettae have not been reported (Lowy, 1998; Becker et al., 2014; Vandenesch et al., 
1993; Murdoch et al., 1996; Bȍcher et al., 2009; Tee et al., 2003; Kuroda et al., 2005; 
Widerstrȍm et al., 2012; Suzuki et al., 2012; Wang et al., 2012).17 out of 19 
staphylococcal species identified in this study have been previously reported to cause 
infections (Archer, 1998; Becker et al., 2014).  The most common staphylococcal 
species were S. epidermidis (28%), followed by S. hominis (24%), and S. haemolyticus 
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(11%).  S. epidermidis, S. hominis, and S. haemolyticus were also dominant in all 
isolation sites. S. epidermidis was predominantly found in hands, handbags, 
transportation facilities, supermarkets, restaurants, while S. haemolyticus was 
predominantly found in hotels, library, and hotel air samples, and S. hominis dominant 
in BCF. Soge et al., 2009 found that S. epidermidis was the most common CoNS 
species in US West Coast public marine beaches, followed by S. saprophyticus (Soge et 
al., 2009). S. haemolyticus was predominantly in both hotel and hotel air samples. Both 
samples were collected in the same hotel environment, which support the theory that the 
airborne bacteria are derived from the environment and building occupants (Fox et al., 
2011). S. hominis, S. haemolyticus and S. epidermidis were previously recovered from 
the baby feces and breast milk (Albesharat et al., 2011). In this study, the sampling sites 
of baby care facilities include dummies and nappy changing area, and the predominant 
species were consistent with species that were found in the baby rectum.  Many other 
species, including S. capitis, S. warneri, S. pasteuri, S. saprophyticus, S. cohnii, S. 
aureus, S. simiae, S. sciuri, S. pettenkoferi, S. lugdunensis, S. equorum, S. caprae, S. 
xylosus, S. auricularis, S. simulans, S. arlettae, were not prevalent. The findings of this 
study are consistent with those found in other reports studying CoNS isolated from 
patients, medical devices and the hospital environment (Minto et al., 1999; Sheikh & 
Mehdinejad, 2012). Sheikh & Mehdinejad, (2012) characterized 134 nosocomial 
associated CoNS belonging to 16 species, and the majority were identified to be S. 
epidermidis (19.4%) and S. haemolyticus (14.9%). Minto et al., (1999) found that S. 
epidermidis (68.2%), S. haemolyticus (11.1%), and S. hominis (3.2%) were predominant 
in 126 CoNS strains that were recovered from blood samples. Most of staphylococcal 
species were isolated from humans; and some staphylococci were recovered from 
sources such as soil, water and food (Kamal et al., 2013; Normanno et al., 2007). S. 
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simiae is reported to be isolated from squirrel monkeys of South American (Pantucek, 
2005). In this study, 19 staphylococcal species were isolated from human-related 
environment, including baby care facilities, hotels, library, restaurants, supermarkets, 
transportation facilities, hands, handbags and air of hotels.    
To our knowledge, this is the first systematic taxonomic analysis of staphylococci 
isolated from human hands and inanimate sites in the London region, UK. In this study, 
mass spectral patterns among strains were compared to discern intra- and inter-species 
taxonomic relationships.  Staphylococci recovered from different sites were found to be 
taxonomically closely related, which aids the understanding of the transmission and 
dissemination of staphylococcal isolates. This has also been discussed by other authors 
(Simões et al., 2011) .  Staphylococci isolates recovered from hands were taxonomically 
closely related to the isolates recovered from hotels, supermarkets, restaurants, library, 
transportation facilities, handbags, baby care facilities, air samples, and hands. Pratt et 
al., (2001) reported that poor hand hygiene is one of the major causes of cross 
contamination and antibiotic resistance transmission in health care facilities. The 
findings in this study support this hypothesis as the majority of the isolates were 
recovered from hand touched inanimate objects. In addition, de Neeling et al., (2007) 
reported the isolation of MRSA from slaughterhouse air samples, and demonstrated the 
transmission of MRSA via aerosols. Moreover, in this study air isolates were recovered 
from hotel environments, and the taxonomic relationship between isolates recovered 
from air and different sites in the same hotels was demonstrated.  
MALDI-TOF MS 
The importance of rapid and accurate identification of microorganisms have been 
demonstrated (Valentine et al., 2005; Yao et al., 2002). Matrix-assisted laser 
desorption/ionization-time-of-flight mass spectrometry (MALDI-TOF MS) has been 
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proved to be a high throughput technique for bacterial identification in clinical 
laboratories (Van Veen et al., 2010). MALDI-TOF MS identifies the species by 
comparing mass spectrum pattern with reference patterns in the database (Maier et al., 
2006). MALDI-TOF MS has been employed to identify yeasts (Candida) and bacteria, 
such as Actinomyces, Corynebacterium, Enterobacter, Enterococcus, Escherichia coli, 
Micrococcus luteus, Pseudomonas aeruginosa, S. aureus, that were recovered from 
various clinical specimens, including blood, cerebrospinal fluid, pus, biopsies, 
respiratory tract, wounds, and stools (Dhiman et al., 2011; Seng et al., 2009). Dubois et 
al., (2012) tested 767 clinical isolates with MALDI-TOF MS, and 96.2% of isolates 
showed correct identification, including 86.7% of isolates were identified into species 
level and 9.5% of isolates were identified into genus level, while 1.3% misidentified,  
and 2.5% unidentified. In this study, 86% of 1152 environmental isolates provided 
reliable identification, including species level (73%), genus level (13%) and 
unidentified (14%). Generally, the percentage of reliable identification of environmental 
isolates is lower than clinical isolates. MALDI-TOF MS is a revolutionary new 
identification technique that was first introduced in 1996 (Claydon et al., 1996). The 
reproducibility and reliability of MALDI-TOF MS in identifying microorganisms has 
been extensively examined (Carbonnelle et al., 2007; Majcherczyk et al., 2006; Sandrin 
et al., 2013).  16S rRNA gene sequence is an older molecular technique for bacterial 
taxonomic study used since the 1980s (Janda & Abbott, 2007), and is a routine 
approach for identifying microorganisms in  microbiology labs (Clarridge, 2004).  In 
this study, MALDI-TOF MS was in good agreement (92%) with the 16S rRNA gene 
sequencing in identifying staphylococcal species. With 5 inconsistent isolates, 3 of them 
were consistent with the second match of 16S rRNA sequencing identification results, 
and 2 of them were inconsistent. The 16S rRNA sequencings were compared to NCBI 
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databases, various species with same score were displayed. Therefore, the identification 
accuracy of staphylococci may be affected (Loonen et al., 2012). Function stability, 
ubiquitous presence in all organisms and the fact that different positions in 16S rRNA 
sequences change at very different rates make 16S rRNA gene sequencing is an 
efficacious tool for phylogenetic analysis (Woese, 1987). Ribosomal protein, like 16S 
ribosomal DNA, is very stable (Maier et al., 2006).  The ribosomal proteins patterns can 
be detected by MALDI-TOF MS, which correspond to the 16S ribosomal DNA 
sequence (Hotta et al., 2010; Maier et al., 2006).  Therefore, profile analysis of MALDI-
TOF MS result in a similar family tree in comparison with 16S rRNA gene sequences 
(Maier et al., 2006).   It is reported that MALDI-TOF MS can be used for genotyping, 
phenotyping, and determining antibiotic resistance (DeMarco & Ford, 2013; 
Ghebranious et al., 2005). In this study, MALDI-TOF MS data have been used for 
taxonomic analysis of staphylococci. 
In this study, a family tree was built based on the MALDI-TOF MS profile of 
environmental staphylococci, and taxonomic relationship of staphylococci recovered 
from different sites has been assessed. Taxonomic relationship can be analysed based on 
16S rRNA gene sequences, though it is very difficult to handle a large quantity of data 
with regard to turnaround time and costs (Veen et al, 2010),  
While MALDI-TOF MS has been certified to be a useful, rapid, reliable technique for 
identification microorganisms in medical and food safety industries, concerns have been 
raised on the reproducibility of this technique (Schumaker et al., 2012). Reproducibility 
can be referred to as the accuracy of identified strains (Sandrin et al., 2013). The 
reproducibility was assessed by testing fresh cultures from different days, or by 
different operators (Majcherczyk et al., 2006; Schumaker et al., 2012). However, no 
standardized approach has been used to report reproducibility (Sandrin et al., 2013).  
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Until now, reproducibility of MALDI-TOF MS has been assessed for clinical and food 
isolates, but assessment of environmental isolates has not been reported (Carbonnelle et 
al., 2007; Majcherczyk et al., 2006). In this study, 1-3 isolates of each staphylococcal 
species were selected to assess the reproducibility of MALDI-TOF MS in identifying 
environmental staphylococci. The findings from this study demonstrated that MALDI-
TOF MS has an excellent reproducibility (98.5%) in identifiying environmental 
staphylococci, which is consistent with previous studies (Schumaker et al., 2012).  
Antibiotic resistance 
The presence of resistance towards most of the available antibiotics has been recognized 
in staphylococcal species (Becker et al., 2014). In comparation with clinical 
staphylococci, the antibiotic resistance in environmental staphylococcal isolates is less 
known. The susceptibility towards antibiotics can be determined using the antimicrobial 
susceptibility test (Jorgensen & Ferraro, 2009). Susceptibility patterns of staphylococcal 
species against antimicrobial agents in this study showed that the majority of 
staphylococci were resistant to penicillin (66%) and fusidic acid (67%). The antibiotic 
that the isolates displayed the least degree of resistance to was chloramphenicol (5%). 
Generally, it is widely accepted that clinical isolates demonstrate higher levels of 
antibiotic resistance due to consistent antibiotic exposure (Antoniadou et al., 2013). 80% 
of clinical CoNS were reported to be resistant to oxacillin in Europe (Hanberger et al., 
2001); whereas 7% of isolates were resistant to oxacillin in this study,  which is 
incompatible to their findings. Ferreira et al., (2002) reported 61.6% and 21.4% of 
clinical staphylococcal strains were resistant to oxacillin and mupirocin respectively, 
which is higher than the percentage of resistance in this study (oxacillin 7%, mupirocin 
16%).  Agvald-Ohman et al., (2004) reported 86%, 48%, and 54% of clinical 
staphylococci were resistant to oxacillin, erythromycin, and gentamicin accordingly, 
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which is higher than environmental staphylococci in this study (oxacillin 7%, 
erythromycin 33%, gentamicin 10%). In addition, Mohan et al., (2002) reported 40% of 
clinical staphylococci were resistant to chloramphenicol, whereas, 5% of staphylococci 
were resistant to chloramphenicol is in this study. Akinkunmi & Lamikanra, (2010) 
reported that 34.2% of clinical staphylococci were resistant to tetracycline in 
comparison with 18% of environmental staphylococci in this study.  Fritsche et al., 
(2003) showed 21% of clinical staphylococci were resistant to cefepime, while 10% of 
staphylococci were resistant to cefepime in this study. Meanwhile, resistant to fusidic 
acid (32.2%), vancomycin (0%), amoxicillin (10%) and streptomycin (16%) in clinical 
staphylococcal strains is lower than the percentage of environmental staphylococci 
isolates (fusidic acid 67%, vancomycin 24%, amoxicillin 27%, streptomycin 31%) in 
this study (Akinkunmi & Lamikanra, 2010; Ferreira et al., 2002; Idriss et al., 2014).     
Coagulase negative staphylococci are considered to be less virulent compared to S. 
aureus due to they rarely produce toxins or virulence factors (Otto, 2013). Neverthless, 
isolation of a wide range of multiple antibiotic resistant coagulase negative 
staphylococci in this study is a worrisome finding. Agvald-Ohman et al., (2004) 
reported multidrug resistant CoNS from clinical samples, which is compatible with 
environmental staphylococci. In this study, multi-resistance was commonly seen: 
including 0.3% of staphylococcal isolates resistant to more than 10 antibiotics; and 20.8% 
resistant to at least five tested antibiotics. It is reported that more than 80% of isolates 
recovered from swine and chicken manure were resistant to at least one antibiotic in 
China (Zhu et al., 2013). 96% staphylococcal species were resistant to at least 1 
antibiotic in this study, which is higher than the percentage reported by Zhu et al., 
(2013). Only 4% staphylococcal isolates were susceptible to all the tested antibiotics in 
this study. The level of multiple antibiotic resistant isolates recovered from different 
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sites was varied. According to Soge et al., (2009), the multiple antibiotic resistant CoNS 
recovered from public beaches were 62%. In this study, the multiple antibiotic 
resistance ratios of CoNS recovered from baby care facilities, hotels, library, restaurants, 
supermarkets, hotel air samples, handbags, and hands were higher than the ratio 
determined in CoNS recovered from US West Coast public marine beaches. In general, 
all the isolates (100%) recovered from hotel air samples were multiple antibiotic 
resistance, while 58% of isolates recovered from transportation facilities showed lowest 
multiple antibiotic resistance ratio. The multiple antibiotic resistance ratios of hands 
were between baby care facilities and handbags (personal items) as well as hotels, hotel 
air, library, restaurants, supermarkets and transportation facilities (public settings). The 
variation of multiple antibiotic resistance ratio was also observed within personal items 
and public settings, and no pattern was determined. 
Multiple drug resistant microorganisms were first reported in the late 1950s (Levy & 
Marshall, 2004), and later in 2007, the number of multidrug-resistant bacteria infections 
was 400,000, of which 25,000 were lethal in Europe only (Bush et al., 2011). In this 
study, multiple antibiotic resistant staphylococci were isolated from all 9 sites, and 544 
(80%) staphylococcal isolates were resistant to two or more antibiotics. Staphylococci 
can acquire antibiotic resistance by horizontal gene transfer or genetic mutation (Otto, 
2013).  Different mechanisms contribute to the  antibiotic resistance of microorganisms 
(Blair et al., 2014). The environment plays an important role in the development of 
antibiotic resistance in microorganisms (Cantas et al., 2013). Antimicrobial agents from 
antimicrobial producing bacteria in soil and the human therapeutics, animal therapeutics, 
sewage, agriculture and veterinary industries favour the selection of antibiotic resistance 
genes, and thus make the environment a reservoir of antibiotic resistance bacteria and 
antibiotic resistance genes (Cantas et al., 2013).  The findings of high levels of multiple 
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resistant staphylococci in the environment support the theory that antibiotics in the 
natural environment contribute to the selection of antibiotic resistance microorganisms  
Sexton et al., (2006) reported that the environment may play an important role in the 
dissemination of antibiotic resistance. In this study, MALDI-TOF MS data were 
combined with antibiotic resistance profiles for taxonomic analysis. 30 multiple 
antibiotic resistant staphylococci were taxonomically closely related to 30 susceptible 
staphylococci respectively, indicating that these might belong to the same genotype as 
the founding strain. Kraemer & Iandolo, (1990) reported the transfer of antibiotic 
resistance genes between species or interspecies, which may be a contributing factor in 
the development of different antibiotic resistance patterns in taxonomically closely 
related isolates. Additionally,  Thouverez et al., (2003) has shown the correlation of 
antibiotic susceptibility and the MRSA genotype over a 4-year period.  In this study, it 
was showed that taxonomically closely related antibiotic resistant staphylococci were 
recovered from different sites with varied antibiotic susceptibility profile. Up to 9 
antibiotic susceptibility variations were observed in two taxonomically closely related 
staphylococci, which were recovered from same site, and up to 8 antibiotic 
susceptibility variations were found in other two taxonomically closely related 
staphylococci recovered from different sites.  This finding also supports the theory that 
transfer of antibiotic resistant determinants contribute to the development of different 
antibiotic resistance patterns in taxonomically closely related isolates (Kraemer & 
Iandolo, 1990).  
Community associated MRSA USA300, is an epidemic strain responsible for severe 
antibiotic resistance associated infections, which has reportedly been recovered from 
frequently touched surfaces in buses serving both hospital and community routes in 
potugal, which indicates the spillover of MRSA from hospital settings to the community 
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(Lutz et al., 2014). The taxonomic analysis of this study showed low diversity among 
each staphylococcal species. The dissemination of antimicrobial resistance in the 
environment is associated with ubiquitous bacteria. Staphylococci, as one of the 
ubiquitous bacteria, are known to be able to survive in the environment as well as 
colonize on humans (Cantas et al., 2013). In this study, staphylococci recovered from 
different sites were determined to be taxonomically closely related. In addition, no 
obvious differences of antibiotic susceptibility profile were observed between clusters 
that were formed by isolates recovered from different sites and clusters that were 
formed by isolates recovered from same site. This finding also supports the theory that 
the spread of antimicrobial resistance is associated with the dissemination of ubiquitous 
bacteria in the environment (Cantas et al., 2013).  
Methicillin resistant staphylococci are a major public health problem, with severe 
economic and health consequences (Stefani & Varaldo, 2003). mecA gene encodes for 
penicillin binding protein 2a (PBP2a), which has a low affinity to β-lactam antibiotics 
and confers the methicillin resistant (Tulinski et al., 2012). Hussain et al., (2000) 
assessed the correlation of the presence of mecA gene and oxacillin susceptibility 
breakpoints (0.5 mg l
-1
) in 493 clinical CoNS of 11 species, and classified these 
staphylococci into 4 categories. The mecA gene was determined in category I and II 
staphylococci, and the percentage of mecA positive isolates was as followings: S. 
haemolyticus (83.3%), S. epidermidis (61.9%), S. hominis (51.8%), S. cohnii (28.5%), S. 
warneri (27.3%), and S. saprophyticus (9.0%) (Hussain et al., 2000). Category II (S. 
cohnii, S. warneri, S. saprophyticus) differed from category I (S. haemolyticus, S. 
epidermidis, S. hominis) by their low mecA-positive ratio (Hussain et al., 2000). In this 
study, S. haemolyticus (24%), S. epidermidis (12%), S. hominis (6%) had mecA-positive 
strains but with lower mecA-positive ratios in comparision with clinical isolates. In 
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addition, S. cohnii (36%) and S. saprophyticus (20%) of category II recovered from this 
study showed higher mecA-positive ratio than clinical isolates, whereas, lower mecA-
positive ratio was observed in S. warneri (13%) of this study. It is reported that no 
mecA gene was found in category III and IV staphylococci, including  S. xylosus, S. 
lugdunensis, S. capitis, S.simulans, and S. schleiferi (Hussain et al., 2000). In this study, 
no mecA gene was determined in S. xylosus and S. simulans, which is consistent with 
clinical study report. In contrast, the presence of mecA gene was determined in S. 
lugdunensis (20%) and S. capitis (8%). It is also reported that category III (S. 
lugdunensis and S. xylosus) lack mecA gene, but phenotypically resistant to oxacillin. In 
their study, Hussain et al have not explained why this occurs (Hussain et al., 2000), 
however, proteomic data in this study suggested that expression of PBPs remain the 
same or upregulated, resulting the mecA-negative conjugant being phenotypically 
resistant to oxacillin. In contrast with Hussain et al’s finding, S. lugdunensis recovered 
from this study was determined to be mecA positive and resistant to oxacillin. In this 
study, S. simiae, as sister species of S. aureus, was not identified to harbour mecA gene 
(Suzuki et al., 2012). The origin of mecA gene in S. aureus is considered to be from the 
common ancestor of S. fleurettii, S. vitulinus and S. sciuri (Tsubakishita et al., 2010). 
Moreover, mecA1 gene of S. sciuri can mediate the high-level oxacillin resistance in S. 
aureus (Harrison et al., 2014). In this study, the high mecA-positive ratio of S. sciuri 
(83%) is a worrisome finding. 
Oxacillin susceptible MRSA (OS-MRSA), that has been reported worldwide (Hososaka 
et al., 2007; Saeed et al., 2010), is defined as oxacillin susceptible mecA gene positive S. 
aureus (Hososaka et al., 2007). Hososaka et al (2007) also indicate the possibility of 
high level resistance induced by beta-lactam antibiotics. In this study, 12 S. aureus were 
neither oxacillin resistance nor mecA gene positive, and 89 mecA gene positive CoNS 
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were determined. The MICs (oxacillin) of mecA gene positive staphylococci varied 
from 0.015 to 256 mg l
-1
, and 39 out of 89 mecA-positive CoNS were susceptible to 
oxacillin. The mecA gene positive, oxacillin susceptible CoNS were prevalent in 
environmental staphylococci. The mecA gene encodes a penicillin binding protein 2a, 
which has a low affinity to β-lactam antibiotics, and is thus phenotypically resistant to 
β-lactam antibiotics (Tomasz et al., 1989). In this study, the expression of mecA gene 
has been assessed in 4 CoNS with MIC range from 0.12 to 256 mg l
-1
. The presence of 
PBP2a was determined in high oxacillin resistant isolates, but not in S. epidermidis 111 
(MIC 0.12 mg l
-1
) and S. hominis 506 (MIC 0.5 mg l
-1
). The proteomic results of this 
study help to understand the oxacillin resistant variation of mecA gene positive 
staphylococci. Pinho et al., (2001) has reported that the optimal expression of 
methicillin resistant in MRSA requires collaboration of PBP2a and PBP2. TPase 
domain of PBP2a is involved in transpeptidation, and TGase domain of PBP2 is 
essential for transglycosylation in presence of methicillin (Pinho et al., 2001). 
Predictably, the presence of PBP2 has been determined in 2 PBP2a positive CoNS in 
this study.   
The mecC gene shares less than 70% similarity with original mecA gene, and present in 
SCCmec type XI (Becker et al., 2014). mecC gene has been recovered from human and 
varied animal hosts (Loncaric et al., 2013); however, no mecC gene positive 
staphylococci was determined in this study. To date, there are 4 mecA gene homologues 
have been reported, including mecA1 (80%), mecA2 (90%), mecB (60%) and mecC 
(70%). It is believed that novel mecA homologues may be identified in the future (Ito et 
al, 2012).  
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SCCmec and MLST 
SCCmec is a mobile genetic element, comprising of mecA gene, recombinase gene, 
regulatory elements and additional genes (Monecke et al., 2011). The variation of 
SCCmec confers the sources of MRSA (Monecke et al., 2011). Therefore, SCCmec is a 
molecular typing technique for epidemiological study of staphylococci (Oliveira & 
Tomasz, 2002). The structural diversity of SCCmec has been reported in hospital 
environments (Barbier et al., 2011; Zong et al., 2011). The variation in SCCmec is 
related to the high throughput of individuals in the hospital tested (Barbier et al., 2011). 
The first identification information of SCCmec type I, II, III elements are as followings: 
Type I (1961, UK), type II (1982, Japan) and type III (1985, New Zealand). SCCmec 
type I, II, III of MRSA has been reported to be associated with hospital (Monecke et al., 
2011). Whilist, SCCmec type IV and V are present in community associated MRSA 
(Monecke et al., 2011). In addition, it is found that the presence of SCCmec elements is 
associated with slow growth rate (Monecke et al., 2011), and the slow growth rate has 
been considered to be a disadvantage of selection in the absence of an antibiotic 
selection pressure (Ender et al., 2004; Lee et al., 2007). In this case, isolates carrying 
SCCmec are not as competent as wild type strains in the absence of antibiotics 
(Monecke et al., 2011).  Moreover, SCCmec type IV and I have similar structures 
(Oliveira & Tomasz, 2002). SCCmec type IV lacks a flanking region in comparison 
with SCCmec type I (Oliveira & Tomasz, 2002), and thus the type IV SCCmec element 
represents increased mobility by its smaller size (Oliveira & Tomasz, 2002). In this 
study, SCCmec types were identified in CoNS. 15 CoNS out of 89 (17%) mecA gene 
positive staphylococci were assigned to SCCmec type I, II or III, while SCCmec type IV 
and V took 29% (n=26). In the environment, community associated SCCmec type is 
more prevalent than nosocomial associated SCCmec types, which may support the 
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theory of the advantage in the spread of smaller SCCmec elements (Oliveira & Tomasz, 
2002). SCCmec type VI was identified in clinical MRSA that were recovered from 
Portugal and has been redefined in 2006 (Oliveira & Tomasz, 2002). Moreover, type 
VIII SCCmec has been first identified in 2009 in Canada (Zhang et al., 2009). One of 
each type has been identified in this study, whereas SCCmec types IX were not detected 
in this study. It has been reported by others that the distribution of SCCmec types in 
MRCoNS varies and may depend on the human host and geographical locations of the 
isolates (IWG-SCC, 2009; Oliveira et al., 2006; Zhang et al., 2009; Zong et al., 2011). 
In previous reports, SCCmec types I, II, III and V were found to be the most common in 
environmental isolates, such isolates were taken from areas such as public beaches 
(Soge et al., 2009). In this study, SCCmec type I, IV, and V have been identified to be 
prevalent in environmental isolates. Becker et al., (2014) has summarized the 
community and livestock associated SCCmec types, including S. capitis (I, IA, II, III, 
IV, IVa, V, NT), S. cohnii (NT), S. epidermidis (I, IIa, IIb, III, III (variant), IV, IVa, IVb, 
IVc, IVd, IVe, IVg, V, VI, NT), S. haemolyticus (I, II, II.1, III, III (variant), IV, V, NT), 
S. honomis (I, III, IV, NT), S. pasteuri (IVc), S. saprophyticus (III, NT), S. sciuri (I, III, 
IIIA, V, VII, NT) and S. warneri (IV, IV.1, IVb, IVE, NT). In addition, NT, which 
stands for  non-typeable and/or novel non-designated types, was identified in S. capitis, 
S. cohnii, S. epidermidis, S. haemolyticus, S. hominis, S. saprophyticus, S. sciuri, S, 
warneri. In this study, species associated SCCmec types differed from Becker et al. The 
SCCmec types found in S. capitis (I, NT), S. haemolyticus (I, II, V, NT) and S. hominis 
(I, V, NT) of this study is less than community associated SCCmec types. whereas, S. 
cohnii (I, V, NT), S. pasteuri (NT), S. saprophyticus (IV, NT), S. sciuri (II, VIII, NT), S. 
warneri (I, V, NT) harbors different SCCmec types in comparison with community 
associated staphylococci. SCCmec types of S. epidermidis in this study is consistent 
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with community associated S. epidermidis.  In addition, associations were found 
between SCCmec carriage and certain species, for example SCCmec type V was 
preferentially associated with S. haemolyticus, S. hominis, S. warneri, and S. 
epidermidis. Previously, with clinical isolates, type V SCCmec was reported to be 
associated mainly with S. haemolyticus (Zong et al., 2011).  
Apart from the variations in the classified SCCmec types isolated, 22 unclassified 
SCCmec types were also reported in this study. Eight of these had a combination of 
class A mec complex and ccrC, six carried a combination of class B mec and ccrC, one 
carried class B mec and ccr3, and seven had a combination of class A mec complex and 
ccr type 1. The 1A has been reported by other workers to be a new type 1A (Bouchami 
et al., 2011). SCCmec harbouring mecA but lacking ccr is known as pseudo (ψ)-
SCCmec, while it is reported that SCCmec12263 possess a ccr complex but lack mecA 
(Harrison et al., 2013; Katayama et al., 2003).  23 isolates (29%) of this study could not 
be typed as they lack either mec complex or ccr complex.  It is known that SCCmec 
without ccr and mec genes have been classified as ψ SCC elements (Becker et al., 2014), 
and ψ SCC element was identified in one S. saprophyticus of this study.  
S. epidermidis is considered to be clinical contaminant, and thus epidemiological studies 
of S. epidermidis are limited (Herwaldt et al., 1996; Wang et al., 2003). To date, studies 
on S. epidermidis have been focused on clinical isolates (Li et al., 2009), S. epidermidis 
ST2 has been found to be dominant in hospitals in China, Europe and USA, and is 
associated with the presence of ica operon and IS256 (insertion sequences) positive (Li 
et al., 2009; Mendes et al., 2012; Miragaia et al., 2007). A wide range of genetic 
variation existing amongst S. epidermidis isolates has been demonstrated (Hussain et al., 
2000) In this study, 14 new MLST types were assigned for 19 S. epidermidis isolates. 
MLST is a powerful tool for global epidemiological studies (Oliveira & Tomasz, 2002),  
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since it can identify important genetic background correlation of staphylococci 
recovered all over the world by comparing the MLST types (Diep et al., 2004), 
Internationally recognized clones S. epidermidis ST59 has been isolated from hospital 
in Taiwan, Denmark, Mexico, Cape Verde, Spain, Hungary, USA and China, and 
associated with SCCmec type V (Li et al., 2009; Mendes et al., 2012; Miragaia et al., 
2007).  In this study, S. epidermidis ST59 was associated with SCCmec type IV, and 
this is the first report of ST59 associated with SCCmec type IV, which is different to 
those already reported. Mendes et al., (2012) reported the isolation of S. epidermidis 
ST360 from clinical specimens in the USA, however, little information of S. epidermdis 
ST360 has been reported. In this study, S. epidermidis ST360 is combined with 
SCCmec type V. In addition, isolates recovered from human hands (259) and hotels 
(124) shared the same MLST type: ST602, which suggested the possible correlation of 
staphylococci recovered from different sites. However, S. epidermidis 259 harboured 
SCCmec type V, whereas S. epidermidis 124 was associated with SCCmec IV. 3 S. 
epidermidis isolates of this study recovered from library (133, 134, 135) were assigned 
the same MLST type; however, S. epidermidis 133, 134, 135 harboured SCCmec type 
3B, I, IV accordingly. The same MLST type associated with different SCCmec types 
has been reported previously, such as S. epidermidis ST2 harbouring type II, III, IV and 
non-typable SCCmec, and ST22 is associated with SCCmec type III, IV and V 
(Miragaia et al., 2007). It is believed that different MRSA clones can appear in some 
clonal complexes (CC), and lead to the isolates with the same MLST type but different 
SCCmec type (Robinson & Enright, 2004). This theory is supported by the findings of 
same MLST type associated with different SCCmec types in this study.  
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Antibiotic resistant and virulence genes in S. epidermidis 118 (G6_2) 
S. epidermidis is an important opportunistic pathogen, which is commonly related to 
infections due to indwelling medical devices (Becker et al., 2014). A pan-genome 
sequence analysis of 71 S. epidermidis that are recovered from healthy human bodies 
shows that formate dehydrogenase is exclusively present in the commensal lineage 
(Conlan et al., 2012). In this study, the formate dehydrogenase was present in S. 
epidermidis 118 (G6_2).  In addition, the phylogenetic relationship indicates the close 
relationship of S. epidermidis 118 (G6_2) with SRR1656389, SRR1656376 and 
SE_BCM-HMP0060 strains that were recovered from intensive care units (Roach et al., 
2015).  
Antibiotic resistance genes detected in S. epidermidis 118 (G6_2) 
Zankari et al., (2013) reported that WGS presented high antimicrobial susceptibility 
concordance with phenotypic tests in E. coli. Moreover, the promising feature of WGS 
for antimicrobial susceptibility prediction in a clinical isolate S. aureus was also 
demonstrated (Gordon et al., 2014). In this study, the correlation between antibiotic 
resistance genes and phenotypic antimicrobial susceptibility was determined in S. 
epidermidis 118 (G6_2).  aac(6')-aph(2''); blaZ; mecA;  fosA; msr(A); mph(C); tet(K); 
ileS and fusA in the genome of S. epidermidis 118 (G6_2); these are responsible for the 
streptomycin, gentamicin, penicillin, oxacillin, amoxicillin, cefepime, cefoxitin, 
fosfomycin, erythromycin, tetracycline, fusidic acid, and mupirocin resistance (Bernat 
et al., 1997; Bryan et al., 2004; Daigle et al., 1999; Fiebelkorn et al., 2003; Hodgson et 
al., 1994; Howden & Grayson, 2006; Olsen et al., 2006; Ubukata et al., 1989; Wang et 
al., 2008). S. epidermidis G6_2 harboured 9 antibiotic resistance genes, which is greater 
than those contained in clinical reference strains. blaZ is known to encode an enzyme 
inactivated β-lactam by hydrolysis of antibiotics. aac(6')-aph(2''), fosA and mph(C) are 
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known to inactivate aminoglycoside, fosfomycin and macrolide antibiotics by encoding 
transferases that form a covalent bond with antibiotics. mecA and ileS encodes penicillin 
binding protein 2a and additional isoleucyl tRNA synthetase which has low affinity to 
β-lactam antibiotics and mupirocin respectively. msr(A) and tet(K) encode efflux that 
confers to macrolide and  tetracycline resistance. Finally, the fusA mutation has 
contributed to the fusidic acid resitance (Cookson, 1998; Hodgson et al., 1994; Howden 
& Grayson, 2006; Martemyanov et al., 2001; Matsuoka et al., 2003; Ng et al., 2001; 
Schmitz, 1999). Five different mechanisms are involved in multiple antibiotic 
resistances of S. epidermidis 118 (G6_2).  
S. epidermidis has been considered to be a reservoir of antibiotic resistance genes, 
which facilitate the survival of S. aureus by horizontal transfer of antibiotic resistant 
determinants (Otto, 2013). There is evidence to support the theory that S. epidermidis is 
a reservoir of antibiotic resistance gene for S. aureus. Staphylococcal cassette 
chromosome mec (SCCmec) elements and arginine catabolic mobile elements (ACME) 
were found more frequently in S. epidermidis than S. aureus. Moreover, SCCmec type 
IV of S. epidermidis showed 98-98% similarity to SCCmec type IVa in S. aureus, and 
ccrAB gene in S. epidermidis are 100% identical to S. aureus. In addition, the 
methicillin resistant is more prevalent among S. epidermidis than S. aureus (Otto, 2013).   
In this study, S. epidermidis 118 (G6_2) was observed to harbour 9 antibiotic resistance 
determinants, thus supporting Otto’s theory.  In addition, Qin et al., (2012) reported a 
Campylobacter coli harbouring 6 aminoglycoside resistance genes isolated from 
chicken slaughterhouses. In contrast with C. coli harbouring 6 aminoglycoside 
resistance determinants,  9 antibiotic resistance determinants of S. epidermidis 118 
(G6_2) are responsible for the resistance of 7 classes of antibiotics, including steroid, 
aminoglycoside, beta-lactam, fosfomycin, microlide, tetracycline, and monoxycarbolic 
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acid antibiotics. The development of antibiotic resistance is mostly due to the gene 
transfer (Otto, 2013). Mobile genetic elements, such as plasmids, transposons, 
pathogenic islands and chromosomal cassette, contribute to the dissemination of 
antibiotic resistance genes (Zhu et al., 2013). In this study, 5 out of 9 antibiotic 
resistance genes were located on plasmids of S. epidermidis 118 (G6_2), indicating the 
high mobility of these antibiotic resistance determinants. Recently, using different 
genome sequence approaches, Méric et al., (2015) has shown that S. aureus and S. 
epidermidis share considerable interspecies mobile genetic elements. 
In addition to the multiple antibiotic resistant determinants, the copper responsive gene 
(cptV) and copper chaperone (copZ) were found in S. epidermidis 118 (G6_2), whose 
functions are known to encode proteins for copper efflux and adaption to copper stress 
(Schelder et al., 2011). Zhu et al., (2013) reported that the heavy metal is co-selective 
pressure, preserves the presence of antibiotic resistance genes in bacteria. Moreover, 
three functional genes: qac, yehS and Tn552, were found to be located in one of the S. 
epidermidis 118 (G6_2) plasmids. Quaternary ammonium compounds (QAC) are 
widely used in the food industry and clinical environment as low toxic detergents; 
however, QAC resistant staphylococci have been emerged in communities and the food 
industries (Heir et al., 1998).  qac genes are known to encode QAC-resistance protein 
which are responsible for the efflux of QAC and dye from cells (Heir et al., 1998).  In 
bacteria, ABC transporters are crucial for nutrient uptake and exportation of toxin and 
antibiotics (Davidson & Chen, 2004). yehS gene is known to be one of the genes that 
encode ABC transporter ATP-binding protein, which involves in nutrient uptake and 
secretion of toxins and antimicrobial agents from the cell (Davidson & Chen, 2004). 
Tn552 is a beta-lactamase related transposon, which is known for encoding beta-
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lactamase and two regulatory proteins: blaI, blaR1, which control the expression of 
beta-lactamase (Rowland & Dyke, 1990).  
Virulence genes determined in S. epidermidis 118 (G6_2) 
Virulence genes found in S. aureus express a variety of virulence proteins, including 
enterotoxin, exotoxin, hemolysin (alpha, beta, gamma, and delta), nuclease, protease, 
and lipase (Dinges et al., 2000).  Proteins encoded by virulence genes are generally 
involved in converting host tissue into nutrients for the growth of bacteria and invasion 
(Dinges et al., 2000). setC is a pyrogenic toxin superantigen, and can trigger toxic shock 
syndrome by causing massive cytokine release (Dinges et al., 2000). In this study, setC 
was exclusively determined in S. epidermidis 118 (G6_2).  Alpha-hemolysin has 
neurotoxic and dermonecrotic effects on a variety of mammalian cells and delta-
hemolysin is capable of lysing a wide range of mammalian cells (Dinges et al., 2000);  
however, the mechanism by which beta-hemolysin causes disease has not yet been 
clarified (Schwan et al., 2003). In this study, only beta-hemolysin encoding gene hlb 
was present in S. epidermidis 118 (G6_2). The nuclease can facilitate S. aureus escape 
from neutrophils and therefore undermine the immune system. nuc was present in S. 
epidermidis 118 (G6_2) and reference isolates (Berends et al., 2010). Extracellular 
protease, including serine proteinase (sspA), cysteine proteinase (sspB) and staphopain 
A (sspP), were known to have putative roles in virulence (Shaw et al., 2004; Zarfel et al., 
2013). In addition to sspA and sspB, S. epidermidis G6_2 harbours sspP exclusively. lip, 
geh and lipA are members of the bacteria lipase family, and might be involved in 
pathogenicity by reducing the ability of immune cells to undertake phagocytosis ability 
(Stehr et al., 2003). lip, geh and lipA were all present in S. epidermidis 118 (G6_2). In 
addition, clp proteinase found in staphylococci is more like a stress response protein, 
and degrades misfolded proteins under stress conditions (Michel et al., 2006). Moreover, 
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lytN found in S. aureus N315 and S. epidermidis 118 (G6_2) encodes cell wall 
hydrolase/autolysin (Lindsay et al., 2005). Immunodominant staphylococcal antigen A 
(isaA) and immunodominant staphylococcal antigen B (isaB) were identified as a 
putative autolysin (Stapleton et al., 2007). Both isaA and isaB were determined in S. 
epidermidis 118 (G6_2). sfpA gene was reported to be located on a plasmid  of E. coli,  
and encoding sfp fimbriae mediating the mannose-resistant hemagglutination (MRHA) 
(Müsken et al., 2008). The finding of this gene in S. epidermidis 118 (G6_2) strain is 
supportive evidence that the transfer of virulence factors may occur via plasmids (Zhu 
et al., 2013). In C. difficile, sigD is a regulon, which positively controls toxin expression 
via regulation of tcdR transcription (El Meouche et al., 2013). The sigD gene has been 
shown to regulate the expression of tcdA, tcdB toxins, which are involved in the early 
stages intestine tract colonization of Clostridium difficile and cause intestinal damage 
(El Meouche et al., 2013).  sigD gene was detected in S. epidermidis 118 (G6_2) and to 
my knowledge this is the first report of the sigD gene found in staphylococci.  The study 
also showed that tcdA was present in S. epidermidis 118 (G6_2). The polysaccharide 
intercellular adhesin gene ica is the gene that confers biofilm synthesis of 
staphylococcal species (Arciola et al., 2001; Zhang et al., 2003) No ica gene was 
detected in S. epidermidis 118 (G6_2) in this study, and thus S. epidermidis 118 (G6_2) 
is a non-biofilm forming isolate. Phenol soluble modulins responsible for immune 
evasion of S. epidemidis were determined in S. epidermidis 118 (G6_2), RP62a and 
ATCC12228 (Liles et al., 2001). 
Various surface proteins contribute to the pathogenicity of staphylococci, which can 
enable them to invade hosts and remain there (Becker et al., 2014). sdrC, sdrD, sdrE are 
considered to be the surface protein of S. aureus (Foster et al., 2014), while sdrF, sdrG, 
sdrH are S. epidermidis associated surface proteins (McCrea et al., 2000). sdrC, sdrD, 
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and sdrE of S. aureus have crucial role in colonization and evasion of the host cells 
(Foster et al., 2014). In this study, sdrC and sdrD were first reported to be expressed in 
S. epidermidis. Autolysin (atl) is expressed in S. aureus, and for S. epidermidis, the 
homolog of atl which mediates initial adhesion functions is known as atlE (Becker et al., 
2014). Moreover, cell wall associated fibronectin binding protein (ebh), elastin binding 
protein (ebp) and bifunctional autolysin (atl), are found in both S. aureus and S. 
epidermidis (Gill et al., 2005). Another surface protein, sas is known to transfer from S. 
epidermidis to S. aureus via prophage (Otto, 2013).  Additionally, pls is found in S. 
aureus and S. epidermidis, and is known to regulate the adhesion process (Josefsson et 
al., 2005) and mediate methicillin resistant (Gill et al., 2005). In this study, sasK, ebh, 
ebp and atl were found in S. epidermidis 118 (G6_8) and all reference staphylococcal 
species, while pls was only found in S. epidermidis RP62a and 118 (G6_2). S. 
epidermidis 118 (G6_2) presented fewer virulence genes than S. aureus N315, however, 
it showed equivalent or even more virulence than two clinical S. epidermidis strains. 
Moreover, S. epidermidis 118 (G6_2) harbours 9 antibiotic resistance genes, more than 
were found in clinical reference staphylococci.   
mecA transfer in vitro 
Methicillin resistant is encoded on a mobile genomic island named SCCmec (Kondo et 
al., 2007). The origin of SCCmec in S. aureus is considered to be acquired from CoNS, 
which has been documented by Otto (2013). Theories supporting this hypothesis 
include the high level of SCCmec homologies in both S. aureus and CoNS as well as the 
occurrence of mecA gene in CoNS is more frequent than in S. aureus (Otto, 2013). 
Under laboratory conditions, mecA gene cannot be transferred by conjugation and 
transformation, whereas, phage mediated transduction of SCCmec within two S. aureus 
have been reported (Cohen & Sweeney, 1973). No phage mediated transduction of 
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SCCmec elements between different staphylococcal species has been reported 
(Katayama et al., 2000).  The SCCmec transfer mechanism remains to be solved. In this 
study, the mecA gene was not transferred between staphylococcal species during the in 
vitro mating experiment, which was confirmed by Southern blotting, PFGE, LC-
MS/MS and MIC assays. This finding is in concordance with previous report by 
Bloemendaal et al., (2010). Bloemendaal et al (2010) suggested that unsuccessful 
transfer of SCCmec is due to low frequencies or unfavourable in vitro conditions, since 
Bloemendaal et al (2010) indicated that one methicillin resistant S. aureus was derived 
from methicillin susceptible  S. aureus  by horizontal mecA gene transfer in vivo.  4 mg 
l
-1
 oxacillin supplemented mannitol salt agar is recommended to be used as a reliable 
screening medium for detection and identification of methicillin resistant S. aureus 
(Lally et al., 1985).  However, it is reported that oxacillin supplemented MSA shows 
relatively low sensitivity in the selection of MRSA in comparison with conmercialized 
selective agar (Stoakes et al., 2006). PCR is a widely used genetic method for antibiotic 
resistance gene determination (Sakoulas et al., 2001; Zhang et al., 2008); However, 
false positive results have been reported previously (Tham et al., 1991).  PFGE and 
Southern blotting are considered to be more reliable techniques in detecting the 
presence of specific genes (Trindade et al., 2003). In this study, the conjugant growing 
on 4 mg l
-1
 oxacillin supplemented mannitol salt agar (MSA, Oxoid Basingstoke UK) 
was determined to be mecA gene negative S. aureus (MSSA). In order to find out the 
reason of survival of MSSA on oxacillin supplemented MSA, it is essential to examine 
and compare, at a proteomic level, the successful transfer of mecA/SCCmec, as 
proteomics is a powerful tool to determine functional genomics (Ziebandt et al., 2010).  
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Stress response mediate the antibiotic resistance 
It is well established that methicillin resistant is determined by penicillin binding 
protein 2a with low affinity to β-lactam antibiotics, encoded by the mecA gene 
(Wielders et al., 2002). No penicillin binding protein 2a was detected in either 
conjugant or S. aureus (recipient). However, upregulation of proteins involved in 
various stress responses was observed. Previous studies have revealed that bacterial can 
acquire antibiotic resistance through vertical transmission from ancestors, such as the 
target of an antibiotic being altered by mutation to reduce affinity, or adjust the 
efficiency of efflux pumps that are involved in clearance of antibiotic from cells or 
degradative systems (Hastings et al., 2004). Increased single nucleotide mutations were 
observed after exposure to antibiotics, including nucleotide mutation in mprF gene, 
point mutation in spa gene and nos gene mutant (Richards et al., 2015). Caspermeyer, 
(2015) has shown that adaptation and survival ability of S. aureus is increased after 
exposure to a single antibiotic, and emphasis on the role of mutation in antibiotic 
resistance evolution. Stress environment increase the mutation and thus contribute to 
selective advantages (Foster, 2005a).  In this study, oxacillin most likely acted as a 
stress source, triggering stress responses of S. aureus and elevating the mutation rate, 
and thus contributing to the oxacillin resistant phenotype that allowed them to survive 
and proliferate on oxacillin supplemented mannitol salt agar. Finally, vertically 
transmission of these resistance traits to offspring enabled their survival in oxacillin 
supplemented mannitol salt agar. Proteomic level analysis is a unique approach to 
reveal the stress responses of bacteria (Xiao et al., 2003), and it has been successfully 
employed to look at the linezolid stress response of S. aureus (Bernardo et al., 2004).   
The beta-lactam mediated SOS response has been previously reported in clinical mecA 
positive, oxacillin susceptible MRSA (Cuirolo et al., 2009), and the LexA/RecA protein 
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regulated SOS response increases the mutation rate which allows the selection of high 
oxacillin resistant populations from mecA positive, oxacillin susceptible MRSA 
(Cuirolo et al., 2009). Similar phenomena were found in this study, increased 
expression of RecA gene in mecA negative S. aureus was observed after exposure to 
beta-lactam antibiotic.  
Mismatch repair is important for genomic integrity (Foster, 2005a); however, mismatch 
repair protein may remain at low levels under stress conditions so that mutations cannot 
be corrected (Foster, 2005a). It was found that the expression of MutS (key gene for 
mismatch repair) remained the same after exposure to beta-lactam antibiotic in this 
study. It is reported that bacteria can acquire resistant traits by mutation and altering the 
efficiency of degradation system. Additionally, these traits can be vertically transferred 
to offspring  (Hastings et al., 2004). Upregulation of proteins that are involved in 
degradation were observed in this study.  
The stringent response is known to be triggered by the stressful environment (Gao et al., 
2010), and has been reported to tolerate antibiotic resistance in Enterococcus faecalis 
(Abranches et al., 2009). The proteins responsible for amino acid biosynthesis and 
transport processes are observed to be upregulated in the stringent responses (Anderson 
et al., 2006). ABC transporter is one such transport protein (Anderson et al., 2006), and 
is known to be one of the most significant contributing factors for antibiotic resistance 
(Gupta et al., 2010). In this study, ABC transporter and drug resistance transporter 
(EmrB/QacA) were found to be upregulated in presence of oxacillin.  
The heat shock response is known to be induced by temperature or DNA damage 
(Guisbert et al., 2008; Muthaiyan et al., 2012). Heat-denatured proteins are known to be 
targeted by ClpC and then degraded by ClpP (Frees et al., 2004). As part of this system, 
ClpB is speculated to interact with heat shock proteins (DnaK, DnaJ) to solubilize the 
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protein aggregates (Mogk et al., 2003). Urease operon (ureA-ureD) are known to 
convert urease to ammonia and CO2 (Anderson et al., 2006). The increased expression 
of urease operon is all known to help address the effects of temperature elevation 
(Anderson et al., 2006). GroE is important for transcription under heat elevation, as it 
protects the RNA polymerase holoenzyme from heat inactivation (Ziemienowicz et al., 
1993). In this study, the isolates that were used for comparative proteomic analysis were 
both cultured at 37℃; however, these heat shock response associated proteins (ClpB, 
ClpC, ClpP, urea-ureD, GroE) were upregulated in presence of oxacillin. Foster, 
(2005a) has reported that other conditions responsible for unfolded proteins can trigger 
heat shock response. The finding of this study supports that the heat shock response can 
be triggered by antibiotic associated stress (Guisbert et al., 2008; Muthaiyan et al., 
2012). 
Heat shock protein is a family of proteins that are active during exposure to stress 
environments, such as excess heat, oxygen and UV light (Cao et al., 1999; Matz et al., 
1995; Ritossa, 1962). Hsp40 (DnaJ) controls protein homeostasis in the cell (Cuéllar et 
al., 2013). Hsp20 (GrpE) has been reported to assist reactivation of heat-inactivated 
RNA polymerase (Ziemienowicz et al., 1993). Heat shock protein 20, 40, 70 were all 
found to be upregulated in conjugant of this study.   
The upregulation of virulence genes is also induced under stress conditions (Anderson 
et al., 2006). In this study, virulence factors such as zinc metalloprotease (ftsH), 
protease, Clp protease (clp), and clumping factor A (clfA), were found to be expressed 
at increased levels in the presence of oxacillin. In addition, The PBPs are membrane-
associated proteins that catalyse the synthesis of cell wall peptidoglycan in S. aureus, 
and peptidoglycan is an important component of the bacterial cell wall (Dmitriev et al., 
2004; Memmi et al., 2008). Muthaiyan et al., (2012) has assessed the killing effect of 
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Valencia orange essential oil on S. aureus, and downregulation of PBPs and 
peptidoglycan was observed in the presence of the Valencia orange essential oil. In this 
study, expression of PBPs remained the same or upregulated, and upregulation of 
peptidoglycan biosynthesis associated proteins (mur) were observed in conjugant. This 




















Chapter 10 Concluding remarks    
The introduction of antibiotic in clinical use is a revolutionary paradigm in morden  
medicine (Gensini et al., 2007). However, the misuse of antibiotics has led to the global 
crisis of antimicrobial resistance (Bartlett et al., 2013).  The presence of antimicrobial 
resistance determinants is due to evolutionary selection by the environment, and thus 
the environment acts as a reservoir of antibiotic resistance determinants (Wright, 2007). 
Staphylococci, as an opportunistic pathogen, are the major cause of nosocomial 
infections, and the emergence of antibiotic resistance in staphylococci poses a major 
threat to public health (Becker et al., 2014). Meanwhile, development of new 
antimicrobial agents has been slowed down by the economic and regulatory barriers, 
and staphylococci continue adapting new antibiotic resistance feature for survival 
(Bartlett et al., 2013). Thus it is necessary to carry out antibiotic resistance screening. 
The data of resistance-related research can notify public health authorities to make the 
right strategies to control and limit the spread of antibiotic resistance in environment 
(Bartlett et al., 2013).  
This study has assessed the distribution of antibiotic resistance of staphylococcal 
species in environment. The significant findings of my study are as follows: 
1. 19 staphylococcal species were identified in this study, and 17 species were 
previously reported to be isolated from clinical specimens. Taxonomic 
correlations were determined in staphylococci recovered from human hands and 
8 non-biological sites; 
2. This is the first report of the employment of MALDI-TOF MS for identification 
of a large amount of environmental staphylococci. The reliability of MALDI-
TOF MS in identifying environmental staphylococcal species was confirmed. In 
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addition, reproducibility of MALDI-TOF MS in identifying environmental 
staphylococci was assessed for the first time with two different modes of 
MALDI-TOF MS in automated fashion, and MALDI-TOF MS was confirmed to 
be a highly reproducible method for identifying environmental staphylococci. 
3. Multiple antibiotic resistance staphylococci were widely distributed in the 
environment, and 80% staphylococci were resistant to two or more antibiotics. 
Varied antibiotic susceptibility profiles were observed within taxonomically 
closely related staphylococci, suggesting the acquisition of antibiotic resistance 
determinants by mutation and HGT. Cluster analysis also showed no significant 
difference between multidrug resistant and susceptible staphylococci. This 
demonstrates that antibiotic resistance genes are produced in both pathogenic 
and non-pathogenic bacteria as defined by ‘resistomes’. 
4. The ratio of mecA-positive environmental CoNS was generally lower than the 
ratios reported by clinical study; however, the species of mecA-positive 
environmental CoNS were more diverse than the species in clinical study 
reports. Oxacillin susceptible mecA-positive CoNS (OS-MRCoNS) was first 
determined in environmental CoNS. Unassigned or untypable SCCmec types 
were dominant in environmental staphylococci. For assigned SCCmec types, 
SCCmec type V was prevalent in the environment. 17 S. epidermidis harboured 
new MLST types, and ST59 was firstly reported to be associated with SCCmec 
type IV. Same ST type with varied SCCmec types was observed in this study. 
5. Whole genome sequencing was applied to an environmental S. epidermidis, 
leading to the identification of 29 virulence genes, 8 surface proteins and 9 
antibiotic resistance determinants. 5 out of 9 antibiotic resistance determinants 
were located on plasmids, which suggest the high mobility of these antibiotic 
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resistant determinants. Multiple virulence factors and antibiotic resistance genes 
suggest that S. epidermidis 118 (G6_2) could be more virulent and infections 
could be more difficult to treat. A highly pathogenic S. epidermidis 118 (G6_2), 
recovered from inanimate sites in hotel rooms has been reported.   
6. mecA gene transfer in natural conditions via conjugation was not observed, and 
more sophisticated mechanisms may be required to trigger mecA gene transfer 
between staphylococcal species in vitro. Whole proteomic expression 
differences were detected and quantified in S. aureus cultured with and without 
oxacillin. Proteins involved in stress response, transporter mediated antibiotic 
resistance, virulence and gene expression regulation were exclusively or 
increasingly expressed in S. aureus when exposed to oxacillin. This finding 
indicates the new trait of antibiotic resistance of Staphylococcus spp., and may 
be a potential threat to public health. 
In conclusion, the dissemination of multidrug resistance staphylococci in non-healthcare 
environments is evidence that these environments act as a reservoir for antibiotic 
resistant pathogens and determinants.  Antibiotic resistance genes from environmental 











Chapter 11 Future work 
This study provides a general overview of antibiotic resistance in environmental 
staphylococci, and it is a worrisome finding of wide-spread dissenmination of multiple 
antibiotic resistant staphylococci in non-healthcare related environments.  New MLST 
types identified in environmental staphylococci displayed the distinctive lineage. In 
addition, a high virulence and antibiotic resistant S. epidermidis was recovered from 
hotel rooms at an establishment with a generally high standard of hygiene. Finally, 
mecA gene transfer was not observed in vitro; however, proteomic analysis has revealed 
that the stress responses of S. aureus were triggered to adapt to survive in the presence 
of oxacillin. 
MALDI-TOF MS has been reported to be a useful, rapid, reliable tool in identifying 
microorganisms; however, concerns of reproducibility of this technique have been 
raised (Schumaker et al., 2012). The reproducibility of MALDI-TOF MS refers to the 
accuracy with which strains are identified (Sandrin et al., 2013). The reproducibility 
was obtained by testing fresh cultures from different days, and different operators 
(Majcherczyk et al., 2006; Schumaker et al., 2012). However, no standardized approach 
has been used to report reproducibility (Sandrin et al., 2013). In this study, the 
reproducibility of 34 environmental staphylococcal isolates belonging to 18 species was 
tested with two modes of MALDI-TOF MS. More environmental samples need to be 
tested for further validation of MALDI-TOF MS reproducibility in future.  
In this study, the antibiotic resistance is determined by disc diffusion method, minimum 
inhibitory method or resistance gene PCR, however, disc diffusion assay and minimum 
inhibitory method require at least one working day to get the results, and PCR still 
needs several consecutive steps to get the results (Jorgensen & Ferraro., 2009; 
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Cherkaoui et al., 2010). As the development of MALDI-TOF MS, uses of MALDI-TOF 
MS for rapid identification of resistance against β-lactam antibiotics have been reported. 
The resistance of β-lactam can be detected by mass spectrometry by a molecular mass 
shift, which is caused by the hydrolysis of the β-lactam ring (Sparbier et al., 2012). In 
the future, it would be great to employ MALDI-TOF MS for rapid determination of the 
susceptibility towards β-lactam antibiotic instead of traditional disc diffusion methods. 
The whole genomic sequence of S. epidermidis 118 (G6_2) provides an insight into the 
genomic composition of an environmental S. epidermidis. The presence of multiple 
virulence genes and antibiotic resistance genes make S. epidermidis 118 (G6_2) a 
potential threat to public health, as S. epidermidis 118 (G6_2) harbours more antibiotic 
resistance and virulence genes than other two well-known clinical reference S. 
epidermidis strains. In order to better characterize the pathogenicity of S. epidermidis 
118 (G6_2), it is necessary to carry out animal research to assess the pathogenicity of 
the S. epidermidis 118 (G6_2) in vivo. In the future, the S. epidermidis 118 (G6_2) 
virulence can be assessed by in rabbit urinary tract infection, blood vessel infection, and 
endocarditis models. After clinical, histopathologic, bacteriological and serological 
examination of urinary tract infection, blood vessel infection and endocarditis, the 
pathogenicity of S. epidermidis 118 (G6_2) can be characterized.  
Similar to S. epidermidis 118 (G6_2), 3 S. haemolyticus and 1 S. saprophyticus species 
were identified that displayed multiple antibiotic resistances and whose oxacillin MICs 
reach up to 256 mg l
-1
.  S. saprophyticus is the second only to E. coli as a major cause of 
urinary tract infection, and surface-associated protein of S. saprophyticus contributes to 
its ability to adhere to urothelial cells (Raz et al., 2005).  S. haemolyticus and S. 
epidermidis, are the most prevalent staphylococcal species, and both are major causes of 
neonatal infections (Becker et al., 2014). The highly plastic genome of S. haemolyticus 
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confers frequent genomic rearrangement, insertion, and acquisition of antibiotic 
resistance (Takeuchi et al., 2005). There are a lot of genomic data on S. aureus and S. 
epidermidis, however, little is known on the other staphylococcal species. Therefore, 
these environmental S. haemolyticus and S. saprophyticus can be further assessed by 
whole genome sequencing to determine their genomic features that contribute to their 
pathogenicity.  Moreover, further pan genome sequencing of environmental multidrug 
resistant Staphylococcus spp. would immensially contribute to the further findings of 
antibiotic resistance transmission between intra species.  In the future, genomic work 
can broaden our knowledge to other staphylococci. 
Finally, the transfer mechanism of SCCmec elements has not been elucidated. 
Bloemendaal et al., (2010) has reported that methicillin resistant S. aureus was derived 
from methicillin susceptible S. aureus by horizontal mecA gene transfer in vivo; 
however, this process can not be replicated with in vitro conjugation of the same S. 
aureus strains (Bloemendaal et al., 2010). Recently, Ray et al (2016) successfully 
observed the conjugative transfer of SCCmec from S. epidermidis to S. aureus by 
inserting the SCCmec elements into a staphylococcal plasmid, however, these manual 
modifications may not happen in nature. Previous studies have demonstrated enhanced 
horizontal transfer of mobile genetic elements in cells grown under biofilm formation 
conditions (Madsen et al., 2012), it will be worthwhile to try conjugative transfer of 
SCCmec using biofilm cultured cells. Additionally, the transformation of SCCmec 
elements faces difficulties by common laboratory method, and for now, transformation 
can not replicate this process (Otto, 2013). In the future, it may worth to try 
transformation of SCCmec elements via improved methods. In contrast, experimentally 
phage mediated transduction of SCCmec within two S. aureus has been reported (Cohen 
& Sweeney, 1973), however, no phage mediated transduction of SCCmec elements 
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between different staphylococcal species has been reported (Katayama et al., 2000). 
Recently, Chen et al., (2015) have described staphylococcal intra- and interspecies 
genetic elements transfer by cos phages. Phage mediated transduction is one of the 
important horizontal gene transfer mechanisms, and acts as one of the main 
evolutionary driving forces of bacteria (Chen et al., 2015). Therefore, it remains to find 
out if the SCCmec elements can be transferred by phage transduction. In the future, it is 
worth to try phage-mediated transduction to assess the SCCmec transfer between 
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Appendix I Buffers and Solutions 
I.1 Culture mediums 
Nutrient agar (Oxoid Ltd, Basingstoke, UK) 
28 g nutrient agar powder  
1 L ddH2O  
Nutrient broth (Oxoid Ltd, Basingstoke, UK) 
13 g nutrient broth powder  
1 L ddH2O 
Mannitol salt agar (Oxoid Ltd, Basingstoke, UK) 
111 g mannitol salt agar powder  
1 L ddH2O 
Brilliance
TM
 UTI clarity agar (Oxoid Ltd, Basingstoke, UK) 
39 g Brilliance
TM
 UTI clarity agar powder  
1 L ddH2O 
Iso-sensitest agar (Oxoid Ltd, Basingstoke, UK) 
31.4 g iso-sensitest agar powder 
1 L ddH2O 
Tryptic soy agar (Oxoid Ltd, Basingstoke, UK) 
40 g tryptic soy agar powder  
1 L ddH2O 
Tryptic soy broth (Oxoid Ltd, Basingstoke, UK) 
30 g tryptic soy broth powder 
1 L ddH2O 
I.2 General buffers 
50×TAE buffer 
0.04 M Tris-Acetate 
0.001 M EDTA  
6×DNA Loading dye 
50 % (v/v) Glycerol 
0.25 % (w/v) Bromophenol  
0.25 % (w/v) Xylene cyanol 
I.3 Southern hybridization buffer and solutions 
Depurination solution 





0.5 M NaOH 
1.5 M NaCl 
Dissolve in ddH2O 
Neutralization buffer 
0.5 M Tris-HCl 
3 M NaCl 
Dissolve in ddH2O 
pH 7.0 
20×SSC 
3 M NaCl 
0.3 M Trisodium citrate 
Dissolve in ddH2O 
pH 7.0 
Maleic acid buffer 
1 M Maleic acid buffer 
1.5 M NaCl 
Detection buffer 
1 M Tris 
1 M NaCl 
Blocking solution 
10 % (v/v) Blocking reagent (Roche) 
90 % (w/v) Maleic acid buffer 
 
I.4 PFGE buffers and solutions 
SE Buffer  
15 mM NaCl 
5 mM EDTA 
First lysis buffer 
6 mM Tris,  
100 mM EDTA,  
1 M NaCl,  
0.5 % (w/v) Brij 58,   
0.2 % (w/v) Sodium deoxycholate,  
0.5 % (w/v) N-Lauroyl sarcosine,  
1 mM MgCl2 
 
Alkaline Lysis Buffer/proteinase K 
1 % (w/v) N-Lauroyl sarcosine,  
0.5 M EDTA 
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10 mM Tris 
10 mM EDTA  
Dissolved in ddH2O 
pH 7.5 
0.5× TBE 
45 mM Tris-borate 














Appendix II Antibiotic susceptibility data 
II.1 Antibiotic susceptibility profile of all staphylococci 
ID Species Sites OX PG  VAN  MUP  CEF  GM  FC  S  A  E  T   C 
1 Staphylococcus arlettae BCF S R S S S S R R R R S S 
 1/1(tested/total)              
 
2 Staphylococcus aureus BCF S S S S S S R S R I S I 
3 Staphylococcus aureus BCF S R S R S R R I R R S S 
4 Staphylococcus aureus BCF S R S R S S R S S S S S 
5 Staphylococcus aureus DSH S R R S I R S R S S S S 
6 Staphylococcus aureus DSH S R R S I R S S R S S S 
7 Staphylococcus aureus DSH S R R S I S R R R S S S 
8 Staphylococcus aureus DSR S R S S S R R R S R S S 
9 Staphylococcus aureus DSR S R S I S R R S R R S S 
10 Staphylococcus aureus DSS S R R I S S R S S I S S 
11 Staphylococcus aureus DSS S R S S S S R S S S S S 
12 Staphylococcus aureus DSS S R R I S R R S R S S S 
13 Staphylococcus aureus HB S S R S I R R R S S S R 
 12/12(tested/total)              
 
14 Staphylococcus auricularis DST S S S S S S S S S S S S 
15 Staphylococcus auricularis DST S R R I R S R S R S S S 
 2/2(tested/total)              
Note: A: amoxicillin (10 µg); CEF: cefepime (30 µg); C: chloramphenicol (30 µg); E: erythromycin (5 µg); FC: fusidic acid (10 µg); GM: 
gentamicin (10 µg); MUP: mupirocin (20 µg); OX: Oxacillin (1 µg);  PG: penicillin G (1 unit); S: streptomycin (10 µg);  T: tetracycline (10 




ID Species Sites OX PG  VAN  MUP  CEF  GM  FC  S  A  E  T   C 
16 Staphylococcus capitis BCF S S S R S S R S S S S S 
17 Staphylococcus capitis BCF S R S R S S R S S S S S 
18 Staphylococcus capitis BCF S R S S S S R S R S S S 
19 Staphylococcus capitis DSH S R S R S S S S S S S S 
20 Staphylococcus capitis DSH S R R S S S R I S I S S 
21 Staphylococcus capitis DSH S S R R R R R R R R S R 
22 Staphylococcus capitis DSH S R S S S S S R S S S S 
23 Staphylococcus capitis DSH S R R S S S R R R S S S 
24 Staphylococcus capitis DSH S S S S S S R R S S S S 
25 Staphylococcus capitis DSH S R S S S S S R S S S S 
26 Staphylococcus capitis DSH S S R S I S S S S S S S 
27 Staphylococcus capitis DSH S S S S S S S R S R S R 
28 Staphylococcus capitis DSH S R S S S S S R S S S S 
29 Staphylococcus capitis DSH S R R R S S S R S S S S 
30 Staphylococcus capitis DSL S S S S S S R R S S R S 
31 Staphylococcus capitis DSL S S S S S S S R S S S S 
32 Staphylococcus capitis DSL S R S S S S S R R S S S 
33 Staphylococcus capitis DSR S R S S S S R S S S S S 
34 Staphylococcus capitis DSR             
35 Staphylococcus capitis DSR S R S S S S S S S R S S 
36 Staphylococcus capitis DSR S R R S S S R S S S R S 
37 Staphylococcus capitis DSR S S S S S S R S S S S S 
38 Staphylococcus capitis DSR S R S R S S S S S S S S 
39 Staphylococcus capitis DSR S R S S S S R S S S S S 
40 Staphylococcus capitis DSR             
41 Staphylococcus capitis DSR             
42 Staphylococcus capitis DSR             
Note: A: amoxicillin (10 µg); CEF: cefepime (30 µg); C: chloramphenicol (30 µg); E: erythromycin (5 µg); FC: fusidic acid (10 µg); GM: 
gentamicin (10 µg); MUP: mupirocin (20 µg); OX: Oxacillin (1 µg);  PG: penicillin G (1 unit); S: streptomycin (10 µg);  T: tetracycline (10 
µg);  VAN: vancomycin (5 µg). 
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ID Species Sites OX PG  VAN  MUP  CEF  GM  FC  S  A  E  T   C 
43 Staphylococcus capitis DSS S R R I S S R R S S S S 
44 Staphylococcus capitis DSS S R S S S S R S S S S S 
45 Staphylococcus capitis DSS S R S S S S R S S S R S 
46 Staphylococcus capitis DSS S R S S S S R S S S S S 
47 Staphylococcus capitis DSS S R R I S S R S S S S S 
48 Staphylococcus capitis DSS S R S S S S R S S S R S 
49 Staphylococcus capitis DSS S R S R S S S S S R S R 
50 Staphylococcus capitis DST S R S S S S R R R R S S 
51 Staphylococcus capitis DST S R S S S S S R R S S S 
52 Staphylococcus capitis DST S S S S S S S S S S S S 
53 Staphylococcus capitis DST S S S S S S R S S S S S 
54 Staphylococcus capitis DST S R S S S S R S S S S S 
55 Staphylococcus capitis DST S S S R S S S S S S S S 
56 Staphylococcus capitis DST S S S S S S S S S S S S 
57 Staphylococcus capitis DST S S S S S S R S S S S S 
58 Staphylococcus capitis DST S S S I S S R S S S S S 
59 Staphylococcus capitis DST S S S R S S R S S S S S 
60 Staphylococcus capitis DST S S S S S S R S S S S S 
61 Staphylococcus capitis DST S R S S S S R S S S S S 
62 Staphylococcus capitis DST S R S S S S R S S S S S 
63 Staphylococcus capitis DST S S S S I S S S S S S S 
64 Staphylococcus capitis HB S S S S S S S R S R S S 
65 Staphylococcus capitis HB S R S S S S S S S S S S 
66 Staphylococcus capitis HB S S S S S S S R S S S S 
67 Staphylococcus capitis HB S R S S S S R R R S S S 
68 Staphylococcus capitis HH S R R R S S S R R S S S 
69 Staphylococcus capitis HH S R S S S S R R R S R S 
70 Staphylococcus capitis HH S R S S S S S R S S R S 
Note: A: amoxicillin (10 µg); CEF: cefepime (30 µg); C: chloramphenicol (30 µg); E: erythromycin (5 µg); FC: fusidic acid (10 µg); GM: 
gentamicin (10 µg); MUP: mupirocin (20 µg); OX: Oxacillin (1 µg);  PG: penicillin G (1 unit); S: streptomycin (10 µg);  T: tetracycline (10 
µg);  VAN: vancomycin (5 µg). 
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ID Species Sites OX PG  VAN  MUP  CEF  GM  FC  S  A  E  T   C 
71 Staphylococcus capitis HH R S S S S S S R S S S S 
72 Staphylococcus capitis HH S S S S S S S R S S S S 
73 Staphylococcus capitis HH S S S S S S R R S S S S 
74 Staphylococcus capitis HH S R S S S S R R R S S S 
75 Staphylococcus capitis HH R R S S S S R R S S S S 
76 Staphylococcus capitis HH S S S S I S S R S S S S 
77 Staphylococcus capitis HH S R S S S S R R S S S S 
78 Staphylococcus capitis HH S R S S I S R R R S S S 
79 Staphylococcus capitis HH S R S S S S R R R S S S 
80 Staphylococcus capitis HH S S S S S S S S R S S S 
81 Staphylococcus capitis HH R R S S R S R R R R S S 
82 Staphylococcus capitis HH S R S S S S S R R S S S 
83 Staphylococcus capitis HH S S S R S S R R S S S S 
84 Staphylococcus capitis HH S S S S S S R R S S S S 
85 Staphylococcus capitis HH S S R I S S R S S R S S 
86 Staphylococcus capitis HH S S S I S S R S S I S S 
87 Staphylococcus capitis HH S R S I S S R S R S R S 
88 Staphylococcus capitis HH S S R S S S S S S R S S 
89 Staphylococcus capitis HH S R S I S S R S S S S S 
90 Staphylococcus capitis HH S R S S S S R S S S S S 
91 Staphylococcus capitis HH S S S I S S S R S S S S 
92 Staphylococcus capitis HH S R R I S S S S S S S S 
93 Staphylococcus capitis HH S R R R R S R S R S S R 
94 Staphylococcus capitis HH S S S I S S R S S R S S 
 75/79(tested/total)              
95 Staphylococcus caprae DSS S R S S S S R S S S S S 
96 Staphylococcus caprae HB S R S S S S R R R S S S 
 2/2(tested/total)              
Note: A: amoxicillin (10 µg); CEF: cefepime (30 µg); C: chloramphenicol (30 µg); E: erythromycin (5 µg); FC: fusidic acid (10 µg); GM: 
gentamicin (10 µg); MUP: mupirocin (20 µg); OX: Oxacillin (1 µg);  PG: penicillin G (1 unit); S: streptomycin (10 µg);  T: tetracycline (10 
µg);  VAN: vancomycin (5 µg). 
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ID Species Sites OX PG  VAN  MUP  CEF  GM  FC  S  A  E  T   C 
 
97 Staphylococcus cohnii BCF S R S S R S R R S R S S 
98 Staphylococcus cohnii BCF S R S R R S R R R S S S 
99 Staphylococcus cohnii DSH S R R S S S R S R R S S 
100 Staphylococcus cohnii DSH R R S R S S S S R R S S 
101 Staphylococcus cohnii DSH S R S S S S R S S R S R 
102 Staphylococcus cohnii DSH S R S S S S R R S R S S 
103 Staphylococcus cohnii DSH S R S S R S R R S S S S 
104 Staphylococcus cohnii DSL S S S S S S R R S R S S 
105 Staphylococcus cohnii DSL S - S S S S R S S S S S 
106 Staphylococcus cohnii HAS R R S R R S R I S S S S 
107 Staphylococcus cohnii HAS R R R S R S R R S R R R 
108 Staphylococcus cohnii HH R S S S I S R R S R R S 
109 Staphylococcus cohnii HH S R R S I S R R R S S S 
110 Staphylococcus cohnii HH S R S S S S R S S R S S 
 14/14(tested/total)              
 
111 Staphylococcus epidermidis BCF S R S S S S S S S S S S 
112 Staphylococcus epidermidis BCF S R S S S S R S R S S S 
113 Staphylococcus epidermidis BCF S R S S S S R S S S S S 
114 Staphylococcus epidermidis BCF S S S S S S R S S R S S 
115 Staphylococcus epidermidis BCF S R S S S S S S S R S S 
116 Staphylococcus epidermidis BCF S R S I S S R S R S S S 
117 Staphylococcus epidermidis BCF S R S S S S R S R I R S 
118 Staphylococcus epidermidis DSH R R S R R R R I R R R S 
119 Staphylococcus epidermidis DSH S R S S S S S S R I R S 
120 Staphylococcus epidermidis DSH S R R S S S R S S I S S 
121 Staphylococcus epidermidis DSH S R S S S S R R R I R R 
Note: A: amoxicillin (10 µg); CEF: cefepime (30 µg); C: chloramphenicol (30 µg); E: erythromycin (5 µg); FC: fusidic acid (10 µg); GM: 
gentamicin (10 µg); MUP: mupirocin (20 µg); OX: Oxacillin (1 µg);  PG: penicillin G (1 unit); S: streptomycin (10 µg);  T: tetracycline (10 
µg);  VAN: vancomycin (5 µg). 
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ID Species Sites OX PG  VAN  MUP  CEF  GM  FC  S  A  E  T   C 
122 Staphylococcus epidermidis DSH S R S R S S R R S S S S 
123 Staphylococcus epidermidis DSH S R S S I S R R S S S S 
124 Staphylococcus epidermidis DSH R R R S R S R R R S R S 
125 Staphylococcus epidermidis DSH S S R S I S S R S S S S 
126 Staphylococcus epidermidis DSH R R R S I S S R R R S S 
127 Staphylococcus epidermidis DSH R R R S I S S S R R R S 
128 Staphylococcus epidermidis DSH S R R S R R S R R S S R 
129 Staphylococcus epidermidis DSL S R S S S S R R R R R S 
130 Staphylococcus epidermidis DSL S R R S S S S R R S S S 
131 Staphylococcus epidermidis DSL S R R R R S R S R S S S 
132 Staphylococcus epidermidis DSL S R S S S S S R R S S S 
133 Staphylococcus epidermidis DSL R R S S S S R R R R R S 
134 Staphylococcus epidermidis DSL R R S S S S R R R R R S 
135 Staphylococcus epidermidis DSL R R S S S S R R R R R S 
136 Staphylococcus epidermidis DSL S R S S S S S R S R S S 
137 Staphylococcus epidermidis DSL S R S S S S S R R R S S 
138 Staphylococcus epidermidis DSR S S R S R S R S S R S S 
139 Staphylococcus epidermidis DSR R R R R R S R S R R R S 
140 Staphylococcus epidermidis DSR S R R R R R R S R S R S 
141 Staphylococcus epidermidis DSR S R S S S S R S R S R S 
142 Staphylococcus epidermidis DSR S R R I S S R S S R S S 
143 Staphylococcus epidermidis DSR S R R R R R R S R R S S 
144 Staphylococcus epidermidis DSR S S S S S S R S S S S S 
145 Staphylococcus epidermidis DSR S R S S S S R S S S S S 
146 Staphylococcus epidermidis DSR S R S S S S R S S R S S 
147 Staphylococcus epidermidis DSR S R R S S S R S S R S S 
148 Staphylococcus epidermidis DSR S S S S S S R S S R S S 
149 Staphylococcus epidermidis DSR S R R S S R R S S R R S 
Note: A: amoxicillin (10 µg); CEF: cefepime (30 µg); C: chloramphenicol (30 µg); E: erythromycin (5 µg); FC: fusidic acid (10 µg); GM: 
gentamicin (10 µg); MUP: mupirocin (20 µg); OX: Oxacillin (1 µg);  PG: penicillin G (1 unit); S: streptomycin (10 µg);  T: tetracycline (10 
µg);  VAN: vancomycin (5 µg). 
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150 Staphylococcus epidermidis DSR S R R S S R S S S R S S 
151 Staphylococcus epidermidis DSR S R S S S S R S S S S S 
152 Staphylococcus epidermidis DSR S R S R S S R S S S S S 
153 Staphylococcus epidermidis DSR R R S S S S R S S S S S 
154 Staphylococcus epidermidis DSR S S S S S S R S S R S S 
155 Staphylococcus epidermidis DSR S R S S S S S S S S S S 
156 Staphylococcus epidermidis DSR S R S S R R S S S S S S 
157 Staphylococcus epidermidis DSR S R S S S S S S S S S S 
158 Staphylococcus epidermidis DSR S R S S S S R S S R S S 
159 Staphylococcus epidermidis DSR S R S S S S R S S S S S 
160 Staphylococcus epidermidis DSR S R S S S S R S S S S S 
161 Staphylococcus epidermidis DSR S R S R S S S S S S S S 
162 Staphylococcus epidermidis DSR S R S S S S S S S S S S 
163 Staphylococcus epidermidis DSR S R S S S S S S S S R S 
164 Staphylococcus epidermidis DSR S R S I S S S S S S S S 
165 Staphylococcus epidermidis DSR S R S S S S S S S S S S 
166 Staphylococcus epidermidis DSR             
167 Staphylococcus epidermidis DSR             
168 Staphylococcus epidermidis DSR S R S R S S S S S R S S 
169 Staphylococcus epidermidis DSR S S S S S S R S S R S S 
170 Staphylococcus epidermidis DSR S R S S S S R S S S S S 
171 Staphylococcus epidermidis DSR S R S S S S S S S S S S 
172 Staphylococcus epidermidis DSR S R S S S S R S S S S S 
173 Staphylococcus epidermidis DSR S S S S S S R S S S S S 
174 Staphylococcus epidermidis DSS             
175 Staphylococcus epidermidis DSS S R S I S S S S S R S S 
176 Staphylococcus epidermidis DSS S S S S S S R S S I S S 
177 Staphylococcus epidermidis DSS S R R S S S S S S R S S 
Note: A: amoxicillin (10 µg); CEF: cefepime (30 µg); C: chloramphenicol (30 µg); E: erythromycin (5 µg); FC: fusidic acid (10 µg); GM: 
gentamicin (10 µg); MUP: mupirocin (20 µg); OX: Oxacillin (1 µg);  PG: penicillin G (1 unit); S: streptomycin (10 µg);  T: tetracycline (10 
µg);  VAN: vancomycin (5 µg). 
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178 Staphylococcus epidermidis DSS S R R S S S R S S R R S 
179 Staphylococcus epidermidis DSS S R S I I S S S R R S S 
180 Staphylococcus epidermidis DSS S R R I S S R S S S S S 
181 Staphylococcus epidermidis DSS S R S S S S R S R S S S 
182 Staphylococcus epidermidis DSS S S S I S S S S S S S S 
183 Staphylococcus epidermidis DSS S S S I S S S S S R S S 
184 Staphylococcus epidermidis DSS S R S S S S R S S S S S 
185 Staphylococcus epidermidis DSS S R R S S S S S S S S S 
186 Staphylococcus epidermidis DSS S R S S S S S S R S S S 
187 Staphylococcus epidermidis DSS R R R S S S S S S R S S 
188 Staphylococcus epidermidis DSS S R S R R R R S R S S S 
189 Staphylococcus epidermidis DSS S R R R R R R S R S S S 
190 Staphylococcus epidermidis DSS S S S S S S S S S S S S 
191 Staphylococcus epidermidis DSS R R S S S S R S R S S S 
192 Staphylococcus epidermidis DSS S R R S S S R S S S S S 
193 Staphylococcus epidermidis DSS S S S S S S S S S S S S 
194 Staphylococcus epidermidis DSS S S S S S S S S S S S S 
195 Staphylococcus epidermidis DSS S S S S S S S S S S S S 
196 Staphylococcus epidermidis DSS S R S S S S R S S S S S 
197 Staphylococcus epidermidis DSS S R R S S S R S S S S S 
198 Staphylococcus epidermidis DSS             
199 Staphylococcus epidermidis DSS S R S I S S R S S S S S 
200 Staphylococcus epidermidis DST S R S S S S R S R R S S 
201 Staphylococcus epidermidis DST S R S S S S S R R R R S 
202 Staphylococcus epidermidis DST S S R R S S R I S S S S 
203 Staphylococcus epidermidis DST S S S S S S R S S R S S 
204 Staphylococcus epidermidis DST S S R R S S S S S R S S 
205 Staphylococcus epidermidis DST S R S S S S S R R R R S 
Note: A: amoxicillin (10 µg); CEF: cefepime (30 µg); C: chloramphenicol (30 µg); E: erythromycin (5 µg); FC: fusidic acid (10 µg); GM: 
gentamicin (10 µg); MUP: mupirocin (20 µg); OX: Oxacillin (1 µg);  PG: penicillin G (1 unit); S: streptomycin (10 µg);  T: tetracycline (10 
µg);  VAN: vancomycin (5 µg). 
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206 Staphylococcus epidermidis DST S R R S S S R S R R S S 
207 Staphylococcus epidermidis DST S S S S S S R S S S S S 
208 Staphylococcus epidermidis DST S S S S S S S S S R S S 
209 Staphylococcus epidermidis DST S S S S S S R S S S S S 
210 Staphylococcus epidermidis DST S S R R S S R S S R S S 
211 Staphylococcus epidermidis DST S R S S S S R S R R S S 
212 Staphylococcus epidermidis DST S S S S S S R S S R S S 
213 Staphylococcus epidermidis DST S S R S S S R S S S S S 
214 Staphylococcus epidermidis DST S R S S S S S S R R S S 
215 Staphylococcus epidermidis DST S S S S S S R S S S S S 
216 Staphylococcus epidermidis DST S R S S S S R S R R S S 
217 Staphylococcus epidermidis DST             
218 Staphylococcus epidermidis DST             
219 Staphylococcus epidermidis DST S S S S S S R S S S S S 
220 Staphylococcus epidermidis DST S R S S S S R S R R S S 
221 Staphylococcus epidermidis DST             
222 Staphylococcus epidermidis DST S R S S S S S S S S S S 
223 Staphylococcus epidermidis DST S S R S S S S S S R S S 
224 Staphylococcus epidermidis DST S S S S S S R S S S S S 
225 Staphylococcus epidermidis DST S S S S S S S S S R S S 
226 Staphylococcus epidermidis DST S S S S S S S S S R S S 
227 Staphylococcus epidermidis DST S S S S S S R S S S S S 
228 Staphylococcus epidermidis DST S S S R S S S S S S S S 
229 Staphylococcus epidermidis DST S R S S S S S S S S S S 
230 Staphylococcus epidermidis DST S R R S S S R S R I S S 
231 Staphylococcus epidermidis DST S S S S S S R S S S S S 
232 Staphylococcus epidermidis DST S R S I S S S S S R S S 
233 Staphylococcus epidermidis HB S R S S I S S S S R R S 
Note: A: amoxicillin (10 µg); CEF: cefepime (30 µg); C: chloramphenicol (30 µg); E: erythromycin (5 µg); FC: fusidic acid (10 µg); GM: 
gentamicin (10 µg); MUP: mupirocin (20 µg); OX: Oxacillin (1 µg);  PG: penicillin G (1 unit); S: streptomycin (10 µg);  T: tetracycline (10 
µg);  VAN: vancomycin (5 µg). 
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234 Staphylococcus epidermidis HB R S S R S S R R S R R S 
235 Staphylococcus epidermidis HB S S S S S S S S S S R S 
236 Staphylococcus epidermidis HB S S R S R R R R S S R S 
237 Staphylococcus epidermidis HB S S S S S S R S S S S S 
238 Staphylococcus epidermidis HB S R S S S S R R S S S S 
239 Staphylococcus epidermidis HH S S S R S S S S S S S R 
240 Staphylococcus epidermidis HH S S R S S R R S S S S S 
241 Staphylococcus epidermidis HH             
242 Staphylococcus epidermidis HH             
243 Staphylococcus epidermidis HH             
244 Staphylococcus epidermidis HH S R S S S S S S S S S S 
245 Staphylococcus epidermidis HH S R S S S S R R R R S S 
246 Staphylococcus epidermidis HH S R S R S S S S S S S S 
247 Staphylococcus epidermidis HH S R S S S S S R S S S S 
248 Staphylococcus epidermidis HH S R S R I S S S S S S S 
249 Staphylococcus epidermidis HH S R R S S S R R S S R S 
250 Staphylococcus epidermidis HH S R S R S S R R R S S S 
251 Staphylococcus epidermidis HH S R S S S S R R R R S S 
252 Staphylococcus epidermidis HH S S S S S S R R S S R S 
253 Staphylococcus epidermidis HH S S S R I R R R S S S S 
254 Staphylococcus epidermidis HH S R R S S S S R S S S S 
255 Staphylococcus epidermidis HH S R S S I S R R S S S S 
256 Staphylococcus epidermidis HH S R R R I S R R R R S R 
257 Staphylococcus epidermidis HH S R S S S S S S R I R S 
258 Staphylococcus epidermidis HH S S R S S S R R S R S S 
259 Staphylococcus epidermidis HH R R S S R S R R R R R S 
260 Staphylococcus epidermidis HH S S S S S S R R S S S S 
261 Staphylococcus epidermidis HH S R S S S S R R S S S S 
Note: A: amoxicillin (10 µg); CEF: cefepime (30 µg); C: chloramphenicol (30 µg); E: erythromycin (5 µg); FC: fusidic acid (10 µg); GM: 
gentamicin (10 µg); MUP: mupirocin (20 µg); OX: Oxacillin (1 µg);  PG: penicillin G (1 unit); S: streptomycin (10 µg);  T: tetracycline (10 
µg);  VAN: vancomycin (5 µg). 
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262 Staphylococcus epidermidis HH S S S R S S S R S S S S 
263 Staphylococcus epidermidis HH S R S S S S R R R S R S 
264 Staphylococcus epidermidis HH S S S R S S R R S S S S 
265 Staphylococcus epidermidis HH S S S S S S R R S S S S 
266 Staphylococcus epidermidis HH S R R R S S R S S R S S 
267 Staphylococcus epidermidis HH S R S I S S R S S R S S 
268 Staphylococcus epidermidis HH S R S I S S R S S R R S 
269 Staphylococcus epidermidis HH S R R S S S R S S S S S 
270 Staphylococcus epidermidis HH S R R S S S R S R R S S 
271 Staphylococcus epidermidis HH S R S S S S R S S R S S 
272 Staphylococcus epidermidis HH S R S I S S R S S R S S 
273 Staphylococcus epidermidis HH S R R I S S R S S S S S 
274 Staphylococcus epidermidis HH S R R S S S R S S R R S 
275 Staphylococcus epidermidis HH S R R I S S R S S S S S 
276 Staphylococcus epidermidis HH S R S I S S R S S R S S 
277 Staphylococcus epidermidis HH S R S S S S S S S R S S 
278 Staphylococcus epidermidis HH S R R S S S S S R R S S 
279 Staphylococcus epidermidis HH R R R S S S R S S R S S 
280 Staphylococcus epidermidis HH S R R S S S R S S R S S 
281 Staphylococcus epidermidis HH S S S S S S R S S R S S 
282 Staphylococcus epidermidis HH S R S S S S S S S R S S 
283 Staphylococcus epidermidis HH S R S I R S S S S R S S 
284 Staphylococcus epidermidis HH S R R R R S S S S S S S 
285 Staphylococcus epidermidis HH S R S S S S R S S R S S 
286 Staphylococcus epidermidis HH S S S R S S R S S R R S 
287 Staphylococcus epidermidis HH S R R R R R R S R S S R 
288 Staphylococcus epidermidis HH S R S S S S R S S S S S 
289 Staphylococcus epidermidis HH S R S S S S R S S R S S 
Note: A: amoxicillin (10 µg); CEF: cefepime (30 µg); C: chloramphenicol (30 µg); E: erythromycin (5 µg); FC: fusidic acid (10 µg); GM: 
gentamicin (10 µg); MUP: mupirocin (20 µg); OX: Oxacillin (1 µg);  PG: penicillin G (1 unit); S: streptomycin (10 µg);  T: tetracycline (10 
µg);  VAN: vancomycin (5 µg). 
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290 Staphylococcus epidermidis HH S R R I R S R S S S S R 
291 Staphylococcus epidermidis HH S R S S S S R R S S S S 
292 Staphylococcus epidermidis HH S R R R S S R S S S S S 
293 Staphylococcus epidermidis HH S R S S S S S S S S S S 
294 Staphylococcus epidermidis HH             
295 Staphylococcus epidermidis HH S R R S S S S S S S S S 
296 Staphylococcus epidermidis HH             
297 Staphylococcus epidermidis HH S S S I S S S S S R S S 
298 Staphylococcus epidermidis HH S R S S S S R S S R S S 
299 Staphylococcus epidermidis HH S R R S S S R S S R S S 
300 Staphylococcus epidermidis HH             
301 Staphylococcus epidermidis HH             
302 Staphylococcus epidermidis HH             
303 Staphylococcus epidermidis HH             
304 Staphylococcus epidermidis HH S R S S S S R S S S S S 
305 Staphylococcus epidermidis HH S R R S S S S S S R R S 
306 Staphylococcus epidermidis HH S R S R S S R S S R S S 
307 Staphylococcus epidermidis HH             
308 Staphylococcus epidermidis HH R R S R S S R S R R S S 
 181/198(tested/total)              
 
309 Staphylococcus equorum DSH S R S S S S S S S I S S 
310 Staphylococcus equorum DST S R R R S S R R R S R S 
311 Staphylococcus equorum DST S S S S S S S S S I S S 
 3/3(tested/total)              
 
312 Staphylococcus haemolyticus BCF S S S S S S S S S S S S 
313 Staphylococcus haemolyticus BCF S S R S S S R R S S R S 
Note: A: amoxicillin (10 µg); CEF: cefepime (30 µg); C: chloramphenicol (30 µg); E: erythromycin (5 µg); FC: fusidic acid (10 µg); GM: 
gentamicin (10 µg); MUP: mupirocin (20 µg); OX: Oxacillin (1 µg);  PG: penicillin G (1 unit); S: streptomycin (10 µg);  T: tetracycline (10 
µg);  VAN: vancomycin (5 µg). 
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314 Staphylococcus haemolyticus BCF S R S R R R R R R I S R 
315 Staphylococcus haemolyticus BCF S R S I S S R S R R S S 
316 Staphylococcus haemolyticus DSH R R R R R S R I S R S R 
317 Staphylococcus haemolyticus DSH R R R S R R R R R S R R 
318 Staphylococcus haemolyticus DSH R R S S R R R R R R S S 
319 Staphylococcus haemolyticus DSH R R S S R S R I R R S S 
320 Staphylococcus haemolyticus DSH R R R R R S R I S S R R 
321 Staphylococcus haemolyticus DSH S R R S S S R I R S S S 
322 Staphylococcus haemolyticus DSH S R S S S S S I R S R S 
323 Staphylococcus haemolyticus DSH S S S S S R S R R I R S 
324 Staphylococcus haemolyticus DSH S R S S S S S I R S R S 
325 Staphylococcus haemolyticus DSH S R R R S R R S R I S S 
326 Staphylococcus haemolyticus DSH S S S S S S S S R I S S 
327 Staphylococcus haemolyticus DSH S R S R S S R S R S S S 
328 Staphylococcus haemolyticus DSH S R S R S S R S R I S S 
329 Staphylococcus haemolyticus DSH S R S S S S R R R I S S 
330 Staphylococcus haemolyticus DSH S S R S R S R S R S S S 
331 Staphylococcus haemolyticus DSH S S S S S S R S R I S S 
332 Staphylococcus haemolyticus DSH S S S S R S S S R I R S 
333 Staphylococcus haemolyticus DSH S R R S S S R S S I S S 
334 Staphylococcus haemolyticus DSH S R S S S S R S S I S S 
335 Staphylococcus haemolyticus DSH S S S S R S S S R I R R 
336 Staphylococcus haemolyticus DSH S S R S S S S S R I R S 
337 Staphylococcus haemolyticus DSH S R S S R S R R S I R S 
338 Staphylococcus haemolyticus DSH S R S S S S S R R I S S 
339 Staphylococcus haemolyticus DSH S R R S S S R R R I S S 
340 Staphylococcus haemolyticus DSH S S S S S S S S S I R S 
341 Staphylococcus haemolyticus DSH S S S S S S S S R I R S 
Note: A: amoxicillin (10 µg); CEF: cefepime (30 µg); C: chloramphenicol (30 µg); E: erythromycin (5 µg); FC: fusidic acid (10 µg); GM: 
gentamicin (10 µg); MUP: mupirocin (20 µg); OX: Oxacillin (1 µg);  PG: penicillin G (1 unit); S: streptomycin (10 µg);  T: tetracycline (10 
µg);  VAN: vancomycin (5 µg). 
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342 Staphylococcus haemolyticus DSH S R S S S S R S S I R S 
343 Staphylococcus haemolyticus DSH S S S R S S R S S S S S 
344 Staphylococcus haemolyticus DSH S S S S S R R S S I R S 
345 Staphylococcus haemolyticus DSH S S S S R S R S S I S S 
346 Staphylococcus haemolyticus DSH S S S S S S S S S I S S 
347 Staphylococcus haemolyticus DSH S R S R R S R R S R R R 
348 Staphylococcus haemolyticus DSH             
349 Staphylococcus haemolyticus DSH             
350 Staphylococcus haemolyticus DSH             
351 Staphylococcus haemolyticus DSH             
352 Staphylococcus haemolyticus DSH             
353 Staphylococcus haemolyticus DSH S R S S I S R R R R S S 
354 Staphylococcus haemolyticus DSH S S R S I R S S S R S S 
355 Staphylococcus haemolyticus DSH R R S S R R R R R S R S 
356 Staphylococcus haemolyticus DSH S S S S I S S R S S S S 
357 Staphylococcus haemolyticus DSH S S S R S S S S S S S S 
358 Staphylococcus haemolyticus DSH S S R S I S R R S S S S 
359 Staphylococcus haemolyticus DSH S R R S R S R R S S S R 
360 Staphylococcus haemolyticus DSH S S S S S S R S S S S R 
361 Staphylococcus haemolyticus DSL S S S S I S R R S S R S 
362 Staphylococcus haemolyticus DSL R R S S I S S R R S S S 
363 Staphylococcus haemolyticus DSL S S R S I S S R S S S S 
364 Staphylococcus haemolyticus DSL S S R S I S R R S S S S 
365 Staphylococcus haemolyticus DSL S R R S I S R R S S S S 
366 Staphylococcus haemolyticus DSL S S R S I S S R S S S S 
367 Staphylococcus haemolyticus DSL R R S S R S S R R S S S 
368 Staphylococcus haemolyticus DSL S S S S I S S R S R R S 
369 Staphylococcus haemolyticus DSL S R S S S S R R S R S R 
Note: A: amoxicillin (10 µg); CEF: cefepime (30 µg); C: chloramphenicol (30 µg); E: erythromycin (5 µg); FC: fusidic acid (10 µg); GM: 
gentamicin (10 µg); MUP: mupirocin (20 µg); OX: Oxacillin (1 µg);  PG: penicillin G (1 unit); S: streptomycin (10 µg);  T: tetracycline (10 
µg);  VAN: vancomycin (5 µg). 
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370 Staphylococcus haemolyticus DSL S S S S S S R R S S S S 
371 Staphylococcus haemolyticus DSR S S S S S S S S S S S S 
372 Staphylococcus haemolyticus DSR S S S I S S R S S S S S 
373 Staphylococcus haemolyticus DSS S R S S S S R S S R S S 
374 Staphylococcus haemolyticus DSS S R R I S S R S S I R S 
375 Staphylococcus haemolyticus DSS S R S I S S R S S S S S 
376 Staphylococcus haemolyticus DSS S R S R R S R S S R S S 
377 Staphylococcus haemolyticus DST S R S S S R R R R R S S 
378 Staphylococcus haemolyticus DST S S S S S S S I S R S S 
379 Staphylococcus haemolyticus HAS R R S S R S R R S R R S 
380 Staphylococcus haemolyticus HAS R R R R S S R R S R R R 
381 Staphylococcus haemolyticus HH S S S S I S S R S S S S 
382 Staphylococcus haemolyticus HH S R S S I S R R S R S S 
383 Staphylococcus haemolyticus HH S R R R I R R R R S R S 
384 Staphylococcus haemolyticus HH R R S R S S R R S S S S 
385 Staphylococcus haemolyticus HH S S S S R S R R R R R S 
386 Staphylococcus haemolyticus HH S R R I S S R S S R R S 
387 Staphylococcus haemolyticus HH S S S S S S R S S R S S 
388 Staphylococcus haemolyticus HH S R S I S S R S R S S S 
389 Staphylococcus haemolyticus HH S R S I S S R S S S S S 
390 Staphylococcus haemolyticus HH S S R I S R R R S R R S 
 74/79(tested/total)              
 
391 Staphylococcus hominis BCF S R S S S S R S S S S S 
392 Staphylococcus hominis BCF S R S S S S R S R S S S 
393 Staphylococcus hominis BCF S R S S S S R S R S S S 
394 Staphylococcus hominis BCF S S S S S S R S S S S S 
395 Staphylococcus hominis BCF S R S S S S R S R R S S 
Note: A: amoxicillin (10 µg); CEF: cefepime (30 µg); C: chloramphenicol (30 µg); E: erythromycin (5 µg); FC: fusidic acid (10 µg); GM: 
gentamicin (10 µg); MUP: mupirocin (20 µg); OX: Oxacillin (1 µg);  PG: penicillin G (1 unit); S: streptomycin (10 µg);  T: tetracycline (10 
µg);  VAN: vancomycin (5 µg). 
287 
 
ID Species Sites OX PG  VAN  MUP  CEF  GM  FC  S  A  E  T   C 
396 Staphylococcus hominis BCF S S S R S S R S S S S S 
397 Staphylococcus hominis BCF S R S S S S R S R S S S 
398 Staphylococcus hominis BCF S R S S R S R S R R R S 
399 Staphylococcus hominis DSH R R R S S S R S S S S R 
400 Staphylococcus hominis DSH S R R R S S R S R R R S 
401 Staphylococcus hominis DSH S R S R R S R I R R S S 
402 Staphylococcus hominis DSH S S S S S S R S R S S S 
403 Staphylococcus hominis DSH S R S S S S R S R S S S 
404 Staphylococcus hominis DSH S R S S S S R R S I S S 
405 Staphylococcus hominis DSH S R S S S S S R S S S S 
406 Staphylococcus hominis DSH S R S S S S S S S S S S 
407 Staphylococcus hominis DSH S S S S S S S S R S S S 
408 Staphylococcus hominis DSH S R S S S S R S S I R S 
409 Staphylococcus hominis DSH S S S S S S R S S S S S 
410 Staphylococcus hominis DSH S S S S S S R S S S S S 
411 Staphylococcus hominis DSH             
412 Staphylococcus hominis DSH S R S S S S R S R R S S 
413 Staphylococcus hominis DSH R S S R S S R R S S S S 
414 Staphylococcus hominis DSH S R R S I S S S R S S S 
415 Staphylococcus hominis DSH S S S S I S S S S S S S 
416 Staphylococcus hominis DSH S R S S I S S R R S R S 
417 Staphylococcus hominis DSH S R S S I S S R S S S S 
418 Staphylococcus hominis DSH S R R S R S S S R S S S 
419 Staphylococcus hominis DSH S R S S I S S R R R S S 
420 Staphylococcus hominis DSH S R S S R S R R R R S S 
421 Staphylococcus hominis DSH S R S S I S R R S S S S 
422 Staphylococcus hominis DSH S R S S S S S R S S S S 
423 Staphylococcus hominis DSH S R S S I R S R R S S S 
Note: A: amoxicillin (10 µg); CEF: cefepime (30 µg); C: chloramphenicol (30 µg); E: erythromycin (5 µg); FC: fusidic acid (10 µg); GM: 
gentamicin (10 µg); MUP: mupirocin (20 µg); OX: Oxacillin (1 µg);  PG: penicillin G (1 unit); S: streptomycin (10 µg);  T: tetracycline (10 
µg);  VAN: vancomycin (5 µg). 
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424 Staphylococcus hominis DSH S S S S S S S S S S S S 
425 Staphylococcus hominis DSH S S S R S S S R S S S S 
426 Staphylococcus hominis DSH S R S S I S R R R R S S 
427 Staphylococcus hominis DSH S R S S I S S S S S S S 
428 Staphylococcus hominis DSH S S R S S S S R S S S S 
429 Staphylococcus hominis DSH S S S R S S S S S S S S 
430 Staphylococcus hominis DSH S R S R S S R R S S S S 
431 Staphylococcus hominis DSH             
432 Staphylococcus hominis DSH S R S S I S R R S S S S 
433 Staphylococcus hominis DSL S R S S S S S R S S S S 
434 Staphylococcus hominis DSR S S S I S S R S S S S S 
435 Staphylococcus hominis DSR S R S R R R R S R S S S 
436 Staphylococcus hominis DSR S S S S S R R S S S S S 
437 Staphylococcus hominis DSR S R S I S S R S S R S S 
438 Staphylococcus hominis DSR S R S R S S R S S S R S 
439 Staphylococcus hominis DSR S S S S S S R S S R S S 
440 Staphylococcus hominis DSR S R S S S S R S S S S S 
441 Staphylococcus hominis DSR S R S S S S S S S S S S 
442 Staphylococcus hominis DSR S R S I S S R S S R R S 
443 Staphylococcus hominis DSR S R S S S S R S S S S S 
444 Staphylococcus hominis DSR S R S R S S R S S S R S 
445 Staphylococcus hominis DSR S S S I S S S S S S S S 
446 Staphylococcus hominis DSR S R S S S S R S S R R S 
447 Staphylococcus hominis DSR S R R I S S R S R S R S 
448 Staphylococcus hominis DSR S R R S S R R R S S S S 
449 Staphylococcus hominis DSR S R S I S S R S S R S S 
450 Staphylococcus hominis DSR S R R I S S R S S S S S 
451 Staphylococcus hominis DSR S S S S S S S S S R S S 
Note: A: amoxicillin (10 µg); CEF: cefepime (30 µg); C: chloramphenicol (30 µg); E: erythromycin (5 µg); FC: fusidic acid (10 µg); GM: 
gentamicin (10 µg); MUP: mupirocin (20 µg); OX: Oxacillin (1 µg);  PG: penicillin G (1 unit); S: streptomycin (10 µg);  T: tetracycline (10 
µg);  VAN: vancomycin (5 µg). 
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452 Staphylococcus hominis DSR S S S I S R R S S R S S 
453 Staphylococcus hominis DSR S S S S S S S S S S S S 
454 Staphylococcus hominis DSR S S R S S S S S S R R S 
455 Staphylococcus hominis DSR S R S S S S R S S S S S 
456 Staphylococcus hominis DSR S R S S S S R S S S S S 
457 Staphylococcus hominis DSR S S S S S S S S S R S S 
458 Staphylococcus hominis DSR S R S I S S S S S R S S 
459 Staphylococcus hominis DSR S R S S S S R S S S S S 
460 Staphylococcus hominis DSR S R S S S S R S S S S S 
461 Staphylococcus hominis DSR S S S S S S R S S R S S 
462 Staphylococcus hominis DSR S S S S S S R S S S S S 
463 Staphylococcus hominis DSR S S S S S S S S S S S S 
464 Staphylococcus hominis DSR S S S I S S R S S S S S 
465 Staphylococcus hominis DSR             
466 Staphylococcus hominis DSR S S R S S S R S S S S S 
467 Staphylococcus hominis DSR S R S S S S R S S R S S 
468 Staphylococcus hominis DSS S R S R S S R S R R R R 
469 Staphylococcus hominis DSS S S S R S S S S S S S S 
470 Staphylococcus hominis DSS S R S S S S R S S R S S 
471 Staphylococcus hominis DSS S R S I S S R S S S S S 
472 Staphylococcus hominis DSS S R R I S S R S S S R S 
473 Staphylococcus hominis DSS S R S I S S R S S R S S 
474 Staphylococcus hominis DSS S R S R S S S S S R R S 
475 Staphylococcus hominis DSS S R S S S S R S S R S S 
476 Staphylococcus hominis DSS S R S S S S S S S S S S 
477 Staphylococcus hominis DSS S S S S S S R S S R S S 
478 Staphylococcus hominis DSS S S S I S S R S S R S S 
479 Staphylococcus hominis DSS S S S S S S R S S R S S 
Note: A: amoxicillin (10 µg); CEF: cefepime (30 µg); C: chloramphenicol (30 µg); E: erythromycin (5 µg); FC: fusidic acid (10 µg); GM: 
gentamicin (10 µg); MUP: mupirocin (20 µg); OX: Oxacillin (1 µg);  PG: penicillin G (1 unit); S: streptomycin (10 µg);  T: tetracycline (10 
µg);  VAN: vancomycin (5 µg). 
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ID Species Sites OX PG  VAN  MUP  CEF  GM  FC  S  A  E  T   C 
480 Staphylococcus hominis DSS S S S S S S R S S R S S 
481 Staphylococcus hominis DSS S R S I S S R S S R S S 
482 Staphylococcus hominis DSS S R S S S S S S S S R S 
483 Staphylococcus hominis DSS S R S R R R R S S R R R 
484 Staphylococcus hominis DSS S R S S S S R S S S S S 
485 Staphylococcus hominis DSS S R S S S S S R S R S S 
486 Staphylococcus hominis DSS S R S S S S R S S S S S 
487 Staphylococcus hominis DSS S R S S S S R S S S S S 
488 Staphylococcus hominis DSS S R S S S S R S S S R S 
489 Staphylococcus hominis DSS S R S S S S R S S S S S 
490 Staphylococcus hominis DSS S R S S S R R S S S S S 
491 Staphylococcus hominis DSS S R S S S S R R S R S R 
492 Staphylococcus hominis DSS S R S S I S R S S R S S 
493 Staphylococcus hominis DSS S R S S S S R S S S R S 
494 Staphylococcus hominis DSS S S S S S S S S S S S R 
495 Staphylococcus hominis DSS S R S S S S S S S R R S 
496 Staphylococcus hominis DSS S S R S S S S S S S S S 
497 Staphylococcus hominis DSS S R S S S S S S S R R S 
498 Staphylococcus hominis DSS R R S S S S R S S R S S 
499 Staphylococcus hominis DSS S R S S S S R S S S S S 
500 Staphylococcus hominis DSS             
501 Staphylococcus hominis DSS S S S S S S S S S S S S 
502 Staphylococcus hominis DSS S R S S S S S S S S S S 
503 Staphylococcus hominis DSS S S S S S S S S S R S S 
504 Staphylococcus hominis DSS S S S S S S R S S S S S 
505 Staphylococcus hominis DSS S R S S S S R S S S S S 
506 Staphylococcus hominis DSS R S R S S S R S S S S S 
507 Staphylococcus hominis DST S R S S S S R R R S S S 
Note: A: amoxicillin (10 µg); CEF: cefepime (30 µg); C: chloramphenicol (30 µg); E: erythromycin (5 µg); FC: fusidic acid (10 µg); GM: 
gentamicin (10 µg); MUP: mupirocin (20 µg); OX: Oxacillin (1 µg);  PG: penicillin G (1 unit); S: streptomycin (10 µg);  T: tetracycline (10 
µg);  VAN: vancomycin (5 µg). 
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ID Species Sites OX PG  VAN  MUP  CEF  GM  FC  S  A  E  T   C 
508 Staphylococcus hominis DST S R S S S S R R R S S S 
509 Staphylococcus hominis DST S R S S S S S S S S S S 
510 Staphylococcus hominis DST S R S S S S R R R R R S 
511 Staphylococcus hominis DST S R S S S S S R R R S S 
512 Staphylococcus hominis DST S S S S S S R S S R S S 
513 Staphylococcus hominis DST S S S S S S R S S S S S 
514 Staphylococcus hominis DST S R S S S S S S S S S S 
515 Staphylococcus hominis DST S R S S S S S S S S S S 
516 Staphylococcus hominis DST S S S S S S S S S S S S 
517 Staphylococcus hominis HB S R S S S S R R S R S S 
518 Staphylococcus hominis HB S R R S S S S S S S R S 
519 Staphylococcus hominis HH             
520 Staphylococcus hominis HH S S S S S R R S S S S S 
521 Staphylococcus hominis HH S S R S S S S S S S S S 
522 Staphylococcus hominis HH S S S S I S S R S S S S 
523 Staphylococcus hominis HH             
524 Staphylococcus hominis HH S R S S S S R R S S S S 
525 Staphylococcus hominis HH S S S R S S R R S S S S 
526 Staphylococcus hominis HH S S S S R S R R S S S S 
527 Staphylococcus hominis HH S R S S I S R R S R S S 
528 Staphylococcus hominis HH S R R S R S S S R S S S 
529 Staphylococcus hominis HH S S S S I S R R S S R S 
530 Staphylococcus hominis HH S R R S S S R S S S S S 
531 Staphylococcus hominis HH S R S I S S R S S S S S 
532 Staphylococcus hominis HH S S S I S S R S S R S S 
533 Staphylococcus hominis HH S R S S S S S S S R S S 
534 Staphylococcus hominis HH S R S S S S R S S S S S 
535 Staphylococcus hominis HH S R S R I S R S R R R S 
Note: A: amoxicillin (10 µg); CEF: cefepime (30 µg); C: chloramphenicol (30 µg); E: erythromycin (5 µg); FC: fusidic acid (10 µg); GM: 
gentamicin (10 µg); MUP: mupirocin (20 µg); OX: Oxacillin (1 µg);  PG: penicillin G (1 unit); S: streptomycin (10 µg);  T: tetracycline (10 
µg);  VAN: vancomycin (5 µg). 
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ID Species Sites OX PG  VAN  MUP  CEF  GM  FC  S  A  E  T   C 
536 Staphylococcus hominis HH S S S S S S S S S R R S 
537 Staphylococcus hominis HH S R R S S S S S S R S S 
538 Staphylococcus hominis HH S R R S S S R R S R R S 
539 Staphylococcus hominis HH S S S I S S S S S S S S 
540 Staphylococcus hominis HH S R S S S R S S S R R S 
541 Staphylococcus hominis HH S R S S S S S R S R R S 
542 Staphylococcus hominis HH S R S S S S S S R R S S 
543 Staphylococcus hominis HH S S S S S S S S S S S S 
544 Staphylococcus hominis HH S R S S S S S S S R R S 
545 Staphylococcus hominis HH S R S I S S R S S R R S 
546 Staphylococcus hominis HH S S S S S S R R S R S S 
547 Staphylococcus hominis HH S R S S S S R S S R S S 
548 Staphylococcus hominis HH S R S S S S R S S S S S 
549 Staphylococcus hominis HH S R S I S S R S S R R S 
550 Staphylococcus hominis HH S R S S S S R S S S S S 
551 Staphylococcus hominis HH S S S I S R R R S R S S 
552 Staphylococcus hominis HH S R S S S S R S S S S S 
553 Staphylococcus hominis HH             
554 Staphylococcus hominis HH S R S I S S R S S S S S 
555 Staphylococcus hominis HH S R S S S S R S S R R S 
556 Staphylococcus hominis HH S R S I S S R S S S S S 
557 Staphylococcus hominis HH S R R S S S R R S R S S 
558 Staphylococcus hominis HH S S S S S S R S S R S S 
559 Staphylococcus hominis HH S S S S S S R S S S S S 
560 Staphylococcus hominis HH S R R S S S R S R S R S 
561 Staphylococcus hominis HH S R S S S S R S S R R S 
562 Staphylococcus hominis HH             
563 Staphylococcus hominis HH             
Note: A: amoxicillin (10 µg); CEF: cefepime (30 µg); C: chloramphenicol (30 µg); E: erythromycin (5 µg); FC: fusidic acid (10 µg); GM: 
gentamicin (10 µg); MUP: mupirocin (20 µg); OX: Oxacillin (1 µg);  PG: penicillin G (1 unit); S: streptomycin (10 µg);  T: tetracycline (10 
µg);  VAN: vancomycin (5 µg). 
293 
 
 164/173(tested/total)              
 
ID Species Sites OX PG  VAN  MUP  CEF  GM  FC  S  A  E  T   C 
564 Staphylococcus lugdunensis DSH R R S S S S S I S R S S 
565 Staphylococcus lugdunensis DSH S R S R S S R S S I S S 
566 Staphylococcus lugdunensis DSH S R S S S S R S S I S S 
567 Staphylococcus lugdunensis DSL S R R S S S R I S S S S 
568 Staphylococcus lugdunensis DSL S S S S S S S S S S S S 
 5/5(tested/total)              
 
569 Staphylococcus pasteuri DSH S S S S S S S S S I S S 
570 Staphylococcus pasteuri DSR S R S I S S R S S S S S 
571 Staphylococcus pasteuri DSR S R S I S S R S S I S S 
572 Staphylococcus pasteuri DSR S R S I S S R S S R R S 
573 Staphylococcus pasteuri DSR S R S I S S R S R R R S 
574 Staphylococcus pasteuri DSR S S S S S S R S S S S S 
575 Staphylococcus pasteuri DSR S R S I S S R S R R S S 
576 Staphylococcus pasteuri DSS S R R I S S R S S R S S 
577 Staphylococcus pasteuri DSS S R S R R S R S R R S S 
578 Staphylococcus pasteuri DSS S R R S S S S S S R S S 
579 Staphylococcus pasteuri DST S R S S S R R R S S S S 
580 Staphylococcus pasteuri DST S R S S S S R S R R S S 
581 Staphylococcus pasteuri DST S R S R R S R S R R S S 
582 Staphylococcus pasteuri DST S R S S S S R S S S S S 
583 Staphylococcus pasteuri DST S R S S S S R S S R S S 
584 Staphylococcus pasteuri DST S S S S S S S S S S R S 
585 Staphylococcus pasteuri DST S S S S S S S S S S S S 
586 Staphylococcus pasteuri DST S R S S S S S S R S S S 
587 Staphylococcus pasteuri DST S R R S S S S S R S S S 
Note: A: amoxicillin (10 µg); CEF: cefepime (30 µg); C: chloramphenicol (30 µg); E: erythromycin (5 µg); FC: fusidic acid (10 µg); GM: 
gentamicin (10 µg); MUP: mupirocin (20 µg); OX: Oxacillin (1 µg);  PG: penicillin G (1 unit); S: streptomycin (10 µg);  T: tetracycline (10 
µg);  VAN: vancomycin (5 µg). 
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ID Species Sites OX PG  VAN  MUP  CEF  GM  FC  S  A  E  T   C 
588 Staphylococcus pasteuri DST S R R S S S S S R S S S 
589 Staphylococcus pasteuri HB S R S S S S R R S R S S 
590 Staphylococcus pasteuri HH S S S S I S S R S S S R 
591 Staphylococcus pasteuri HH             
592 Staphylococcus pasteuri HH S S S R S S R R S S S S 
593 Staphylococcus pasteuri HH R R S S S R R R R S S S 
594 Staphylococcus pasteuri HH             
595 Staphylococcus pasteuri HH S S S S S R R R S S S S 
596 Staphylococcus pasteuri HH S R S S I S R R R R R S 
597 Staphylococcus pasteuri HH R R S R I S S R S S S S 
598 Staphylococcus pasteuri HH S R R S S S S S S R R S 
599 Staphylococcus pasteuri HH S R S S S S R S S R S S 
600 Staphylococcus pasteuri HH S S S S S S R S S R S S 
601 Staphylococcus pasteuri HH S S S I S S R S S S S S 
602 Staphylococcus pasteuri HH S S S I S S R S S S S S 
 32/34(tested/total)              
               
603 Staphylococcus pettenkoferi DSH R R R S R R R R R R R R 
604 Staphylococcus pettenkoferi DSH S R S S S S S S S I S S 
605 Staphylococcus pettenkoferi DSH S S S S S S R R S S S S 
606 Staphylococcus pettenkoferi DST S R S S S S S S R S S S 
607 Staphylococcus pettenkoferi HH S S S S I S R R S S S S 
 5/5(tested/total)              
 
608 Staphylococcus saprophyticus BCF S R S S S R R S R S S S 
609 Staphylococcus saprophyticus BCF S R S S S R R S R R S S 
610 Staphylococcus saprophyticus BCF S R S S S S R S S S S S 
611 Staphylococcus saprophyticus BCF S R S R S S R S S R S S 
Note: A: amoxicillin (10 µg); CEF: cefepime (30 µg); C: chloramphenicol (30 µg); E: erythromycin (5 µg); FC: fusidic acid (10 µg); GM: 
gentamicin (10 µg); MUP: mupirocin (20 µg); OX: Oxacillin (1 µg);  PG: penicillin G (1 unit); S: streptomycin (10 µg);  T: tetracycline (10 
µg);  VAN: vancomycin (5 µg). 
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ID Species Sites OX PG  VAN  MUP  CEF  GM  FC  S  A  E  T   C 
612 Staphylococcus saprophyticus BCF R R S R S S R S S R S S 
613 Staphylococcus saprophyticus BCF S R S S S S R S S S S S 
614 Staphylococcus saprophyticus BCF S R R R S S R S R R S S 
615 Staphylococcus saprophyticus BCF S R S S S S R S S S S S 
616 Staphylococcus saprophyticus BCF R R R R S S R I R R R S 
617 Staphylococcus saprophyticus DSH S R R S I S R R S R S S 
618 Staphylococcus saprophyticus DSL S R S S S S R R S S S S 
619 Staphylococcus saprophyticus DSL S R S S S S R S S S S S 
620 Staphylococcus saprophyticus DSS S R R I S S R S S R S S 
621 Staphylococcus saprophyticus DSS S R S R R S R S R S R S 
622 Staphylococcus saprophyticus DSS S R S S S S R S S S S R 
623 Staphylococcus saprophyticus DSS S R S S S S R S S S S R 
624 Staphylococcus saprophyticus HH S S S S S S R S S S S S 
625 Staphylococcus saprophyticus HH S S S S S S R S S S S S 
626 Staphylococcus saprophyticus HH S R S S S S R S S S S S 
627 Staphylococcus saprophyticus HH R R S I S S R S S S R S 
 20/20(tested/total)              
 
628 Staphylococcus sciuri DSH R R R S R S R I S S S R 
629 Staphylococcus sciuri DSH S S S R S S S S S S S S 
630 Staphylococcus sciuri DSH R R R R I S R R S S S S 
631 Staphylococcus sciuri DSH S S S R I S R R S S S S 
632 Staphylococcus sciuri DSH R R S S I S R R R S S S 
633 Staphylococcus sciuri DSH R R S R I R R R R S S S 
 6/6(tested/total)              
 
634 Staphylococcus simiae DST S S S S S S R S S S S S 
635 Staphylococcus simiae DST S 3 R S S S S S S S S S 
Note: A: amoxicillin (10 µg); CEF: cefepime (30 µg); C: chloramphenicol (30 µg); E: erythromycin (5 µg); FC: fusidic acid (10 µg); GM: 
gentamicin (10 µg); MUP: mupirocin (20 µg); OX: Oxacillin (1 µg);  PG: penicillin G (1 unit); S: streptomycin (10 µg);  T: tetracycline (10 
µg);  VAN: vancomycin (5 µg). 
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636 Staphylococcus simiae DST S S R S S S R S S S S S 
637 Staphylococcus simiae DST S S S I S S S S S S S S 
638 Staphylococcus simiae DST S S S S S S R S S S S S 
639 Staphylococcus simiae DST S S S S S S R S S S S S 
640 Staphylococcus simiae DST S S S S S S S S S S S S 
641 Staphylococcus simiae DST S S S S S S S S S S S S 
642 Staphylococcus simiae DST S S S S S S S S S S S S 
643 Staphylococcus simiae DST S R R S S S S S S S S S 
 10/10(tested/total)              
 
644 Staphylococcus simulans BCF S R S S S S R S S S S S 
 1/1(tested/total)              
 
645 Staphylococcus warneri BCF S R S S S S R S S S S S 
646 Staphylococcus warneri BCF S S S R S R R S S S S S 
647 Staphylococcus warneri BCF S R S S S R R S R S S S 
648 Staphylococcus warneri BCF S R S S S R R S R S S S 
649 Staphylococcus warneri BCF S S S I S S R S S R S S 
650 Staphylococcus warneri BCF S S S S S S R S S S S S 
651 Staphylococcus warneri BCF S S S S S S R S S S S S 
652 Staphylococcus warneri BCF S R S S S S R S S S S S 
653 Staphylococcus warneri DSH S R S S S S S I S R S S 
654 Staphylococcus warneri DSH S R R S S S R I S S S S 
655 Staphylococcus warneri DSH S S S R S R R R S I S S 
656 Staphylococcus warneri DSH S R S S S S R R R I R S 
657 Staphylococcus warneri DSH S R R S S S R S S I S S 
658 Staphylococcus warneri DSH S S S R S S S S S S S S 
659 Staphylococcus warneri DSH R R R R S S R R R S S S 
Note: A: amoxicillin (10 µg); CEF: cefepime (30 µg); C: chloramphenicol (30 µg); E: erythromycin (5 µg); FC: fusidic acid (10 µg); GM: 
gentamicin (10 µg); MUP: mupirocin (20 µg); OX: Oxacillin (1 µg);  PG: penicillin G (1 unit); S: streptomycin (10 µg);  T: tetracycline (10 
µg);  VAN: vancomycin (5 µg). 
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ID Species Sites OX PG  VAN  MUP  CEF  GM  FC  S  A  E  T   C 
660 Staphylococcus warneri DSH S R R S I R R R R S S S 
661 Staphylococcus warneri DSH S R S S R S R R R R S S 
662 Staphylococcus warneri DSH S R S S S R R R R S R S 
663 Staphylococcus warneri DSH S R S S I S S S R S R S 
664 Staphylococcus warneri DSH S S S S S S S R R S S S 
665 Staphylococcus warneri DSH S S S S I R R R S R S S 
666 Staphylococcus warneri DSH S S S R S S S S S S S S 
667 Staphylococcus warneri DSH S S R S S S S S S S S S 
668 Staphylococcus warneri DSH S R R S S S S S R S S S 
669 Staphylococcus warneri DSH S S R S S S S S S S S S 
670 Staphylococcus warneri DSL S S R S S S S R S S S S 
671 Staphylococcus warneri DSL S S S S S S S R S S S S 
672 Staphylococcus warneri DSL S S R S S S R R S R R S 
673 Staphylococcus warneri DSL S S R S S S R R R S S S 
674 Staphylococcus warneri DSL S S R S S S S R S S S S 
675 Staphylococcus warneri DSL S R R S S S R R R S S S 
676 Staphylococcus warneri DSR S R R I S S S S S S S S 
677 Staphylococcus warneri DSR S R R S S R S S S R S S 
678 Staphylococcus warneri DSR S S S S S R S S S R S S 
679 Staphylococcus warneri DSR S R S S S R R S S R R S 
680 Staphylococcus warneri DSR S S R S S S R S S S S S 
681 Staphylococcus warneri DSR S R S S S S S S S S S S 
682 Staphylococcus warneri DSS S S S R S S S S S S S S 
683 Staphylococcus warneri DSS S R R R S S R S S S S S 
684 Staphylococcus warneri DST S R R R S R S R R I S S 
685 Staphylococcus warneri DST S R R R S R S R R S S S 
686 Staphylococcus warneri DST S R R R S R S R R S S S 
687 Staphylococcus warneri DST S S S S S R R S S S S S 
Note: A: amoxicillin (10 µg); CEF: cefepime (30 µg); C: chloramphenicol (30 µg); E: erythromycin (5 µg); FC: fusidic acid (10 µg); GM: 
gentamicin (10 µg); MUP: mupirocin (20 µg); OX: Oxacillin (1 µg);  PG: penicillin G (1 unit); S: streptomycin (10 µg);  T: tetracycline (10 
µg);  VAN: vancomycin (5 µg). 
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ID Species Sites OX PG  VAN  MUP  CEF  GM  FC  S  A  E  T   C 
688 Staphylococcus warneri DST S R S S S S R S R R S S 
689 Staphylococcus warneri DST S R S S S S R S R S S S 
690 Staphylococcus warneri DST S R S S S S R S R S S S 
691 Staphylococcus warneri DST S S S S S S R S R S S S 
692 Staphylococcus warneri DST S S S S S S S S S S S S 
693 Staphylococcus warneri DST S S S S S S R S S S S S 
694 Staphylococcus warneri HB S R S S S S S S S S R S 
695 Staphylococcus warneri HB S S S S I S R R S R S R 
696 Staphylococcus warneri HH S S S R S R S R S R S S 
697 Staphylococcus warneri HH S S S S I S R R S S S S 
698 Staphylococcus warneri HH S R S S S S R R R R S S 
699 Staphylococcus warneri HH S R S S S S R R R R S S 
700 Staphylococcus warneri HH S R R S I R R R S R R S 
701 Staphylococcus warneri HH S S S R S S R R S I S S 
702 Staphylococcus warneri HH S R S S S R R R R S R S 
703 Staphylococcus warneri HH S S R S R R R R R R R S 
704 Staphylococcus warneri HH R R S S I S R R R R S S 
705 Staphylococcus warneri HH S R R S R S R R R R S S 
706 Staphylococcus warneri HH S S S S R S R R S S S S 
707 Staphylococcus warneri HH S R S S S S R S S S S S 
708 Staphylococcus warneri HH S S S S R S R R R R R S 
709 Staphylococcus warneri HH S R S S S S S R S S S S 
710 Staphylococcus warneri HH S R S S R S R R R R S S 
711 Staphylococcus warneri HH S R S S S S R S S S S S 
712 Staphylococcus warneri HH S R S S S S S S S S R S 
 68/68(tested/total)              
 
Note: A: amoxicillin (10 µg); CEF: cefepime (30 µg); C: chloramphenicol (30 µg); E: erythromycin (5 µg); FC: fusidic acid (10 µg); GM: 
gentamicin (10 µg); MUP: mupirocin (20 µg); OX: Oxacillin (1 µg);  PG: penicillin G (1 unit); S: streptomycin (10 µg);  T: tetracycline (10 
µg);  VAN: vancomycin (5 µg). 
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ID Species Sites OX PG  VAN  MUP  CEF  GM  FC  S  A  E  T   C 
713 Staphylococcus xylosus HH S R R R I R R R S S R S 
714 Staphylococcus xylosus HH S R S S R S R R S S S S 
 2/2(tested/total)              
Note: A: amoxicillin (10 µg); CEF: cefepime (30 µg); C: chloramphenicol (30 µg); E: erythromycin (5 µg); FC: fusidic acid (10 µg); GM: 
gentamicin (10 µg); MUP: mupirocin (20 µg); OX: Oxacillin (1 µg);  PG: penicillin G (1 unit); S: streptomycin (10 µg);  T: tetracycline (10 µg);  
VAN: vancomycin (5 µg). 
BCF- baby care facility; DSH- different sites of hotels; DSL- different sites of a library; DSR- different sites of restaurants; DSS- different sites 













II.2 Antibiotic susceptibility variation of closely related staphylococci 
ID Species Cluster Sites OX PG  VAN  MUP  CEF  GM  FC  S  A  E  T   C 
455 Staphylococcus hominis 1 Restaurants 
S R S 
S 
S S R S S S S S 
554 Staphylococcus hominis  Hands I 
                
471 Staphylococcus hominis 2 Supermarkets 
S R S 
I 
S S R S S S S S 
440 Staphylococcus hominis  Restaurants S 
                
458 Staphylococcus hominis 3 Restaurants 
S R S I S S 
S 
S S R 
S 
S 
549 Staphylococcus hominis  Hands R R 
                
493 Staphylococcus hominis 4 Supermarkets 





544 Staphylococcus hominis  Hands S R 
                
503 Staphylococcus hominis 5 Supermarkets 
S S 
S 
S S S S S S 
R 
S S 
521 Staphylococcus hominis  Hands R S 
                
543 Staphylococcus hominis 6 Hands 
S 
S 




S S S 
403 Staphylococcus hominis  Hotels R R R 
                
430 Staphylococcus hominis 7 Hotels 
S R S 
R 
S S R 
R S 
S S S 
397 Staphylococcus hominis  Baby care facilities S S R 
                
488 Staphylococcus hominis 8 Supermarkets 
S R 
S S 
S S R S S S 
R 
S 
450 Staphylococcus hominis  Restaurants R I S 
                
556 Staphylococcus hominis 9 Hands 
S R S 
I 
S S R S 
S S 
S S 
395 Staphylococcus hominis  Baby care facilities S R R 
Note: A: amoxicillin (10 µg); CEF: cefepime (30 µg); C: chloramphenicol (30 µg); E: erythromycin (5 µg); FC: fusidic acid (10 µg); GM: gentamicin 
(10 µg); MUP: mupirocin (20 µg); OX: Oxacillin (1 µg);  PG: penicillin G (1 unit); S: streptomycin (10 µg);  T: tetracycline  (10 µg);  VAN: 
vancomycin (5 µg). 
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ID Species Cluster Sites OX PG  VAN  MUP  CEF  GM  FC  S  A  E  T   C 
517 Staphylococcus hominis 10 Handbages 
S 
R 





394 Staphylococcus hominis  Baby care facilities S S S 
                







S S R R S 
536 Staphylococcus hominis  Hands S S S 
                





S S R 
S 
S R S S 
546 Staphylococcus hominis  Hands S S R 
                
463 Staphylococcus hominis 13 Restaurants 




S S S S 
526 Staphylococcus hominis  Hands R R R 
                





S S S S S S 
R 
S 
445 Staphylococcus hominis  Restaurants S I S 
                
508 Staphylococcus hominis 15 Supermarkets 
S R S S S S 
R R R 
S S S 
502 Staphylococcus hominis  Hotels S S S 
                







S S S S 
425 Staphylococcus hominis  Hotels S R S R 
                










539 Staphylococcus hominis  Hands S I S S 
                







S S S S 
396 Staphylococcus hominis  Baby care facilities S R R S 
Note: A: amoxicillin (10 µg); CEF: cefepime (30 µg); C: chloramphenicol (30 µg); E: erythromycin (5 µg); FC: fusidic acid (10 µg); GM: gentamicin 
(10 µg); MUP: mupirocin (20 µg); OX: Oxacillin (1 µg);  PG: penicillin G (1 unit); S: streptomycin (10 µg);  T: tetracycline  (10 µg);  VAN: 
vancomycin (5 µg). 
                
302 
 
ID Species Cluster Sites OX PG  VAN  MUP  CEF  GM  FC  S  A  E  T   C 
476 Staphylococcus hominis 19 Supermarkets 
S 
R S 
S S S S S S 
S S 
S 
454 Staphylococcus hominis  Restaurants S R R R 
                
510 Staphylococcus hominis 20 Supermarkets 
S R 
S S 





447 Staphylococcus hominis  Restaurants R I S S 
                
438 Staphylococcus hominis 21 Restaurants 
S R S R 
S 
S R 
S S S R 
S 
401 Staphylococcus hominis  Hotels R I R R S 
                
548 Staphylococcus hominis 22 Hands 
S R 
S S 
S S R S 
S S S 
S 
400 Staphylococcus hominis  Hotels R R R R R 
                
451 Staphylococcus hominis 23 Restaurants S S S 






399 Staphylococcus hominis  Hotels R R R R S R 
                
483 Staphylococcus hominis 24 Supermarkets 
S R S 
R R R 
R S S 
R R R 
534 Staphylococcus hominis  Hands S S S S S S 
                
478 Staphylococcus hominis 25 Supermarkets 
S 








448 Staphylococcus hominis  Restaurants R R S R R S 
                
479 Staphylococcus hominis 26 Supermarkets 
S S S S S S R S S R S S 
480 Staphylococcus hominis  Supermarkets 
                
499 Staphylococcus hominis 27 Supermarkets 
S R S S S S R S S S S S 
505 Staphylococcus hominis  Supermarkets 
Note: A: amoxicillin (10 µg); CEF: cefepime (30 µg); C: chloramphenicol (30 µg); E: erythromycin (5 µg); FC: fusidic acid (10 µg); GM: gentamicin 
(10 µg); MUP: mupirocin (20 µg); OX: Oxacillin (1 µg);  PG: penicillin G (1 unit); S: streptomycin (10 µg);  T: tetracycline  (10 µg);  VAN: 
vancomycin (5 µg). 
                
303 
 
ID Species Cluster Sites OX PG  VAN  MUP  CEF  GM  FC  S  A  E  T   C 
437 Staphylococcus hominis 28 Restaurants 
S R S I S S R S S R S S 
449 Staphylococcus hominis  Restaurants 
                
459 Staphylococcus hominis 29 Restaurants 
S R S S S S 
R 
S S S S S 
441 Staphylococcus hominis  Restaurants S 
                
460 Staphylococcus hominis 30 Restaurants 
S 
R 
S S S S R S S S S S 
462 Staphylococcus hominis  Restaurants S 
                
464 Staphylococcus hominis 31 Restaurants 
S S S I S 
S 
R S S 
S 
S S 
452 Staphylococcus hominis  Restaurants R R 
                
541 Staphylococcus hominis 32 Hands 




S R R S 
540 Staphylococcus hominis  Hands R S 
                
393 Staphylococcus hominis 33 Baby care facilities 
S R S S 
S 
S R S R 
S S 
S 
398 Staphylococcus hominis  Baby care facilities R R R 
                





S S S S S 
R R 
S 
469 Staphylococcus hominis  Supermarkets S R S S 
                
538 Staphylococcus hominis 35 Hands 
S R 
R 





533 Staphylococcus hominis  Hands S S S S 
                
180 Staphylococcus epidermidis 1 Supermarkets 
S R R I S S R S S S S S 
275 Staphylococcus epidermidis  Hands 
Note: A: amoxicillin (10 µg); CEF: cefepime (30 µg); C: chloramphenicol (30 µg); E: erythromycin (5 µg); FC: fusidic acid (10 µg); GM: gentamicin 
(10 µg); MUP: mupirocin (20 µg); OX: Oxacillin (1 µg);  PG: penicillin G (1 unit); S: streptomycin (10 µg);  T: tetracycline  (10 µg);  VAN: 





ID Species Cluster Sites OX PG  VAN  MUP  CEF  GM  FC  S  A  E  T   C 
232 Staphylococcus epidermidis 2 Transportation facilities 
S R S 
I 
S S S S S R S S 
115 Staphylococcus epidermidis  Baby care facilities S 
                
175 Staphylococcus epidermidis 3 Supermarkets 
S R S I S S S S S 
R 
S S 
164 Staphylococcus epidermidis  Restaurants S 
                
194 Staphylococcus epidermidis 4 Supermarkets 
S 
S 
S S S S S S S S S S 
293 Staphylococcus epidermidis  Hands R 
                
186 Staphylococcus epidermidis 5 Supermarkets 




S S S 
160 Staphylococcus epidermidis  Restaurants R S 
                
150 Staphylococcus epidermidis 6 Restaurants 
S R R S S 
R 
S S S 
R 
S S 
295 Staphylococcus epidermidis  Hands S S 
                
192 Staphylococcus epidermidis 7 Supermarkets 
S 
R R 
S S S R S S S S S 
209 Staphylococcus epidermidis  Transportation facilities S S 
                
146 Staphylococcus epidermidis 8 Restaurants 
S 
R S 
S S S 
R 
S S R S S 
223 Staphylococcus epidermidis  Transportation facilities S R S 
                
196 Staphylococcus epidermidis 9 Supermarkets 





136 Staphylococcus epidermidis  Library S R R 
                





S S R S S 
S 
S S 
306 Staphylococcus epidermidis  Hands R R R 
Note: A: amoxicillin (10 µg); CEF: cefepime (30 µg); C: chloramphenicol (30 µg); E: erythromycin (5 µg); FC: fusidic acid (10 µg); GM: gentamicin 
(10 µg); MUP: mupirocin (20 µg); OX: Oxacillin (1 µg);  PG: penicillin G (1 unit); S: streptomycin (10 µg);  T: tetracycline  (10 µg);  VAN: 





ID Species Cluster Sites OX PG  VAN  MUP  CEF  GM  FC  S  A  E  T   C 
176 Staphylococcus epidermidis 11 Supermarkets 
S 
S 





117 Staphylococcus epidermidis  Baby care facilities R R R 
                
203 Staphylococcus epidermidis 12 Transportation facilities 
S 
S 





155 Staphylococcus epidermidis  Restaurants R S S 
                
280 Staphylococcus epidermidis 13 Hands 
S R 
R 





111 Staphylococcus epidermidis  Baby care facilities S S S 
                
216 Staphylococcus epidermidis 14 Transportation facilities 
S R 
S 





274 Staphylococcus epidermidis  Hands R S R 
                
189 Staphylococcus epidermidis 15 Supermarkets 
S R R 
R R R 
R S R 
S 
S S 
270 Staphylococcus epidermidis  Hands S S S R 
                
247 Staphylococcus epidermidis 16 Hands 







233 Staphylococcus epidermidis  Handbags I S R R 
                








168 Staphylococcus epidermidis  Restaurants S R S R 
                
230 Staphylococcus epidermidis 18 Transportation facilities 
S 
R R 
S S S R S 
R I 
S S 
114 Staphylococcus epidermidis  Baby care facilities S S S R 
                










272 Staphylococcus epidermidis  Hands R I R R 
Note: A: amoxicillin (10 µg); CEF: cefepime (30 µg); C: chloramphenicol (30 µg); E: erythromycin (5 µg); FC: fusidic acid (10 µg); GM: gentamicin 
(10 µg); MUP: mupirocin (20 µg); OX: Oxacillin (1 µg);  PG: penicillin G (1 unit); S: streptomycin (10 µg);  T: tetracycline  (10 µg);  VAN: 





ID Species Cluster Sites OX PG  VAN  MUP  CEF  GM  FC  S  A  E  T   C 
162 Staphylococcus epidermidis 20 Restaurants 
S R 
S S S 
S 
S 
S S S S 
S 
290 Staphylococcus epidermidis  Hands R I R R R 
                




S S S S 
S S R S 
236 Staphylococcus epidermidis  Handbags S R R R R R 
                




S S R S 
R S S 
S 
128 Staphylococcus epidermidis  Hotels S R R R S R R 
                
134 Staphylococcus epidermidis 23 Library 
R R S S S S R R R R R S 
135 Staphylococcus epidermidis  Library 
                
215 Staphylococcus epidermidis 24 Transportation facilities 
S S S S S S R S S S S S 
219 Staphylococcus epidermidis  Transportation facilities 
                
207 Staphylococcus epidermidis 25 Transportation facilities 
S S 
S 
S S S R S S S S S 
213 Staphylococcus epidermidis  Transportation facilities R 
                
208 Staphylococcus epidermidis 26 Transportation facilities 
S S S S S S 
S 
S S R S S 
212 Staphylococcus epidermidis  Transportation facilities R 
                
171 Staphylococcus epidermidis 27 Restaurants 
S R S S S S 
S 
S S S S S 
151 Staphylococcus epidermidis  Restaurants R 
                
304 Staphylococcus epidermidis 28 Hands 
S R S S S S R S S 
S 
S S 
289 Staphylococcus epidermidis  Hands R 
Note: A: amoxicillin (10 µg); CEF: cefepime (30 µg); C: chloramphenicol (30 µg); E: erythromycin (5 µg); FC: fusidic acid (10 µg); GM: gentamicin 
(10 µg); MUP: mupirocin (20 µg); OX: Oxacillin (1 µg);  PG: penicillin G (1 unit); S: streptomycin (10 µg);  T: tetracycline  (10 µg);  VAN: 





ID Species Cluster Sites OX PG  VAN  MUP  CEF  GM  FC  S  A  E  T   C 
263 Staphylococcus epidermidis 29 Hands 
S R S S S S R R R 
S R 
S 
251 Staphylococcus epidermidis  Hands R S 
                
227 Staphylococcus epidermidis 30 Transportation facilities 





225 Staphylococcus epidermidis  Transportation facilities S R 
                
291 Staphylococcus epidermidis 31 Hands 
S R 
S S 
S S R 
R 
S S S S 
292 Staphylococcus epidermidis  Hands R R S 
                
249 Staphylococcus epidermidis 32 Hands 
S 
R R S S S 
R R S S 
R 
S 
253 Staphylococcus epidermidis  Hands S S R I R S 
                
258 Staphylococcus epidermidis 33 Hands 
S 






248 Staphylococcus epidermidis  Hands R S R I S S S 
                






S S S 
S 
139 Staphylococcus epidermidis  Restaurants R R R S R R R R 
                





S R S S 
S 
S S 
345 Staphylococcus haemolyticus  Hotels S S R I 
                
332 Staphylococcus haemolyticus 2 Hotels 
S S S S 
R 
S S S 
R I R 
S 
312 Staphylococcus haemolyticus  Baby care facilities S S S S 
                
362 Staphylococcus haemolyticus 3 Library R 





R S S 
S 
337 Staphylococcus haemolyticus  Hotels S R R S I R 
Note: A: amoxicillin (10 µg); CEF: cefepime (30 µg); C: chloramphenicol (30 µg); E: erythromycin (5 µg); FC: fusidic acid (10 µg); GM: gentamicin 
(10 µg); MUP: mupirocin (20 µg); OX: Oxacillin (1 µg);  PG: penicillin G (1 unit); S: streptomycin (10 µg);  T: tetracycline  (10 µg);  VAN: 





ID Species Cluster Sites OX PG  VAN  MUP  CEF  GM  FC  S  A  E  T   C 









390 Staphylococcus haemolyticus  Hands R I R R R R R 
               
382 Staphylococcus haemolyticus 5 Hands S 
R 




R S S 
320 Staphylococcus haemolyticus  Hotels R R R R I S R R 
                




S S R I S 
S 
379 Staphylococcus haemolyticus  Hotel air samples R R R R R S R R 
                
364 Staphylococcus haemolyticus 7 Library 
S S R S I S 
R 
R S S S S 
366 Staphylococcus haemolyticus  Library S 
                
361 Staphylococcus haemolyticus 8 Library 
S S 
S 
S I S 
R 
R S S 
R 
S 
363 Staphylococcus haemolyticus  Library R S S 
                
368 Staphylococcus haemolyticus 9 Library 
S 
S S 





365 Staphylococcus haemolyticus  Library R R R S S 
                









347 Staphylococcus haemolyticus  Hotels S R S S R R 
                
339 Staphylococcus haemolyticus 11 Hotels 
S 
R R 
S S S 




340 Staphylococcus haemolyticus  Hotels S S S S S R 
                




S S S I 
R S R 
S 
317 Staphylococcus haemolyticus  Hotels R R R R R R R 
Note: A: amoxicillin (10 µg); CEF: cefepime (30 µg); C: chloramphenicol (30 µg); E: erythromycin (5 µg); FC: fusidic acid (10 µg); GM: gentamicin 
(10 µg); MUP: mupirocin (20 µg); OX: Oxacillin (1 µg);  PG: penicillin G (1 unit); S: streptomycin (10 µg);  T: tetracycline  (10 µg);  VAN: 





ID Species Cluster Sites OX PG  VAN  MUP  CEF  GM  FC  S  A  E  T   C 
39 Staphylococcus capitis 1 Restaurants 
S R S S S S R S S S S S 
61 Staphylococcus capitis  Transportation facilities 
                
30 Staphylococcus capitis 2 Library 
S S S 
S 





16 Staphylococcus capitis  Baby care facilities R S S 
                
18 Staphylococcus capitis 3 Baby care facilities 






S S S 
19 Staphylococcus capitis  Hotels R S S 
                
37 Staphylococcus capitis 4 Restaurants 
S S 
S 





88 Staphylococcus capitis  Hands R S R 
                





S S S 
R 
S 
92 Staphylococcus capitis  Hands R I S S 
                







S S S S S 
26 Staphylococcus capitis  Hotels S R I S 
                










87 Staphylococcus capitis  Hands R I R R 
                










69 Staphylococcus capitis  Hands R S R R R 
                
75 Staphylococcus capitis 9 Hands R R 






27 Staphylococcus capitis  Hotels S S S R R 
Note: A: amoxicillin (10 µg); CEF: cefepime (30 µg); C: chloramphenicol (30 µg); E: erythromycin (5 µg); FC: fusidic acid (10 µg); GM: gentamicin 
(10 µg); MUP: mupirocin (20 µg); OX: Oxacillin (1 µg);  PG: penicillin G (1 unit); S: streptomycin (10 µg);  T: tetracycline  (10 µg);  VAN: 





ID Species Cluster Sites OX PG  VAN  MUP  CEF  GM  FC  S  A  E  T   C 










76 Staphylococcus capitis  Hands S I S R S 
                
93 Staphylococcus capitis 11 Hands 
S R 
R R R 
S 
R S R 
S S 
R 
28 Staphylococcus capitis  Hotels S S S S R S S 
                
90 Staphylococcus capitis 12 Hands 
S 
R 
S S S S R 
S 
S S S S 
84 Staphylococcus capitis  Hands S R 
                
56 Staphylococcus capitis 13 Transportation facilities 




S S S S S 
58 Staphylococcus capitis  Transportation facilities I R 
                
71 Staphylococcus capitis 14 Hands R 
S S S S S S 
R S 
S S S 
80 Staphylococcus capitis  Hands S S R 
                
21 Staphylococcus capitis 15 Hotels 
S 





22 Staphylococcus capitis  Hotels R S S S S S S S S 
                
681 Staphylococcus warneri 1 Restaurants 
S R S S S S S S S S 
S 
S 
712 Staphylococcus warneri  Hands R 
                
711 Staphylococcus warneri 2 Hands 





653 Staphylococcus warneri  Hotels S I R 
                
690 Staphylococcus warneri 3 Transportation facilities 




S R S 
S 
S 
663 Staphylococcus warneri  Hotels I S R 
Note: A: amoxicillin (10 µg); CEF: cefepime (30 µg); C: chloramphenicol (30 µg); E: erythromycin (5 µg); FC: fusidic acid (10 µg); GM: gentamicin 
(10 µg); MUP: mupirocin (20 µg); OX: Oxacillin (1 µg);  PG: penicillin G (1 unit); S: streptomycin (10 µg);  T: tetracycline  (10 µg);  VAN: 





ID Species Cluster Sites OX PG  VAN  MUP  CEF  GM  FC  S  A  E  T   C 
671 Staphylococcus warneri 4 Library 







649 Staphylococcus warneri  Baby care facilities I R S R 
                
684 Staphylococcus warneri 5 Transportation facilities 
S R 




661 Staphylococcus warneri  Hotels S S R S R R 
                
679 Staphylococcus warneri 6 Restaurants 
S R 
S 
S S R 
R 
S S R 
R 
S 
677 Staphylococcus warneri  Restaurants R S S 
                
706 Staphylococcus warneri 7 Hands 
S S S S R S R R 
S S S 
S 
708 Staphylococcus warneri  Hands R R R 
                
688 Staphylococcus warneri 8 Transportation facilities 
S 
R 
S S S S R S 
R R 
S S 
693 Staphylococcus warneri  Transportation facilities S S S 
                
672 Staphylococcus warneri 9 Library 





674 Staphylococcus warneri  Library S S S 
                
685 Staphylococcus warneri 10 Transportation facilities 
S 
R R R 
S 
R S R 
R S S S 
691 Staphylococcus warneri  Transportation facilities S S S S R S 
Note: A: amoxicillin (10 µg); CEF: cefepime (30 µg); C: chloramphenicol (30 µg); E: erythromycin (5 µg); FC: fusidic acid (10 µg); GM: 
gentamicin (10 µg); MUP: mupirocin (20 µg); OX: Oxacillin (1 µg);  PG: penicillin G (1 unit); S: streptomycin (10 µg);  T: tetracycline  (10 
µg);  VAN: vancomycin (5 µg). 
